data_2mus_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mus _Structure_validation_residue.Date_analyzed 2017-01-27 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.58 0.228 . . . . 10.0 110.776 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -112.22 128.43 56.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.799 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 263' ' ' SER . 30.1 m -152.15 159.06 43.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 10.0 111.495 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.56 43.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.142 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.54 -61.62 1.37 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.684 0.278 . . . . 10.0 111.262 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.74 131.84 33.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.833 0.349 . . . . 10.0 111.058 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.8 mt -127.07 128.32 70.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.835 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -114.75 99.26 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.214 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.7 122.09 46.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.731 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.705 0.288 . . . . 10.0 111.417 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.496 ' HB3' ' H ' ' A' ' 271' ' ' GLY . 7.6 tp10 63.89 72.06 0.47 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.455 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.5 mtm-85 55.91 32.73 20.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.439 -0.8 . . . . 10.0 111.713 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.65 159.24 17.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.337 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -137.31 147.97 46.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.623 -0.262 . . . . 10.0 110.575 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.57 141.72 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.518 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -134.86 138.3 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.6 tp -125.14 128.79 48.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.932 0.396 . . . . 10.0 110.99 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.35 -110.09 0.75 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.856 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -156.76 156.6 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.5 t -125.47 121.78 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.798 0.333 . . . . 10.0 110.611 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.06 101.61 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.689 -0.485 . . . . 10.0 109.689 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.463 HG21 ' H ' ' A' ' 248' ' ' ALA . 94.2 m -74.09 145.37 44.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.23 8.66 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.463 ' H ' HG21 ' A' ' 246' ' ' THR . . . -80.29 -6.59 58.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.846 0.355 . . . . 10.0 110.935 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -121.05 38.82 3.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.327 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.3 mm? 72.81 -167.65 0.12 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.249 -0.887 . . . . 10.0 111.067 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -78.54 -174.61 3.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.615 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.92 71.07 2.64 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.487 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.15 -45.54 96.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.905 -0.665 . . . . 10.0 111.542 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 75.5 mt 70.33 138.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.314 0.646 . . . . 10.0 111.752 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 66.87 90.1 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.687 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.87 -45.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.813 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 -86.75 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 55.4 t0 60.22 79.64 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.389 0.614 . . . . 10.0 109.978 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.49 24.1 10.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.925 -0.579 . . . . 10.0 111.563 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 7.7 t -148.94 148.11 29.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.496 . . . . 10.0 111.476 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 118.54 30.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.849 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -115.09 105.82 13.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.389 -0.368 . . . . 10.0 110.157 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 227' ' ' SER . 70.7 m -140.32 135.16 31.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 10.0 110.78 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.93 145.99 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.766 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.17 -70.87 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.03 0.381 . . . . 10.0 112.03 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 125.29 47.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 10.0 112.581 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 16.9 t -121.15 119.81 60.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.657 . . . . 10.0 109.579 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.88 119.89 60.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.701 0.286 . . . . 10.0 110.95 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.48 107.29 0.91 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.557 -0.617 . . . . 10.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -126.9 124.77 40.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.091 0.472 . . . . 10.0 111.187 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.496 ' H ' ' HB3' ' A' ' 235' ' ' GLU . . . 93.32 73.83 1.24 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.872 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 54.66 36.63 26.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.594 0.358 . . . . 10.0 111.846 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.1 m -86.46 150.18 24.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.226 0.536 . . . . 10.0 110.876 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -119.85 124.82 47.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.646 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.24 113.74 44.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.235 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.38 111.54 22.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.755 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.06 86.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.962 0.41 . . . . 10.0 109.919 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.23 170.92 22.67 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.216 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -92.99 151.83 19.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.737 0.303 . . . . 10.0 110.51 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.22 158.71 25.47 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.056 0.455 . . . . 10.0 110.817 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.11 101.27 5.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 10.0 108.942 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -151.22 165.91 30.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.789 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -137.92 -16.99 0.65 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.163 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -72.67 -37.0 68.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.252 0.548 . . . . 10.0 110.035 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -164.98 156.53 28.56 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.671 -0.972 . . . . 10.0 110.671 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -80.86 74.95 7.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.393 0.596 . . . . 10.0 110.671 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 21.4 t90 69.59 -58.36 0.52 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.089 0.868 . . . . 10.0 111.71 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -142.65 96.29 2.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.864 0.364 . . . . 10.0 110.646 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -166.3 125.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.085 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -150.56 21.11 0.82 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.511 0.672 . . . . 10.0 109.853 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -75.56 144.12 42.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.633 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.12 32.23 3.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.528 -0.76 . . . . 10.0 109.326 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -103.32 120.56 41.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.265 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -95.26 142.84 27.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.821 0.343 . . . . 10.0 110.425 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 p80 . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.051 179.361 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' B' ' 261' ' ' THR . 39.3 ttm180 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.436 HD22 ' HA2' ' B' ' 278' ' ' GLY . 85.0 m-20 -117.89 152.94 34.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 10.0 110.807 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 48.9 m -147.13 91.96 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.122 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -97.04 161.75 13.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' B' ' 265' ' ' LYS . 14.4 mttm -123.2 -72.53 0.68 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.008 -0.277 . . . . 10.0 111.741 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -127.74 114.19 16.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.148 0.499 . . . . 10.0 111.13 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 77.6 mt -118.62 123.83 72.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.886 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -118.67 124.27 46.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.419 0.628 . . . . 10.0 111.451 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.58 123.26 40.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.948 -1.023 . . . . 10.0 110.135 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -138.48 162.95 33.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 10.0 110.904 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.71 62.77 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.249 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 60.16 26.62 16.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -78.62 157.57 28.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.037 0.446 . . . . 10.0 110.923 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 135.48 35.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.522 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.16 138.92 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.972 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -126.4 131.77 51.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.093 0.473 . . . . 10.0 110.166 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.1 100.7 10.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.73 -177.99 29.29 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -95.8 157.96 15.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.401 . . . . 10.0 110.531 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.17 122.61 69.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.978 0.418 . . . . 10.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.25 124.71 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 72.8 p -93.75 174.02 7.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 10.0 112.022 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.17 -20.06 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.546 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.8 -19.33 57.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.284 0.564 . . . . 10.0 110.249 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -86.68 -4.05 59.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.342 -0.845 . . . . 10.0 110.398 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.62 118.14 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.739 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.84 62.47 1.05 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.839 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -135.19 -142.89 4.65 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.924 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.12 91.2 0.6 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.344 -0.702 . . . . 10.0 111.344 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 16.6 mt -79.59 -27.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.277 0.473 . . . . 10.0 112.277 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -116.55 111.24 19.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.944 0.402 . . . . 10.0 111.099 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 14.7 pt -137.03 40.83 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.23 50.1 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.428 -0.806 . . . . 10.0 111.44 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -84.98 63.85 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.554 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -92.69 103.72 16.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.574 . . . . 10.0 110.385 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' THR . . . . . 0.556 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 13.4 t -167.45 150.44 6.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 10.0 111.571 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 31.7 m -118.56 117.96 30.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.141 -0.936 . . . . 10.0 108.908 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -99.4 100.9 12.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.212 0.529 . . . . 10.0 110.387 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.5 m -106.12 143.32 34.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.931 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.67 144.28 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.642 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 20.6 mttt -94.41 -80.1 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.38 0.511 . . . . 10.0 112.38 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 125.59 53.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.592 0.59 . . . . 10.0 112.592 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 87.5 t -118.58 123.71 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.652 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 5.5 t -109.74 126.46 66.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.305 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.36 98.48 0.34 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -122.36 124.18 43.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 10.0 111.258 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 98.36 58.92 0.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.565 -0.826 . . . . 10.0 112.849 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 57.07 37.68 28.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.051 0.541 . . . . 10.0 111.984 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 19.6 m -77.57 150.78 34.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.454 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.62 124.13 49.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.874 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.18 122.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.778 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -118.82 108.27 14.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.218 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.72 92.56 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.106 0.479 . . . . 10.0 110.004 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.436 ' HA2' HD22 ' B' ' 226' ' ' ASN . . . 155.93 -178.82 32.28 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.493 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -99.35 161.33 13.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.42 158.97 33.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.167 0.508 . . . . 10.0 111.091 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 1.0 OUTLIER -139.4 81.44 1.83 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.13 -0.941 . . . . 10.0 108.668 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.434 ' HA2' ' HG1' ' B' ' 246' ' ' THR . . . -118.77 -98.54 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.749 -0.66 . . . . 10.0 113.067 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.02 -37.33 2.71 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.929 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -90.45 53.72 2.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.231 0.539 . . . . 10.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.97 132.92 4.95 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' C' ' 244' ' ' VAL . 16.6 m-85 -82.4 76.0 9.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.41 0.148 . . . . 10.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' C' ' 238' ' ' ARG . 18.9 t90 70.55 -51.28 0.66 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.06 0.85 . . . . 10.0 111.529 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.61 -172.07 1.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.5 0.19 . . . . 10.0 110.797 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.21 118.71 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.217 0.532 . . . . 10.0 111.287 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 290' ' ' HIS . . . . . 0.487 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 40.0 t60 -138.9 128.72 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 291' ' ' HIS . . . . . 0.504 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 15.5 t-160 -152.51 116.75 4.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.26 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -133.29 -176.14 4.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 10.0 111.832 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -118.03 126.34 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.568 -0.742 . . . . 10.0 109.813 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -80.78 -139.6 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.469 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 295' ' ' HIS . . . . . 0.429 ' HB2' ' CE1' ' C' ' 291' ' ' HIS . 47.6 t60 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.404 -0.807 . . . . 10.0 110.013 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.556 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 13.8 ptt-85 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 6.4 m120 -128.22 141.04 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.039 0.447 . . . . 10.0 110.593 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.4 m -145.98 132.66 19.92 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.45 149.69 52.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.375 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' B' ' 265' ' ' LYS . 16.0 tttm -101.64 -67.34 0.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.241 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -124.24 120.33 31.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.835 0.35 . . . . 10.0 111.616 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.02 117.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.141 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.514 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 4.7 ttm180 -110.45 119.66 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.467 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.46 104.03 7.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.485 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.514 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 13.3 pt-20 -128.03 173.05 10.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.119 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 62.36 64.26 0.97 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.532 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' C' ' 272' ' ' GLU . 7.3 ttp180 57.23 42.91 24.6 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.268 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.41 168.76 10.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.503 -0.317 . . . . 10.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.432 ' HB2' ' CZ3' ' B' ' 287' ' ' TRP . 1.1 ptp180 -149.89 138.91 21.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.83 0.347 . . . . 10.0 110.387 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.5 138.13 52.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.286 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' B' ' 276' ' ' LEU . 2.8 tt0 -125.16 127.29 46.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.222 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -105.68 85.56 2.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.333 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.33 -169.65 42.41 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.225 -0.988 . . . . 10.0 112.34 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -100.19 155.06 17.96 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.099 -0.334 . . . . 10.0 110.099 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' B' ' 286' ' ' PHE . 41.3 t -109.77 118.64 57.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.2 t -111.74 110.51 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -81.81 166.35 20.07 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.976 -0.29 . . . . 10.0 110.43 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.78 5.1 1.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.68 -18.91 20.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.897 0.38 . . . . 10.0 110.335 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.52 88.07 5.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 10.0 110.172 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 31.1 mt -127.25 8.59 6.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.747 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -124.46 105.36 9.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.238 0.542 . . . . 10.0 110.939 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -173.35 154.3 19.93 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.341 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.0 -171.19 13.13 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.564 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.0 tt -98.05 107.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.3 0.572 . . . . 10.0 110.398 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -139.94 118.74 12.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.804 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 tt -89.73 112.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 23.1 m -143.98 -172.7 3.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.065 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.0 146.53 39.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.072 0.463 . . . . 10.0 110.606 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.08 140.09 52.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 260' ' ' THR . . . . . 0.496 ' HA ' ' OD1' ' D' ' 258' ' ' ASP . 0.4 OUTLIER -60.29 139.52 57.57 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.611 0.72 . . . . 10.0 111.25 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.13 106.54 18.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.402 -0.817 . . . . 10.0 110.64 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.7 t-20 -115.23 126.15 54.2 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -143.68 145.78 32.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.904 0.383 . . . . 10.0 111.14 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.52 143.67 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.258 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 265' ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 3.4 ttmt -85.57 -61.85 1.67 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.8 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 21.3 m -135.54 131.3 35.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.07 118.31 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.474 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 20.6 t -113.86 107.21 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.754 0.311 . . . . 10.0 110.555 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -110.3 130.05 9.67 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.16 -0.543 . . . . 10.0 112.066 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -135.02 124.52 24.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.809 0.338 . . . . 10.0 111.397 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 91.54 77.39 1.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 10.0 113.121 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' C' ' 236' ' ' ARG . 2.0 mt-10 52.33 33.82 13.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.904 0.482 . . . . 10.0 111.753 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.82 147.82 48.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.241 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -125.46 121.06 32.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.205 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.94 120.63 61.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.845 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.438 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -116.01 105.12 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.55 91.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.167 0.508 . . . . 10.0 109.86 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.9 -173.05 35.17 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.303 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.47 149.23 22.92 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.075 -0.342 . . . . 10.0 110.075 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.9 138.59 48.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.935 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 1.9 t80 -120.39 102.02 8.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -141.77 173.57 23.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.54 -0.838 . . . . 10.0 112.538 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -126.39 -28.43 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.694 -0.765 . . . . 10.0 112.394 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -94.18 76.27 4.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 10.0 109.962 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 84.87 -113.77 3.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.154 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -151.48 -157.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 11.8 t90 -43.65 -53.47 5.72 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.598 0.561 . . . . 10.0 111.66 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 288' ' ' ASP . . . . . 0.487 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.4 OUTLIER -122.54 171.0 9.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.575 -0.45 . . . . 10.0 110.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 289' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -121.3 85.82 2.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.513 0.673 . . . . 10.0 111.064 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -117.93 -44.34 2.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.397 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 291' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' B' ' 295' ' ' HIS . 1.6 t-80 -142.55 171.3 14.24 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.906 0.335 . . . . 10.0 111.906 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 54.56 96.43 0.02 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.759 -1.11 . . . . 10.0 112.688 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -101.55 -164.83 1.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.386 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -71.02 146.28 49.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.452 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 63.1 m170 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.674 -0.679 . . . . 10.0 110.361 -179.585 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . 0.626 ' HD2' ' CG ' ' D' ' 258' ' ' ASP . 1.1 tpm_? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.042 0.448 . . . . 10.0 110.488 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' D' ' 262' ' ' ASN . 15.7 m120 -104.12 135.52 45.45 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 27.6 m -145.71 135.45 23.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.783 0.325 . . . . 10.0 111.014 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.47 131.46 43.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.011 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' C' ' 265' ' ' LYS . 85.2 tttt -81.52 -69.98 0.57 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.737 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 124.75 39.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.437 . . . . 10.0 111.824 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.47 126.78 71.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.368 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' D' ' 232' ' ' ARG . 3.7 mmm180 -118.21 121.04 39.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.6 -0.273 . . . . 10.0 110.384 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 233' ' ' THR . . . . . 0.449 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 2.2 p -125.27 117.14 23.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.745 0.307 . . . . 10.0 110.635 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -129.34 149.04 51.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 10.0 111.8 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 67.21 80.6 0.21 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.116 -0.947 . . . . 10.0 112.658 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 57.51 16.25 3.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.397 -0.82 . . . . 10.0 112.731 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.42 152.53 36.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.662 0.268 . . . . 10.0 111.022 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.86 154.32 48.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.199 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.57 136.21 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.875 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -122.95 129.4 51.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.403 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.42 90.73 3.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.597 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 177.5 -106.95 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.187 -1.006 . . . . 10.0 112.67 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -171.67 158.02 4.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.72 108.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.0 0.428 . . . . 10.0 111.335 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 17.6 t -104.72 108.39 24.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 246' ' ' THR . . . . . 0.568 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 72.6 p -87.05 162.05 17.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.009 -0.541 . . . . 10.0 111.983 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.62 -5.34 42.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.687 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.386 0.612 . . . . 10.0 110.075 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -93.17 166.77 12.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.274 -0.876 . . . . 10.0 110.001 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 6.3 tp -155.09 -169.8 3.29 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -76.77 70.59 3.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 10.0 110.924 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -166.78 74.82 0.14 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 99.95 0.02 56.25 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.505 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.23 -24.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.028 0.442 . . . . 10.0 111.505 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.81 70.67 9.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.498 . . . . 10.0 110.178 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 256' ' ' ILE . . . . . 0.413 HD13 HG22 ' D' ' 256' ' ' ILE . 14.5 tt -58.42 -25.62 28.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.334 -0.848 . . . . 10.0 111.558 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m 63.38 -153.33 0.33 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.541 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 258' ' ' ASP . . . . . 0.626 ' CG ' ' HD2' ' D' ' 225' ' ' ARG . 1.3 m-20 -107.89 111.33 23.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 10.0 110.139 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -111.6 -87.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.2 t -87.59 159.37 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.067 0.46 . . . . 10.0 111.455 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 17.1 m -110.25 123.14 49.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.866 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . 0.478 ' HB2' ' ND2' ' D' ' 226' ' ' ASN . 15.2 m120 -114.5 107.89 16.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 18.1 m -125.9 116.29 21.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.837 0.351 . . . . 10.0 110.862 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.52 143.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 265' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 17.4 mmtp -95.88 -52.92 3.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.048 0.759 . . . . 10.0 113.048 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.14 121.96 36.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.74 113.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.683 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.28 125.29 74.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.832 0.349 . . . . 10.0 110.835 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -135.86 129.31 4.92 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.963 -0.562 . . . . 10.0 112.047 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -139.38 130.32 26.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.026 0.441 . . . . 10.0 111.433 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.34 81.39 0.79 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.294 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' E' ' 236' ' ' ARG . 1.4 tm-20 58.13 74.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.332 0.587 . . . . 10.0 110.193 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 273' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 4.0 m -125.85 140.38 52.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.437 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.77 121.4 36.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.75 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.064 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.75 105.77 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.147 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 19.2 mm -108.61 95.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.883 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.7 -177.89 33.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.102 -0.57 . . . . 10.0 112.18 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.59 164.24 12.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.635 0.255 . . . . 10.0 110.404 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.71 134.22 50.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -125.4 118.36 25.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.543 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . 0.568 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 153.92 -178.13 31.0 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.282 -0.961 . . . . 10.0 113.405 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.21 47.75 1.01 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.766 -0.534 . . . . 10.0 111.766 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -92.82 4.84 53.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.461 0.648 . . . . 10.0 109.881 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 83.86 -56.52 5.05 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . 0.447 ' CE1' HG22 ' E' ' 244' ' ' VAL . 0.8 OUTLIER -172.88 143.0 1.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . 0.471 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 44.0 t90 -48.75 -66.73 0.35 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.252 0.345 . . . . 10.0 111.787 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 288' ' ' ASP . . . . . 0.471 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 16.9 t0 -149.32 115.04 5.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.109 0.48 . . . . 10.0 110.302 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -136.02 173.8 11.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.671 . . . . 10.0 109.187 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -85.44 -56.95 3.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.528 0.204 . . . . 10.0 110.803 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -159.4 -168.52 2.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 10.0 111.216 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -92.54 -165.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.169 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -66.73 123.32 19.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 10.0 110.378 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -108.43 160.24 16.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.309 -0.853 . . . . 10.0 109.797 179.595 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.565 0.221 . . . . 10.0 110.484 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -119.61 120.84 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.083 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.89 149.04 50.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.549 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 133.44 24.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.148 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -68.83 0.76 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.622 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' E' ' 266' ' ' THR . 28.4 t70 -124.69 125.3 43.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 10.0 112.098 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 62.4 mt -128.49 124.05 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.113 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -120.76 121.02 37.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.781 0.324 . . . . 10.0 110.336 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 233' ' ' THR . . . . . 0.591 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 3.1 p -129.99 108.85 10.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.665 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.53 152.92 46.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.967 0.358 . . . . 10.0 111.967 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 66.18 79.89 0.23 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.527 -0.761 . . . . 10.0 112.114 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' D' ' 272' ' ' GLU . 13.2 ttp180 53.35 67.02 1.07 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.165 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' D' ' 273' ' ' SER . . . -129.99 162.28 29.04 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.169 -0.923 . . . . 10.0 110.675 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.54 146.77 28.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.349 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.28 122.99 61.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.359 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -120.52 118.51 30.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.775 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.75 100.18 8.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.019 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . 0.539 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 169.73 -173.71 43.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . 0.566 ' HB2' ' OD1' ' E' ' 279' ' ' ASN . 5.7 p-10 -111.02 144.21 40.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.87 0.367 . . . . 10.0 110.262 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . 0.447 HG22 ' CE1' ' D' ' 286' ' ' PHE . 55.1 t -98.5 130.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.987 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.77 110.6 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.529 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -61.0 164.05 5.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.011 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.12 -19.9 63.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.374 0.509 . . . . 10.0 112.374 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.29 -11.66 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.843 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.89 -155.56 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.943 -0.571 . . . . 10.0 111.137 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.34 142.56 27.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -82.36 62.59 6.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.44 0.638 . . . . 10.0 109.779 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 106.44 -170.23 16.2 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.1 80.55 1.54 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.477 -0.868 . . . . 10.0 111.901 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.54 -0.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.421 0.629 . . . . 10.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.26 73.32 0.98 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 10.0 110.489 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.8 pt -81.63 96.01 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 10.9 m -127.18 150.33 49.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.528 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.49 125.42 31.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.432 0.634 . . . . 10.0 110.245 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -124.94 46.12 2.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.575 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.1 t -149.21 141.47 24.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.002 0.429 . . . . 10.0 110.713 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 8.1 m -114.93 111.69 21.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.097 -0.502 . . . . 10.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -128.82 98.9 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.403 . . . . 10.0 110.465 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 9.9 m -107.83 117.55 34.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.173 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 15.5 t -100.32 126.57 53.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.415 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 265' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -82.61 -73.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.675 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 266' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' E' ' 230' ' ' ASP . 88.9 m -144.9 120.39 10.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.944 0.402 . . . . 10.0 111.435 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.15 121.38 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.088 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.3 t -116.08 128.85 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.146 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.26 124.37 3.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.047 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -124.91 111.75 15.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.032 0.444 . . . . 10.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.4 92.77 1.73 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.342 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.62 55.69 2.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.217 0.532 . . . . 10.0 110.38 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 127.1 42.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 5.8 mtm105 -119.8 106.96 12.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.003 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.1 111.67 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.37 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.68 106.58 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.125 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.4 mm -114.52 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.222 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 168.45 -135.3 3.56 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.381 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' E' ' 243' ' ' ASN . 0.1 OUTLIER -118.97 137.57 53.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.722 0.296 . . . . 10.0 110.814 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 4.4 pt-20 -97.41 126.64 42.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' E' ' 244' ' ' VAL . 24.1 t80 -164.6 93.24 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.33 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.01 -90.8 0.4 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.279 -0.962 . . . . 10.0 112.964 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 283' ' ' GLY . . . . . 0.528 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 153.03 28.55 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.172 -0.537 . . . . 10.0 112.316 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.79 -65.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 10.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.95 23.47 1.16 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.373 -0.918 . . . . 10.0 113.219 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -152.31 106.76 3.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER 73.43 7.87 5.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.244 1.021 . . . . 10.0 108.345 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 288' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.7 OUTLIER -154.14 169.69 22.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.619 -1.628 . . . . 10.0 107.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -159.62 163.93 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.764 0.316 . . . . 10.0 110.846 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 290' ' ' HIS . . . . . 0.528 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 1.6 p-80 -158.37 -179.76 8.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.505 -0.771 . . . . 10.0 109.784 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -85.88 -73.0 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 64.6 t60 70.9 155.52 0.15 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.953 0.783 . . . . 10.0 111.392 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -111.63 128.46 56.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.578 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.98 142.25 31.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.888 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 . . . . . 0 C--O 1.246 0.884 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.33 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.986 -0.375 . . . . 10.0 109.986 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -114.03 136.72 52.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.029 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.06 132.75 28.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 10.0 110.946 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.3 164.32 17.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.192 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 265' ' ' LYS . 47.4 tttm -125.59 -69.09 0.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.848 0.356 . . . . 10.0 111.169 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -128.36 124.37 36.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.055 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.1 mt -136.72 131.55 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.334 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -129.38 111.69 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.206 0.527 . . . . 10.0 110.485 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -109.94 124.36 51.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.382 -0.826 . . . . 10.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -140.69 157.39 45.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.823 0.344 . . . . 10.0 111.375 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.8 72.64 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.484 -0.78 . . . . 10.0 111.514 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 56.57 35.97 26.87 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.315 -0.857 . . . . 10.0 111.703 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.6 149.24 22.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.121 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -132.97 145.71 51.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.922 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 2.6 p -136.81 125.29 34.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.194 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -125.57 130.96 52.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.868 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.21 122.74 48.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.416 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.51 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 144.64 -165.17 27.63 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.67 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -95.69 142.98 27.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 10.0 110.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.36 98.5 6.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.364 0.602 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.38 121.01 46.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.181 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 m -97.06 151.21 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.578 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.71 -12.89 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.112 0.482 . . . . 10.0 111.428 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -81.94 4.22 23.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.803 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -141.24 59.09 1.52 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.703 -0.68 . . . . 10.0 109.918 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 70.04 -160.12 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.425 -0.807 . . . . 10.0 111.415 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -95.45 -174.42 3.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.991 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.54 2.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.294 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.71 -43.36 99.36 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.812 -0.515 . . . . 10.0 111.812 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 70.5 mt 71.98 133.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 122.996 0.519 . . . . 10.0 111.734 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 62.9 88.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.377 -0.828 . . . . 10.0 111.619 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.18 -56.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.773 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.1 p -118.33 -86.45 0.64 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.04 0.385 . . . . 10.0 112.04 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.6 t70 63.06 84.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.716 0.635 . . . . 10.0 110.289 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -129.16 13.51 6.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.081 -0.508 . . . . 10.0 111.342 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 4.9 t -145.29 134.98 23.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.377 0.608 . . . . 10.0 111.549 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -85.37 116.57 23.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.712 . . . . 10.0 109.58 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -100.03 120.56 40.02 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.813 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.0 p -137.21 128.22 27.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.087 0.47 . . . . 10.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.93 136.21 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 229' ' ' LYS . 71.6 mmtt -93.12 -56.79 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.811 0.671 . . . . 10.0 112.811 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.77 128.91 44.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.706 0.632 . . . . 10.0 112.706 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.04 129.07 67.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.306 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.7 124.07 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.374 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.34 118.15 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.191 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -134.89 115.27 13.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.15 79.65 1.47 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.697 -0.763 . . . . 10.0 113.485 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 59.0 29.28 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.487 0.551 . . . . 10.0 112.487 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 5.5 m -77.94 141.65 38.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.402 0.62 . . . . 10.0 111.563 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -119.26 120.23 36.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.761 . . . . 10.0 109.505 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 48.5 t -113.92 118.02 57.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.242 -0.436 . . . . 10.0 110.68 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.93 116.55 27.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.404 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.24 95.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.75 160.39 9.48 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.686 -0.768 . . . . 10.0 112.069 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -77.18 148.94 35.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.74 0.305 . . . . 10.0 110.934 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 164.58 14.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.112 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -139.89 106.36 5.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.617 -0.719 . . . . 10.0 109.772 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -166.15 148.55 13.81 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.59 -0.814 . . . . 10.0 113.158 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -129.5 7.27 6.25 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.655 -0.784 . . . . 10.0 112.661 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -97.55 -13.35 21.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.674 . . . . 10.0 110.031 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.0 145.55 5.08 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.679 -0.968 . . . . 10.0 110.679 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -77.83 96.1 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.694 0.247 . . . . 10.0 110.618 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.406 ' CZ3' ' HB2' ' B' ' 238' ' ' ARG . 7.0 t90 67.9 -70.52 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.859 0.724 . . . . 10.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -167.07 96.22 0.5 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.667 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -162.67 119.24 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.318 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -122.36 106.01 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.701 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -116.55 143.57 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.288 -0.414 . . . . 10.0 109.948 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -153.55 21.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.835 -0.166 . . . . 10.0 111.359 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -127.53 124.85 39.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 10.0 111.581 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 154.48 41.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.288 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' HIS . . . . . 0.407 ' HB2' ' NH2' ' D' ' 236' ' ' ARG . 20.3 p-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.129 -0.939 . . . . 10.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -120.6 133.77 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.233 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' B' ' 263' ' ' SER . 16.3 m -130.85 111.33 12.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.915 0.388 . . . . 10.0 111.301 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -110.16 130.29 55.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.629 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' B' ' 265' ' ' LYS . 0.0 OUTLIER -86.36 -68.92 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.92 120.43 16.05 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.964 0.412 . . . . 10.0 111.196 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.81 131.12 67.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 10.0 111.141 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' B' ' 232' ' ' ARG . 12.1 mmt85 -114.53 112.4 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.245 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.42 112.47 18.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.721 0.296 . . . . 10.0 110.974 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -133.13 150.72 52.02 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.507 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 67.89 81.04 0.2 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.443 -0.799 . . . . 10.0 113.128 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 32.8 mtm-85 54.99 22.95 4.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.196 0.598 . . . . 10.0 112.082 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -80.08 154.27 28.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.338 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.406 ' HB2' ' CZ3' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -137.49 138.25 39.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.925 -0.579 . . . . 10.0 110.379 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.74 131.37 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.112 0.482 . . . . 10.0 110.662 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -120.97 131.17 54.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.345 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' B' ' 277' ' ' ILE . 3.4 mm? -104.88 104.6 14.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.474 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.98 178.33 21.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.35 -0.929 . . . . 10.0 112.673 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -93.26 147.54 22.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.728 0.299 . . . . 10.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.54 131.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.675 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.44 113.46 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.104 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 44.4 p -90.28 171.37 9.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.381 . . . . 10.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.9 -10.23 51.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.2 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.82 -14.21 60.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.06 -6.71 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.221 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.38 114.11 3.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.535 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 23.4 t60 60.18 56.86 3.15 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.841 0.713 . . . . 10.0 110.533 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -136.34 -111.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.624 -0.717 . . . . 10.0 111.462 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.57 166.9 24.69 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.22 -0.752 . . . . 10.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 117.059 0.429 . . . . 10.0 111.057 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.25 106.92 19.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.89 0.376 . . . . 10.0 110.639 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 4.3 pt -136.5 61.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.298 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.9 m 67.34 29.52 7.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.213 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -81.14 79.41 7.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.569 0.699 . . . . 10.0 111.027 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.89 85.81 2.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.622 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.9 t -138.17 176.82 8.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.032 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.9 m -140.02 113.27 8.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.144 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -100.59 121.74 42.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.901 0.382 . . . . 10.0 110.695 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' B' ' 227' ' ' SER . 1.9 m -134.54 137.03 43.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.48 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.6 p -137.41 138.87 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.347 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 23.4 mttt -86.46 -80.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.82 120.77 42.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.2 t -115.99 105.32 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.538 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.24 113.19 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.464 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.07 134.09 9.05 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.44 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -144.81 141.06 28.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.317 -0.253 . . . . 10.0 110.317 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.73 69.07 1.43 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.198 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 59.87 42.18 16.81 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.797 0.439 . . . . 10.0 111.659 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.5 t -69.41 137.52 52.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.185 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -115.66 102.16 9.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.015 -0.539 . . . . 10.0 109.63 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 7.7 t -102.06 122.26 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.843 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.426 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -119.77 115.25 23.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.268 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.419 ' HB ' HD11 ' B' ' 241' ' ' LEU . 13.0 mm -104.5 83.57 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.819 0.342 . . . . 10.0 110.634 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.03 174.34 27.61 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.285 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -90.22 164.7 14.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.61 165.27 19.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.899 0.38 . . . . 10.0 110.099 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 2.4 t80 -143.58 78.94 1.61 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.334 -0.848 . . . . 10.0 108.834 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -112.62 -122.75 4.05 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.694 -0.765 . . . . 10.0 113.162 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 155.31 -61.95 0.36 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.303 -0.719 . . . . 10.0 111.303 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -83.67 74.49 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.58 121.15 3.85 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.388 -1.085 . . . . 10.0 110.388 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -83.49 79.27 9.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.939 0.37 . . . . 10.0 111.327 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' B' ' 276' ' ' LEU . 21.0 t90 71.28 -48.28 0.67 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.199 0.937 . . . . 10.0 112.255 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -127.7 -175.62 3.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.899 0.381 . . . . 10.0 110.432 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -92.71 131.84 37.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.998 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -164.34 91.24 0.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.12 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -130.09 130.14 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.03 -0.532 . . . . 10.0 109.632 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.93 -173.08 4.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.588 0.232 . . . . 10.0 111.133 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -111.81 132.45 54.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.98 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -87.15 -177.01 5.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.437 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.285 -0.864 . . . . 10.0 110.134 179.731 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.582 0.229 . . . . 10.0 110.409 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . 0.412 ' HB3' HG23 ' C' ' 277' ' ' ILE . 15.5 m120 -126.51 103.4 7.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 133.51 52.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.13 0.491 . . . . 10.0 111.871 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -130.11 122.28 27.97 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.037 -0.727 . . . . 10.0 109.037 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' C' ' 265' ' ' LYS . 48.8 tttm -82.69 -80.87 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.395 0.517 . . . . 10.0 112.395 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' C' ' 266' ' ' THR . 0.2 OUTLIER -109.39 122.27 47.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.268 0.556 . . . . 10.0 111.835 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . 0.4 HG23 HD12 ' C' ' 231' ' ' ILE . 88.4 mt -127.65 137.76 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.474 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.47 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 40.0 ttm-85 -128.76 119.51 24.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.92 93.57 3.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.049 0.452 . . . . 10.0 110.355 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.47 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 6.1 pt-20 -120.01 158.68 26.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.743 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 65.68 73.17 0.4 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 10.0 111.354 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 59.31 36.62 23.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.262 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.3 156.47 17.21 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.276 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -145.82 150.56 36.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.664 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 131.16 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.408 ' HB3' HD23 ' C' ' 276' ' ' LEU . 8.6 tt0 -115.81 127.16 54.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 10.0 109.958 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.11 88.25 3.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.774 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.48 171.6 31.89 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.168 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -84.34 152.58 24.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.779 0.323 . . . . 10.0 110.324 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.12 118.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.791 0.329 . . . . 10.0 110.939 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 46.6 t -121.06 110.91 29.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.031 0.443 . . . . 10.0 110.2 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.9 p -82.6 160.4 22.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.827 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.89 -4.74 7.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.76 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.41 -15.87 44.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.188 0.518 . . . . 10.0 110.242 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -100.01 94.15 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.496 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.02 20.97 13.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.338 0.59 . . . . 10.0 109.834 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -111.15 144.18 40.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.04 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.18 134.4 3.31 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.086 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.55 171.74 14.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.921 -0.657 . . . . 10.0 111.493 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.3 tp -87.17 115.74 28.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.146 0.498 . . . . 10.0 109.746 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -160.28 149.81 17.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.005 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 tt -95.32 130.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.416 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 35.3 m -153.31 169.49 22.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.792 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 258' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' D' ' 257' ' ' SER . 0.5 OUTLIER -94.53 130.11 41.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.044 0.449 . . . . 10.0 110.108 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -115.72 145.45 42.76 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.345 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.5 t -55.24 135.84 49.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.317 0.579 . . . . 10.0 111.013 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 56.0 m -96.41 139.28 32.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.951 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 20.7 t-20 -133.65 140.34 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.674 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -154.01 139.17 17.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.802 0.334 . . . . 10.0 110.126 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.39 147.15 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 265' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 1.1 mtpt -85.46 -58.84 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.432 . . . . 10.0 112.097 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 266' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 39.9 m -141.58 128.0 20.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.25 117.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.638 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.24 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.107 0.48 . . . . 10.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.51 138.81 15.02 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.797 -0.716 . . . . 10.0 111.667 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.25 125.6 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.912 0.356 . . . . 10.0 111.493 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.44 82.99 0.99 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.921 -0.656 . . . . 10.0 113.465 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 60.55 23.68 13.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.86 0.362 . . . . 10.0 111.377 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.18 136.82 57.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.204 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -128.07 109.91 11.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.525 -0.761 . . . . 10.0 109.825 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 37.7 t -100.45 133.82 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.759 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.409 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -127.71 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.088 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' C' ' 226' ' ' ASN . 35.3 mm -105.04 95.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.379 . . . . 10.0 110.221 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.67 -171.23 33.65 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.254 -0.738 . . . . 10.0 111.254 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.24 148.1 30.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 10.0 109.801 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -106.95 142.32 36.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 111.084 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -129.31 104.32 7.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.501 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -173.93 175.83 46.45 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.684 -0.77 . . . . 10.0 112.134 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.29 -8.71 24.9 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.541 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.67 63.58 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.166 0.508 . . . . 10.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.48 -84.74 1.07 Allowed Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.064 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.42 -51.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.409 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 8.6 t90 -144.85 -67.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 288' ' ' ASP . . . . . 0.425 ' OD2' ' HD2' ' D' ' 238' ' ' ARG . 2.1 p30 -107.13 165.28 11.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.066 -0.516 . . . . 10.0 109.784 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -114.65 50.65 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.916 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -79.85 -53.19 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.473 . . . . 10.0 111.811 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.13 172.24 10.7 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.954 -0.298 . . . . 10.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 66.53 173.8 0.24 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -177.85 -153.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.347 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -76.22 157.85 32.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.607 179.346 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . 0.503 ' HB3' ' HA ' ' D' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.315 0.579 . . . . 10.0 110.372 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 12.5 m120 -99.23 138.8 35.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 227' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' D' ' 263' ' ' SER . 18.3 m -154.27 148.46 25.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.071 0.462 . . . . 10.0 111.086 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.45 134.09 31.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.802 -0.635 . . . . 10.0 109.732 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' C' ' 265' ' ' LYS . 12.6 tmtt? -86.13 -64.78 1.1 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.064 -0.255 . . . . 10.0 111.382 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.8 124.18 45.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.004 0.372 . . . . 10.0 112.004 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 55.3 mt -131.3 122.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -121.57 120.43 34.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.274 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -120.06 115.23 23.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.534 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.915 0.388 . . . . 10.0 112.029 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 62.18 90.01 0.08 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.981 1.104 . . . . 10.0 113.981 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . 0.656 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 29.8 mtt180 62.57 3.17 1.05 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.602 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.95 142.56 49.42 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.987 0.422 . . . . 10.0 111.408 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . 0.425 ' HD2' ' OD2' ' C' ' 288' ' ' ASP . 0.3 OUTLIER -133.68 150.07 51.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.412 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -136.55 137.21 47.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.883 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -115.57 140.7 48.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.375 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.7 75.77 1.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.054 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . 0.561 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . -171.19 -138.79 2.6 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.223 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -139.57 132.54 29.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.87 113.86 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.117 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.4 t -117.88 106.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 246' ' ' THR . . . . . 0.509 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 0.6 OUTLIER -81.52 158.69 24.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.229 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.87 -0.97 8.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.149 0.5 . . . . 10.0 111.38 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.95 -10.5 57.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.161 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.67 113.57 26.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.049 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 6.6 mp -111.35 -166.29 1.06 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.61 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -63.13 129.64 41.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.508 0.194 . . . . 10.0 110.6 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 133.66 50.6 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.026 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.39 18.18 8.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.432 -0.89 . . . . 10.0 112.593 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -74.26 -17.52 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.094 0.473 . . . . 10.0 111.314 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -104.69 88.48 2.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 10.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 20.0 tt -82.59 -10.59 12.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.883 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 257' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' C' ' 258' ' ' ASP . 37.7 m 61.06 -133.72 0.67 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.042 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 258' ' ' ASP . . . . . 0.438 ' OD2' ' HD2' ' D' ' 225' ' ' ARG . 2.0 t0 -122.98 137.09 55.05 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -138.57 -83.65 0.29 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.507 -0.477 . . . . 10.0 112.033 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 12.9 t -79.29 156.31 28.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.198 0.523 . . . . 10.0 111.657 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 261' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' D' ' 225' ' ' ARG . 23.3 m -111.24 118.94 37.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.231 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 4.0 m120 -120.52 106.41 11.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 263' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' D' ' 227' ' ' SER . 23.1 m -127.61 132.58 49.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.475 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' E' ' 228' ' ' ALA . 10.1 p -120.86 144.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.638 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 265' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -82.86 -51.65 7.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.802 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 50.1 m -142.54 122.22 13.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.09 122.16 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.334 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.85 123.13 67.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.135 0.493 . . . . 10.0 111.083 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.49 134.32 10.27 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -138.4 115.05 10.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.202 0.501 . . . . 10.0 111.474 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.17 93.12 0.79 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.967 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . 0.656 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 52.8 mm-40 54.94 33.3 19.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.214 0.53 . . . . 10.0 111.527 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -75.78 144.54 41.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.737 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -127.49 103.25 7.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.248 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 62.4 t -98.73 117.89 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.49 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . 0.443 ' HB2' ' CH2' ' D' ' 287' ' ' TRP . 0.6 OUTLIER -114.08 106.16 14.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.531 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 30.6 mm -102.43 86.36 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . 162.21 -171.41 38.09 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.527 -0.844 . . . . 10.0 112.365 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -113.02 162.74 15.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.275 -0.268 . . . . 10.0 110.275 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.77 142.97 49.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 10.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -135.19 116.27 14.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.209 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . 0.509 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 152.29 166.28 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.481 -0.866 . . . . 10.0 112.422 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -83.98 71.57 2.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -117.1 -5.72 11.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.095 0.474 . . . . 10.0 110.292 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.94 -54.6 4.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.069 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -163.07 144.9 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.151 -0.315 . . . . 10.0 110.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . 0.443 ' CH2' ' HB2' ' D' ' 276' ' ' LEU . 34.6 t90 -59.52 -63.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.244 0.34 . . . . 10.0 111.25 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 288' ' ' ASP . . . . . 0.462 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 60.1 t0 -146.03 115.29 7.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 10.0 109.97 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -142.87 161.83 37.08 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.93 -51.92 7.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.673 0.273 . . . . 10.0 110.7 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -156.57 -175.44 5.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.444 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -91.93 -151.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.851 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.18 119.55 10.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.807 0.337 . . . . 10.0 110.757 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -113.28 154.59 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.168 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.656 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' E' ' 261' ' ' THR . 93.3 mtt180 . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' E' ' 262' ' ' ASN . 9.5 m120 -130.84 120.66 24.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.945 0.402 . . . . 10.0 111.14 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 227' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' E' ' 263' ' ' SER . 1.3 m -118.74 141.9 48.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' D' ' 264' ' ' VAL . . . -132.17 133.26 44.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.167 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . 0.574 ' HB3' ' O ' ' E' ' 265' ' ' LYS . 1.1 ttmm -91.25 -77.72 0.41 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.899 -0.32 . . . . 10.0 111.143 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.7 126.78 51.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 10.0 111.666 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 66.5 mt -132.82 124.03 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -122.15 109.82 14.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.537 . . . . 10.0 110.3 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.5 p -113.53 96.82 6.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.358 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -117.07 152.22 35.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.441 . . . . 10.0 112.103 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 65.15 81.5 0.21 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.741 -1.118 . . . . 10.0 111.441 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 50.82 63.69 2.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.07 -0.968 . . . . 10.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.78 155.28 45.4 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.985 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . 0.462 ' HE ' ' CG ' ' D' ' 288' ' ' ASP . 0.1 OUTLIER -136.48 149.35 48.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.885 -178.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.09 127.12 32.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.92 -0.582 . . . . 10.0 109.982 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -120.75 128.11 52.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.589 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.47 92.42 3.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.751 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 167.53 -165.31 38.56 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.765 -0.731 . . . . 10.0 112.172 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -103.44 150.18 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.953 0.406 . . . . 10.0 110.783 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.81 110.93 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.911 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.17 112.09 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.096 0.474 . . . . 10.0 110.431 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 246' ' ' THR . . . . . 0.553 HG21 ' H ' ' E' ' 248' ' ' ALA . 14.5 t -76.02 179.4 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.72 -7.53 11.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.035 0.754 . . . . 10.0 113.035 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . 0.553 ' H ' HG21 ' E' ' 246' ' ' THR . . . -67.49 -30.85 70.65 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.754 -0.461 . . . . 10.0 109.754 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.96 -173.59 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.072 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 60.9 mt -89.48 123.51 33.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.889 -0.596 . . . . 10.0 109.618 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -63.96 -28.41 69.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.81 -167.48 25.45 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.003 -0.839 . . . . 10.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 85.88 92.56 0.85 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 10.0 112.238 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 35.0 mt -78.75 -31.77 15.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.626 . . . . 10.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 255' ' ' ARG . . . . . 0.407 ' HA ' ' NE ' ' E' ' 255' ' ' ARG . 0.4 OUTLIER -84.74 83.53 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.777 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.29 109.75 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 10.0 110.075 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 35.5 m -143.13 140.82 31.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.055 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.79 130.94 35.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.262 0.553 . . . . 10.0 110.338 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -108.42 -52.8 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.67 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.4 t -67.79 133.69 49.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.465 0.65 . . . . 10.0 111.319 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 261' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 94.9 m -121.69 113.11 19.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.694 -0.684 . . . . 10.0 109.889 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . 0.463 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 11.2 m120 -115.86 141.25 48.35 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.52 -0.764 . . . . 10.0 110.281 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 263' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' E' ' 227' ' ' SER . 73.3 m -142.22 133.34 26.07 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.34 138.31 49.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.183 0.516 . . . . 10.0 110.411 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 265' ' ' LYS . . . . . 0.574 ' O ' ' HB3' ' E' ' 229' ' ' LYS . 80.8 mttt -84.18 -60.79 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.211 -0.449 . . . . 10.0 112.144 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.5 m -135.92 123.71 22.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 t -120.23 111.23 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.403 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -114.39 110.51 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.758 0.313 . . . . 10.0 111.029 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.0 117.43 3.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.014 -0.613 . . . . 10.0 111.7 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.02 114.07 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.748 0.309 . . . . 10.0 111.519 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.0 90.54 0.4 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.819 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 60.76 85.77 0.11 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.178 0.513 . . . . 10.0 111.319 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.41 136.1 48.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.94 104.26 10.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.35 117.89 51.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.024 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.03 113.08 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.139 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 38.3 mm -107.65 87.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.388 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 166.56 -156.39 28.25 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.901 -0.666 . . . . 10.0 111.948 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -110.18 145.58 37.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.97 0.414 . . . . 10.0 110.293 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' E' ' 288' ' ' ASP . 0.7 OUTLIER -106.21 146.71 29.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.541 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -159.17 84.49 0.79 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.045 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.36 -104.92 1.31 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.239 -0.981 . . . . 10.0 113.19 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 283' ' ' GLY . . . . . 0.409 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 154.36 59.95 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.204 -0.522 . . . . 10.0 111.916 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -135.45 -59.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.516 0.198 . . . . 10.0 110.726 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.5 19.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.55 -0.833 . . . . 10.0 113.65 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -156.13 113.86 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.397 0.599 . . . . 10.0 109.944 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 68.24 16.29 9.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.086 0.946 . . . . 10.0 108.799 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 288' ' ' ASP . . . . . 0.465 ' HA ' ' HG3' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -154.97 168.53 26.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.993 -1.458 . . . . 10.0 108.14 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -153.32 143.43 22.24 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.852 -0.339 . . . . 10.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 290' ' ' HIS . . . . . 0.409 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 2.2 p-80 -149.34 178.65 8.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.979 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -105.12 -62.96 1.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.679 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 t60 66.65 168.35 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.758 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -108.32 107.07 17.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.997 0.427 . . . . 10.0 110.003 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.02 132.31 42.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.72 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.773 0 CA-C-O 118.49 -0.767 . . . . 10.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.206 -0.294 . . . . 10.0 110.206 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -105.21 142.4 35.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.9 m -147.15 137.47 23.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.781 0.324 . . . . 10.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -140.87 151.93 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.321 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -112.46 -56.84 2.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -137.02 121.32 18.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.853 0.359 . . . . 10.0 111.378 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 54.2 mt -128.14 119.01 49.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.084 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -127.84 110.83 12.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.309 0.576 . . . . 10.0 110.532 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.95 127.16 51.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.555 -0.748 . . . . 10.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.73 176.94 8.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.426 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 60.53 66.9 0.88 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.077 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 57.8 65.44 1.32 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.901 -1.045 . . . . 10.0 110.94 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -131.81 178.68 6.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 238' ' ' ARG . 6.2 ptp180 -159.18 155.12 26.55 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.026 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.18 136.74 59.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.471 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -129.21 134.41 47.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.994 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.53 138.12 51.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.278 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.74 -123.1 2.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.312 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -143.91 141.71 30.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 41.8 t -105.41 110.52 31.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.216 0.531 . . . . 10.0 111.56 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.12 108.51 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.647 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.424 ' HB ' ' HA2' ' A' ' 282' ' ' GLY . 12.0 m -84.62 149.72 25.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.183 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.3 -14.17 16.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.64 -13.3 56.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 10.0 110.904 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -106.94 25.31 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.431 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 3.9 mm? 70.95 -159.64 0.13 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.258 -0.883 . . . . 10.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.404 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 48.8 p-80 -76.86 169.63 17.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.235 0.541 . . . . 10.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -77.58 80.13 1.33 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.3 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.04 -36.6 93.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.218 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 255' ' ' ARG . 29.8 mt 72.72 146.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.547 0.792 . . . . 10.0 111.68 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.488 ' N ' HG23 ' A' ' 254' ' ' ILE . 67.4 ttt180 61.85 87.54 0.1 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.286 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 20.7 mt -123.38 -67.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.96 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 p -101.34 -90.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.861 -0.154 . . . . 10.0 111.408 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.1 t0 56.1 69.1 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.706 0.628 . . . . 10.0 110.932 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -121.07 2.65 10.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 10.0 110.623 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -136.38 152.0 50.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.38 127.85 42.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.345 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -101.77 83.61 2.43 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -108.81 116.69 32.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.602 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 228' ' ' ALA . 14.2 p -119.81 140.31 44.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.7 mttm -91.84 -79.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.179 0.437 . . . . 10.0 112.179 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 128.73 54.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.06 119.54 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.456 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.73 125.27 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.774 0.321 . . . . 10.0 111.491 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -128.91 129.31 6.11 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.197 -0.525 . . . . 10.0 111.934 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -145.01 111.87 5.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.901 0.382 . . . . 10.0 111.339 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.16 82.57 1.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.867 -0.683 . . . . 10.0 112.952 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 52.17 50.59 18.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.506 0.669 . . . . 10.0 110.996 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 m -102.26 141.64 34.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.966 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -121.15 119.43 32.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.32 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 55.2 t -103.31 119.07 51.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.918 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -114.15 103.6 11.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.36 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 8.8 mm -96.98 101.54 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.358 -0.383 . . . . 10.0 109.992 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 142.44 179.24 19.14 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.847 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.15 159.95 15.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.846 0.323 . . . . 10.0 110.642 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.96 156.86 39.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.447 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.86 86.97 2.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.325 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.424 ' HA2' ' HB ' ' A' ' 246' ' ' THR . . . -109.02 -145.83 11.4 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.353 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -174.35 -82.29 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -88.89 89.99 8.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.337 -0.986 . . . . 10.0 108.337 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 108.08 110.28 3.4 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.511 -1.035 . . . . 10.0 110.511 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -75.6 81.89 2.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.573 0.225 . . . . 10.0 110.916 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.5 t90 67.35 -69.6 0.13 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.145 0.903 . . . . 10.0 111.777 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.33 90.71 3.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.735 0.302 . . . . 10.0 110.749 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -155.42 136.38 13.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.561 -0.29 . . . . 10.0 110.772 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -157.93 34.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.068 -0.715 . . . . 10.0 109.068 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.22 132.13 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.836 -0.62 . . . . 10.0 111.52 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -137.16 15.87 3.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.639 0.733 . . . . 10.0 109.433 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -91.54 84.3 5.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.032 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -66.22 126.21 27.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.955 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.302 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.4 142.04 40.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.242 -0.651 . . . . 10.0 109.242 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.9 m -143.92 126.85 16.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.83 0.348 . . . . 10.0 111.091 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.18 134.95 47.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.405 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' B' ' 265' ' ' LYS . 50.9 mmtt -87.38 -59.39 2.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.451 -0.34 . . . . 10.0 111.776 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' B' ' 266' ' ' THR . 26.0 t70 -146.14 123.94 11.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.481 . . . . 10.0 110.869 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.06 130.61 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.06 113.05 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.446 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 1.3 p -124.06 114.12 19.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.653 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.23 156.05 48.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.971 0.415 . . . . 10.0 111.39 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 60.78 80.19 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.019 -0.991 . . . . 10.0 112.185 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 58.04 37.02 26.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.664 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.74 141.85 30.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 10.0 110.533 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.58 131.21 46.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.747 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.43 133.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.131 0.491 . . . . 10.0 111.093 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -115.98 125.77 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.877 -0.601 . . . . 10.0 109.987 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.35 83.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.141 -0.482 . . . . 10.0 111.307 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.93 -177.27 42.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.169 -1.015 . . . . 10.0 112.938 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -90.06 139.63 30.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 10.0 110.201 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 92.7 t -104.6 114.22 43.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.496 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.9 t -119.71 106.5 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.978 0.418 . . . . 10.0 110.028 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 82.5 p -79.66 173.11 12.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.049 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.29 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 10.0 112.096 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.92 -21.59 50.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.784 0.326 . . . . 10.0 110.524 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.485 ' HB3' ' CD1' ' B' ' 281' ' ' TYR . . . -93.71 17.95 11.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.25 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.69 106.0 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.883 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t60 65.06 82.39 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.954 0.784 . . . . 10.0 111.481 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.6 -135.87 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.915 -0.66 . . . . 10.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.17 127.61 6.14 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.294 -0.722 . . . . 10.0 111.294 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 36.3 mt -119.94 -33.23 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.048 0.451 . . . . 10.0 111.218 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -86.19 88.62 7.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.842 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt -120.37 54.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.569 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 m 65.92 38.25 5.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.615 -0.72 . . . . 10.0 110.332 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.96 61.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.226 -0.897 . . . . 10.0 111.541 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -104.8 98.1 7.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.004 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 9.0 t -156.57 148.54 22.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.281 0.562 . . . . 10.0 111.326 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' C' ' 225' ' ' ARG . 0.1 OUTLIER -118.94 98.39 6.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.238 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -88.01 116.29 26.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' C' ' 227' ' ' SER . 0.0 OUTLIER -124.08 135.45 53.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.566 -0.743 . . . . 10.0 111.61 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.18 135.79 49.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.274 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 0.5 OUTLIER -80.63 -73.93 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.508 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 0.6 OUTLIER -124.15 139.2 54.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.36 121.97 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.167 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.59 119.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.834 0.35 . . . . 10.0 110.984 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.85 117.55 3.19 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -134.45 119.48 18.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.75 0.275 . . . . 10.0 111.364 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.98 87.15 1.08 Allowed Glycine 0 C--N 1.329 0.15 0 C-N-CA 120.863 -0.684 . . . . 10.0 113.474 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 53.04 41.01 32.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.867 0.467 . . . . 10.0 111.51 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.0 t -76.92 154.21 33.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.282 0.563 . . . . 10.0 111.439 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -136.36 106.56 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.912 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.74 126.11 64.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.014 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.89 117.3 28.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.35 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.52 85.32 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.241 0.543 . . . . 10.0 109.776 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.96 168.29 19.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.056 -0.818 . . . . 10.0 111.056 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -88.83 158.55 18.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.223 0.511 . . . . 10.0 110.234 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.42 162.16 24.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.271 0.557 . . . . 10.0 111.039 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' B' ' 249' ' ' ALA . 2.7 t80 -140.35 95.78 2.93 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.047 -0.979 . . . . 10.0 108.862 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -120.9 -122.91 2.96 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.957 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' B' ' 285' ' ' GLY . . . 151.34 -44.17 0.67 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.855 -0.898 . . . . 10.0 110.855 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -82.72 35.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.804 0.812 . . . . 10.0 109.2 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' B' ' 283' ' ' GLY . . . 136.23 172.0 12.47 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.42 -1.472 . . . . 10.0 109.42 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.417 ' C ' ' H ' ' B' ' 288' ' ' ASP . 40.4 m-85 -112.98 62.82 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 22.1 t90 71.3 -45.87 0.63 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.103 0.877 . . . . 10.0 110.591 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 288' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' C' ' 274' ' ' ARG . 37.5 t70 -101.14 151.17 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.287 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.86 101.23 12.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.418 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 290' ' ' HIS . . . . . 0.634 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 36.0 t60 -131.89 134.88 46.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.423 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -154.38 126.33 7.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.023 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.23 -167.44 2.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.696 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -119.23 127.1 52.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.751 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -70.8 165.77 22.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.775 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.629 -0.7 . . . . 10.0 110.289 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' B' ' 261' ' ' THR . 20.3 ptt-85 . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 109.876 -0.416 . . . . 10.0 109.876 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -120.56 133.22 55.41 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.247 0.342 . . . . 10.0 110.639 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' B' ' 263' ' ' SER . 67.7 m -139.25 133.28 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.843 0.354 . . . . 10.0 110.558 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.96 51.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.623 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -90.39 -72.72 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.68 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -123.97 121.67 35.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.995 0.426 . . . . 10.0 111.46 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.47 126.71 74.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.856 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.416 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 38.6 ttm-85 -113.62 120.69 41.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.2 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 86.84 2.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 10.0 110.49 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.416 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 5.6 pt-20 -117.17 172.7 7.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.631 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.503 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 48.2 mt-10 65.95 59.74 0.7 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 64.19 15.41 9.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.399 -0.818 . . . . 10.0 112.748 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.63 156.87 32.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.844 0.354 . . . . 10.0 111.462 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.494 HH22 ' CD ' ' C' ' 272' ' ' GLU . 0.2 OUTLIER -137.23 146.62 45.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.31 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.19 140.07 44.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.768 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -125.16 124.66 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.395 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.21 97.46 8.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.181 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.77 32.76 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.534 -0.841 . . . . 10.0 112.496 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.49 158.87 15.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 10.0 110.218 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.84 110.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.961 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.47 121.43 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.002 0.43 . . . . 10.0 110.968 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 246' ' ' THR . . . . . 0.481 ' C ' ' H ' ' C' ' 248' ' ' ALA . 11.0 p -87.84 165.88 14.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.917 -0.583 . . . . 10.0 109.734 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.05 26.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.291 0.567 . . . . 10.0 111.975 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' C' ' 246' ' ' THR . . . -117.75 -10.22 10.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.155 0.502 . . . . 10.0 110.142 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -96.44 73.34 2.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.245 0.545 . . . . 10.0 110.701 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 14.0 mt -109.35 -16.93 13.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.043 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -86.55 76.73 9.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.307 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.75 8.19 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -116.75 164.0 12.41 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 17.1 tt -77.32 128.93 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 10.0 110.57 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -157.29 110.79 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.403 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 5.7 tt -81.99 99.35 5.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.944 0.878 . . . . 10.0 110.379 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -132.97 -176.52 4.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 10.0 110.091 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 258' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 0.2 OUTLIER -64.33 157.14 26.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.836 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.25 138.81 22.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 9.7 t -64.71 127.07 29.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.287 0.565 . . . . 10.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.07 137.18 38.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.528 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . 0.427 ' OD1' ' HB3' ' D' ' 241' ' ' LEU . 25.8 t-20 -133.18 132.19 41.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 10.0 110.408 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 263' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' D' ' 227' ' ' SER . 17.8 m -151.49 150.2 30.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.737 0.303 . . . . 10.0 110.858 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.34 144.85 25.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 265' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 2.4 mtpt -88.2 -70.76 0.62 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.719 0.637 . . . . 10.0 112.719 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 128.66 51.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.478 0.547 . . . . 10.0 112.478 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.55 118.33 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.588 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 85.5 t -110.05 120.4 61.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.053 0.454 . . . . 10.0 110.928 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -123.48 122.94 5.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.268 -0.733 . . . . 10.0 111.268 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.456 ' HB2' ' HG2' ' D' ' 234' ' ' GLU . 27.4 mttm -138.43 141.19 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.63 0.252 . . . . 10.0 111.472 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . 0.503 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 71.61 79.77 0.39 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.868 -0.605 . . . . 10.0 113.519 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . 0.494 ' CD ' HH22 ' C' ' 238' ' ' ARG . 36.5 mm-40 55.18 39.77 31.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.053 0.454 . . . . 10.0 111.585 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 157.65 23.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 10.0 111.296 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.604 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 1.3 mtm180 -137.7 118.56 14.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.06 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.98 126.7 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.276 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.557 ' HB2' ' CZ3' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -117.42 112.47 20.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.243 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 34.1 mm -111.32 87.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.14 0.495 . . . . 10.0 110.062 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 162.59 -175.61 38.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.964 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -95.64 145.2 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.091 0.472 . . . . 10.0 110.162 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.47 143.47 37.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -130.1 101.42 5.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.605 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -133.27 -158.1 8.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.673 -0.775 . . . . 10.0 112.509 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.9 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.432 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -72.05 -17.51 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 10.0 111.183 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . 0.407 ' HA2' ' HE3' ' D' ' 284' ' ' LYS . . . 168.3 -143.72 8.33 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.803 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.407 ' HB2' ' H ' ' C' ' 287' ' ' TRP . 9.7 p90 -104.53 -160.14 0.75 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.889 -0.412 . . . . 10.0 109.889 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.604 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 9.2 t90 -49.18 -43.79 42.43 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.481 0.488 . . . . 10.0 112.281 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 288' ' ' ASP . . . . . 0.634 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.0 OUTLIER -122.76 168.89 11.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.648 -0.421 . . . . 10.0 111.122 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -120.54 38.56 3.97 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.183 0.808 . . . . 10.0 113.183 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -65.61 -51.19 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.075 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 291' ' ' HIS . . . . . 0.414 ' HB2' HH22 ' D' ' 274' ' ' ARG . 6.0 m170 -130.13 177.28 7.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 71.34 155.73 0.15 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.884 0.74 . . . . 10.0 111.423 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.1 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.205 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -126.94 -176.01 3.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.709 -0.662 . . . . 10.0 110.747 -179.453 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . 0.548 ' HD3' ' OD2' ' D' ' 258' ' ' ASP . 6.0 mpt_? . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.864 0.364 . . . . 10.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -108.95 116.48 32.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 227' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' C' ' 263' ' ' SER . 19.9 m -138.58 132.63 31.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.006 0.431 . . . . 10.0 111.239 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.85 142.11 48.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.73 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 23.5 tttp -88.78 -71.5 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -118.21 119.74 35.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.723 0.297 . . . . 10.0 111.41 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 57.1 mt -122.8 118.71 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.041 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -110.61 124.56 52.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.904 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 233' ' ' THR . . . . . 0.444 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.6 OUTLIER -135.93 104.89 5.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.039 0.447 . . . . 10.0 110.462 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' C' ' 270' ' ' LYS . 1.7 mt-10 -128.59 162.13 27.99 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 66.97 72.28 0.36 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.677 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . 0.533 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 4.6 mtp180 55.82 32.5 19.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.872 -0.603 . . . . 10.0 111.928 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.26 173.35 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.98 0.419 . . . . 10.0 111.579 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.93 152.36 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.492 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 1.8 p -143.27 135.97 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.602 . . . . 10.0 110.434 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -124.06 128.63 49.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.19 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . 0.427 ' HB3' ' OD1' ' C' ' 262' ' ' ASN . 3.1 mm? -110.66 101.79 10.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.355 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.31 -108.97 0.35 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.956 -1.116 . . . . 10.0 113.214 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -164.65 158.12 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.13 112.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.987 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.3 t -117.67 128.79 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 10.0 110.088 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 246' ' ' THR . . . . . 0.497 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 2.1 p -109.54 161.37 15.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.99 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.84 -2.06 6.59 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.9 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.17 59.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.996 0.427 . . . . 10.0 110.263 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -112.53 102.86 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.952 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.56 -159.88 0.76 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.095 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -71.0 79.45 0.65 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.267 0.556 . . . . 10.0 110.693 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -146.07 39.93 1.1 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.928 -0.869 . . . . 10.0 110.928 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.04 31.15 7.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.412 -0.675 . . . . 10.0 111.412 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.7 tt -74.39 -19.48 17.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.349 . . . . 10.0 111.397 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -78.39 69.51 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.532 0.682 . . . . 10.0 110.117 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.57 -16.73 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.085 . . . . 10.0 111.935 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 257' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 10.5 m 61.67 -127.16 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 258' ' ' ASP . . . . . 0.548 ' OD2' ' HD3' ' D' ' 225' ' ' ARG . 1.1 t0 -125.21 137.88 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 259' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' E' ' 257' ' ' SER . 9.6 tp60 -136.27 -72.43 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.521 -0.472 . . . . 10.0 112.128 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 8.7 t -78.69 151.39 32.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.467 0.651 . . . . 10.0 111.522 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -114.84 90.9 3.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.586 -0.734 . . . . 10.0 109.397 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 7.4 m120 -98.45 112.84 24.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.478 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -129.01 99.71 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.497 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 13.2 p -97.09 142.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 10.0 109.873 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 265' ' ' LYS . . . . . 0.57 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 1.8 mptt -95.81 -50.45 4.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.75 0.648 . . . . 10.0 112.75 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 11.1 m -133.49 122.61 23.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.638 -0.664 . . . . 10.0 112.281 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.77 117.75 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.991 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.55 110.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.679 -0.237 . . . . 10.0 110.593 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -118.01 120.12 4.63 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.383 -0.437 . . . . 10.0 112.331 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -135.05 127.39 30.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.829 -0.218 . . . . 10.0 111.525 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.48 83.6 1.12 Allowed Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.174 -0.536 . . . . 10.0 113.631 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . 0.533 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 5.8 mp0 53.28 32.96 14.48 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.945 0.498 . . . . 10.0 111.799 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.7 t -75.94 147.98 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.143 0.497 . . . . 10.0 110.85 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . 0.414 HH22 ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.89 113.35 15.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.793 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 47.4 t -101.16 110.58 28.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 10.0 110.447 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.87 106.59 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 18.1 mm -105.18 89.98 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.7 -169.72 35.13 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.875 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -107.98 167.77 9.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.622 0.249 . . . . 10.0 110.715 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.21 140.79 52.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.548 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.06 114.05 13.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.079 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . 0.497 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 162.99 163.69 16.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.363 -0.923 . . . . 10.0 112.734 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -97.45 58.38 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.508 -0.854 . . . . 10.0 112.255 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . 0.407 ' HE3' ' HA2' ' C' ' 285' ' ' GLY . 39.2 tttm -116.72 12.74 14.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.236 0.541 . . . . 10.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.31 -50.25 4.16 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.665 -0.698 . . . . 10.0 113.077 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -170.27 157.48 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . 0.513 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 25.3 t90 -60.75 -62.91 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.706 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 288' ' ' ASP . . . . . 0.513 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 7.7 t70 -146.12 124.53 12.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.165 0.507 . . . . 10.0 110.098 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.76 172.45 12.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 10.0 109.847 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -101.33 -51.25 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 111.042 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -156.68 -173.09 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.701 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -100.3 -159.21 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.207 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -76.06 103.37 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 10.0 110.374 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -103.81 175.08 5.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.537 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.574 -0.727 . . . . 10.0 109.57 179.786 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' E' ' 261' ' ' THR . 76.4 mtt180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 18.6 m120 -133.02 110.99 10.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.206 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 7.0 m -118.08 145.13 45.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 10.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.76 125.68 25.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.793 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' E' ' 265' ' ' LYS . 42.1 mttm -77.09 -70.14 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.53 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -129.73 129.79 44.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.355 -0.384 . . . . 10.0 111.367 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.53 126.08 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.256 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -117.09 110.65 18.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 10.0 110.269 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 233' ' ' THR . . . . . 0.437 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 1.4 p -125.14 103.77 8.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.428 -0.805 . . . . 10.0 111.186 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -132.95 154.7 50.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 10.0 111.848 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . 0.419 ' HB3' ' H ' ' E' ' 271' ' ' GLY . 33.7 tt0 65.45 76.1 0.34 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.469 -0.787 . . . . 10.0 111.067 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 56.59 71.04 0.59 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.221 -0.899 . . . . 10.0 110.455 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -127.49 159.7 33.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.168 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 139.04 38.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.531 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.28 124.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.135 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -126.16 125.34 42.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.541 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mp -119.62 100.64 7.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.395 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.99 -173.38 40.84 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.298 -0.721 . . . . 10.0 111.298 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -103.49 154.53 19.35 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.15 129.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.409 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.2 99.15 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 10.0 110.837 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 246' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' D' ' 282' ' ' GLY . 7.5 t -69.15 169.64 11.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.202 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.51 -21.09 62.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.822 0.344 . . . . 10.0 111.7 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.09 73.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.998 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.72 -163.46 0.19 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.295 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.46 107.95 20.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.213 -0.449 . . . . 10.0 109.863 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -77.74 81.93 4.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.046 0.45 . . . . 10.0 110.722 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.24 140.98 10.5 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.839 -0.619 . . . . 10.0 112.016 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 119.55 98.47 1.77 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.75 -0.738 . . . . 10.0 111.906 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.67 -27.56 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.266 0.555 . . . . 10.0 110.471 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.05 59.23 5.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.405 0.621 . . . . 10.0 110.148 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 6.0 pt -86.09 123.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 257' ' ' SER . . . . . 0.469 ' HA ' ' NE2' ' D' ' 259' ' ' GLN . 67.0 m -152.96 166.61 31.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.672 -0.24 . . . . 10.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.38 117.76 9.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.851 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.49 16.29 8.23 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.35 0.5 . . . . 10.0 112.35 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -152.34 136.86 16.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.09 -0.381 . . . . 10.0 110.932 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 261' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 31.4 m -121.97 112.88 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.175 0.512 . . . . 10.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . 0.428 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 15.7 m120 -115.41 114.87 25.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.832 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.1 m -118.82 121.07 39.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 10.0 109.977 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -108.96 147.12 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 10.0 110.112 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 265' ' ' LYS . . . . . 0.655 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 82.6 mttt -85.88 -79.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 13.0 m -131.07 132.08 44.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.875 0.369 . . . . 10.0 111.143 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 t -121.98 106.21 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.967 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.53 125.89 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.663 -0.244 . . . . 10.0 110.549 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -145.47 136.67 6.6 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.545 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.89 130.37 22.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' E' ' 235' ' ' GLU . . . 84.17 85.93 0.89 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.555 -0.831 . . . . 10.0 111.82 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 60.55 60.82 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 10.0 110.85 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.68 136.06 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.701 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.63 104.25 8.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.911 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.28 120.21 58.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.853 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.98 119.94 29.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 28.1 mm -117.75 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 10.0 110.981 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.15 -176.22 34.42 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.499 -0.641 . . . . 10.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -91.63 139.91 30.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.877 -0.416 . . . . 10.0 109.877 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.86 159.83 15.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.333 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -169.64 99.6 0.32 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.275 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.9 -114.56 1.43 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.549 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 283' ' ' GLY . . . . . 0.494 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 166.64 58.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.313 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -137.88 -59.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.443 0.163 . . . . 10.0 110.781 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.62 13.19 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.358 -0.925 . . . . 10.0 113.824 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -152.76 114.35 4.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.161 0.481 . . . . 10.0 109.795 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 73.16 10.92 5.15 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.81 0.814 . . . . 10.0 109.302 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -145.88 -179.9 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.546 -1.206 . . . . 10.0 109.173 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -161.55 137.13 7.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.188 -0.301 . . . . 10.0 110.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 290' ' ' HIS . . . . . 0.494 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 7.3 p-80 -150.33 169.45 21.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.397 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -76.65 -70.76 0.43 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.303 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 292' ' ' HIS . . . . . 0.444 ' HB2' ' NE2' ' E' ' 290' ' ' HIS . 13.7 t60 69.46 153.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.21 0.604 . . . . 10.0 111.615 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -127.08 112.2 14.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.189 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -95.3 -176.25 3.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.761 -0.637 . . . . 10.0 109.807 179.57 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 110.494 -0.188 . . . . 10.0 110.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -117.34 127.16 53.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 263' ' ' SER . 13.4 m -149.16 159.43 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 10.0 111.428 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.15 162.4 35.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.004 -0.544 . . . . 10.0 109.996 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -121.37 -75.46 0.59 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 10.0 111.844 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 266' ' ' THR . 29.0 t70 -113.51 117.47 31.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.866 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.447 HD13 HG22 ' A' ' 231' ' ' ILE . 31.8 pt -136.0 144.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.525 -0.307 . . . . 10.0 111.096 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -142.26 126.95 18.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.092 0.472 . . . . 10.0 110.93 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 21.0 p -121.79 113.28 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.271 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.47 158.65 37.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 10.0 111.4 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.49 71.76 0.55 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.427 -0.806 . . . . 10.0 111.908 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 34.9 mtm105 56.63 42.5 26.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 10.0 111.908 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.4 153.23 20.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.282 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -134.41 160.49 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.511 -0.313 . . . . 10.0 111.069 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 138.59 23.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -135.3 122.04 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 10.0 109.935 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.47 133.69 53.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.768 0.318 . . . . 10.0 110.253 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.402 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 140.97 -119.17 1.49 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.204 -0.522 . . . . 10.0 112.281 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -147.42 143.78 28.17 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.78 107.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.848 0.356 . . . . 10.0 111.362 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.93 120.2 50.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.561 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 m -85.67 151.6 23.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.619 . . . . 10.0 109.907 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.68 -14.89 60.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -87.11 -1.88 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.002 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -119.59 52.99 1.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.265 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 65.96 -158.07 0.26 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.102 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -93.09 178.91 5.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.995 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -80.62 69.03 3.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.483 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.63 68.33 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.238 -0.745 . . . . 10.0 111.238 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.5 mt 70.51 144.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.259 0.623 . . . . 10.0 112.477 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.19 60.56 1.17 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.3 -0.863 . . . . 10.0 111.153 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.73 -50.75 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.54 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.5 p -128.61 -83.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.848 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.5 t70 54.29 72.56 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.77 0.669 . . . . 10.0 110.615 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -119.18 24.24 10.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.95 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 4.4 t -139.21 140.91 37.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.35 0.595 . . . . 10.0 112.009 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -91.23 112.46 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.105 -0.952 . . . . 10.0 110.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.423 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 15.6 m-20 -115.46 113.53 23.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 227' ' ' SER . 37.3 m -142.95 124.76 15.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 10.0 110.957 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.8 152.57 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.774 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 -56.88 2.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.83 -0.348 . . . . 10.0 111.48 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 10.5 m -133.75 130.32 37.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.49 124.31 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.919 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 14.8 t -115.92 117.42 55.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.817 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.38 119.32 4.25 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.105 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -134.49 123.32 23.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.925 0.393 . . . . 10.0 111.361 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.91 70.05 1.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.714 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 25.7 tt0 54.83 51.0 14.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.469 0.652 . . . . 10.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.88 144.7 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.508 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -119.03 112.68 19.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.288 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.58 115.14 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.842 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.53 111.05 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.845 0.355 . . . . 10.0 110.251 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 15.1 mm -101.94 98.85 7.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.822 0.344 . . . . 10.0 110.147 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.72 161.09 8.59 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.016 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.43 152.06 36.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.639 0.257 . . . . 10.0 110.361 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -175.79 2.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.027 0.441 . . . . 10.0 111.04 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -158.26 97.17 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.459 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.04 -147.8 5.7 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.253 -0.975 . . . . 10.0 114.149 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -175.31 -83.93 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.746 -0.542 . . . . 10.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -81.92 81.39 7.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.248 0.547 . . . . 10.0 109.573 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 120.11 108.12 2.19 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.655 -0.978 . . . . 10.0 110.655 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -74.34 83.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.658 0.266 . . . . 10.0 110.724 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t90 69.11 -65.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.206 -0.906 . . . . 10.0 111.191 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -154.13 91.83 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.959 0.409 . . . . 10.0 110.838 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -156.84 129.8 7.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -147.9 85.9 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -118.25 137.52 52.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.231 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -132.55 14.01 4.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.558 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -89.4 134.52 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.841 -0.6 . . . . 10.0 110.28 179.615 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.069 -0.345 . . . . 10.0 110.069 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -116.89 123.69 47.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.002 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -109.97 90.54 3.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.823 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -94.94 163.8 13.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.165 -0.47 . . . . 10.0 109.962 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -125.09 -80.71 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.979 -0.288 . . . . 10.0 111.754 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -121.1 117.1 26.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.946 0.403 . . . . 10.0 111.273 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.85 123.16 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -118.28 113.49 21.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.717 0.294 . . . . 10.0 110.515 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.71 113.52 22.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.711 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.14 160.53 31.74 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.045 0.45 . . . . 10.0 111.813 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.63 74.35 0.4 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.19 -0.914 . . . . 10.0 112.456 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 21.4 mtm-85 55.06 39.78 31.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.2 0.524 . . . . 10.0 111.099 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -93.81 151.74 19.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.821 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 128.61 23.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.993 -0.549 . . . . 10.0 109.764 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.9 137.67 56.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.127 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -118.96 123.04 43.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.66 87.85 4.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.412 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.423 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . 160.71 -178.63 36.63 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.587 -0.816 . . . . 10.0 112.315 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -89.81 163.33 15.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.597 0.237 . . . . 10.0 110.389 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.3 131.8 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.766 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.39 110.22 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.985 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 33.8 p -88.26 168.63 12.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.671 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.74 -5.1 14.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.512 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.43 -13.17 57.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 10.0 110.573 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' B' ' 281' ' ' TYR . . . -87.66 3.23 48.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.548 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.96 118.62 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.352 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 65.93 28.38 10.63 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.656 0.597 . . . . 10.0 111.355 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -106.76 -172.41 22.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.012 -0.613 . . . . 10.0 112.543 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.02 121.0 6.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.774 -0.53 . . . . 10.0 111.774 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 12.1 mt -104.27 -23.6 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.754 0.311 . . . . 10.0 111.699 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' C' ' 253' ' ' GLY . 14.6 tpt180 -93.22 91.59 7.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.909 0.385 . . . . 10.0 110.26 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.35 45.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.335 . . . . 10.0 111.296 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 60.14 33.51 21.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.048 -0.523 . . . . 10.0 111.394 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -63.24 131.95 50.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.383 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -156.81 76.38 0.87 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.206 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' THR . . . . . 0.568 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 3.7 t -151.95 161.63 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.063 0.459 . . . . 10.0 111.323 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -127.87 123.88 36.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.841 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.23 125.21 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 142.71 50.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.239 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.22 148.81 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -104.93 -77.41 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.457 -0.497 . . . . 10.0 111.973 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.17 119.07 38.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.259 0.552 . . . . 10.0 112.293 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.63 109.51 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.432 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 74.8 t -104.83 118.23 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.372 . . . . 10.0 110.658 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.57 133.06 8.19 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.351 -0.699 . . . . 10.0 111.351 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -145.16 122.35 11.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 10.0 111.719 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.28 78.79 1.42 Allowed Glycine 0 C--O 1.238 0.387 0 C-N-CA 120.639 -0.791 . . . . 10.0 113.347 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 55.27 36.48 27.12 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.286 0.565 . . . . 10.0 110.556 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 273' ' ' SER . . . . . 0.486 ' HG ' ' C ' ' B' ' 269' ' ' GLY . 0.0 OUTLIER -65.37 143.31 57.82 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.882 -1.053 . . . . 10.0 111.643 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -125.0 103.85 8.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.497 -0.774 . . . . 10.0 109.595 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.68 115.48 45.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.452 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 112.4 24.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 43.6 mm -101.83 81.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 10.0 110.231 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.18 178.88 33.59 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.007 -0.616 . . . . 10.0 112.336 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -92.93 160.85 14.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.41 172.18 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.961 0.41 . . . . 10.0 110.752 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 4.4 t80 -142.15 76.34 1.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.662 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -90.27 -137.75 6.99 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.677 -0.692 . . . . 10.0 113.248 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 156.42 -50.56 0.44 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.403 -0.679 . . . . 10.0 111.403 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -91.1 1.84 56.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 10.0 109.75 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -177.74 165.33 34.89 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.592 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -108.45 76.55 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 16.4 t90 70.41 -48.1 0.64 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.017 0.823 . . . . 10.0 111.397 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -117.62 178.24 4.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.91 117.55 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 10.0 110.784 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -139.66 132.46 29.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.438 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 291' ' ' HIS . . . . . 0.422 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 0.1 OUTLIER -157.55 118.23 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.022 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.9 -172.41 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -110.38 137.58 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 10.0 111.764 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -97.87 169.4 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.619 -0.718 . . . . 10.0 111.072 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 48.0 t60 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.629 -0.701 . . . . 10.0 110.416 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.568 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 29.8 ptt180 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.444 0.164 . . . . 10.0 110.678 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -126.52 127.08 44.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.463 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' C' ' 263' ' ' SER . 14.7 m -134.89 132.7 38.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 10.0 111.379 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.17 153.79 47.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.336 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -103.86 -77.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.762 -0.375 . . . . 10.0 111.635 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.1 118.36 35.8 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.254 0.549 . . . . 10.0 111.643 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.83 119.13 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.66 . . . . 10.0 109.985 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -108.03 116.99 32.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.535 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.518 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 0.6 OUTLIER -131.43 102.16 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 10.0 110.781 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -132.91 164.2 27.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.232 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 64.72 71.15 0.47 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.439 -0.801 . . . . 10.0 111.041 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 56.39 65.31 1.45 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 121.327 0.584 . . . . 10.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.75 163.45 25.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.422 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -149.79 143.77 25.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.38 135.05 49.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.636 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -118.57 123.11 44.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.584 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.408 HD11 ' HB ' ' C' ' 277' ' ' ILE . 4.2 mm? -96.59 76.58 2.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.578 -0.737 . . . . 10.0 109.632 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 172.55 170.21 36.07 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.252 -0.975 . . . . 10.0 112.212 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -81.6 162.88 22.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.013 -0.366 . . . . 10.0 110.013 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.98 119.67 61.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 10.0 110.736 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.3 t -113.94 109.13 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 39.4 p -80.56 163.73 23.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.541 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 2.67 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.272 0.471 . . . . 10.0 112.272 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.54 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 10.0 110.514 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -84.61 77.3 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.716 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 5.0 mt -112.31 15.36 20.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.387 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -120.89 111.19 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.139 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.42 -113.45 0.3 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.766 -0.73 . . . . 10.0 111.936 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 253' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' B' ' 255' ' ' ARG . . . 128.03 -127.57 5.77 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.812 -0.709 . . . . 10.0 111.498 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.1 tt -152.56 120.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.273 0.559 . . . . 10.0 111.122 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -166.32 133.78 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.639 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -107.22 132.53 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.57 -0.286 . . . . 10.0 110.234 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.43 -169.98 1.74 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.16 141.52 22.97 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.0 0.429 . . . . 10.0 110.951 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.67 146.79 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.716 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 6.1 t -75.77 149.27 38.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.83 128.43 55.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.514 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.99 129.72 44.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.786 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 263' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' C' ' 227' ' ' SER . 5.7 m -143.26 150.61 39.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.746 0.308 . . . . 10.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.56 144.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.267 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 265' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 23.6 ttmt -88.49 -66.32 0.93 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.424 0.528 . . . . 10.0 112.424 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 23.7 m -130.38 124.9 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.82 123.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.487 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 64.2 t -115.63 114.71 47.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.66 -0.246 . . . . 10.0 111.011 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.24 121.95 5.22 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.955 -0.64 . . . . 10.0 111.906 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -132.99 121.82 23.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 10.0 111.453 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.25 90.86 0.41 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.842 -0.694 . . . . 10.0 113.851 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 56.0 47.45 19.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.923 0.392 . . . . 10.0 111.372 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.25 152.61 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.146 0.498 . . . . 10.0 110.651 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.53 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 0.6 OUTLIER -137.91 117.32 12.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.138 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.73 124.38 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.892 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.493 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -119.58 112.47 19.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.763 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . 0.408 ' HB ' HD11 ' C' ' 241' ' ' LEU . 41.0 mm -106.92 90.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.019 0.437 . . . . 10.0 109.933 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.35 -170.65 35.69 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.222 -0.751 . . . . 10.0 111.222 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.96 155.46 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.96 0.38 . . . . 10.0 110.353 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.94 140.91 51.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.968 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 25.1 t80 -129.86 112.81 13.93 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.304 -0.628 . . . . 10.0 109.304 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -165.85 163.0 36.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.357 -0.925 . . . . 10.0 112.483 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.61 1.89 30.66 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -86.86 36.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.102 0.477 . . . . 10.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.63 -83.43 1.4 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.982 -0.847 . . . . 10.0 110.982 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -164.29 -167.44 1.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.53 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 10.1 t90 -42.29 -48.83 5.06 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.861 0.726 . . . . 10.0 112.687 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 288' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' C' ' 290' ' ' HIS . 0.0 OUTLIER -125.89 153.07 44.71 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.49 -0.484 . . . . 10.0 111.215 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 289' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -104.44 82.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.492 0.663 . . . . 10.0 110.787 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 290' ' ' HIS . . . . . 0.476 ' HB2' ' OD1' ' C' ' 288' ' ' ASP . 14.9 t-80 -112.53 -55.94 2.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.453 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 291' ' ' HIS . . . . . 0.434 ' HB2' ' NH2' ' D' ' 274' ' ' ARG . 0.7 OUTLIER -134.11 173.27 11.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 10.0 111.754 -178.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 292' ' ' HIS . . . . . 0.411 ' HB2' ' H ' ' D' ' 289' ' ' ASN . 17.1 t-80 52.36 88.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.866 -1.061 . . . . 10.0 113.155 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -94.16 178.7 5.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.298 -0.865 . . . . 10.0 109.377 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -62.24 110.08 1.52 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.987 0.422 . . . . 10.0 111.074 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 37.2 m80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.657 -0.687 . . . . 10.0 109.691 178.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . 0.419 ' HD3' ' CG ' ' D' ' 258' ' ' ASP . 2.2 mpt_? . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.785 0.326 . . . . 10.0 110.438 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' D' ' 262' ' ' ASN . 2.7 m-20 -75.47 109.72 9.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.452 . . . . 10.0 110.189 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.66 146.85 52.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.519 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.48 143.2 51.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.164 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 44.4 tttm -90.06 -73.37 0.52 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.341 -0.391 . . . . 10.0 111.647 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.3 120.56 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.832 0.308 . . . . 10.0 111.832 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.54 121.13 58.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.819 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -116.7 114.04 23.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.662 -0.245 . . . . 10.0 110.51 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.1 p -118.42 100.85 7.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.675 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.38 148.51 42.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.09 0.472 . . . . 10.0 111.922 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 62.56 84.84 0.14 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.076 -0.965 . . . . 10.0 112.218 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . 0.473 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 40.8 mtt180 67.92 -8.81 0.51 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.739 1.014 . . . . 10.0 113.739 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -60.6 149.84 33.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.353 0.597 . . . . 10.0 112.314 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -139.25 153.98 47.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.281 -0.872 . . . . 10.0 109.687 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.09 140.17 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.645 0.26 . . . . 10.0 111.679 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -129.5 133.54 47.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.202 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.43 95.62 5.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.73 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . 0.48 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . 171.39 -119.61 0.8 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.915 -0.659 . . . . 10.0 112.686 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -153.51 158.03 40.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.86 109.91 30.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.247 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 19.3 t -111.48 114.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 246' ' ' THR . . . . . 0.529 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 68.9 p -78.07 164.89 24.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 10.0 110.816 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.64 -4.51 34.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.034 0.445 . . . . 10.0 111.1 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.5 12.94 13.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 10.0 111.044 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -121.82 105.62 10.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.632 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.44 -162.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.556 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.51 88.27 3.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.071 0.463 . . . . 10.0 111.224 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -157.17 46.88 0.48 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.239 -0.744 . . . . 10.0 111.239 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 105.89 24.09 7.12 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.925 -0.87 . . . . 10.0 110.925 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 6.8 tt -66.95 -19.11 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 112.144 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -92.81 63.16 3.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 10.0 110.388 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.01 -29.59 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 12.9 m 67.07 -168.09 0.2 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.747 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 258' ' ' ASP . . . . . 0.419 ' CG ' ' HD3' ' D' ' 225' ' ' ARG . 11.5 m-20 -78.4 100.84 6.97 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.943 -0.392 . . . . 10.0 109.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 259' ' ' GLN . . . . . 0.6 ' HA ' HE21 ' D' ' 259' ' ' GLN . 0.1 OUTLIER -82.37 -70.55 0.54 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 11.0 t -113.27 160.63 18.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.93 0.395 . . . . 10.0 110.551 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 5.8 m -106.23 96.59 6.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 6.4 t30 -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.83 0.347 . . . . 10.0 110.088 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.21 125.39 40.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.93 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.55 143.53 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 265' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 0.0 OUTLIER -97.1 -50.1 4.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -128.45 122.02 30.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.64 125.16 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.013 -0.54 . . . . 10.0 109.687 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.18 127.45 74.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.812 0.339 . . . . 10.0 110.913 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.4 2.67 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -130.22 121.18 25.7 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.96 0.41 . . . . 10.0 111.281 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.04 66.28 1.04 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.65 -0.786 . . . . 10.0 112.76 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . 0.473 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 8.1 tt0 56.81 56.29 5.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.417 0.627 . . . . 10.0 111.552 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 45.7 t -92.13 155.73 17.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.027 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . 0.434 ' NH2' ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.31 109.95 12.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.027 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 32.1 t -101.22 113.69 38.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.927 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -116.93 106.39 13.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.035 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 10.7 mm -102.05 71.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.063 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . -175.12 -167.97 35.06 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.642 -0.79 . . . . 10.0 112.266 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -114.4 166.91 11.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.484 -0.191 . . . . 10.0 110.484 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.71 147.26 48.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 10.0 110.697 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -137.91 105.14 5.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.029 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . 0.529 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 168.8 173.72 36.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.832 -1.175 . . . . 10.0 113.516 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -96.53 43.84 2.04 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.777 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -91.97 -19.33 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 10.0 109.728 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.91 -45.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.097 -0.801 . . . . 10.0 111.097 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -169.25 143.17 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.244 -0.478 . . . . 10.0 109.762 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -54.98 -64.94 0.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.409 0.443 . . . . 10.0 111.65 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -140.64 108.7 5.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.091 0.472 . . . . 10.0 110.668 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 289' ' ' ASN . . . . . 0.411 ' H ' ' HB2' ' C' ' 292' ' ' HIS . 8.7 t-20 -132.43 165.4 24.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.061 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -92.2 -64.68 1.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.669 0.271 . . . . 10.0 111.072 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -135.94 -170.02 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.688 -0.233 . . . . 10.0 110.419 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -105.28 -158.01 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -74.23 121.36 21.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.717 0.294 . . . . 10.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -133.98 -174.73 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 63.2 m80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.627 -0.701 . . . . 10.0 110.463 179.744 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . 0.428 ' H ' ' CG ' ' E' ' 258' ' ' ASP . 1.2 mpt_? . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 23.4 m120 -113.65 134.95 54.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 227' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' E' ' 263' ' ' SER . 18.2 m -143.55 137.17 28.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.763 0.316 . . . . 10.0 110.512 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.9 146.11 50.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.19 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -95.71 -69.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.482 -0.326 . . . . 10.0 111.818 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -128.5 124.89 37.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.509 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.4 120.56 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.524 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -116.41 116.25 27.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.165 0.507 . . . . 10.0 111.214 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 233' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' E' ' 237' ' ' ALA . 29.2 p -112.68 111.41 22.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.146 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -122.59 138.72 54.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.97 87.2 0.12 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.467 -0.788 . . . . 10.0 112.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 48.81 44.25 21.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.002 -0.999 . . . . 10.0 112.214 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . 0.41 ' CB ' ' HB ' ' E' ' 233' ' ' THR . . . -98.69 160.39 14.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.172 -0.467 . . . . 10.0 109.921 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.29 148.23 49.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.635 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.13 120.94 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.445 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -127.03 119.43 26.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.013 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.6 109.49 17.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . 0.449 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 161.13 -172.87 37.48 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.253 -0.499 . . . . 10.0 111.914 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -98.87 139.07 35.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 110.932 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -98.64 124.59 51.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.97 118.32 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.361 . . . . 10.0 111.058 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 246' ' ' THR . . . . . 0.439 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 14.2 t -72.06 173.66 8.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.076 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.56 70.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 10.0 111.229 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -69.11 -20.49 64.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.953 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.24 -159.98 0.26 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 66.7 mt -96.9 124.16 40.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -80.11 86.86 5.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 10.0 109.679 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 108.76 -152.24 17.01 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.899 -0.881 . . . . 10.0 110.899 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.26 80.06 0.36 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.221 -0.99 . . . . 10.0 111.871 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 52.3 mt -73.3 -29.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.119 0.485 . . . . 10.0 110.157 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.1 74.42 1.09 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.137 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 256' ' ' ILE . . . . . 0.405 ' HB ' ' OE1' ' D' ' 259' ' ' GLN . 9.2 pt -81.21 124.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 14.7 m -142.33 -179.81 6.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.067 0.46 . . . . 10.0 111.786 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 258' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' E' ' 225' ' ' ARG . 25.6 t70 -84.97 130.9 34.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.768 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -130.2 -58.62 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.1 t -69.56 139.18 53.71 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.375 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 35.8 m -113.93 110.81 20.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.719 -0.673 . . . . 10.0 109.797 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.91 120.85 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.081 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 263' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' E' ' 227' ' ' SER . 16.3 m -136.29 131.57 34.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.47 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.43 150.75 29.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.615 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 265' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -88.06 -88.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.788 0.292 . . . . 10.0 111.788 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 10.4 m -110.93 125.5 53.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 10.0 111.49 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 5.8 t -116.1 108.98 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.888 -0.596 . . . . 10.0 109.518 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.54 122.15 62.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.407 -0.36 . . . . 10.0 110.875 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.73 108.96 0.69 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.734 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -120.18 123.61 43.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.344 -0.243 . . . . 10.0 110.344 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.25 74.62 1.28 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.129 -0.558 . . . . 10.0 112.106 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 61.4 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.759 0.79 . . . . 10.0 110.997 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 39.0 m -139.02 141.83 38.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.21 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.98 97.76 6.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.154 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.27 104.16 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 10.0 109.708 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.05 114.02 23.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.608 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 34.0 mm -119.41 107.29 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.925 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 162.74 -125.67 1.44 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.395 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -138.24 129.15 26.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.913 0.387 . . . . 10.0 110.284 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . 0.575 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 0.2 OUTLIER -92.43 138.45 31.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.327 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -171.7 92.99 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.978 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . 0.439 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -132.07 -87.52 0.38 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.255 -0.974 . . . . 10.0 112.829 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 283' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 148.18 38.23 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.199 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -121.77 -68.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.732 -0.275 . . . . 10.0 110.744 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.56 9.9 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.175 -1.012 . . . . 10.0 113.802 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 286' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' E' ' 287' ' ' TRP . 17.6 t80 -138.27 108.68 6.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.512 0.656 . . . . 10.0 109.595 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 287' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' E' ' 286' ' ' PHE . 0.7 OUTLIER 70.59 16.59 6.89 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -177.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 288' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -161.14 172.81 16.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.089 -1.414 . . . . 10.0 109.357 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -172.3 158.82 4.54 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.746 -0.206 . . . . 10.0 110.539 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 290' ' ' HIS . . . . . 0.437 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 0.6 OUTLIER -155.51 -177.44 6.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -92.53 -70.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 10.0 112.102 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 10.9 t60 71.12 160.42 0.22 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.69 0.619 . . . . 10.0 111.364 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -96.98 119.27 35.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.409 -0.359 . . . . 10.0 110.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -105.66 154.02 21.02 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.613 -0.708 . . . . 10.0 110.847 -179.368 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.58 0.228 . . . . 10.0 110.776 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -112.22 128.43 56.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.799 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 263' ' ' SER . 30.1 m -152.15 159.06 43.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 10.0 111.495 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.56 43.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.142 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.54 -61.62 1.37 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.684 0.278 . . . . 10.0 111.262 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.74 131.84 33.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.833 0.349 . . . . 10.0 111.058 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.8 mt -127.07 128.32 70.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.835 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -114.75 99.26 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.214 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.7 122.09 46.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.731 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.705 0.288 . . . . 10.0 111.417 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.496 ' HB3' ' H ' ' A' ' 271' ' ' GLY . 7.6 tp10 63.89 72.06 0.47 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.455 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.5 mtm-85 55.91 32.73 20.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.439 -0.8 . . . . 10.0 111.713 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.65 159.24 17.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.337 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -137.31 147.97 46.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.623 -0.262 . . . . 10.0 110.575 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.57 141.72 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.518 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -134.86 138.3 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.6 tp -125.14 128.79 48.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.932 0.396 . . . . 10.0 110.99 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.35 -110.09 0.75 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.856 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -156.76 156.6 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.5 t -125.47 121.78 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.798 0.333 . . . . 10.0 110.611 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.06 101.61 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.689 -0.485 . . . . 10.0 109.689 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.463 HG21 ' H ' ' A' ' 248' ' ' ALA . 94.2 m -74.09 145.37 44.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.23 8.66 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.463 ' H ' HG21 ' A' ' 246' ' ' THR . . . -80.29 -6.59 58.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.846 0.355 . . . . 10.0 110.935 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -121.05 38.82 3.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.327 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.3 mm? 72.81 -167.65 0.12 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.249 -0.887 . . . . 10.0 111.067 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -78.54 -174.61 3.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.615 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.92 71.07 2.64 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.487 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.15 -45.54 96.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.905 -0.665 . . . . 10.0 111.542 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 75.5 mt 70.33 138.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.314 0.646 . . . . 10.0 111.752 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 66.87 90.1 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.687 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.87 -45.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.813 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 -86.75 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 55.4 t0 60.22 79.64 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.389 0.614 . . . . 10.0 109.978 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.49 24.1 10.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.925 -0.579 . . . . 10.0 111.563 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 7.7 t -148.94 148.11 29.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.496 . . . . 10.0 111.476 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 118.54 30.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.849 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -115.09 105.82 13.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.389 -0.368 . . . . 10.0 110.157 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 227' ' ' SER . 70.7 m -140.32 135.16 31.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 10.0 110.78 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.93 145.99 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.766 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.17 -70.87 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.03 0.381 . . . . 10.0 112.03 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 125.29 47.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 10.0 112.581 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 16.9 t -121.15 119.81 60.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.657 . . . . 10.0 109.579 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.88 119.89 60.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.701 0.286 . . . . 10.0 110.95 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.48 107.29 0.91 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.557 -0.617 . . . . 10.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -126.9 124.77 40.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.091 0.472 . . . . 10.0 111.187 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.496 ' H ' ' HB3' ' A' ' 235' ' ' GLU . . . 93.32 73.83 1.24 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.872 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 54.66 36.63 26.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.594 0.358 . . . . 10.0 111.846 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.1 m -86.46 150.18 24.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.226 0.536 . . . . 10.0 110.876 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -119.85 124.82 47.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.646 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.24 113.74 44.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.235 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.38 111.54 22.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.755 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.06 86.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.962 0.41 . . . . 10.0 109.919 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.23 170.92 22.67 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.216 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -92.99 151.83 19.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.737 0.303 . . . . 10.0 110.51 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.22 158.71 25.47 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.056 0.455 . . . . 10.0 110.817 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.11 101.27 5.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 10.0 108.942 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -151.22 165.91 30.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.789 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -137.92 -16.99 0.65 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.163 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -72.67 -37.0 68.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.252 0.548 . . . . 10.0 110.035 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -164.98 156.53 28.56 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.671 -0.972 . . . . 10.0 110.671 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -80.86 74.95 7.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.393 0.596 . . . . 10.0 110.671 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 21.4 t90 69.59 -58.36 0.52 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.089 0.868 . . . . 10.0 111.71 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -142.65 96.29 2.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.864 0.364 . . . . 10.0 110.646 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -166.3 125.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.085 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -150.56 21.11 0.82 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.511 0.672 . . . . 10.0 109.853 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -75.56 144.12 42.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.633 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.12 32.23 3.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.528 -0.76 . . . . 10.0 109.326 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -103.32 120.56 41.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.265 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -95.26 142.84 27.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.821 0.343 . . . . 10.0 110.425 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 p80 . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.051 179.361 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' B' ' 261' ' ' THR . 39.3 ttm180 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.436 HD22 ' HA2' ' B' ' 278' ' ' GLY . 85.0 m-20 -117.89 152.94 34.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 10.0 110.807 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 48.9 m -147.13 91.96 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.122 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -97.04 161.75 13.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' B' ' 265' ' ' LYS . 14.4 mttm -123.2 -72.53 0.68 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.008 -0.277 . . . . 10.0 111.741 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -127.74 114.19 16.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.148 0.499 . . . . 10.0 111.13 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 77.6 mt -118.62 123.83 72.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.886 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -118.67 124.27 46.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.419 0.628 . . . . 10.0 111.451 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.58 123.26 40.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.948 -1.023 . . . . 10.0 110.135 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -138.48 162.95 33.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 10.0 110.904 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.71 62.77 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.249 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 60.16 26.62 16.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -78.62 157.57 28.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.037 0.446 . . . . 10.0 110.923 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 135.48 35.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.522 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.16 138.92 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.972 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -126.4 131.77 51.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.093 0.473 . . . . 10.0 110.166 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.1 100.7 10.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.73 -177.99 29.29 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -95.8 157.96 15.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.401 . . . . 10.0 110.531 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.17 122.61 69.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.978 0.418 . . . . 10.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.25 124.71 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 72.8 p -93.75 174.02 7.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 10.0 112.022 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.17 -20.06 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.546 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.8 -19.33 57.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.284 0.564 . . . . 10.0 110.249 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -86.68 -4.05 59.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.342 -0.845 . . . . 10.0 110.398 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.62 118.14 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.739 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.84 62.47 1.05 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.839 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -135.19 -142.89 4.65 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.924 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.12 91.2 0.6 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.344 -0.702 . . . . 10.0 111.344 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 16.6 mt -79.59 -27.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.277 0.473 . . . . 10.0 112.277 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -116.55 111.24 19.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.944 0.402 . . . . 10.0 111.099 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 14.7 pt -137.03 40.83 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.23 50.1 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.428 -0.806 . . . . 10.0 111.44 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -84.98 63.85 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.554 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -92.69 103.72 16.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.574 . . . . 10.0 110.385 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' THR . . . . . 0.556 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 13.4 t -167.45 150.44 6.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 10.0 111.571 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 31.7 m -118.56 117.96 30.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.141 -0.936 . . . . 10.0 108.908 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -99.4 100.9 12.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.212 0.529 . . . . 10.0 110.387 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.5 m -106.12 143.32 34.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.931 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.67 144.28 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.642 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 20.6 mttt -94.41 -80.1 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.38 0.511 . . . . 10.0 112.38 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 125.59 53.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.592 0.59 . . . . 10.0 112.592 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 87.5 t -118.58 123.71 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.652 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 5.5 t -109.74 126.46 66.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.305 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.36 98.48 0.34 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -122.36 124.18 43.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 10.0 111.258 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 98.36 58.92 0.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.565 -0.826 . . . . 10.0 112.849 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 57.07 37.68 28.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.051 0.541 . . . . 10.0 111.984 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 19.6 m -77.57 150.78 34.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.454 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.62 124.13 49.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.874 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.18 122.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.778 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -118.82 108.27 14.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.218 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.72 92.56 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.106 0.479 . . . . 10.0 110.004 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.436 ' HA2' HD22 ' B' ' 226' ' ' ASN . . . 155.93 -178.82 32.28 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.493 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -99.35 161.33 13.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.42 158.97 33.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.167 0.508 . . . . 10.0 111.091 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 1.0 OUTLIER -139.4 81.44 1.83 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.13 -0.941 . . . . 10.0 108.668 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.434 ' HA2' ' HG1' ' B' ' 246' ' ' THR . . . -118.77 -98.54 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.749 -0.66 . . . . 10.0 113.067 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.02 -37.33 2.71 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.929 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -90.45 53.72 2.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.231 0.539 . . . . 10.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.97 132.92 4.95 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' C' ' 244' ' ' VAL . 16.6 m-85 -82.4 76.0 9.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.41 0.148 . . . . 10.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' C' ' 238' ' ' ARG . 18.9 t90 70.55 -51.28 0.66 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.06 0.85 . . . . 10.0 111.529 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.61 -172.07 1.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.5 0.19 . . . . 10.0 110.797 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.21 118.71 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.217 0.532 . . . . 10.0 111.287 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . 0.487 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 40.0 t60 -138.9 128.72 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . 0.504 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 15.5 t-160 -152.51 116.75 4.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.26 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -133.29 -176.14 4.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 10.0 111.832 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -118.03 126.34 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.568 -0.742 . . . . 10.0 109.813 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -80.78 -139.6 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.469 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . 0.429 ' HB2' ' CE1' ' C' ' 291' ' ' HIS . 47.6 t60 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.404 -0.807 . . . . 10.0 110.013 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.556 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 13.8 ptt-85 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 6.4 m120 -128.22 141.04 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.039 0.447 . . . . 10.0 110.593 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.4 m -145.98 132.66 19.92 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.45 149.69 52.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.375 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' B' ' 265' ' ' LYS . 16.0 tttm -101.64 -67.34 0.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.241 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -124.24 120.33 31.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.835 0.35 . . . . 10.0 111.616 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.02 117.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.141 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.514 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 4.7 ttm180 -110.45 119.66 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.467 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.46 104.03 7.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.485 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.514 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 13.3 pt-20 -128.03 173.05 10.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.119 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 62.36 64.26 0.97 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.532 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' C' ' 272' ' ' GLU . 7.3 ttp180 57.23 42.91 24.6 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.268 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.41 168.76 10.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.503 -0.317 . . . . 10.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.432 ' HB2' ' CZ3' ' B' ' 287' ' ' TRP . 1.1 ptp180 -149.89 138.91 21.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.83 0.347 . . . . 10.0 110.387 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.5 138.13 52.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.286 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' B' ' 276' ' ' LEU . 2.8 tt0 -125.16 127.29 46.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.222 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -105.68 85.56 2.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.333 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.33 -169.65 42.41 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.225 -0.988 . . . . 10.0 112.34 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -100.19 155.06 17.96 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.099 -0.334 . . . . 10.0 110.099 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' B' ' 286' ' ' PHE . 41.3 t -109.77 118.64 57.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.2 t -111.74 110.51 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -81.81 166.35 20.07 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.976 -0.29 . . . . 10.0 110.43 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.78 5.1 1.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.68 -18.91 20.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.897 0.38 . . . . 10.0 110.335 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.52 88.07 5.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 10.0 110.172 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 31.1 mt -127.25 8.59 6.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.747 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -124.46 105.36 9.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.238 0.542 . . . . 10.0 110.939 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -173.35 154.3 19.93 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.341 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.0 -171.19 13.13 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.564 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.0 tt -98.05 107.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.3 0.572 . . . . 10.0 110.398 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -139.94 118.74 12.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.804 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 tt -89.73 112.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 23.1 m -143.98 -172.7 3.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.065 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.0 146.53 39.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.072 0.463 . . . . 10.0 110.606 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.08 140.09 52.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 260' ' ' THR . . . . . 0.496 ' HA ' ' OD1' ' D' ' 258' ' ' ASP . 0.4 OUTLIER -60.29 139.52 57.57 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.611 0.72 . . . . 10.0 111.25 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.13 106.54 18.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.402 -0.817 . . . . 10.0 110.64 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.7 t-20 -115.23 126.15 54.2 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -143.68 145.78 32.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.904 0.383 . . . . 10.0 111.14 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.52 143.67 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.258 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 265' ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 3.4 ttmt -85.57 -61.85 1.67 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.8 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 21.3 m -135.54 131.3 35.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.07 118.31 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.474 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 20.6 t -113.86 107.21 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.754 0.311 . . . . 10.0 110.555 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -110.3 130.05 9.67 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.16 -0.543 . . . . 10.0 112.066 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -135.02 124.52 24.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.809 0.338 . . . . 10.0 111.397 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 91.54 77.39 1.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 10.0 113.121 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' C' ' 236' ' ' ARG . 2.0 mt-10 52.33 33.82 13.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.904 0.482 . . . . 10.0 111.753 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.82 147.82 48.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.241 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -125.46 121.06 32.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.205 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.94 120.63 61.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.845 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.438 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -116.01 105.12 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 32.2 mm -101.55 91.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.167 0.508 . . . . 10.0 109.86 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.9 -173.05 35.17 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.303 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.47 149.23 22.92 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.075 -0.342 . . . . 10.0 110.075 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.9 138.59 48.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.935 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 1.9 t80 -120.39 102.02 8.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -141.77 173.57 23.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.54 -0.838 . . . . 10.0 112.538 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -126.39 -28.43 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.694 -0.765 . . . . 10.0 112.394 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -94.18 76.27 4.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 10.0 109.962 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 84.87 -113.77 3.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.154 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -151.48 -157.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 11.8 t90 -43.65 -53.47 5.72 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.598 0.561 . . . . 10.0 111.66 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . 0.487 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.4 OUTLIER -122.54 171.0 9.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.575 -0.45 . . . . 10.0 110.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -121.3 85.82 2.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.513 0.673 . . . . 10.0 111.064 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -117.93 -44.34 2.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.397 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' B' ' 295' ' ' HIS . 1.6 t-80 -142.55 171.3 14.24 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.906 0.335 . . . . 10.0 111.906 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 54.56 96.43 0.02 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.759 -1.11 . . . . 10.0 112.688 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -101.55 -164.83 1.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.386 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -71.02 146.28 49.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.452 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 63.1 m170 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.674 -0.679 . . . . 10.0 110.361 -179.585 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . 0.626 ' HD2' ' CG ' ' D' ' 258' ' ' ASP . 1.1 tpm_? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.042 0.448 . . . . 10.0 110.488 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' D' ' 262' ' ' ASN . 15.7 m120 -104.12 135.52 45.45 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 227' ' ' SER . . . . . 0.448 ' HB3' ' CAF' ' B' ' 301' ' ' 3LS . 27.6 m -145.71 135.45 23.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.783 0.325 . . . . 10.0 111.014 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.47 131.46 43.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.011 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' C' ' 265' ' ' LYS . 85.2 tttt -81.52 -69.98 0.57 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.737 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 124.75 39.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.437 . . . . 10.0 111.824 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.47 126.78 71.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.368 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' D' ' 232' ' ' ARG . 3.7 mmm180 -118.21 121.04 39.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.6 -0.273 . . . . 10.0 110.384 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 233' ' ' THR . . . . . 0.449 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 2.2 p -125.27 117.14 23.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.745 0.307 . . . . 10.0 110.635 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -129.34 149.04 51.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 10.0 111.8 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 67.21 80.6 0.21 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.116 -0.947 . . . . 10.0 112.658 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 57.51 16.25 3.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.397 -0.82 . . . . 10.0 112.731 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.42 152.53 36.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.662 0.268 . . . . 10.0 111.022 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.86 154.32 48.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.199 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.57 136.21 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.875 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -122.95 129.4 51.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.403 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.42 90.73 3.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.597 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 177.5 -106.95 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.187 -1.006 . . . . 10.0 112.67 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -171.67 158.02 4.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.72 108.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.0 0.428 . . . . 10.0 111.335 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 17.6 t -104.72 108.39 24.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 246' ' ' THR . . . . . 0.568 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 72.6 p -87.05 162.05 17.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.009 -0.541 . . . . 10.0 111.983 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.62 -5.34 42.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.687 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.386 0.612 . . . . 10.0 110.075 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -93.17 166.77 12.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.274 -0.876 . . . . 10.0 110.001 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 6.3 tp -155.09 -169.8 3.29 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -76.77 70.59 3.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 10.0 110.924 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -166.78 74.82 0.14 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 99.95 0.02 56.25 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.505 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.23 -24.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.028 0.442 . . . . 10.0 111.505 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.81 70.67 9.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.498 . . . . 10.0 110.178 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . 0.413 HD13 HG22 ' D' ' 256' ' ' ILE . 14.5 tt -58.42 -25.62 28.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.334 -0.848 . . . . 10.0 111.558 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m 63.38 -153.33 0.33 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.541 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . 0.626 ' CG ' ' HD2' ' D' ' 225' ' ' ARG . 1.3 m-20 -107.89 111.33 23.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 10.0 110.139 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -111.6 -87.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.2 t -87.59 159.37 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.067 0.46 . . . . 10.0 111.455 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 17.1 m -110.25 123.14 49.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.866 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . 0.478 ' HB2' ' ND2' ' D' ' 226' ' ' ASN . 15.2 m120 -114.5 107.89 16.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 18.1 m -125.9 116.29 21.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.837 0.351 . . . . 10.0 110.862 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.52 143.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 265' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 17.4 mmtp -95.88 -52.92 3.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.048 0.759 . . . . 10.0 113.048 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.14 121.96 36.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.74 113.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.683 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.28 125.29 74.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.832 0.349 . . . . 10.0 110.835 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -135.86 129.31 4.92 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.963 -0.562 . . . . 10.0 112.047 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -139.38 130.32 26.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.026 0.441 . . . . 10.0 111.433 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.34 81.39 0.79 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.294 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' E' ' 236' ' ' ARG . 1.4 tm-20 58.13 74.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.332 0.587 . . . . 10.0 110.193 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 273' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 4.0 m -125.85 140.38 52.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.437 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.77 121.4 36.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.75 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.064 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.75 105.77 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.147 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 19.2 mm -108.61 95.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.883 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.7 -177.89 33.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.102 -0.57 . . . . 10.0 112.18 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.59 164.24 12.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.635 0.255 . . . . 10.0 110.404 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.71 134.22 50.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -125.4 118.36 25.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.543 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . 0.568 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 153.92 -178.13 31.0 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.282 -0.961 . . . . 10.0 113.405 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.21 47.75 1.01 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.766 -0.534 . . . . 10.0 111.766 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -92.82 4.84 53.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.461 0.648 . . . . 10.0 109.881 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 83.86 -56.52 5.05 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . 0.447 ' CE1' HG22 ' E' ' 244' ' ' VAL . 0.8 OUTLIER -172.88 143.0 1.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . 0.471 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 44.0 t90 -48.75 -66.73 0.35 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.252 0.345 . . . . 10.0 111.787 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . 0.471 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 16.9 t0 -149.32 115.04 5.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.109 0.48 . . . . 10.0 110.302 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -136.02 173.8 11.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.671 . . . . 10.0 109.187 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -85.44 -56.95 3.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.528 0.204 . . . . 10.0 110.803 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -159.4 -168.52 2.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 10.0 111.216 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -92.54 -165.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.169 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -66.73 123.32 19.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 10.0 110.378 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -108.43 160.24 16.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.309 -0.853 . . . . 10.0 109.797 179.595 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.565 0.221 . . . . 10.0 110.484 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -119.61 120.84 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.083 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.89 149.04 50.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.549 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 133.44 24.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.148 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -68.83 0.76 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.622 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' E' ' 266' ' ' THR . 28.4 t70 -124.69 125.3 43.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 10.0 112.098 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 62.4 mt -128.49 124.05 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.113 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -120.76 121.02 37.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.781 0.324 . . . . 10.0 110.336 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 233' ' ' THR . . . . . 0.591 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 3.1 p -129.99 108.85 10.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.665 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.53 152.92 46.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.967 0.358 . . . . 10.0 111.967 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 66.18 79.89 0.23 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.527 -0.761 . . . . 10.0 112.114 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' D' ' 272' ' ' GLU . 13.2 ttp180 53.35 67.02 1.07 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.165 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' D' ' 273' ' ' SER . . . -129.99 162.28 29.04 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.169 -0.923 . . . . 10.0 110.675 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.54 146.77 28.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.349 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.28 122.99 61.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.359 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -120.52 118.51 30.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.775 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.75 100.18 8.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.019 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . 0.539 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 169.73 -173.71 43.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . 0.566 ' HB2' ' OD1' ' E' ' 279' ' ' ASN . 5.7 p-10 -111.02 144.21 40.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.87 0.367 . . . . 10.0 110.262 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . 0.447 HG22 ' CE1' ' D' ' 286' ' ' PHE . 55.1 t -98.5 130.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.987 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.77 110.6 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.529 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -61.0 164.05 5.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.011 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.12 -19.9 63.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.374 0.509 . . . . 10.0 112.374 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.29 -11.66 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.843 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.89 -155.56 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.943 -0.571 . . . . 10.0 111.137 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.34 142.56 27.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -82.36 62.59 6.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.44 0.638 . . . . 10.0 109.779 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 106.44 -170.23 16.2 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.1 80.55 1.54 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.477 -0.868 . . . . 10.0 111.901 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.54 -0.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.421 0.629 . . . . 10.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.26 73.32 0.98 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 10.0 110.489 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.8 pt -81.63 96.01 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 10.9 m -127.18 150.33 49.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.528 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.49 125.42 31.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.432 0.634 . . . . 10.0 110.245 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -124.94 46.12 2.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.575 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.1 t -149.21 141.47 24.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.002 0.429 . . . . 10.0 110.713 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 8.1 m -114.93 111.69 21.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.097 -0.502 . . . . 10.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -128.82 98.9 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.403 . . . . 10.0 110.465 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 9.9 m -107.83 117.55 34.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.173 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 15.5 t -100.32 126.57 53.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.415 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 265' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -82.61 -73.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.675 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 266' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' E' ' 230' ' ' ASP . 88.9 m -144.9 120.39 10.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.944 0.402 . . . . 10.0 111.435 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.15 121.38 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.088 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.3 t -116.08 128.85 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.146 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.26 124.37 3.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.047 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -124.91 111.75 15.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.032 0.444 . . . . 10.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.4 92.77 1.73 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.342 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.62 55.69 2.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.217 0.532 . . . . 10.0 110.38 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 127.1 42.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 5.8 mtm105 -119.8 106.96 12.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.003 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.1 111.67 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.37 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.68 106.58 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.125 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.4 mm -114.52 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.222 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 168.45 -135.3 3.56 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.381 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . 0.566 ' OD1' ' HB2' ' E' ' 243' ' ' ASN . 0.1 OUTLIER -118.97 137.57 53.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.722 0.296 . . . . 10.0 110.814 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 4.4 pt-20 -97.41 126.64 42.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' E' ' 244' ' ' VAL . 24.1 t80 -164.6 93.24 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.33 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.01 -90.8 0.4 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.279 -0.962 . . . . 10.0 112.964 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . 0.528 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 153.03 28.55 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.172 -0.537 . . . . 10.0 112.316 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.79 -65.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 10.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.95 23.47 1.16 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.373 -0.918 . . . . 10.0 113.219 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -152.31 106.76 3.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER 73.43 7.87 5.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.244 1.021 . . . . 10.0 108.345 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.7 OUTLIER -154.14 169.69 22.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.619 -1.628 . . . . 10.0 107.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -159.62 163.93 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.764 0.316 . . . . 10.0 110.846 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . 0.528 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 1.6 p-80 -158.37 -179.76 8.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.505 -0.771 . . . . 10.0 109.784 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -85.88 -73.0 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 64.6 t60 70.9 155.52 0.15 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.953 0.783 . . . . 10.0 111.392 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -111.63 128.46 56.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.578 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.98 142.25 31.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.888 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 . . . . . 0 C--O 1.246 0.884 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.33 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' 3LS . . . . . 0.651 ' SAK' ' OAA' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.986 -0.375 . . . . 10.0 109.986 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -114.03 136.72 52.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.029 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.06 132.75 28.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 10.0 110.946 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.3 164.32 17.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.192 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 265' ' ' LYS . 47.4 tttm -125.59 -69.09 0.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.848 0.356 . . . . 10.0 111.169 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -128.36 124.37 36.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.055 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.1 mt -136.72 131.55 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.334 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -129.38 111.69 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.206 0.527 . . . . 10.0 110.485 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -109.94 124.36 51.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.382 -0.826 . . . . 10.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -140.69 157.39 45.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.823 0.344 . . . . 10.0 111.375 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.8 72.64 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.484 -0.78 . . . . 10.0 111.514 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 56.57 35.97 26.87 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.315 -0.857 . . . . 10.0 111.703 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.6 149.24 22.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.121 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -132.97 145.71 51.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.922 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 2.6 p -136.81 125.29 34.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.194 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -125.57 130.96 52.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.868 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.21 122.74 48.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.416 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.51 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 144.64 -165.17 27.63 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.67 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -95.69 142.98 27.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 10.0 110.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.36 98.5 6.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.364 0.602 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.38 121.01 46.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.181 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 m -97.06 151.21 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.578 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.71 -12.89 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.112 0.482 . . . . 10.0 111.428 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -81.94 4.22 23.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.803 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -141.24 59.09 1.52 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.703 -0.68 . . . . 10.0 109.918 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 70.04 -160.12 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.425 -0.807 . . . . 10.0 111.415 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -95.45 -174.42 3.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.991 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.54 2.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.294 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.71 -43.36 99.36 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.812 -0.515 . . . . 10.0 111.812 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 70.5 mt 71.98 133.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 122.996 0.519 . . . . 10.0 111.734 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 62.9 88.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.377 -0.828 . . . . 10.0 111.619 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.18 -56.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.773 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.1 p -118.33 -86.45 0.64 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.04 0.385 . . . . 10.0 112.04 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.6 t70 63.06 84.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.716 0.635 . . . . 10.0 110.289 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -129.16 13.51 6.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.081 -0.508 . . . . 10.0 111.342 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 4.9 t -145.29 134.98 23.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.377 0.608 . . . . 10.0 111.549 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -85.37 116.57 23.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.712 . . . . 10.0 109.58 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -100.03 120.56 40.02 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.813 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.0 p -137.21 128.22 27.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.087 0.47 . . . . 10.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.93 136.21 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 229' ' ' LYS . 71.6 mmtt -93.12 -56.79 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.811 0.671 . . . . 10.0 112.811 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.77 128.91 44.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.706 0.632 . . . . 10.0 112.706 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.04 129.07 67.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.306 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.7 124.07 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.374 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.34 118.15 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.191 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -134.89 115.27 13.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.15 79.65 1.47 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.697 -0.763 . . . . 10.0 113.485 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 59.0 29.28 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.487 0.551 . . . . 10.0 112.487 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 5.5 m -77.94 141.65 38.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.402 0.62 . . . . 10.0 111.563 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -119.26 120.23 36.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.761 . . . . 10.0 109.505 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 48.5 t -113.92 118.02 57.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.242 -0.436 . . . . 10.0 110.68 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.93 116.55 27.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.404 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.24 95.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.75 160.39 9.48 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.686 -0.768 . . . . 10.0 112.069 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -77.18 148.94 35.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.74 0.305 . . . . 10.0 110.934 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 164.58 14.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.112 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -139.89 106.36 5.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.617 -0.719 . . . . 10.0 109.772 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -166.15 148.55 13.81 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.59 -0.814 . . . . 10.0 113.158 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -129.5 7.27 6.25 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.655 -0.784 . . . . 10.0 112.661 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -97.55 -13.35 21.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.674 . . . . 10.0 110.031 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.0 145.55 5.08 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.679 -0.968 . . . . 10.0 110.679 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -77.83 96.1 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.694 0.247 . . . . 10.0 110.618 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.406 ' CZ3' ' HB2' ' B' ' 238' ' ' ARG . 7.0 t90 67.9 -70.52 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.859 0.724 . . . . 10.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -167.07 96.22 0.5 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.667 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -162.67 119.24 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.318 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -122.36 106.01 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.701 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -116.55 143.57 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.288 -0.414 . . . . 10.0 109.948 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -153.55 21.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.835 -0.166 . . . . 10.0 111.359 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -127.53 124.85 39.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 10.0 111.581 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 154.48 41.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.288 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . 0.407 ' HB2' ' NH2' ' D' ' 236' ' ' ARG . 20.3 p-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.129 -0.939 . . . . 10.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -120.6 133.77 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.233 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' B' ' 263' ' ' SER . 16.3 m -130.85 111.33 12.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.915 0.388 . . . . 10.0 111.301 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -110.16 130.29 55.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.629 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.521 ' HE3' ' OBG' ' B' ' 301' ' ' 3LS . 0.0 OUTLIER -86.36 -68.92 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.92 120.43 16.05 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.964 0.412 . . . . 10.0 111.196 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.81 131.12 67.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 10.0 111.141 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' B' ' 232' ' ' ARG . 12.1 mmt85 -114.53 112.4 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.245 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.42 112.47 18.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.721 0.296 . . . . 10.0 110.974 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -133.13 150.72 52.02 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.507 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 67.89 81.04 0.2 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.443 -0.799 . . . . 10.0 113.128 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 32.8 mtm-85 54.99 22.95 4.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.196 0.598 . . . . 10.0 112.082 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -80.08 154.27 28.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.338 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.406 ' HB2' ' CZ3' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -137.49 138.25 39.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.925 -0.579 . . . . 10.0 110.379 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.74 131.37 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.112 0.482 . . . . 10.0 110.662 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -120.97 131.17 54.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.345 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' B' ' 277' ' ' ILE . 3.4 mm? -104.88 104.6 14.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.474 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.98 178.33 21.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.35 -0.929 . . . . 10.0 112.673 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -93.26 147.54 22.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.728 0.299 . . . . 10.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.54 131.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.675 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.44 113.46 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.104 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 44.4 p -90.28 171.37 9.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.381 . . . . 10.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.9 -10.23 51.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.2 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.82 -14.21 60.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.06 -6.71 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.221 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.38 114.11 3.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.535 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 23.4 t60 60.18 56.86 3.15 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.841 0.713 . . . . 10.0 110.533 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -136.34 -111.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.624 -0.717 . . . . 10.0 111.462 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.57 166.9 24.69 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.22 -0.752 . . . . 10.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 117.059 0.429 . . . . 10.0 111.057 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.25 106.92 19.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.89 0.376 . . . . 10.0 110.639 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 4.3 pt -136.5 61.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.298 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.9 m 67.34 29.52 7.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.213 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -81.14 79.41 7.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.569 0.699 . . . . 10.0 111.027 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.89 85.81 2.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.622 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.9 t -138.17 176.82 8.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.032 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.9 m -140.02 113.27 8.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.144 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -100.59 121.74 42.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.901 0.382 . . . . 10.0 110.695 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' B' ' 227' ' ' SER . 1.9 m -134.54 137.03 43.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.48 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.6 p -137.41 138.87 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.347 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 23.4 mttt -86.46 -80.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.82 120.77 42.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.2 t -115.99 105.32 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.538 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.24 113.19 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.464 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.07 134.09 9.05 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.44 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -144.81 141.06 28.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.317 -0.253 . . . . 10.0 110.317 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.73 69.07 1.43 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.198 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 59.87 42.18 16.81 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.797 0.439 . . . . 10.0 111.659 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.5 t -69.41 137.52 52.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.185 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -115.66 102.16 9.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.015 -0.539 . . . . 10.0 109.63 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 7.7 t -102.06 122.26 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.843 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.426 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -119.77 115.25 23.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.268 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.419 ' HB ' HD11 ' B' ' 241' ' ' LEU . 13.0 mm -104.5 83.57 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.819 0.342 . . . . 10.0 110.634 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.03 174.34 27.61 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.285 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -90.22 164.7 14.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.61 165.27 19.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.899 0.38 . . . . 10.0 110.099 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 2.4 t80 -143.58 78.94 1.61 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.334 -0.848 . . . . 10.0 108.834 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -112.62 -122.75 4.05 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.694 -0.765 . . . . 10.0 113.162 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 155.31 -61.95 0.36 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.303 -0.719 . . . . 10.0 111.303 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -83.67 74.49 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.58 121.15 3.85 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.388 -1.085 . . . . 10.0 110.388 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -83.49 79.27 9.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.939 0.37 . . . . 10.0 111.327 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' B' ' 276' ' ' LEU . 21.0 t90 71.28 -48.28 0.67 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.199 0.937 . . . . 10.0 112.255 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -127.7 -175.62 3.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.899 0.381 . . . . 10.0 110.432 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -92.71 131.84 37.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.998 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -164.34 91.24 0.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.12 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -130.09 130.14 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.03 -0.532 . . . . 10.0 109.632 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.93 -173.08 4.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.588 0.232 . . . . 10.0 111.133 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -111.81 132.45 54.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.98 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -87.15 -177.01 5.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.437 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.285 -0.864 . . . . 10.0 110.134 179.731 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.582 0.229 . . . . 10.0 110.409 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . 0.412 ' HB3' HG23 ' C' ' 277' ' ' ILE . 15.5 m120 -126.51 103.4 7.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 133.51 52.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.13 0.491 . . . . 10.0 111.871 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -130.11 122.28 27.97 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.037 -0.727 . . . . 10.0 109.037 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' C' ' 265' ' ' LYS . 48.8 tttm -82.69 -80.87 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.395 0.517 . . . . 10.0 112.395 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' C' ' 266' ' ' THR . 0.2 OUTLIER -109.39 122.27 47.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.268 0.556 . . . . 10.0 111.835 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . 0.4 HG23 HD12 ' C' ' 231' ' ' ILE . 88.4 mt -127.65 137.76 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.474 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.47 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 40.0 ttm-85 -128.76 119.51 24.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.92 93.57 3.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.049 0.452 . . . . 10.0 110.355 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.47 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 6.1 pt-20 -120.01 158.68 26.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.743 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 65.68 73.17 0.4 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 10.0 111.354 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 59.31 36.62 23.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.262 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.3 156.47 17.21 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.276 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -145.82 150.56 36.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.664 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 131.16 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.408 ' HB3' HD23 ' C' ' 276' ' ' LEU . 8.6 tt0 -115.81 127.16 54.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 10.0 109.958 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.11 88.25 3.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.774 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.48 171.6 31.89 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.168 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -84.34 152.58 24.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.779 0.323 . . . . 10.0 110.324 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.12 118.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.791 0.329 . . . . 10.0 110.939 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 46.6 t -121.06 110.91 29.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.031 0.443 . . . . 10.0 110.2 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.9 p -82.6 160.4 22.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.827 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.89 -4.74 7.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.76 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.41 -15.87 44.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.188 0.518 . . . . 10.0 110.242 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -100.01 94.15 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.496 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.02 20.97 13.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.338 0.59 . . . . 10.0 109.834 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -111.15 144.18 40.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.04 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.18 134.4 3.31 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.086 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.55 171.74 14.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.921 -0.657 . . . . 10.0 111.493 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.3 tp -87.17 115.74 28.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.146 0.498 . . . . 10.0 109.746 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -160.28 149.81 17.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.005 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 tt -95.32 130.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.416 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 35.3 m -153.31 169.49 22.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.792 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' D' ' 257' ' ' SER . 0.5 OUTLIER -94.53 130.11 41.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.044 0.449 . . . . 10.0 110.108 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -115.72 145.45 42.76 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.345 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.5 t -55.24 135.84 49.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.317 0.579 . . . . 10.0 111.013 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 56.0 m -96.41 139.28 32.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.951 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 20.7 t-20 -133.65 140.34 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.674 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -154.01 139.17 17.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.802 0.334 . . . . 10.0 110.126 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.39 147.15 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 265' ' ' LYS . . . . . 0.618 ' HE3' ' OBK' ' B' ' 301' ' ' 3LS . 1.1 mtpt -85.46 -58.84 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.432 . . . . 10.0 112.097 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 266' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 39.9 m -141.58 128.0 20.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.25 117.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.638 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.24 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.107 0.48 . . . . 10.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.51 138.81 15.02 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.797 -0.716 . . . . 10.0 111.667 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.25 125.6 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.912 0.356 . . . . 10.0 111.493 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.44 82.99 0.99 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.921 -0.656 . . . . 10.0 113.465 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 60.55 23.68 13.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.86 0.362 . . . . 10.0 111.377 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.18 136.82 57.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.204 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -128.07 109.91 11.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.525 -0.761 . . . . 10.0 109.825 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 37.7 t -100.45 133.82 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.759 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.409 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -127.71 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.088 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' C' ' 226' ' ' ASN . 35.3 mm -105.04 95.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.379 . . . . 10.0 110.221 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.67 -171.23 33.65 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.254 -0.738 . . . . 10.0 111.254 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.24 148.1 30.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 10.0 109.801 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -106.95 142.32 36.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 111.084 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -129.31 104.32 7.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.501 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -173.93 175.83 46.45 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.684 -0.77 . . . . 10.0 112.134 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.29 -8.71 24.9 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.541 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.67 63.58 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.166 0.508 . . . . 10.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.48 -84.74 1.07 Allowed Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.064 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.42 -51.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.409 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 8.6 t90 -144.85 -67.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . 0.425 ' OD2' ' HD2' ' D' ' 238' ' ' ARG . 2.1 p30 -107.13 165.28 11.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.066 -0.516 . . . . 10.0 109.784 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -114.65 50.65 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.916 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -79.85 -53.19 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.473 . . . . 10.0 111.811 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.13 172.24 10.7 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.954 -0.298 . . . . 10.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 66.53 173.8 0.24 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -177.85 -153.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.347 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -76.22 157.85 32.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.607 179.346 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . 0.503 ' HB3' ' HA ' ' D' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.315 0.579 . . . . 10.0 110.372 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 12.5 m120 -99.23 138.8 35.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 227' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' D' ' 263' ' ' SER . 18.3 m -154.27 148.46 25.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.071 0.462 . . . . 10.0 111.086 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.45 134.09 31.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.802 -0.635 . . . . 10.0 109.732 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' C' ' 265' ' ' LYS . 12.6 tmtt? -86.13 -64.78 1.1 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.064 -0.255 . . . . 10.0 111.382 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.8 124.18 45.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.004 0.372 . . . . 10.0 112.004 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 55.3 mt -131.3 122.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -121.57 120.43 34.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.274 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -120.06 115.23 23.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.534 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.915 0.388 . . . . 10.0 112.029 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 62.18 90.01 0.08 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.981 1.104 . . . . 10.0 113.981 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . 0.656 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 29.8 mtt180 62.57 3.17 1.05 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.602 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.95 142.56 49.42 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.987 0.422 . . . . 10.0 111.408 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . 0.425 ' HD2' ' OD2' ' C' ' 288' ' ' ASP . 0.3 OUTLIER -133.68 150.07 51.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.412 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -136.55 137.21 47.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.883 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -115.57 140.7 48.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.375 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.7 75.77 1.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.054 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . 0.561 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . -171.19 -138.79 2.6 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.223 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -139.57 132.54 29.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.87 113.86 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.117 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.4 t -117.88 106.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 246' ' ' THR . . . . . 0.509 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 0.6 OUTLIER -81.52 158.69 24.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.229 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.87 -0.97 8.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.149 0.5 . . . . 10.0 111.38 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.95 -10.5 57.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.161 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.67 113.57 26.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.049 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 6.6 mp -111.35 -166.29 1.06 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.61 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -63.13 129.64 41.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.508 0.194 . . . . 10.0 110.6 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 133.66 50.6 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.026 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.39 18.18 8.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.432 -0.89 . . . . 10.0 112.593 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -74.26 -17.52 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.094 0.473 . . . . 10.0 111.314 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -104.69 88.48 2.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 10.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 20.0 tt -82.59 -10.59 12.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.883 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 257' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' C' ' 258' ' ' ASP . 37.7 m 61.06 -133.72 0.67 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.042 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . 0.438 ' OD2' ' HD2' ' D' ' 225' ' ' ARG . 2.0 t0 -122.98 137.09 55.05 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -138.57 -83.65 0.29 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.507 -0.477 . . . . 10.0 112.033 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 12.9 t -79.29 156.31 28.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.198 0.523 . . . . 10.0 111.657 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 261' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' D' ' 225' ' ' ARG . 23.3 m -111.24 118.94 37.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.231 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 4.0 m120 -120.52 106.41 11.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 263' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' D' ' 227' ' ' SER . 23.1 m -127.61 132.58 49.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.475 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' E' ' 228' ' ' ALA . 10.1 p -120.86 144.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.638 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 265' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -82.86 -51.65 7.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.802 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 50.1 m -142.54 122.22 13.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.09 122.16 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.334 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.85 123.13 67.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.135 0.493 . . . . 10.0 111.083 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.49 134.32 10.27 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -138.4 115.05 10.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.202 0.501 . . . . 10.0 111.474 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.17 93.12 0.79 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.967 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . 0.656 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 52.8 mm-40 54.94 33.3 19.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.214 0.53 . . . . 10.0 111.527 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -75.78 144.54 41.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.737 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -127.49 103.25 7.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.248 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 62.4 t -98.73 117.89 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.49 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . 0.443 ' HB2' ' CH2' ' D' ' 287' ' ' TRP . 0.6 OUTLIER -114.08 106.16 14.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.531 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 30.6 mm -102.43 86.36 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . 162.21 -171.41 38.09 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.527 -0.844 . . . . 10.0 112.365 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -113.02 162.74 15.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.275 -0.268 . . . . 10.0 110.275 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.77 142.97 49.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 10.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -135.19 116.27 14.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.209 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . 0.509 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 152.29 166.28 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.481 -0.866 . . . . 10.0 112.422 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -83.98 71.57 2.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -117.1 -5.72 11.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.095 0.474 . . . . 10.0 110.292 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.94 -54.6 4.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.069 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -163.07 144.9 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.151 -0.315 . . . . 10.0 110.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . 0.443 ' CH2' ' HB2' ' D' ' 276' ' ' LEU . 34.6 t90 -59.52 -63.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.244 0.34 . . . . 10.0 111.25 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . 0.462 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 60.1 t0 -146.03 115.29 7.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 10.0 109.97 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -142.87 161.83 37.08 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.93 -51.92 7.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.673 0.273 . . . . 10.0 110.7 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -156.57 -175.44 5.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.444 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -91.93 -151.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.851 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.18 119.55 10.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.807 0.337 . . . . 10.0 110.757 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -113.28 154.59 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.168 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.656 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' E' ' 261' ' ' THR . 93.3 mtt180 . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' E' ' 262' ' ' ASN . 9.5 m120 -130.84 120.66 24.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.945 0.402 . . . . 10.0 111.14 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 227' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' E' ' 263' ' ' SER . 1.3 m -118.74 141.9 48.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' D' ' 264' ' ' VAL . . . -132.17 133.26 44.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.167 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . 0.574 ' HB3' ' O ' ' E' ' 265' ' ' LYS . 1.1 ttmm -91.25 -77.72 0.41 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.899 -0.32 . . . . 10.0 111.143 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.7 126.78 51.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 10.0 111.666 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 66.5 mt -132.82 124.03 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -122.15 109.82 14.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.537 . . . . 10.0 110.3 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.5 p -113.53 96.82 6.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.358 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -117.07 152.22 35.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.441 . . . . 10.0 112.103 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 65.15 81.5 0.21 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.741 -1.118 . . . . 10.0 111.441 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 50.82 63.69 2.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.07 -0.968 . . . . 10.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.78 155.28 45.4 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.985 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . 0.462 ' HE ' ' CG ' ' D' ' 288' ' ' ASP . 0.1 OUTLIER -136.48 149.35 48.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.885 -178.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.09 127.12 32.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.92 -0.582 . . . . 10.0 109.982 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -120.75 128.11 52.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.589 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.47 92.42 3.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.751 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 167.53 -165.31 38.56 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.765 -0.731 . . . . 10.0 112.172 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -103.44 150.18 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.953 0.406 . . . . 10.0 110.783 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.81 110.93 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.911 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.17 112.09 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.096 0.474 . . . . 10.0 110.431 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 246' ' ' THR . . . . . 0.553 HG21 ' H ' ' E' ' 248' ' ' ALA . 14.5 t -76.02 179.4 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.72 -7.53 11.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.035 0.754 . . . . 10.0 113.035 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . 0.553 ' H ' HG21 ' E' ' 246' ' ' THR . . . -67.49 -30.85 70.65 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.754 -0.461 . . . . 10.0 109.754 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.96 -173.59 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.072 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 60.9 mt -89.48 123.51 33.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.889 -0.596 . . . . 10.0 109.618 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -63.96 -28.41 69.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.81 -167.48 25.45 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.003 -0.839 . . . . 10.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 85.88 92.56 0.85 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 10.0 112.238 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 35.0 mt -78.75 -31.77 15.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.626 . . . . 10.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . 0.407 ' HA ' ' NE ' ' E' ' 255' ' ' ARG . 0.4 OUTLIER -84.74 83.53 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.777 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.29 109.75 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 10.0 110.075 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 35.5 m -143.13 140.82 31.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.055 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.79 130.94 35.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.262 0.553 . . . . 10.0 110.338 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -108.42 -52.8 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.67 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.4 t -67.79 133.69 49.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.465 0.65 . . . . 10.0 111.319 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 261' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 94.9 m -121.69 113.11 19.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.694 -0.684 . . . . 10.0 109.889 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . 0.463 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 11.2 m120 -115.86 141.25 48.35 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.52 -0.764 . . . . 10.0 110.281 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 263' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' E' ' 227' ' ' SER . 73.3 m -142.22 133.34 26.07 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.34 138.31 49.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.183 0.516 . . . . 10.0 110.411 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 265' ' ' LYS . . . . . 0.574 ' O ' ' HB3' ' E' ' 229' ' ' LYS . 80.8 mttt -84.18 -60.79 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.211 -0.449 . . . . 10.0 112.144 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.5 m -135.92 123.71 22.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 t -120.23 111.23 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.403 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -114.39 110.51 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.758 0.313 . . . . 10.0 111.029 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.0 117.43 3.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.014 -0.613 . . . . 10.0 111.7 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.02 114.07 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.748 0.309 . . . . 10.0 111.519 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.0 90.54 0.4 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.819 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 60.76 85.77 0.11 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.178 0.513 . . . . 10.0 111.319 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.41 136.1 48.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.94 104.26 10.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.35 117.89 51.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.024 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.03 113.08 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.139 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 38.3 mm -107.65 87.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.388 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 166.56 -156.39 28.25 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.901 -0.666 . . . . 10.0 111.948 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -110.18 145.58 37.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.97 0.414 . . . . 10.0 110.293 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' E' ' 288' ' ' ASP . 0.7 OUTLIER -106.21 146.71 29.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.541 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -159.17 84.49 0.79 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.045 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.36 -104.92 1.31 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.239 -0.981 . . . . 10.0 113.19 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . 0.409 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 154.36 59.95 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.204 -0.522 . . . . 10.0 111.916 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -135.45 -59.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.516 0.198 . . . . 10.0 110.726 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.5 19.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.55 -0.833 . . . . 10.0 113.65 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -156.13 113.86 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.397 0.599 . . . . 10.0 109.944 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 68.24 16.29 9.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.086 0.946 . . . . 10.0 108.799 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . 0.465 ' HA ' ' HG3' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -154.97 168.53 26.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.993 -1.458 . . . . 10.0 108.14 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -153.32 143.43 22.24 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.852 -0.339 . . . . 10.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . 0.409 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 2.2 p-80 -149.34 178.65 8.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.979 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -105.12 -62.96 1.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.679 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 t60 66.65 168.35 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.758 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -108.32 107.07 17.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.997 0.427 . . . . 10.0 110.003 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.02 132.31 42.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.72 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.773 0 CA-C-O 118.49 -0.767 . . . . 10.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' 3LS . . . . . 0.795 ' SAK' ' OBK' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.206 -0.294 . . . . 10.0 110.206 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -105.21 142.4 35.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.9 m -147.15 137.47 23.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.781 0.324 . . . . 10.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -140.87 151.93 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.321 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -112.46 -56.84 2.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -137.02 121.32 18.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.853 0.359 . . . . 10.0 111.378 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 54.2 mt -128.14 119.01 49.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.084 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -127.84 110.83 12.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.309 0.576 . . . . 10.0 110.532 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.95 127.16 51.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.555 -0.748 . . . . 10.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.73 176.94 8.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.426 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 60.53 66.9 0.88 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.077 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 57.8 65.44 1.32 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.901 -1.045 . . . . 10.0 110.94 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -131.81 178.68 6.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 238' ' ' ARG . 6.2 ptp180 -159.18 155.12 26.55 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.026 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.18 136.74 59.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.471 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -129.21 134.41 47.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.994 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.53 138.12 51.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.278 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.74 -123.1 2.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.312 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -143.91 141.71 30.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 41.8 t -105.41 110.52 31.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.216 0.531 . . . . 10.0 111.56 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.12 108.51 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.647 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.424 ' HB ' ' HA2' ' A' ' 282' ' ' GLY . 12.0 m -84.62 149.72 25.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.183 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.3 -14.17 16.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.64 -13.3 56.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 10.0 110.904 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -106.94 25.31 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.431 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 3.9 mm? 70.95 -159.64 0.13 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.258 -0.883 . . . . 10.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.404 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 48.8 p-80 -76.86 169.63 17.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.235 0.541 . . . . 10.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -77.58 80.13 1.33 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.3 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.04 -36.6 93.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.218 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 255' ' ' ARG . 29.8 mt 72.72 146.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.547 0.792 . . . . 10.0 111.68 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.488 ' N ' HG23 ' A' ' 254' ' ' ILE . 67.4 ttt180 61.85 87.54 0.1 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.286 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 20.7 mt -123.38 -67.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.96 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 p -101.34 -90.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.861 -0.154 . . . . 10.0 111.408 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.1 t0 56.1 69.1 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.706 0.628 . . . . 10.0 110.932 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -121.07 2.65 10.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 10.0 110.623 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -136.38 152.0 50.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.38 127.85 42.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.345 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -101.77 83.61 2.43 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -108.81 116.69 32.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.602 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 228' ' ' ALA . 14.2 p -119.81 140.31 44.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.7 mttm -91.84 -79.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.179 0.437 . . . . 10.0 112.179 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 128.73 54.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.06 119.54 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.456 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.73 125.27 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.774 0.321 . . . . 10.0 111.491 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -128.91 129.31 6.11 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.197 -0.525 . . . . 10.0 111.934 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -145.01 111.87 5.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.901 0.382 . . . . 10.0 111.339 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.16 82.57 1.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.867 -0.683 . . . . 10.0 112.952 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 52.17 50.59 18.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.506 0.669 . . . . 10.0 110.996 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 m -102.26 141.64 34.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.966 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -121.15 119.43 32.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.32 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 55.2 t -103.31 119.07 51.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.918 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -114.15 103.6 11.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.36 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 8.8 mm -96.98 101.54 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.358 -0.383 . . . . 10.0 109.992 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 142.44 179.24 19.14 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.847 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.15 159.95 15.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.846 0.323 . . . . 10.0 110.642 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.96 156.86 39.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.447 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.86 86.97 2.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.325 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.424 ' HA2' ' HB ' ' A' ' 246' ' ' THR . . . -109.02 -145.83 11.4 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.353 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -174.35 -82.29 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -88.89 89.99 8.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.337 -0.986 . . . . 10.0 108.337 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 108.08 110.28 3.4 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.511 -1.035 . . . . 10.0 110.511 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -75.6 81.89 2.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.573 0.225 . . . . 10.0 110.916 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.5 t90 67.35 -69.6 0.13 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.145 0.903 . . . . 10.0 111.777 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.33 90.71 3.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.735 0.302 . . . . 10.0 110.749 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -155.42 136.38 13.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.561 -0.29 . . . . 10.0 110.772 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -157.93 34.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.068 -0.715 . . . . 10.0 109.068 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.22 132.13 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.836 -0.62 . . . . 10.0 111.52 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -137.16 15.87 3.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.639 0.733 . . . . 10.0 109.433 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -91.54 84.3 5.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.032 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -66.22 126.21 27.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.955 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.302 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.4 142.04 40.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.242 -0.651 . . . . 10.0 109.242 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.9 m -143.92 126.85 16.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.83 0.348 . . . . 10.0 111.091 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.18 134.95 47.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.405 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' B' ' 265' ' ' LYS . 50.9 mmtt -87.38 -59.39 2.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.451 -0.34 . . . . 10.0 111.776 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' B' ' 266' ' ' THR . 26.0 t70 -146.14 123.94 11.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.481 . . . . 10.0 110.869 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.06 130.61 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.06 113.05 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.446 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 1.3 p -124.06 114.12 19.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.653 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.23 156.05 48.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.971 0.415 . . . . 10.0 111.39 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 60.78 80.19 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.019 -0.991 . . . . 10.0 112.185 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 58.04 37.02 26.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.664 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.74 141.85 30.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 10.0 110.533 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.58 131.21 46.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.747 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.43 133.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.131 0.491 . . . . 10.0 111.093 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -115.98 125.77 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.877 -0.601 . . . . 10.0 109.987 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.35 83.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.141 -0.482 . . . . 10.0 111.307 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.93 -177.27 42.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.169 -1.015 . . . . 10.0 112.938 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -90.06 139.63 30.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 10.0 110.201 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 92.7 t -104.6 114.22 43.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.496 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.9 t -119.71 106.5 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.978 0.418 . . . . 10.0 110.028 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 82.5 p -79.66 173.11 12.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.049 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.29 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 10.0 112.096 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.92 -21.59 50.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.784 0.326 . . . . 10.0 110.524 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.485 ' HB3' ' CD1' ' B' ' 281' ' ' TYR . . . -93.71 17.95 11.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.25 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.69 106.0 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.883 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t60 65.06 82.39 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.954 0.784 . . . . 10.0 111.481 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.6 -135.87 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.915 -0.66 . . . . 10.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.17 127.61 6.14 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.294 -0.722 . . . . 10.0 111.294 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 36.3 mt -119.94 -33.23 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.048 0.451 . . . . 10.0 111.218 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -86.19 88.62 7.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.842 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt -120.37 54.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.569 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 m 65.92 38.25 5.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.615 -0.72 . . . . 10.0 110.332 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.96 61.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.226 -0.897 . . . . 10.0 111.541 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -104.8 98.1 7.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.004 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 9.0 t -156.57 148.54 22.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.281 0.562 . . . . 10.0 111.326 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' C' ' 225' ' ' ARG . 0.1 OUTLIER -118.94 98.39 6.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.238 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -88.01 116.29 26.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' C' ' 227' ' ' SER . 0.0 OUTLIER -124.08 135.45 53.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.566 -0.743 . . . . 10.0 111.61 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.18 135.79 49.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.274 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 0.5 OUTLIER -80.63 -73.93 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.508 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 0.6 OUTLIER -124.15 139.2 54.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.36 121.97 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.167 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.59 119.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.834 0.35 . . . . 10.0 110.984 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.85 117.55 3.19 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -134.45 119.48 18.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.75 0.275 . . . . 10.0 111.364 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.98 87.15 1.08 Allowed Glycine 0 C--N 1.329 0.15 0 C-N-CA 120.863 -0.684 . . . . 10.0 113.474 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 53.04 41.01 32.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.867 0.467 . . . . 10.0 111.51 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.0 t -76.92 154.21 33.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.282 0.563 . . . . 10.0 111.439 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -136.36 106.56 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.912 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.74 126.11 64.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.014 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.89 117.3 28.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.35 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.52 85.32 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.241 0.543 . . . . 10.0 109.776 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.96 168.29 19.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.056 -0.818 . . . . 10.0 111.056 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -88.83 158.55 18.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.223 0.511 . . . . 10.0 110.234 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.42 162.16 24.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.271 0.557 . . . . 10.0 111.039 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' B' ' 249' ' ' ALA . 2.7 t80 -140.35 95.78 2.93 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.047 -0.979 . . . . 10.0 108.862 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -120.9 -122.91 2.96 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.957 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' B' ' 285' ' ' GLY . . . 151.34 -44.17 0.67 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.855 -0.898 . . . . 10.0 110.855 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -82.72 35.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.804 0.812 . . . . 10.0 109.2 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' B' ' 283' ' ' GLY . . . 136.23 172.0 12.47 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.42 -1.472 . . . . 10.0 109.42 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.417 ' C ' ' H ' ' B' ' 288' ' ' ASP . 40.4 m-85 -112.98 62.82 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 22.1 t90 71.3 -45.87 0.63 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.103 0.877 . . . . 10.0 110.591 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' C' ' 274' ' ' ARG . 37.5 t70 -101.14 151.17 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.287 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.86 101.23 12.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.418 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . 0.634 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 36.0 t60 -131.89 134.88 46.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.423 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -154.38 126.33 7.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.023 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.23 -167.44 2.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.696 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -119.23 127.1 52.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.751 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -70.8 165.77 22.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.775 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.629 -0.7 . . . . 10.0 110.289 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' B' ' 261' ' ' THR . 20.3 ptt-85 . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 109.876 -0.416 . . . . 10.0 109.876 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -120.56 133.22 55.41 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.247 0.342 . . . . 10.0 110.639 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' B' ' 263' ' ' SER . 67.7 m -139.25 133.28 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.843 0.354 . . . . 10.0 110.558 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.96 51.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.623 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.457 ' HB2' ' OBK' ' B' ' 301' ' ' 3LS . 8.3 tttt -90.39 -72.72 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.68 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -123.97 121.67 35.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.995 0.426 . . . . 10.0 111.46 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.47 126.71 74.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.856 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.416 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 38.6 ttm-85 -113.62 120.69 41.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.2 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 86.84 2.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 10.0 110.49 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.416 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 5.6 pt-20 -117.17 172.7 7.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.631 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.503 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 48.2 mt-10 65.95 59.74 0.7 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 64.19 15.41 9.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.399 -0.818 . . . . 10.0 112.748 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.63 156.87 32.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.844 0.354 . . . . 10.0 111.462 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.494 HH22 ' CD ' ' C' ' 272' ' ' GLU . 0.2 OUTLIER -137.23 146.62 45.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.31 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.19 140.07 44.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.768 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -125.16 124.66 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.395 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.21 97.46 8.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.181 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.77 32.76 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.534 -0.841 . . . . 10.0 112.496 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.49 158.87 15.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 10.0 110.218 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.84 110.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.961 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.47 121.43 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.002 0.43 . . . . 10.0 110.968 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 246' ' ' THR . . . . . 0.481 ' C ' ' H ' ' C' ' 248' ' ' ALA . 11.0 p -87.84 165.88 14.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.917 -0.583 . . . . 10.0 109.734 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.05 26.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.291 0.567 . . . . 10.0 111.975 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' C' ' 246' ' ' THR . . . -117.75 -10.22 10.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.155 0.502 . . . . 10.0 110.142 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -96.44 73.34 2.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.245 0.545 . . . . 10.0 110.701 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 14.0 mt -109.35 -16.93 13.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.043 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -86.55 76.73 9.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.307 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.75 8.19 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -116.75 164.0 12.41 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 17.1 tt -77.32 128.93 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 10.0 110.57 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -157.29 110.79 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.403 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 5.7 tt -81.99 99.35 5.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.944 0.878 . . . . 10.0 110.379 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -132.97 -176.52 4.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 10.0 110.091 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 0.2 OUTLIER -64.33 157.14 26.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.836 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.25 138.81 22.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 9.7 t -64.71 127.07 29.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.287 0.565 . . . . 10.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.07 137.18 38.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.528 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . 0.427 ' OD1' ' HB3' ' D' ' 241' ' ' LEU . 25.8 t-20 -133.18 132.19 41.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 10.0 110.408 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 263' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' D' ' 227' ' ' SER . 17.8 m -151.49 150.2 30.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.737 0.303 . . . . 10.0 110.858 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.34 144.85 25.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 265' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 2.4 mtpt -88.2 -70.76 0.62 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.719 0.637 . . . . 10.0 112.719 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 128.66 51.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.478 0.547 . . . . 10.0 112.478 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.55 118.33 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.588 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 85.5 t -110.05 120.4 61.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.053 0.454 . . . . 10.0 110.928 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -123.48 122.94 5.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.268 -0.733 . . . . 10.0 111.268 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.456 ' HB2' ' HG2' ' D' ' 234' ' ' GLU . 27.4 mttm -138.43 141.19 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.63 0.252 . . . . 10.0 111.472 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . 0.503 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 71.61 79.77 0.39 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.868 -0.605 . . . . 10.0 113.519 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . 0.494 ' CD ' HH22 ' C' ' 238' ' ' ARG . 36.5 mm-40 55.18 39.77 31.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.053 0.454 . . . . 10.0 111.585 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 157.65 23.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 10.0 111.296 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.604 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 1.3 mtm180 -137.7 118.56 14.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.06 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.98 126.7 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.276 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.557 ' HB2' ' CZ3' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -117.42 112.47 20.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.243 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 34.1 mm -111.32 87.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.14 0.495 . . . . 10.0 110.062 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 162.59 -175.61 38.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.964 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -95.64 145.2 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.091 0.472 . . . . 10.0 110.162 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.47 143.47 37.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -130.1 101.42 5.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.605 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -133.27 -158.1 8.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.673 -0.775 . . . . 10.0 112.509 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.9 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.432 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -72.05 -17.51 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 10.0 111.183 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . 0.407 ' HA2' ' HE3' ' D' ' 284' ' ' LYS . . . 168.3 -143.72 8.33 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.803 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.407 ' HB2' ' H ' ' C' ' 287' ' ' TRP . 9.7 p90 -104.53 -160.14 0.75 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.889 -0.412 . . . . 10.0 109.889 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.604 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 9.2 t90 -49.18 -43.79 42.43 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.481 0.488 . . . . 10.0 112.281 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . 0.634 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.0 OUTLIER -122.76 168.89 11.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.648 -0.421 . . . . 10.0 111.122 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -120.54 38.56 3.97 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.183 0.808 . . . . 10.0 113.183 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -65.61 -51.19 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.075 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . 0.414 ' HB2' HH22 ' D' ' 274' ' ' ARG . 6.0 m170 -130.13 177.28 7.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 71.34 155.73 0.15 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.884 0.74 . . . . 10.0 111.423 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.1 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.205 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -126.94 -176.01 3.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.709 -0.662 . . . . 10.0 110.747 -179.453 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . 0.548 ' HD3' ' OD2' ' D' ' 258' ' ' ASP . 6.0 mpt_? . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.864 0.364 . . . . 10.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -108.95 116.48 32.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 227' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' C' ' 263' ' ' SER . 19.9 m -138.58 132.63 31.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.006 0.431 . . . . 10.0 111.239 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.85 142.11 48.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.73 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 23.5 tttp -88.78 -71.5 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -118.21 119.74 35.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.723 0.297 . . . . 10.0 111.41 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 57.1 mt -122.8 118.71 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.041 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -110.61 124.56 52.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.904 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 233' ' ' THR . . . . . 0.444 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.6 OUTLIER -135.93 104.89 5.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.039 0.447 . . . . 10.0 110.462 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' C' ' 270' ' ' LYS . 1.7 mt-10 -128.59 162.13 27.99 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 66.97 72.28 0.36 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.677 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . 0.533 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 4.6 mtp180 55.82 32.5 19.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.872 -0.603 . . . . 10.0 111.928 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.26 173.35 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.98 0.419 . . . . 10.0 111.579 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.93 152.36 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.492 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 1.8 p -143.27 135.97 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.602 . . . . 10.0 110.434 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -124.06 128.63 49.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.19 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . 0.427 ' HB3' ' OD1' ' C' ' 262' ' ' ASN . 3.1 mm? -110.66 101.79 10.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.355 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.31 -108.97 0.35 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.956 -1.116 . . . . 10.0 113.214 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -164.65 158.12 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.13 112.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.987 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.3 t -117.67 128.79 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 10.0 110.088 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 246' ' ' THR . . . . . 0.497 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 2.1 p -109.54 161.37 15.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.99 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.84 -2.06 6.59 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.9 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.17 59.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.996 0.427 . . . . 10.0 110.263 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -112.53 102.86 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.952 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.56 -159.88 0.76 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.095 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -71.0 79.45 0.65 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.267 0.556 . . . . 10.0 110.693 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -146.07 39.93 1.1 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.928 -0.869 . . . . 10.0 110.928 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.04 31.15 7.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.412 -0.675 . . . . 10.0 111.412 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.7 tt -74.39 -19.48 17.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.349 . . . . 10.0 111.397 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -78.39 69.51 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.532 0.682 . . . . 10.0 110.117 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.57 -16.73 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.085 . . . . 10.0 111.935 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 257' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 10.5 m 61.67 -127.16 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . 0.548 ' OD2' ' HD3' ' D' ' 225' ' ' ARG . 1.1 t0 -125.21 137.88 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' E' ' 257' ' ' SER . 9.6 tp60 -136.27 -72.43 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.521 -0.472 . . . . 10.0 112.128 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 8.7 t -78.69 151.39 32.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.467 0.651 . . . . 10.0 111.522 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -114.84 90.9 3.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.586 -0.734 . . . . 10.0 109.397 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 7.4 m120 -98.45 112.84 24.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.478 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -129.01 99.71 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.497 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 13.2 p -97.09 142.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 10.0 109.873 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 265' ' ' LYS . . . . . 0.57 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 1.8 mptt -95.81 -50.45 4.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.75 0.648 . . . . 10.0 112.75 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 11.1 m -133.49 122.61 23.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.638 -0.664 . . . . 10.0 112.281 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.77 117.75 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.991 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.55 110.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.679 -0.237 . . . . 10.0 110.593 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -118.01 120.12 4.63 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.383 -0.437 . . . . 10.0 112.331 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -135.05 127.39 30.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.829 -0.218 . . . . 10.0 111.525 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.48 83.6 1.12 Allowed Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.174 -0.536 . . . . 10.0 113.631 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . 0.533 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 5.8 mp0 53.28 32.96 14.48 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.945 0.498 . . . . 10.0 111.799 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.7 t -75.94 147.98 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.143 0.497 . . . . 10.0 110.85 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . 0.414 HH22 ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.89 113.35 15.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.793 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 47.4 t -101.16 110.58 28.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 10.0 110.447 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.87 106.59 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 18.1 mm -105.18 89.98 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.7 -169.72 35.13 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.875 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -107.98 167.77 9.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.622 0.249 . . . . 10.0 110.715 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.21 140.79 52.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.548 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.06 114.05 13.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.079 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . 0.497 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 162.99 163.69 16.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.363 -0.923 . . . . 10.0 112.734 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -97.45 58.38 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.508 -0.854 . . . . 10.0 112.255 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . 0.407 ' HE3' ' HA2' ' C' ' 285' ' ' GLY . 39.2 tttm -116.72 12.74 14.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.236 0.541 . . . . 10.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.31 -50.25 4.16 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.665 -0.698 . . . . 10.0 113.077 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -170.27 157.48 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . 0.513 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 25.3 t90 -60.75 -62.91 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.706 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . 0.513 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 7.7 t70 -146.12 124.53 12.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.165 0.507 . . . . 10.0 110.098 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.76 172.45 12.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 10.0 109.847 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -101.33 -51.25 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 111.042 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -156.68 -173.09 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.701 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -100.3 -159.21 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.207 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -76.06 103.37 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 10.0 110.374 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -103.81 175.08 5.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.537 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.574 -0.727 . . . . 10.0 109.57 179.786 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' E' ' 261' ' ' THR . 76.4 mtt180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 18.6 m120 -133.02 110.99 10.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.206 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 7.0 m -118.08 145.13 45.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 10.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.76 125.68 25.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.793 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' E' ' 265' ' ' LYS . 42.1 mttm -77.09 -70.14 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.53 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -129.73 129.79 44.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.355 -0.384 . . . . 10.0 111.367 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.53 126.08 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.256 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -117.09 110.65 18.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 10.0 110.269 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 233' ' ' THR . . . . . 0.437 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 1.4 p -125.14 103.77 8.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.428 -0.805 . . . . 10.0 111.186 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -132.95 154.7 50.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 10.0 111.848 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . 0.419 ' HB3' ' H ' ' E' ' 271' ' ' GLY . 33.7 tt0 65.45 76.1 0.34 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.469 -0.787 . . . . 10.0 111.067 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 56.59 71.04 0.59 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.221 -0.899 . . . . 10.0 110.455 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -127.49 159.7 33.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.168 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 139.04 38.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.531 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.28 124.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.135 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -126.16 125.34 42.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.541 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mp -119.62 100.64 7.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.395 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.99 -173.38 40.84 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.298 -0.721 . . . . 10.0 111.298 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -103.49 154.53 19.35 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.15 129.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.409 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.2 99.15 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 10.0 110.837 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 246' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' D' ' 282' ' ' GLY . 7.5 t -69.15 169.64 11.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.202 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.51 -21.09 62.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.822 0.344 . . . . 10.0 111.7 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.09 73.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.998 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.72 -163.46 0.19 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.295 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.46 107.95 20.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.213 -0.449 . . . . 10.0 109.863 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -77.74 81.93 4.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.046 0.45 . . . . 10.0 110.722 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.24 140.98 10.5 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.839 -0.619 . . . . 10.0 112.016 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 119.55 98.47 1.77 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.75 -0.738 . . . . 10.0 111.906 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.67 -27.56 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.266 0.555 . . . . 10.0 110.471 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.05 59.23 5.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.405 0.621 . . . . 10.0 110.148 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 6.0 pt -86.09 123.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 257' ' ' SER . . . . . 0.469 ' HA ' ' NE2' ' D' ' 259' ' ' GLN . 67.0 m -152.96 166.61 31.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.672 -0.24 . . . . 10.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.38 117.76 9.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.851 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.49 16.29 8.23 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.35 0.5 . . . . 10.0 112.35 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -152.34 136.86 16.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.09 -0.381 . . . . 10.0 110.932 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 261' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 31.4 m -121.97 112.88 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.175 0.512 . . . . 10.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . 0.428 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 15.7 m120 -115.41 114.87 25.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.832 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.1 m -118.82 121.07 39.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 10.0 109.977 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -108.96 147.12 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 10.0 110.112 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 265' ' ' LYS . . . . . 0.655 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 82.6 mttt -85.88 -79.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 13.0 m -131.07 132.08 44.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.875 0.369 . . . . 10.0 111.143 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 t -121.98 106.21 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.967 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.53 125.89 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.663 -0.244 . . . . 10.0 110.549 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -145.47 136.67 6.6 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.545 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.89 130.37 22.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' E' ' 235' ' ' GLU . . . 84.17 85.93 0.89 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.555 -0.831 . . . . 10.0 111.82 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 60.55 60.82 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 10.0 110.85 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.68 136.06 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.701 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.63 104.25 8.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.911 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.28 120.21 58.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.853 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.98 119.94 29.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 28.1 mm -117.75 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 10.0 110.981 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.15 -176.22 34.42 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.499 -0.641 . . . . 10.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -91.63 139.91 30.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.877 -0.416 . . . . 10.0 109.877 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.86 159.83 15.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.333 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -169.64 99.6 0.32 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.275 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.9 -114.56 1.43 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.549 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . 0.494 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 166.64 58.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.313 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -137.88 -59.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.443 0.163 . . . . 10.0 110.781 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.62 13.19 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.358 -0.925 . . . . 10.0 113.824 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -152.76 114.35 4.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.161 0.481 . . . . 10.0 109.795 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 73.16 10.92 5.15 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.81 0.814 . . . . 10.0 109.302 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -145.88 -179.9 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.546 -1.206 . . . . 10.0 109.173 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -161.55 137.13 7.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.188 -0.301 . . . . 10.0 110.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . 0.494 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 7.3 p-80 -150.33 169.45 21.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.397 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -76.65 -70.76 0.43 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.303 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . 0.444 ' HB2' ' NE2' ' E' ' 290' ' ' HIS . 13.7 t60 69.46 153.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.21 0.604 . . . . 10.0 111.615 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -127.08 112.2 14.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.189 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -95.3 -176.25 3.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.761 -0.637 . . . . 10.0 109.807 179.57 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' 3LS . . . . . 0.775 ' SAK' ' OAA' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 110.494 -0.188 . . . . 10.0 110.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -117.34 127.16 53.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 263' ' ' SER . 13.4 m -149.16 159.43 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 10.0 111.428 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.15 162.4 35.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.004 -0.544 . . . . 10.0 109.996 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -121.37 -75.46 0.59 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 10.0 111.844 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 266' ' ' THR . 29.0 t70 -113.51 117.47 31.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.866 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.447 HD13 HG22 ' A' ' 231' ' ' ILE . 31.8 pt -136.0 144.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.525 -0.307 . . . . 10.0 111.096 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -142.26 126.95 18.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.092 0.472 . . . . 10.0 110.93 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 21.0 p -121.79 113.28 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.271 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.47 158.65 37.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 10.0 111.4 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.49 71.76 0.55 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.427 -0.806 . . . . 10.0 111.908 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 34.9 mtm105 56.63 42.5 26.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 10.0 111.908 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.4 153.23 20.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.282 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -134.41 160.49 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.511 -0.313 . . . . 10.0 111.069 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 138.59 23.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -135.3 122.04 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 10.0 109.935 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.47 133.69 53.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.768 0.318 . . . . 10.0 110.253 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.402 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 140.97 -119.17 1.49 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.204 -0.522 . . . . 10.0 112.281 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -147.42 143.78 28.17 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.78 107.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.848 0.356 . . . . 10.0 111.362 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.93 120.2 50.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.561 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 m -85.67 151.6 23.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.619 . . . . 10.0 109.907 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.68 -14.89 60.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -87.11 -1.88 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.002 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -119.59 52.99 1.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.265 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 65.96 -158.07 0.26 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.102 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -93.09 178.91 5.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.995 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -80.62 69.03 3.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.483 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.63 68.33 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.238 -0.745 . . . . 10.0 111.238 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.5 mt 70.51 144.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.259 0.623 . . . . 10.0 112.477 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.19 60.56 1.17 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.3 -0.863 . . . . 10.0 111.153 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.73 -50.75 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.54 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.5 p -128.61 -83.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.848 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.5 t70 54.29 72.56 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.77 0.669 . . . . 10.0 110.615 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -119.18 24.24 10.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.95 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 4.4 t -139.21 140.91 37.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.35 0.595 . . . . 10.0 112.009 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -91.23 112.46 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.105 -0.952 . . . . 10.0 110.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.423 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 15.6 m-20 -115.46 113.53 23.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 227' ' ' SER . 37.3 m -142.95 124.76 15.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 10.0 110.957 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.8 152.57 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.774 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 -56.88 2.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.83 -0.348 . . . . 10.0 111.48 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 10.5 m -133.75 130.32 37.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.49 124.31 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.919 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 14.8 t -115.92 117.42 55.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.817 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.38 119.32 4.25 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.105 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -134.49 123.32 23.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.925 0.393 . . . . 10.0 111.361 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.91 70.05 1.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.714 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 25.7 tt0 54.83 51.0 14.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.469 0.652 . . . . 10.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.88 144.7 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.508 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -119.03 112.68 19.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.288 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.58 115.14 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.842 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.53 111.05 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.845 0.355 . . . . 10.0 110.251 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 15.1 mm -101.94 98.85 7.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.822 0.344 . . . . 10.0 110.147 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.72 161.09 8.59 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.016 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.43 152.06 36.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.639 0.257 . . . . 10.0 110.361 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -175.79 2.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.027 0.441 . . . . 10.0 111.04 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -158.26 97.17 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.459 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.04 -147.8 5.7 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.253 -0.975 . . . . 10.0 114.149 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -175.31 -83.93 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.746 -0.542 . . . . 10.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -81.92 81.39 7.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.248 0.547 . . . . 10.0 109.573 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 120.11 108.12 2.19 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.655 -0.978 . . . . 10.0 110.655 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -74.34 83.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.658 0.266 . . . . 10.0 110.724 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t90 69.11 -65.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.206 -0.906 . . . . 10.0 111.191 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -154.13 91.83 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.959 0.409 . . . . 10.0 110.838 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -156.84 129.8 7.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -147.9 85.9 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -118.25 137.52 52.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.231 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -132.55 14.01 4.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.558 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -89.4 134.52 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.841 -0.6 . . . . 10.0 110.28 179.615 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.069 -0.345 . . . . 10.0 110.069 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -116.89 123.69 47.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.002 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -109.97 90.54 3.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.823 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -94.94 163.8 13.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.165 -0.47 . . . . 10.0 109.962 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -125.09 -80.71 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.979 -0.288 . . . . 10.0 111.754 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -121.1 117.1 26.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.946 0.403 . . . . 10.0 111.273 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.85 123.16 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -118.28 113.49 21.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.717 0.294 . . . . 10.0 110.515 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.71 113.52 22.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.711 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.14 160.53 31.74 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.045 0.45 . . . . 10.0 111.813 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.63 74.35 0.4 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.19 -0.914 . . . . 10.0 112.456 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 21.4 mtm-85 55.06 39.78 31.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.2 0.524 . . . . 10.0 111.099 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -93.81 151.74 19.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.821 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 128.61 23.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.993 -0.549 . . . . 10.0 109.764 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.9 137.67 56.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.127 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -118.96 123.04 43.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.66 87.85 4.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.412 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.423 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . 160.71 -178.63 36.63 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.587 -0.816 . . . . 10.0 112.315 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -89.81 163.33 15.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.597 0.237 . . . . 10.0 110.389 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.3 131.8 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.766 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.39 110.22 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.985 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 33.8 p -88.26 168.63 12.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.671 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.74 -5.1 14.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.512 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.43 -13.17 57.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 10.0 110.573 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' B' ' 281' ' ' TYR . . . -87.66 3.23 48.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.548 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.96 118.62 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.352 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 65.93 28.38 10.63 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.656 0.597 . . . . 10.0 111.355 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -106.76 -172.41 22.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.012 -0.613 . . . . 10.0 112.543 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.02 121.0 6.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.774 -0.53 . . . . 10.0 111.774 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 12.1 mt -104.27 -23.6 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.754 0.311 . . . . 10.0 111.699 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' C' ' 253' ' ' GLY . 14.6 tpt180 -93.22 91.59 7.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.909 0.385 . . . . 10.0 110.26 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.35 45.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.335 . . . . 10.0 111.296 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 60.14 33.51 21.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.048 -0.523 . . . . 10.0 111.394 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -63.24 131.95 50.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.383 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -156.81 76.38 0.87 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.206 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' THR . . . . . 0.568 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 3.7 t -151.95 161.63 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.063 0.459 . . . . 10.0 111.323 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -127.87 123.88 36.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.841 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.23 125.21 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 142.71 50.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.239 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.22 148.81 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -104.93 -77.41 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.457 -0.497 . . . . 10.0 111.973 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.17 119.07 38.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.259 0.552 . . . . 10.0 112.293 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.63 109.51 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.432 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 74.8 t -104.83 118.23 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.372 . . . . 10.0 110.658 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.57 133.06 8.19 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.351 -0.699 . . . . 10.0 111.351 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -145.16 122.35 11.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 10.0 111.719 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.28 78.79 1.42 Allowed Glycine 0 C--O 1.238 0.387 0 C-N-CA 120.639 -0.791 . . . . 10.0 113.347 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 55.27 36.48 27.12 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.286 0.565 . . . . 10.0 110.556 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' SER . . . . . 0.486 ' HG ' ' C ' ' B' ' 269' ' ' GLY . 0.0 OUTLIER -65.37 143.31 57.82 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.882 -1.053 . . . . 10.0 111.643 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -125.0 103.85 8.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.497 -0.774 . . . . 10.0 109.595 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.68 115.48 45.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.452 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 112.4 24.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 43.6 mm -101.83 81.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 10.0 110.231 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.18 178.88 33.59 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.007 -0.616 . . . . 10.0 112.336 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -92.93 160.85 14.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.41 172.18 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.961 0.41 . . . . 10.0 110.752 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 4.4 t80 -142.15 76.34 1.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.662 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -90.27 -137.75 6.99 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.677 -0.692 . . . . 10.0 113.248 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 156.42 -50.56 0.44 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.403 -0.679 . . . . 10.0 111.403 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -91.1 1.84 56.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 10.0 109.75 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -177.74 165.33 34.89 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.592 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -108.45 76.55 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 16.4 t90 70.41 -48.1 0.64 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.017 0.823 . . . . 10.0 111.397 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -117.62 178.24 4.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.91 117.55 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 10.0 110.784 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -139.66 132.46 29.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.438 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . 0.422 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 0.1 OUTLIER -157.55 118.23 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.022 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.9 -172.41 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -110.38 137.58 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 10.0 111.764 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -97.87 169.4 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.619 -0.718 . . . . 10.0 111.072 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 48.0 t60 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.629 -0.701 . . . . 10.0 110.416 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.568 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 29.8 ptt180 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.444 0.164 . . . . 10.0 110.678 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -126.52 127.08 44.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.463 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' C' ' 263' ' ' SER . 14.7 m -134.89 132.7 38.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 10.0 111.379 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.17 153.79 47.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.336 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -103.86 -77.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.762 -0.375 . . . . 10.0 111.635 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.1 118.36 35.8 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.254 0.549 . . . . 10.0 111.643 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.83 119.13 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.66 . . . . 10.0 109.985 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -108.03 116.99 32.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.535 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.518 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 0.6 OUTLIER -131.43 102.16 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 10.0 110.781 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -132.91 164.2 27.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.232 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 64.72 71.15 0.47 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.439 -0.801 . . . . 10.0 111.041 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 56.39 65.31 1.45 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 121.327 0.584 . . . . 10.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.75 163.45 25.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.422 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -149.79 143.77 25.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.38 135.05 49.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.636 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -118.57 123.11 44.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.584 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.408 HD11 ' HB ' ' C' ' 277' ' ' ILE . 4.2 mm? -96.59 76.58 2.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.578 -0.737 . . . . 10.0 109.632 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 172.55 170.21 36.07 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.252 -0.975 . . . . 10.0 112.212 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -81.6 162.88 22.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.013 -0.366 . . . . 10.0 110.013 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.98 119.67 61.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 10.0 110.736 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.3 t -113.94 109.13 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 39.4 p -80.56 163.73 23.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.541 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 2.67 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.272 0.471 . . . . 10.0 112.272 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.54 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 10.0 110.514 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -84.61 77.3 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.716 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 5.0 mt -112.31 15.36 20.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.387 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -120.89 111.19 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.139 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.42 -113.45 0.3 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.766 -0.73 . . . . 10.0 111.936 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' B' ' 255' ' ' ARG . . . 128.03 -127.57 5.77 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.812 -0.709 . . . . 10.0 111.498 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.1 tt -152.56 120.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.273 0.559 . . . . 10.0 111.122 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -166.32 133.78 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.639 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -107.22 132.53 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.57 -0.286 . . . . 10.0 110.234 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.43 -169.98 1.74 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.16 141.52 22.97 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.0 0.429 . . . . 10.0 110.951 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.67 146.79 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.716 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 6.1 t -75.77 149.27 38.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.83 128.43 55.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.514 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.99 129.72 44.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.786 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 263' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' C' ' 227' ' ' SER . 5.7 m -143.26 150.61 39.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.746 0.308 . . . . 10.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.56 144.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.267 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 265' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 23.6 ttmt -88.49 -66.32 0.93 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.424 0.528 . . . . 10.0 112.424 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 23.7 m -130.38 124.9 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.82 123.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.487 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 64.2 t -115.63 114.71 47.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.66 -0.246 . . . . 10.0 111.011 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.24 121.95 5.22 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.955 -0.64 . . . . 10.0 111.906 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -132.99 121.82 23.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 10.0 111.453 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.25 90.86 0.41 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.842 -0.694 . . . . 10.0 113.851 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 56.0 47.45 19.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.923 0.392 . . . . 10.0 111.372 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.25 152.61 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.146 0.498 . . . . 10.0 110.651 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.53 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 0.6 OUTLIER -137.91 117.32 12.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.138 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.73 124.38 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.892 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.493 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -119.58 112.47 19.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.763 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . 0.408 ' HB ' HD11 ' C' ' 241' ' ' LEU . 41.0 mm -106.92 90.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.019 0.437 . . . . 10.0 109.933 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.35 -170.65 35.69 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.222 -0.751 . . . . 10.0 111.222 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.96 155.46 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.96 0.38 . . . . 10.0 110.353 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.94 140.91 51.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.968 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 25.1 t80 -129.86 112.81 13.93 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.304 -0.628 . . . . 10.0 109.304 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -165.85 163.0 36.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.357 -0.925 . . . . 10.0 112.483 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.61 1.89 30.66 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -86.86 36.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.102 0.477 . . . . 10.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.63 -83.43 1.4 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.982 -0.847 . . . . 10.0 110.982 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -164.29 -167.44 1.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.53 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 10.1 t90 -42.29 -48.83 5.06 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.861 0.726 . . . . 10.0 112.687 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' C' ' 290' ' ' HIS . 0.0 OUTLIER -125.89 153.07 44.71 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.49 -0.484 . . . . 10.0 111.215 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -104.44 82.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.492 0.663 . . . . 10.0 110.787 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . 0.476 ' HB2' ' OD1' ' C' ' 288' ' ' ASP . 14.9 t-80 -112.53 -55.94 2.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.453 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . 0.434 ' HB2' ' NH2' ' D' ' 274' ' ' ARG . 0.7 OUTLIER -134.11 173.27 11.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 10.0 111.754 -178.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . 0.411 ' HB2' ' H ' ' D' ' 289' ' ' ASN . 17.1 t-80 52.36 88.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.866 -1.061 . . . . 10.0 113.155 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -94.16 178.7 5.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.298 -0.865 . . . . 10.0 109.377 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -62.24 110.08 1.52 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.987 0.422 . . . . 10.0 111.074 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 37.2 m80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.657 -0.687 . . . . 10.0 109.691 178.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . 0.419 ' HD3' ' CG ' ' D' ' 258' ' ' ASP . 2.2 mpt_? . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.785 0.326 . . . . 10.0 110.438 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' D' ' 262' ' ' ASN . 2.7 m-20 -75.47 109.72 9.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.452 . . . . 10.0 110.189 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.66 146.85 52.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.519 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.48 143.2 51.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.164 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 44.4 tttm -90.06 -73.37 0.52 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.341 -0.391 . . . . 10.0 111.647 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.3 120.56 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.832 0.308 . . . . 10.0 111.832 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.54 121.13 58.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.819 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -116.7 114.04 23.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.662 -0.245 . . . . 10.0 110.51 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.1 p -118.42 100.85 7.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.675 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.38 148.51 42.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.09 0.472 . . . . 10.0 111.922 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 62.56 84.84 0.14 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.076 -0.965 . . . . 10.0 112.218 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . 0.473 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 40.8 mtt180 67.92 -8.81 0.51 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.739 1.014 . . . . 10.0 113.739 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -60.6 149.84 33.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.353 0.597 . . . . 10.0 112.314 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -139.25 153.98 47.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.281 -0.872 . . . . 10.0 109.687 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.09 140.17 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.645 0.26 . . . . 10.0 111.679 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -129.5 133.54 47.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.202 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.43 95.62 5.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.73 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . 0.48 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . 171.39 -119.61 0.8 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.915 -0.659 . . . . 10.0 112.686 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -153.51 158.03 40.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.86 109.91 30.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.247 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 19.3 t -111.48 114.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 246' ' ' THR . . . . . 0.529 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 68.9 p -78.07 164.89 24.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 10.0 110.816 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.64 -4.51 34.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.034 0.445 . . . . 10.0 111.1 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.5 12.94 13.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 10.0 111.044 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -121.82 105.62 10.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.632 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.44 -162.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.556 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.51 88.27 3.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.071 0.463 . . . . 10.0 111.224 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -157.17 46.88 0.48 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.239 -0.744 . . . . 10.0 111.239 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 105.89 24.09 7.12 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.925 -0.87 . . . . 10.0 110.925 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 6.8 tt -66.95 -19.11 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 112.144 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -92.81 63.16 3.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 10.0 110.388 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.01 -29.59 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 12.9 m 67.07 -168.09 0.2 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.747 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . 0.419 ' CG ' ' HD3' ' D' ' 225' ' ' ARG . 11.5 m-20 -78.4 100.84 6.97 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.943 -0.392 . . . . 10.0 109.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . 0.6 ' HA ' HE21 ' D' ' 259' ' ' GLN . 0.1 OUTLIER -82.37 -70.55 0.54 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 11.0 t -113.27 160.63 18.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.93 0.395 . . . . 10.0 110.551 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 5.8 m -106.23 96.59 6.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 6.4 t30 -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.83 0.347 . . . . 10.0 110.088 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.21 125.39 40.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.93 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.55 143.53 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 265' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 0.0 OUTLIER -97.1 -50.1 4.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -128.45 122.02 30.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.64 125.16 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.013 -0.54 . . . . 10.0 109.687 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.18 127.45 74.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.812 0.339 . . . . 10.0 110.913 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.4 2.67 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -130.22 121.18 25.7 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.96 0.41 . . . . 10.0 111.281 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.04 66.28 1.04 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.65 -0.786 . . . . 10.0 112.76 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . 0.473 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 8.1 tt0 56.81 56.29 5.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.417 0.627 . . . . 10.0 111.552 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 45.7 t -92.13 155.73 17.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.027 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . 0.434 ' NH2' ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.31 109.95 12.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.027 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 32.1 t -101.22 113.69 38.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.927 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -116.93 106.39 13.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.035 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 10.7 mm -102.05 71.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.063 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . -175.12 -167.97 35.06 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.642 -0.79 . . . . 10.0 112.266 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -114.4 166.91 11.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.484 -0.191 . . . . 10.0 110.484 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.71 147.26 48.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 10.0 110.697 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -137.91 105.14 5.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.029 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . 0.529 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 168.8 173.72 36.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.832 -1.175 . . . . 10.0 113.516 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -96.53 43.84 2.04 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.777 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -91.97 -19.33 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 10.0 109.728 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.91 -45.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.097 -0.801 . . . . 10.0 111.097 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -169.25 143.17 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.244 -0.478 . . . . 10.0 109.762 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -54.98 -64.94 0.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.409 0.443 . . . . 10.0 111.65 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -140.64 108.7 5.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.091 0.472 . . . . 10.0 110.668 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . 0.411 ' H ' ' HB2' ' C' ' 292' ' ' HIS . 8.7 t-20 -132.43 165.4 24.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.061 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -92.2 -64.68 1.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.669 0.271 . . . . 10.0 111.072 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -135.94 -170.02 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.688 -0.233 . . . . 10.0 110.419 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -105.28 -158.01 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -74.23 121.36 21.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.717 0.294 . . . . 10.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -133.98 -174.73 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 63.2 m80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.627 -0.701 . . . . 10.0 110.463 179.744 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . 0.428 ' H ' ' CG ' ' E' ' 258' ' ' ASP . 1.2 mpt_? . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 23.4 m120 -113.65 134.95 54.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 227' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' E' ' 263' ' ' SER . 18.2 m -143.55 137.17 28.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.763 0.316 . . . . 10.0 110.512 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.9 146.11 50.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.19 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 35.6 tttm -95.71 -69.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.482 -0.326 . . . . 10.0 111.818 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -128.5 124.89 37.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.509 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.4 120.56 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.524 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -116.41 116.25 27.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.165 0.507 . . . . 10.0 111.214 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 233' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' E' ' 237' ' ' ALA . 29.2 p -112.68 111.41 22.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.146 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -122.59 138.72 54.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.97 87.2 0.12 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.467 -0.788 . . . . 10.0 112.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 48.81 44.25 21.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.002 -0.999 . . . . 10.0 112.214 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . 0.41 ' CB ' ' HB ' ' E' ' 233' ' ' THR . . . -98.69 160.39 14.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.172 -0.467 . . . . 10.0 109.921 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.29 148.23 49.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.635 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.13 120.94 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.445 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -127.03 119.43 26.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.013 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.6 109.49 17.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . 0.449 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 161.13 -172.87 37.48 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.253 -0.499 . . . . 10.0 111.914 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -98.87 139.07 35.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 110.932 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -98.64 124.59 51.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.97 118.32 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.361 . . . . 10.0 111.058 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 246' ' ' THR . . . . . 0.439 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 14.2 t -72.06 173.66 8.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.076 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.56 70.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 10.0 111.229 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -69.11 -20.49 64.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.953 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.24 -159.98 0.26 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 66.7 mt -96.9 124.16 40.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -80.11 86.86 5.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 10.0 109.679 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 108.76 -152.24 17.01 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.899 -0.881 . . . . 10.0 110.899 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.26 80.06 0.36 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.221 -0.99 . . . . 10.0 111.871 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 52.3 mt -73.3 -29.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.119 0.485 . . . . 10.0 110.157 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.1 74.42 1.09 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.137 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . 0.405 ' HB ' ' OE1' ' D' ' 259' ' ' GLN . 9.2 pt -81.21 124.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 14.7 m -142.33 -179.81 6.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.067 0.46 . . . . 10.0 111.786 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' E' ' 225' ' ' ARG . 25.6 t70 -84.97 130.9 34.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.768 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -130.2 -58.62 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.1 t -69.56 139.18 53.71 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.375 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 35.8 m -113.93 110.81 20.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.719 -0.673 . . . . 10.0 109.797 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.91 120.85 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.081 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 263' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' E' ' 227' ' ' SER . 16.3 m -136.29 131.57 34.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.47 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.43 150.75 29.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.615 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 265' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -88.06 -88.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.788 0.292 . . . . 10.0 111.788 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 10.4 m -110.93 125.5 53.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 10.0 111.49 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 5.8 t -116.1 108.98 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.888 -0.596 . . . . 10.0 109.518 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.54 122.15 62.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.407 -0.36 . . . . 10.0 110.875 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.73 108.96 0.69 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.734 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -120.18 123.61 43.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.344 -0.243 . . . . 10.0 110.344 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.25 74.62 1.28 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.129 -0.558 . . . . 10.0 112.106 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 61.4 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.759 0.79 . . . . 10.0 110.997 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 39.0 m -139.02 141.83 38.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.21 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.98 97.76 6.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.154 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.27 104.16 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 10.0 109.708 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.05 114.02 23.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.608 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 34.0 mm -119.41 107.29 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.925 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 162.74 -125.67 1.44 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.395 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -138.24 129.15 26.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.913 0.387 . . . . 10.0 110.284 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . 0.575 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 0.2 OUTLIER -92.43 138.45 31.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.327 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -171.7 92.99 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.978 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . 0.439 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -132.07 -87.52 0.38 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.255 -0.974 . . . . 10.0 112.829 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . 0.437 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 148.18 38.23 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.199 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -121.77 -68.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.732 -0.275 . . . . 10.0 110.744 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.56 9.9 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.175 -1.012 . . . . 10.0 113.802 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' E' ' 287' ' ' TRP . 17.6 t80 -138.27 108.68 6.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.512 0.656 . . . . 10.0 109.595 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' E' ' 286' ' ' PHE . 0.7 OUTLIER 70.59 16.59 6.89 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -177.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -161.14 172.81 16.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.089 -1.414 . . . . 10.0 109.357 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -172.3 158.82 4.54 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.746 -0.206 . . . . 10.0 110.539 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . 0.437 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 0.6 OUTLIER -155.51 -177.44 6.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -92.53 -70.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 10.0 112.102 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 10.9 t60 71.12 160.42 0.22 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.69 0.619 . . . . 10.0 111.364 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -96.98 119.27 35.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.409 -0.359 . . . . 10.0 110.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -105.66 154.02 21.02 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.613 -0.708 . . . . 10.0 110.847 -179.368 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' 3LS . . . . . 0.661 ' CBI' ' SAK' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.58 0.228 . . . . 10.0 110.776 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -112.22 128.43 56.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.799 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.606 ' O ' ' HA ' ' A' ' 263' ' ' SER . 30.1 m -152.15 159.06 43.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 10.0 111.495 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.56 43.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.142 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.54 -61.62 1.37 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.684 0.278 . . . . 10.0 111.262 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.74 131.84 33.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.833 0.349 . . . . 10.0 111.058 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.8 mt -127.07 128.32 70.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.835 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -114.75 99.26 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.214 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.7 122.09 46.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.731 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.705 0.288 . . . . 10.0 111.417 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.58 ' HB3' ' H ' ' A' ' 271' ' ' GLY . 7.6 tp10 63.89 72.06 0.47 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.455 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 236' ' ' ARG . 29.5 mtm-85 55.91 32.73 20.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.439 -0.8 . . . . 10.0 111.713 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.65 159.24 17.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.337 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -137.31 147.97 46.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.623 -0.262 . . . . 10.0 110.575 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.57 141.72 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.518 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -134.86 138.3 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.6 tp -125.14 128.79 48.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.932 0.396 . . . . 10.0 110.99 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.35 -110.09 0.75 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.856 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -156.76 156.6 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.5 t -125.47 121.78 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.798 0.333 . . . . 10.0 110.611 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.06 101.61 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.689 -0.485 . . . . 10.0 109.689 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 248' ' ' ALA . 94.2 m -74.09 145.37 44.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.23 8.66 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.685 ' H ' HG22 ' A' ' 246' ' ' THR . . . -80.29 -6.59 58.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.846 0.355 . . . . 10.0 110.935 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -121.05 38.82 3.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.327 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.3 mm? 72.81 -167.65 0.12 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.249 -0.887 . . . . 10.0 111.067 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -78.54 -174.61 3.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.615 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.92 71.07 2.64 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.487 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.15 -45.54 96.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.905 -0.665 . . . . 10.0 111.542 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 75.5 mt 70.33 138.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.314 0.646 . . . . 10.0 111.752 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 66.87 90.1 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.687 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.87 -45.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.813 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 -86.75 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 55.4 t0 60.22 79.64 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.389 0.614 . . . . 10.0 109.978 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.49 24.1 10.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.925 -0.579 . . . . 10.0 111.563 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 7.7 t -148.94 148.11 29.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.496 . . . . 10.0 111.476 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 118.54 30.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.849 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -115.09 105.82 13.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.389 -0.368 . . . . 10.0 110.157 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 227' ' ' SER . 70.7 m -140.32 135.16 31.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 10.0 110.78 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.93 145.99 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.766 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.17 -70.87 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.03 0.381 . . . . 10.0 112.03 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 125.29 47.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 10.0 112.581 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 16.9 t -121.15 119.81 60.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.657 . . . . 10.0 109.579 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.88 119.89 60.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.701 0.286 . . . . 10.0 110.95 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.48 107.29 0.91 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.557 -0.617 . . . . 10.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -126.9 124.77 40.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.091 0.472 . . . . 10.0 111.187 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.58 ' H ' ' HB3' ' A' ' 235' ' ' GLU . . . 93.32 73.83 1.24 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.872 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 54.66 36.63 26.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.594 0.358 . . . . 10.0 111.846 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 8.1 m -86.46 150.18 24.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.226 0.536 . . . . 10.0 110.876 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -119.85 124.82 47.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.646 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.24 113.74 44.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.235 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.38 111.54 22.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.755 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.06 86.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.962 0.41 . . . . 10.0 109.919 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.23 170.92 22.67 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.216 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -92.99 151.83 19.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.737 0.303 . . . . 10.0 110.51 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.22 158.71 25.47 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.056 0.455 . . . . 10.0 110.817 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.11 101.27 5.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 10.0 108.942 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -151.22 165.91 30.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.789 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -137.92 -16.99 0.65 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.163 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -72.67 -37.0 68.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.252 0.548 . . . . 10.0 110.035 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -164.98 156.53 28.56 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.671 -0.972 . . . . 10.0 110.671 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -80.86 74.95 7.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.393 0.596 . . . . 10.0 110.671 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 21.4 t90 69.59 -58.36 0.52 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.089 0.868 . . . . 10.0 111.71 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -142.65 96.29 2.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.864 0.364 . . . . 10.0 110.646 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -166.3 125.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.085 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -150.56 21.11 0.82 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.511 0.672 . . . . 10.0 109.853 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -75.56 144.12 42.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.633 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.12 32.23 3.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.528 -0.76 . . . . 10.0 109.326 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -103.32 120.56 41.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.265 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -95.26 142.84 27.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.821 0.343 . . . . 10.0 110.425 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 p80 . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.051 179.361 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' B' ' 261' ' ' THR . 39.3 ttm180 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.481 HD21 ' HA2' ' B' ' 278' ' ' GLY . 85.0 m-20 -117.89 152.94 34.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 10.0 110.807 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 48.9 m -147.13 91.96 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.122 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -97.04 161.75 13.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' B' ' 265' ' ' LYS . 14.4 mttm -123.2 -72.53 0.68 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.008 -0.277 . . . . 10.0 111.741 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -127.74 114.19 16.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.148 0.499 . . . . 10.0 111.13 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 77.6 mt -118.62 123.83 72.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.886 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -118.67 124.27 46.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.419 0.628 . . . . 10.0 111.451 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 1.0 OUTLIER -123.58 123.26 40.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.948 -1.023 . . . . 10.0 110.135 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -138.48 162.95 33.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 10.0 110.904 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.71 62.77 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.249 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 60.16 26.62 16.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -78.62 157.57 28.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.037 0.446 . . . . 10.0 110.923 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 135.48 35.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.522 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.16 138.92 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.972 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -126.4 131.77 51.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.093 0.473 . . . . 10.0 110.166 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.1 100.7 10.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.73 -177.99 29.29 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -95.8 157.96 15.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.401 . . . . 10.0 110.531 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.17 122.61 69.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.978 0.418 . . . . 10.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.25 124.71 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 72.8 p -93.75 174.02 7.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 10.0 112.022 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.17 -20.06 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.546 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.8 -19.33 57.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.284 0.564 . . . . 10.0 110.249 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -86.68 -4.05 59.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.342 -0.845 . . . . 10.0 110.398 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.62 118.14 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.739 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.84 62.47 1.05 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.839 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -135.19 -142.89 4.65 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.924 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.12 91.2 0.6 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.344 -0.702 . . . . 10.0 111.344 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 16.6 mt -79.59 -27.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.277 0.473 . . . . 10.0 112.277 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -116.55 111.24 19.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.944 0.402 . . . . 10.0 111.099 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 14.7 pt -137.03 40.83 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.23 50.1 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.428 -0.806 . . . . 10.0 111.44 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -84.98 63.85 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.554 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -92.69 103.72 16.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.574 . . . . 10.0 110.385 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.567 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 13.4 t -167.45 150.44 6.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 10.0 111.571 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 31.7 m -118.56 117.96 30.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.141 -0.936 . . . . 10.0 108.908 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -99.4 100.9 12.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.212 0.529 . . . . 10.0 110.387 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.5 m -106.12 143.32 34.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.931 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' C' ' 228' ' ' ALA . 12.2 p -148.67 144.28 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.642 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 265' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 20.6 mttt -94.41 -80.1 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.38 0.511 . . . . 10.0 112.38 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 125.59 53.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.592 0.59 . . . . 10.0 112.592 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 87.5 t -118.58 123.71 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.652 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 5.5 t -109.74 126.46 66.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.305 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.36 98.48 0.34 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -122.36 124.18 43.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 10.0 111.258 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 98.36 58.92 0.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.565 -0.826 . . . . 10.0 112.849 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 57.07 37.68 28.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.051 0.541 . . . . 10.0 111.984 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 19.6 m -77.57 150.78 34.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.454 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.62 124.13 49.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.874 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.18 122.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.778 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -118.82 108.27 14.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.218 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.72 92.56 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.106 0.479 . . . . 10.0 110.004 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' B' ' 226' ' ' ASN . . . 155.93 -178.82 32.28 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.493 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -99.35 161.33 13.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.42 158.97 33.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.167 0.508 . . . . 10.0 111.091 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 1.0 OUTLIER -139.4 81.44 1.83 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.13 -0.941 . . . . 10.0 108.668 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.439 ' HA2' ' OG1' ' B' ' 246' ' ' THR . . . -118.77 -98.54 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.749 -0.66 . . . . 10.0 113.067 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.02 -37.33 2.71 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.929 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -90.45 53.72 2.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.231 0.539 . . . . 10.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.97 132.92 4.95 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.543 ' CD2' HG11 ' C' ' 244' ' ' VAL . 16.6 m-85 -82.4 76.0 9.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.41 0.148 . . . . 10.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.442 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 18.9 t90 70.55 -51.28 0.66 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.06 0.85 . . . . 10.0 111.529 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.61 -172.07 1.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.5 0.19 . . . . 10.0 110.797 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.21 118.71 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.217 0.532 . . . . 10.0 111.287 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 290' ' ' HIS . . . . . 0.487 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 40.0 t60 -138.9 128.72 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 291' ' ' HIS . . . . . 0.517 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 1.0 OUTLIER -152.51 116.75 4.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.26 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -133.29 -176.14 4.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 10.0 111.832 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -118.03 126.34 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.568 -0.742 . . . . 10.0 109.813 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -80.78 -139.6 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.469 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 295' ' ' HIS . . . . . 0.452 ' HB2' ' CE1' ' C' ' 291' ' ' HIS . 47.6 t60 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.404 -0.807 . . . . 10.0 110.013 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.567 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 13.8 ptt-85 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 6.4 m120 -128.22 141.04 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.039 0.447 . . . . 10.0 110.593 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.4 m -145.98 132.66 19.92 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -130.45 149.69 52.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.375 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' B' ' 265' ' ' LYS . 16.0 tttm -101.64 -67.34 0.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.241 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -124.24 120.33 31.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.835 0.35 . . . . 10.0 111.616 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.02 117.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.141 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.527 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 4.7 ttm180 -110.45 119.66 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.467 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.46 104.03 7.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.485 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.527 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 13.3 pt-20 -128.03 173.05 10.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.119 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 42.9 mt-10 62.36 64.26 0.97 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.532 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' C' ' 272' ' ' GLU . 7.3 ttp180 57.23 42.91 24.6 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.268 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.41 168.76 10.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.503 -0.317 . . . . 10.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.442 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 1.1 ptp180 -149.89 138.91 21.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.83 0.347 . . . . 10.0 110.387 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.5 138.13 52.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.286 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' B' ' 276' ' ' LEU . 2.8 tt0 -125.16 127.29 46.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.222 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' C' ' 277' ' ' ILE . 1.3 mm? -105.68 85.56 2.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.333 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.33 -169.65 42.41 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.225 -0.988 . . . . 10.0 112.34 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -100.19 155.06 17.96 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.099 -0.334 . . . . 10.0 110.099 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.543 HG11 ' CD2' ' B' ' 286' ' ' PHE . 41.3 t -109.77 118.64 57.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.2 t -111.74 110.51 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -81.81 166.35 20.07 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.976 -0.29 . . . . 10.0 110.43 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.78 5.1 1.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.68 -18.91 20.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.897 0.38 . . . . 10.0 110.335 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.52 88.07 5.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 10.0 110.172 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 31.1 mt -127.25 8.59 6.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.747 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -124.46 105.36 9.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.238 0.542 . . . . 10.0 110.939 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -173.35 154.3 19.93 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.341 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.0 -171.19 13.13 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.564 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.0 tt -98.05 107.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.3 0.572 . . . . 10.0 110.398 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -139.94 118.74 12.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.804 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 tt -89.73 112.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 23.1 m -143.98 -172.7 3.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.065 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.0 146.53 39.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.072 0.463 . . . . 10.0 110.606 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.08 140.09 52.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.507 ' HA ' ' OD1' ' D' ' 258' ' ' ASP . 0.4 OUTLIER -60.29 139.52 57.57 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.611 0.72 . . . . 10.0 111.25 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.645 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 0.7 OUTLIER -99.13 106.54 18.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.402 -0.817 . . . . 10.0 110.64 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.7 t-20 -115.23 126.15 54.2 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -143.68 145.78 32.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.904 0.383 . . . . 10.0 111.14 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.52 143.67 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.258 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 265' ' ' LYS . . . . . 0.605 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 3.4 ttmt -85.57 -61.85 1.67 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.8 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 21.3 m -135.54 131.3 35.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.07 118.31 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.474 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' C' ' 232' ' ' ARG . 20.6 t -113.86 107.21 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.754 0.311 . . . . 10.0 110.555 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 269' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -110.3 130.05 9.67 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.16 -0.543 . . . . 10.0 112.066 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -135.02 124.52 24.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.809 0.338 . . . . 10.0 111.397 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 271' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 91.54 77.39 1.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 10.0 113.121 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 272' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' C' ' 236' ' ' ARG . 2.0 mt-10 52.33 33.82 13.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.904 0.482 . . . . 10.0 111.753 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.82 147.82 48.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.241 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -125.46 121.06 32.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.205 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.94 120.63 61.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.845 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.447 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -116.01 105.12 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.483 ' HB ' HD13 ' C' ' 241' ' ' LEU . 32.2 mm -101.55 91.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.167 0.508 . . . . 10.0 109.86 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.9 -173.05 35.17 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.303 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.47 149.23 22.92 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.075 -0.342 . . . . 10.0 110.075 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.9 138.59 48.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.935 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 1.9 t80 -120.39 102.02 8.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -141.77 173.57 23.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.54 -0.838 . . . . 10.0 112.538 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -126.39 -28.43 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.694 -0.765 . . . . 10.0 112.394 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -94.18 76.27 4.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 10.0 109.962 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 84.87 -113.77 3.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.154 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -151.48 -157.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 11.8 t90 -43.65 -53.47 5.72 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.598 0.561 . . . . 10.0 111.66 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 288' ' ' ASP . . . . . 0.487 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.4 OUTLIER -122.54 171.0 9.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.575 -0.45 . . . . 10.0 110.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 289' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -121.3 85.82 2.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.513 0.673 . . . . 10.0 111.064 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -117.93 -44.34 2.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.397 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 291' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' B' ' 295' ' ' HIS . 1.6 t-80 -142.55 171.3 14.24 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.906 0.335 . . . . 10.0 111.906 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 54.56 96.43 0.02 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.759 -1.11 . . . . 10.0 112.688 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -101.55 -164.83 1.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.386 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -71.02 146.28 49.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.452 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 63.1 m170 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.674 -0.679 . . . . 10.0 110.361 -179.585 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.645 ' N ' ' HG1' ' C' ' 261' ' ' THR . 1.1 tpm_? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.042 0.448 . . . . 10.0 110.488 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -104.12 135.52 45.45 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 227' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' D' ' 263' ' ' SER . 27.6 m -145.71 135.45 23.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.783 0.325 . . . . 10.0 111.014 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.47 131.46 43.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.011 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 229' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' C' ' 265' ' ' LYS . 85.2 tttt -81.52 -69.98 0.57 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.737 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 124.75 39.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.437 . . . . 10.0 111.824 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.47 126.78 71.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.368 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 232' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' D' ' 232' ' ' ARG . 3.7 mmm180 -118.21 121.04 39.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.6 -0.273 . . . . 10.0 110.384 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.452 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 2.2 p -125.27 117.14 23.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.745 0.307 . . . . 10.0 110.635 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -129.34 149.04 51.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 10.0 111.8 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 67.21 80.6 0.21 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.116 -0.947 . . . . 10.0 112.658 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 57.51 16.25 3.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.397 -0.82 . . . . 10.0 112.731 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 237' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -76.42 152.53 36.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.662 0.268 . . . . 10.0 111.022 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.86 154.32 48.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.199 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' D' ' 275' ' ' VAL . 2.4 p -139.57 136.21 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.875 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -122.95 129.4 51.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.403 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.509 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.6 mm? -112.42 90.73 3.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.597 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 177.5 -106.95 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.187 -1.006 . . . . 10.0 112.67 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -171.67 158.02 4.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.72 108.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.0 0.428 . . . . 10.0 111.335 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 17.6 t -104.72 108.39 24.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.581 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 72.6 p -87.05 162.05 17.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.009 -0.541 . . . . 10.0 111.983 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.62 -5.34 42.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.687 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.386 0.612 . . . . 10.0 110.075 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -93.17 166.77 12.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.274 -0.876 . . . . 10.0 110.001 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 250' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' D' ' 250' ' ' LEU . 6.3 tp -155.09 -169.8 3.29 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -76.77 70.59 3.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 10.0 110.924 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -166.78 74.82 0.14 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 99.95 0.02 56.25 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.505 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.23 -24.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.028 0.442 . . . . 10.0 111.505 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.81 70.67 9.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.498 . . . . 10.0 110.178 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 14.5 tt -58.42 -25.62 28.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.334 -0.848 . . . . 10.0 111.558 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m 63.38 -153.33 0.33 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.541 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 258' ' ' ASP . . . . . 0.639 ' CG ' ' HD2' ' D' ' 225' ' ' ARG . 1.3 m-20 -107.89 111.33 23.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 10.0 110.139 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -111.6 -87.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.2 t -87.59 159.37 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.067 0.46 . . . . 10.0 111.455 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 17.1 m -110.25 123.14 49.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.866 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -114.5 107.89 16.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 263' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' D' ' 227' ' ' SER . 18.1 m -125.9 116.29 21.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.837 0.351 . . . . 10.0 110.862 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.52 143.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 265' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 17.4 mmtp -95.88 -52.92 3.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.048 0.759 . . . . 10.0 113.048 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.14 121.96 36.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.74 113.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.683 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.28 125.29 74.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.832 0.349 . . . . 10.0 110.835 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 269' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -135.86 129.31 4.92 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.963 -0.562 . . . . 10.0 112.047 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -139.38 130.32 26.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.026 0.441 . . . . 10.0 111.433 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.34 81.39 0.79 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.294 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 272' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' E' ' 236' ' ' ARG . 1.4 tm-20 58.13 74.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.332 0.587 . . . . 10.0 110.193 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 273' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 4.0 m -125.85 140.38 52.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.437 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.77 121.4 36.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.402 ' HB ' HG23 ' D' ' 239' ' ' VAL . 58.8 t -104.75 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.064 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' D' ' 276' ' ' LEU . 0.6 OUTLIER -115.75 105.77 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.147 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.509 ' HB ' HD13 ' D' ' 241' ' ' LEU . 19.2 mm -108.61 95.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.883 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.7 -177.89 33.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.102 -0.57 . . . . 10.0 112.18 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.59 164.24 12.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.635 0.255 . . . . 10.0 110.404 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.71 134.22 50.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -125.4 118.36 25.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.543 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 282' ' ' GLY . . . . . 0.581 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 153.92 -178.13 31.0 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.282 -0.961 . . . . 10.0 113.405 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.21 47.75 1.01 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.766 -0.534 . . . . 10.0 111.766 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -92.82 4.84 53.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.461 0.648 . . . . 10.0 109.881 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 83.86 -56.52 5.05 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 286' ' ' PHE . . . . . 0.469 ' CE1' HG21 ' E' ' 244' ' ' VAL . 0.8 OUTLIER -172.88 143.0 1.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.488 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 44.0 t90 -48.75 -66.73 0.35 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.252 0.345 . . . . 10.0 111.787 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 288' ' ' ASP . . . . . 0.488 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 16.9 t0 -149.32 115.04 5.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.109 0.48 . . . . 10.0 110.302 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 289' ' ' ASN . . . . . 0.41 HD21 ' HB2' ' E' ' 287' ' ' TRP . 8.6 t-20 -136.02 173.8 11.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.671 . . . . 10.0 109.187 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -85.44 -56.95 3.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.528 0.204 . . . . 10.0 110.803 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -159.4 -168.52 2.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 10.0 111.216 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -92.54 -165.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.169 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -66.73 123.32 19.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 10.0 110.378 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -108.43 160.24 16.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.309 -0.853 . . . . 10.0 109.797 179.595 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.565 0.221 . . . . 10.0 110.484 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -119.61 120.84 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.083 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.89 149.04 50.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.549 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 133.44 24.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.148 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -68.83 0.76 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.622 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' E' ' 266' ' ' THR . 28.4 t70 -124.69 125.3 43.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 10.0 112.098 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 62.4 mt -128.49 124.05 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.113 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -120.76 121.02 37.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.781 0.324 . . . . 10.0 110.336 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.601 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 3.1 p -129.99 108.85 10.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.665 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.53 152.92 46.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.967 0.358 . . . . 10.0 111.967 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 66.18 79.89 0.23 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.527 -0.761 . . . . 10.0 112.114 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 236' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' D' ' 272' ' ' GLU . 13.2 ttp180 53.35 67.02 1.07 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.165 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' D' ' 273' ' ' SER . . . -129.99 162.28 29.04 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.169 -0.923 . . . . 10.0 110.675 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.54 146.77 28.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.349 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.44 HG22 HD12 ' E' ' 241' ' ' LEU . 4.4 p -127.28 122.99 61.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.359 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -120.52 118.51 30.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.775 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.44 HD12 HG22 ' E' ' 239' ' ' VAL . 1.1 mp -114.75 100.18 8.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.019 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 242' ' ' GLY . . . . . 0.55 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 169.73 -173.71 43.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 243' ' ' ASN . . . . . 0.579 ' HB2' ' OD1' ' E' ' 279' ' ' ASN . 5.7 p-10 -111.02 144.21 40.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.87 0.367 . . . . 10.0 110.262 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.469 HG21 ' CE1' ' D' ' 286' ' ' PHE . 55.1 t -98.5 130.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.987 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.77 110.6 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.529 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -61.0 164.05 5.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.011 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.12 -19.9 63.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.374 0.509 . . . . 10.0 112.374 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.29 -11.66 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.843 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.89 -155.56 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.943 -0.571 . . . . 10.0 111.137 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.34 142.56 27.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -82.36 62.59 6.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.44 0.638 . . . . 10.0 109.779 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 106.44 -170.23 16.2 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.1 80.55 1.54 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.477 -0.868 . . . . 10.0 111.901 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.54 -0.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.421 0.629 . . . . 10.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.26 73.32 0.98 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 10.0 110.489 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.8 pt -81.63 96.01 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 10.9 m -127.18 150.33 49.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.528 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.49 125.42 31.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.432 0.634 . . . . 10.0 110.245 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -124.94 46.12 2.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.575 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.1 t -149.21 141.47 24.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.002 0.429 . . . . 10.0 110.713 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 8.1 m -114.93 111.69 21.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.097 -0.502 . . . . 10.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -128.82 98.9 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.403 . . . . 10.0 110.465 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 9.9 m -107.83 117.55 34.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.173 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 15.5 t -100.32 126.57 53.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.415 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 265' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -82.61 -73.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.675 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' E' ' 230' ' ' ASP . 88.9 m -144.9 120.39 10.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.944 0.402 . . . . 10.0 111.435 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.15 121.38 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.088 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.3 t -116.08 128.85 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.146 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.26 124.37 3.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.047 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -124.91 111.75 15.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.032 0.444 . . . . 10.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.4 92.77 1.73 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.342 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.62 55.69 2.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.217 0.532 . . . . 10.0 110.38 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 127.1 42.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 274' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' E' ' 274' ' ' ARG . 5.8 mtm105 -119.8 106.96 12.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.003 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.1 111.67 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.37 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.68 106.58 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.125 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.4 mm -114.52 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.222 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 278' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 168.45 -135.3 3.56 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.381 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 279' ' ' ASN . . . . . 0.579 ' OD1' ' HB2' ' E' ' 243' ' ' ASN . 0.1 OUTLIER -118.97 137.57 53.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.722 0.296 . . . . 10.0 110.814 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 280' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 4.4 pt-20 -97.41 126.64 42.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 281' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' E' ' 244' ' ' VAL . 24.1 t80 -164.6 93.24 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.33 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.01 -90.8 0.4 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.279 -0.962 . . . . 10.0 112.964 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 283' ' ' GLY . . . . . 0.54 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 153.03 28.55 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.172 -0.537 . . . . 10.0 112.316 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.79 -65.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 10.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.95 23.47 1.16 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.373 -0.918 . . . . 10.0 113.219 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -152.31 106.76 3.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 287' ' ' TRP . . . . . 0.41 ' HB2' HD21 ' D' ' 289' ' ' ASN . 0.8 OUTLIER 73.43 7.87 5.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.244 1.021 . . . . 10.0 108.345 -177.121 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 288' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.7 OUTLIER -154.14 169.69 22.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.619 -1.628 . . . . 10.0 107.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -159.62 163.93 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.764 0.316 . . . . 10.0 110.846 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 290' ' ' HIS . . . . . 0.54 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 1.6 p-80 -158.37 -179.76 8.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.505 -0.771 . . . . 10.0 109.784 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -85.88 -73.0 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 64.6 t60 70.9 155.52 0.15 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.953 0.783 . . . . 10.0 111.392 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -111.63 128.46 56.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.578 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.98 142.25 31.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.888 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 . . . . . 0 C--O 1.246 0.884 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.33 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.986 -0.375 . . . . 10.0 109.986 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -114.03 136.72 52.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.029 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.06 132.75 28.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 10.0 110.946 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.3 164.32 17.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.192 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 265' ' ' LYS . 47.4 tttm -125.59 -69.09 0.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.848 0.356 . . . . 10.0 111.169 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -128.36 124.37 36.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.055 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.1 mt -136.72 131.55 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.334 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -129.38 111.69 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.206 0.527 . . . . 10.0 110.485 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -109.94 124.36 51.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.382 -0.826 . . . . 10.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -140.69 157.39 45.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.823 0.344 . . . . 10.0 111.375 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.8 72.64 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.484 -0.78 . . . . 10.0 111.514 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 56.57 35.97 26.87 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.315 -0.857 . . . . 10.0 111.703 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.6 149.24 22.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.121 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -132.97 145.71 51.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.922 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 2.6 p -136.81 125.29 34.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.194 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -125.57 130.96 52.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.868 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.21 122.74 48.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.416 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.515 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 144.64 -165.17 27.63 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.67 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -95.69 142.98 27.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 10.0 110.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.36 98.5 6.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.364 0.602 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.38 121.01 46.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.181 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 m -97.06 151.21 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.578 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.71 -12.89 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.112 0.482 . . . . 10.0 111.428 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -81.94 4.22 23.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.803 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -141.24 59.09 1.52 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.703 -0.68 . . . . 10.0 109.918 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 2.0 mm? 70.04 -160.12 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.425 -0.807 . . . . 10.0 111.415 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.4 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 29.5 p-80 -95.45 -174.42 3.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.54 2.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.294 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.71 -43.36 99.36 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.812 -0.515 . . . . 10.0 111.812 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 70.5 mt 71.98 133.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 122.996 0.519 . . . . 10.0 111.734 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 62.9 88.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.377 -0.828 . . . . 10.0 111.619 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.18 -56.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.773 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.1 p -118.33 -86.45 0.64 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.04 0.385 . . . . 10.0 112.04 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.6 t70 63.06 84.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.716 0.635 . . . . 10.0 110.289 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -129.16 13.51 6.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.081 -0.508 . . . . 10.0 111.342 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.74 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 4.9 t -145.29 134.98 23.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.377 0.608 . . . . 10.0 111.549 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -85.37 116.57 23.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.712 . . . . 10.0 109.58 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.409 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 61.9 m-20 -100.03 120.56 40.02 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.813 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.0 p -137.21 128.22 27.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.087 0.47 . . . . 10.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.93 136.21 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 229' ' ' LYS . 71.6 mmtt -93.12 -56.79 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.811 0.671 . . . . 10.0 112.811 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.77 128.91 44.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.706 0.632 . . . . 10.0 112.706 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.04 129.07 67.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.306 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.7 124.07 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.374 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.34 118.15 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.191 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -134.89 115.27 13.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.15 79.65 1.47 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.697 -0.763 . . . . 10.0 113.485 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 59.0 29.28 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.487 0.551 . . . . 10.0 112.487 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 5.5 m -77.94 141.65 38.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.402 0.62 . . . . 10.0 111.563 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -119.26 120.23 36.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.761 . . . . 10.0 109.505 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 48.5 t -113.92 118.02 57.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.242 -0.436 . . . . 10.0 110.68 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.436 ' HA ' HD22 ' A' ' 276' ' ' LEU . 0.7 OUTLIER -117.93 116.55 27.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.404 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.24 95.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.75 160.39 9.48 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.686 -0.768 . . . . 10.0 112.069 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -77.18 148.94 35.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.74 0.305 . . . . 10.0 110.934 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 164.58 14.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.112 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -139.89 106.36 5.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.617 -0.719 . . . . 10.0 109.772 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -166.15 148.55 13.81 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.59 -0.814 . . . . 10.0 113.158 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -129.5 7.27 6.25 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.655 -0.784 . . . . 10.0 112.661 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -97.55 -13.35 21.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.674 . . . . 10.0 110.031 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.0 145.55 5.08 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.679 -0.968 . . . . 10.0 110.679 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -77.83 96.1 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.694 0.247 . . . . 10.0 110.618 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.407 ' CZ3' ' HB2' ' B' ' 238' ' ' ARG . 7.0 t90 67.9 -70.52 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.859 0.724 . . . . 10.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -167.07 96.22 0.5 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.667 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -162.67 119.24 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.318 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -122.36 106.01 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.701 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -116.55 143.57 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.288 -0.414 . . . . 10.0 109.948 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -153.55 21.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.835 -0.166 . . . . 10.0 111.359 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -127.53 124.85 39.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 10.0 111.581 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 154.48 41.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.288 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' HIS . . . . . 0.408 ' HB2' ' NH2' ' D' ' 236' ' ' ARG . 20.3 p-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.129 -0.939 . . . . 10.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.74 ' N ' ' HG1' ' A' ' 260' ' ' THR . 35.2 ttm180 . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -120.6 133.77 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.233 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' B' ' 263' ' ' SER . 16.3 m -130.85 111.33 12.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.915 0.388 . . . . 10.0 111.301 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -110.16 130.29 55.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.629 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' B' ' 265' ' ' LYS . 0.0 OUTLIER -86.36 -68.92 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.92 120.43 16.05 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.964 0.412 . . . . 10.0 111.196 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.81 131.12 67.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 10.0 111.141 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' B' ' 232' ' ' ARG . 12.1 mmt85 -114.53 112.4 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.245 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.501 HG22 ' HB1' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -121.42 112.47 18.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.721 0.296 . . . . 10.0 110.974 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -133.13 150.72 52.02 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.507 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 67.89 81.04 0.2 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.443 -0.799 . . . . 10.0 113.128 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 32.8 mtm-85 54.99 22.95 4.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.196 0.598 . . . . 10.0 112.082 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.501 ' HB1' HG22 ' B' ' 233' ' ' THR . . . -80.08 154.27 28.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.338 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.407 ' HB2' ' CZ3' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -137.49 138.25 39.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.925 -0.579 . . . . 10.0 110.379 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.413 HG23 ' HB ' ' B' ' 275' ' ' VAL . 3.6 p -133.74 131.37 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.112 0.482 . . . . 10.0 110.662 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -120.97 131.17 54.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.345 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.487 HD13 ' HB ' ' B' ' 277' ' ' ILE . 3.4 mm? -104.88 104.6 14.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.474 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.409 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . 145.98 178.33 21.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.35 -0.929 . . . . 10.0 112.673 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -93.26 147.54 22.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.728 0.299 . . . . 10.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.54 131.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.675 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.44 113.46 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.104 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 44.4 p -90.28 171.37 9.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.381 . . . . 10.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.9 -10.23 51.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.2 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.82 -14.21 60.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.06 -6.71 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.221 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.38 114.11 3.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.535 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 23.4 t60 60.18 56.86 3.15 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.841 0.713 . . . . 10.0 110.533 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -136.34 -111.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.624 -0.717 . . . . 10.0 111.462 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.57 166.9 24.69 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.22 -0.752 . . . . 10.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 117.059 0.429 . . . . 10.0 111.057 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 255' ' ' ARG . . . . . 0.416 ' HD2' ' OD2' ' B' ' 258' ' ' ASP . 0.6 OUTLIER -97.25 106.92 19.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.89 0.376 . . . . 10.0 110.639 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 256' ' ' ILE . . . . . 0.4 HD11 HG11 ' C' ' 245' ' ' VAL . 4.3 pt -136.5 61.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.298 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.9 m 67.34 29.52 7.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.213 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 258' ' ' ASP . . . . . 0.416 ' OD2' ' HD2' ' B' ' 255' ' ' ARG . 3.4 p-10 -81.14 79.41 7.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.569 0.699 . . . . 10.0 111.027 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -123.89 85.81 2.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.622 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.9 t -138.17 176.82 8.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.032 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.9 m -140.02 113.27 8.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.144 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -100.59 121.74 42.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.901 0.382 . . . . 10.0 110.695 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 227' ' ' SER . 1.9 m -134.54 137.03 43.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.48 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.6 p -137.41 138.87 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.347 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 265' ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 23.4 mttt -86.46 -80.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.82 120.77 42.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.2 t -115.99 105.32 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.538 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.24 113.19 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.464 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.07 134.09 9.05 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.44 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -144.81 141.06 28.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.317 -0.253 . . . . 10.0 110.317 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.73 69.07 1.43 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.198 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 59.87 42.18 16.81 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.797 0.439 . . . . 10.0 111.659 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.5 t -69.41 137.52 52.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.185 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -115.66 102.16 9.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.015 -0.539 . . . . 10.0 109.63 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' B' ' 239' ' ' VAL . 7.7 t -102.06 122.26 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.843 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.437 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -119.77 115.25 23.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.268 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.487 ' HB ' HD13 ' B' ' 241' ' ' LEU . 13.0 mm -104.5 83.57 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.819 0.342 . . . . 10.0 110.634 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.03 174.34 27.61 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.285 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -90.22 164.7 14.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.61 165.27 19.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.899 0.38 . . . . 10.0 110.099 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 2.4 t80 -143.58 78.94 1.61 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.334 -0.848 . . . . 10.0 108.834 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -112.62 -122.75 4.05 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.694 -0.765 . . . . 10.0 113.162 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 155.31 -61.95 0.36 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.303 -0.719 . . . . 10.0 111.303 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -83.67 74.49 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.58 121.15 3.85 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.388 -1.085 . . . . 10.0 110.388 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -83.49 79.27 9.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.939 0.37 . . . . 10.0 111.327 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.437 ' CZ2' ' HB2' ' B' ' 276' ' ' LEU . 21.0 t90 71.28 -48.28 0.67 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.199 0.937 . . . . 10.0 112.255 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -127.7 -175.62 3.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.899 0.381 . . . . 10.0 110.432 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -92.71 131.84 37.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.998 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -164.34 91.24 0.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.12 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -130.09 130.14 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.03 -0.532 . . . . 10.0 109.632 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.93 -173.08 4.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.588 0.232 . . . . 10.0 111.133 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -111.81 132.45 54.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.98 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -87.15 -177.01 5.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.437 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.285 -0.864 . . . . 10.0 110.134 179.731 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.582 0.229 . . . . 10.0 110.409 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.441 ' HB3' HG22 ' C' ' 277' ' ' ILE . 15.5 m120 -126.51 103.4 7.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 133.51 52.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.13 0.491 . . . . 10.0 111.871 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -130.11 122.28 27.97 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.037 -0.727 . . . . 10.0 109.037 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' C' ' 265' ' ' LYS . 48.8 tttm -82.69 -80.87 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.395 0.517 . . . . 10.0 112.395 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' C' ' 266' ' ' THR . 0.2 OUTLIER -109.39 122.27 47.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.268 0.556 . . . . 10.0 111.835 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.442 HD11 ' HB1' ' C' ' 228' ' ' ALA . 88.4 mt -127.65 137.76 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.474 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.472 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 40.0 ttm-85 -128.76 119.51 24.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.402 ' C ' ' HB3' ' C' ' 237' ' ' ALA . 0.7 OUTLIER -127.92 93.57 3.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.049 0.452 . . . . 10.0 110.355 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.472 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 6.1 pt-20 -120.01 158.68 26.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.743 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 65.68 73.17 0.4 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 10.0 111.354 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 59.31 36.62 23.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.262 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.402 ' HB3' ' C ' ' C' ' 233' ' ' THR . . . -100.3 156.47 17.21 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.276 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -145.82 150.56 36.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.664 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 131.16 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.418 ' HB3' HD22 ' C' ' 276' ' ' LEU . 8.6 tt0 -115.81 127.16 54.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 10.0 109.958 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.478 HD23 HD13 ' B' ' 277' ' ' ILE . 3.7 mm? -102.11 88.25 3.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.774 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.48 171.6 31.89 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.168 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -84.34 152.58 24.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.779 0.323 . . . . 10.0 110.324 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.12 118.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.791 0.329 . . . . 10.0 110.939 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 46.6 t -121.06 110.91 29.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.031 0.443 . . . . 10.0 110.2 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.9 p -82.6 160.4 22.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.827 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.89 -4.74 7.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.76 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.41 -15.87 44.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.188 0.518 . . . . 10.0 110.242 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -100.01 94.15 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.496 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.02 20.97 13.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.338 0.59 . . . . 10.0 109.834 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -111.15 144.18 40.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.04 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.18 134.4 3.31 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.086 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.55 171.74 14.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.921 -0.657 . . . . 10.0 111.493 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.3 tp -87.17 115.74 28.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.146 0.498 . . . . 10.0 109.746 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -160.28 149.81 17.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.005 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 tt -95.32 130.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.416 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 35.3 m -153.31 169.49 22.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.792 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 258' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' D' ' 257' ' ' SER . 0.5 OUTLIER -94.53 130.11 41.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.044 0.449 . . . . 10.0 110.108 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -115.72 145.45 42.76 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.345 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.5 t -55.24 135.84 49.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.317 0.579 . . . . 10.0 111.013 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 56.0 m -96.41 139.28 32.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.951 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 20.7 t-20 -133.65 140.34 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.674 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -154.01 139.17 17.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.802 0.334 . . . . 10.0 110.126 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.39 147.15 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 265' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 1.1 mtpt -85.46 -58.84 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.432 . . . . 10.0 112.097 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 266' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 39.9 m -141.58 128.0 20.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.25 117.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.638 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.24 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.107 0.48 . . . . 10.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.51 138.81 15.02 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.797 -0.716 . . . . 10.0 111.667 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.25 125.6 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.912 0.356 . . . . 10.0 111.493 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.44 82.99 0.99 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.921 -0.656 . . . . 10.0 113.465 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 60.55 23.68 13.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.86 0.362 . . . . 10.0 111.377 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.18 136.82 57.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.204 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -128.07 109.91 11.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.525 -0.761 . . . . 10.0 109.825 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 37.7 t -100.45 133.82 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.759 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.4 OUTLIER -127.71 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.088 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.441 HG22 ' HB3' ' C' ' 226' ' ' ASN . 35.3 mm -105.04 95.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.379 . . . . 10.0 110.221 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.67 -171.23 33.65 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.254 -0.738 . . . . 10.0 111.254 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.24 148.1 30.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 10.0 109.801 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -106.95 142.32 36.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 111.084 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -129.31 104.32 7.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.501 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -173.93 175.83 46.45 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.684 -0.77 . . . . 10.0 112.134 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.29 -8.71 24.9 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.541 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.67 63.58 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.166 0.508 . . . . 10.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.48 -84.74 1.07 Allowed Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.064 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.42 -51.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.417 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 8.6 t90 -144.85 -67.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 288' ' ' ASP . . . . . 0.443 ' OD2' ' HD2' ' D' ' 238' ' ' ARG . 2.1 p30 -107.13 165.28 11.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.066 -0.516 . . . . 10.0 109.784 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -114.65 50.65 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.916 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -79.85 -53.19 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.473 . . . . 10.0 111.811 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.13 172.24 10.7 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.954 -0.298 . . . . 10.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 66.53 173.8 0.24 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -177.85 -153.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.347 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -76.22 157.85 32.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.607 179.346 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' D' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.315 0.579 . . . . 10.0 110.372 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 226' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 19.4 m-80 -99.23 138.8 35.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 227' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' D' ' 263' ' ' SER . 18.3 m -154.27 148.46 25.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.071 0.462 . . . . 10.0 111.086 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.45 134.09 31.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.802 -0.635 . . . . 10.0 109.732 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 229' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' C' ' 265' ' ' LYS . 12.6 tmtt? -86.13 -64.78 1.1 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.064 -0.255 . . . . 10.0 111.382 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.8 124.18 45.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.004 0.372 . . . . 10.0 112.004 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.45 HG21 HG21 ' D' ' 239' ' ' VAL . 55.3 mt -131.3 122.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -121.57 120.43 34.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.274 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -120.06 115.23 23.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.534 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.915 0.388 . . . . 10.0 112.029 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 62.18 90.01 0.08 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.981 1.104 . . . . 10.0 113.981 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 236' ' ' ARG . . . . . 0.671 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 29.8 mtt180 62.57 3.17 1.05 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.602 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.95 142.56 49.42 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.987 0.422 . . . . 10.0 111.408 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 238' ' ' ARG . . . . . 0.443 ' HD2' ' OD2' ' C' ' 288' ' ' ASP . 0.3 OUTLIER -133.68 150.07 51.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.412 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.45 HG21 HG21 ' D' ' 231' ' ' ILE . 2.5 p -136.55 137.21 47.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.883 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -115.57 140.7 48.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.375 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.459 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.9 mm? -123.7 75.77 1.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.054 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 242' ' ' GLY . . . . . 0.575 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . -171.19 -138.79 2.6 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.223 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -139.57 132.54 29.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.87 113.86 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.117 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.4 t -117.88 106.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.516 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 0.6 OUTLIER -81.52 158.69 24.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.229 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.87 -0.97 8.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.149 0.5 . . . . 10.0 111.38 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.95 -10.5 57.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.161 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.67 113.57 26.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.049 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 6.6 mp -111.35 -166.29 1.06 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.61 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -63.13 129.64 41.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.508 0.194 . . . . 10.0 110.6 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 133.66 50.6 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.026 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.39 18.18 8.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.432 -0.89 . . . . 10.0 112.593 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -74.26 -17.52 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.094 0.473 . . . . 10.0 111.314 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -104.69 88.48 2.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 10.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 20.0 tt -82.59 -10.59 12.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.883 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 257' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' C' ' 258' ' ' ASP . 37.7 m 61.06 -133.72 0.67 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.042 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 258' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' D' ' 225' ' ' ARG . 2.0 t0 -122.98 137.09 55.05 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -138.57 -83.65 0.29 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.507 -0.477 . . . . 10.0 112.033 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 12.9 t -79.29 156.31 28.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.198 0.523 . . . . 10.0 111.657 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' D' ' 225' ' ' ARG . 23.3 m -111.24 118.94 37.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.231 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 4.0 m120 -120.52 106.41 11.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 263' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' D' ' 227' ' ' SER . 23.1 m -127.61 132.58 49.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.475 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' E' ' 228' ' ' ALA . 10.1 p -120.86 144.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.638 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 265' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 19.5 mmtp -82.86 -51.65 7.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.802 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 50.1 m -142.54 122.22 13.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.09 122.16 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.334 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.85 123.13 67.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.135 0.493 . . . . 10.0 111.083 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.49 134.32 10.27 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -138.4 115.05 10.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.202 0.501 . . . . 10.0 111.474 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.17 93.12 0.79 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.967 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 272' ' ' GLU . . . . . 0.671 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 52.8 mm-40 54.94 33.3 19.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.214 0.53 . . . . 10.0 111.527 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -75.78 144.54 41.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.737 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -127.49 103.25 7.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.248 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 62.4 t -98.73 117.89 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.49 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.456 ' HB2' ' CH2' ' D' ' 287' ' ' TRP . 0.6 OUTLIER -114.08 106.16 14.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.531 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.459 ' HB ' HD13 ' D' ' 241' ' ' LEU . 30.6 mm -102.43 86.36 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 278' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . 162.21 -171.41 38.09 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.527 -0.844 . . . . 10.0 112.365 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -113.02 162.74 15.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.275 -0.268 . . . . 10.0 110.275 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.77 142.97 49.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 10.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -135.19 116.27 14.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.209 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 282' ' ' GLY . . . . . 0.516 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 152.29 166.28 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.481 -0.866 . . . . 10.0 112.422 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -83.98 71.57 2.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -117.1 -5.72 11.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.095 0.474 . . . . 10.0 110.292 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.94 -54.6 4.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.069 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -163.07 144.9 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.151 -0.315 . . . . 10.0 110.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' D' ' 276' ' ' LEU . 34.6 t90 -59.52 -63.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.244 0.34 . . . . 10.0 111.25 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 288' ' ' ASP . . . . . 0.495 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 60.1 t0 -146.03 115.29 7.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 10.0 109.97 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -142.87 161.83 37.08 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.93 -51.92 7.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.673 0.273 . . . . 10.0 110.7 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -156.57 -175.44 5.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.444 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -91.93 -151.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.851 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.18 119.55 10.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.807 0.337 . . . . 10.0 110.757 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -113.28 154.59 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.168 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.656 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' E' ' 261' ' ' THR . 93.3 mtt180 . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 226' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' E' ' 262' ' ' ASN . 22.0 m-80 -130.84 120.66 24.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.945 0.402 . . . . 10.0 111.14 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 227' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' E' ' 263' ' ' SER . 1.3 m -118.74 141.9 48.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' D' ' 264' ' ' VAL . . . -132.17 133.26 44.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.167 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' E' ' 265' ' ' LYS . 1.1 ttmm -91.25 -77.72 0.41 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.899 -0.32 . . . . 10.0 111.143 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.7 126.78 51.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 10.0 111.666 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 66.5 mt -132.82 124.03 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -122.15 109.82 14.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.537 . . . . 10.0 110.3 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.5 p -113.53 96.82 6.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.358 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 234' ' ' GLU . . . . . 0.401 ' HG3' ' HG2' ' E' ' 270' ' ' LYS . 5.3 pt-20 -117.07 152.22 35.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.441 . . . . 10.0 112.103 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 65.15 81.5 0.21 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.741 -1.118 . . . . 10.0 111.441 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 50.82 63.69 2.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.07 -0.968 . . . . 10.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.78 155.28 45.4 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.985 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 238' ' ' ARG . . . . . 0.495 ' HE ' ' CG ' ' D' ' 288' ' ' ASP . 0.1 OUTLIER -136.48 149.35 48.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.885 -178.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.09 127.12 32.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.92 -0.582 . . . . 10.0 109.982 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -120.75 128.11 52.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.589 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.4 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 1.0 OUTLIER -116.47 92.42 3.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.751 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 242' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 167.53 -165.31 38.56 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.765 -0.731 . . . . 10.0 112.172 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -103.44 150.18 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.953 0.406 . . . . 10.0 110.783 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.81 110.93 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.911 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.17 112.09 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.096 0.474 . . . . 10.0 110.431 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.693 HG23 ' H ' ' E' ' 248' ' ' ALA . 14.5 t -76.02 179.4 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.72 -7.53 11.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.035 0.754 . . . . 10.0 113.035 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 248' ' ' ALA . . . . . 0.693 ' H ' HG23 ' E' ' 246' ' ' THR . . . -67.49 -30.85 70.65 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.754 -0.461 . . . . 10.0 109.754 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.96 -173.59 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.072 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 60.9 mt -89.48 123.51 33.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.889 -0.596 . . . . 10.0 109.618 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -63.96 -28.41 69.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.81 -167.48 25.45 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.003 -0.839 . . . . 10.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 85.88 92.56 0.85 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 10.0 112.238 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 35.0 mt -78.75 -31.77 15.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.626 . . . . 10.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 255' ' ' ARG . . . . . 0.416 ' HA ' ' NE ' ' E' ' 255' ' ' ARG . 0.4 OUTLIER -84.74 83.53 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.777 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.29 109.75 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 10.0 110.075 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 35.5 m -143.13 140.82 31.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.055 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.79 130.94 35.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.262 0.553 . . . . 10.0 110.338 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -108.42 -52.8 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.67 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.4 t -67.79 133.69 49.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.465 0.65 . . . . 10.0 111.319 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 94.9 m -121.69 113.11 19.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.694 -0.684 . . . . 10.0 109.889 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 262' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' E' ' 226' ' ' ASN . 11.2 m120 -115.86 141.25 48.35 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.52 -0.764 . . . . 10.0 110.281 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 263' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' E' ' 227' ' ' SER . 73.3 m -142.22 133.34 26.07 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.34 138.31 49.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.183 0.516 . . . . 10.0 110.411 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 265' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' E' ' 229' ' ' LYS . 80.8 mttt -84.18 -60.79 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.211 -0.449 . . . . 10.0 112.144 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.5 m -135.92 123.71 22.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 t -120.23 111.23 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.403 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -114.39 110.51 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.758 0.313 . . . . 10.0 111.029 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.0 117.43 3.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.014 -0.613 . . . . 10.0 111.7 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 270' ' ' LYS . . . . . 0.401 ' HG2' ' HG3' ' E' ' 234' ' ' GLU . 0.0 OUTLIER -120.02 114.07 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.748 0.309 . . . . 10.0 111.519 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.0 90.54 0.4 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.819 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 60.76 85.77 0.11 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.178 0.513 . . . . 10.0 111.319 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.41 136.1 48.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.94 104.26 10.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.35 117.89 51.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.024 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.03 113.08 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.139 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' E' ' 226' ' ' ASN . 38.3 mm -107.65 87.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 278' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 166.56 -156.39 28.25 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.901 -0.666 . . . . 10.0 111.948 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -110.18 145.58 37.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.97 0.414 . . . . 10.0 110.293 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 280' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' E' ' 288' ' ' ASP . 0.7 OUTLIER -106.21 146.71 29.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.541 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -159.17 84.49 0.79 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.045 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.36 -104.92 1.31 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.239 -0.981 . . . . 10.0 113.19 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 283' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 154.36 59.95 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.204 -0.522 . . . . 10.0 111.916 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -135.45 -59.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.516 0.198 . . . . 10.0 110.726 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.5 19.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.55 -0.833 . . . . 10.0 113.65 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -156.13 113.86 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.397 0.599 . . . . 10.0 109.944 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 68.24 16.29 9.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.086 0.946 . . . . 10.0 108.799 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 288' ' ' ASP . . . . . 0.466 ' HA ' ' HG3' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -154.97 168.53 26.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.993 -1.458 . . . . 10.0 108.14 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -153.32 143.43 22.24 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.852 -0.339 . . . . 10.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 290' ' ' HIS . . . . . 0.424 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 2.2 p-80 -149.34 178.65 8.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.979 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -105.12 -62.96 1.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.679 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 t60 66.65 168.35 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.758 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -108.32 107.07 17.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.997 0.427 . . . . 10.0 110.003 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.02 132.31 42.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.72 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.773 0 CA-C-O 118.49 -0.767 . . . . 10.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.206 -0.294 . . . . 10.0 110.206 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -105.21 142.4 35.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.9 m -147.15 137.47 23.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.781 0.324 . . . . 10.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -140.87 151.93 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.321 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -112.46 -56.84 2.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -137.02 121.32 18.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.853 0.359 . . . . 10.0 111.378 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 54.2 mt -128.14 119.01 49.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.084 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -127.84 110.83 12.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.309 0.576 . . . . 10.0 110.532 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.95 127.16 51.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.555 -0.748 . . . . 10.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.73 176.94 8.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.426 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 60.53 66.9 0.88 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.077 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 57.8 65.44 1.32 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.901 -1.045 . . . . 10.0 110.94 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -131.81 178.68 6.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 238' ' ' ARG . 6.2 ptp180 -159.18 155.12 26.55 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.026 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.18 136.74 59.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.471 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -129.21 134.41 47.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.994 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.53 138.12 51.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.278 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.74 -123.1 2.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.312 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -143.91 141.71 30.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 41.8 t -105.41 110.52 31.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.216 0.531 . . . . 10.0 111.56 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.12 108.51 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.647 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.418 ' HB ' ' HA2' ' A' ' 282' ' ' GLY . 12.0 m -84.62 149.72 25.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.183 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.3 -14.17 16.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.64 -13.3 56.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 10.0 110.904 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -106.94 25.31 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.431 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 3.9 mm? 70.95 -159.64 0.13 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.258 -0.883 . . . . 10.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.41 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 48.8 p-80 -76.86 169.63 17.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.235 0.541 . . . . 10.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -77.58 80.13 1.33 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.3 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.04 -36.6 93.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.218 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.8 mt 72.72 146.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.547 0.792 . . . . 10.0 111.68 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 61.85 87.54 0.1 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.286 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 20.7 mt -123.38 -67.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.96 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 p -101.34 -90.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.861 -0.154 . . . . 10.0 111.408 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.1 t0 56.1 69.1 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.706 0.628 . . . . 10.0 110.932 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -121.07 2.65 10.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 10.0 110.623 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -136.38 152.0 50.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.38 127.85 42.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.345 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -101.77 83.61 2.43 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -108.81 116.69 32.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.602 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 228' ' ' ALA . 14.2 p -119.81 140.31 44.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.7 mttm -91.84 -79.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.179 0.437 . . . . 10.0 112.179 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 128.73 54.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.06 119.54 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.456 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.73 125.27 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.774 0.321 . . . . 10.0 111.491 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -128.91 129.31 6.11 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.197 -0.525 . . . . 10.0 111.934 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -145.01 111.87 5.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.901 0.382 . . . . 10.0 111.339 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.16 82.57 1.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.867 -0.683 . . . . 10.0 112.952 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 52.17 50.59 18.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.506 0.669 . . . . 10.0 110.996 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 m -102.26 141.64 34.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.966 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -121.15 119.43 32.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.32 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 55.2 t -103.31 119.07 51.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.918 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 276' ' ' LEU . 1.4 tm? -114.15 103.6 11.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.36 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.529 HD13 HD23 ' B' ' 241' ' ' LEU . 8.8 mm -96.98 101.54 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.358 -0.383 . . . . 10.0 109.992 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 142.44 179.24 19.14 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.847 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.15 159.95 15.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.846 0.323 . . . . 10.0 110.642 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.96 156.86 39.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.447 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.86 86.97 2.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.325 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.418 ' HA2' ' HB ' ' A' ' 246' ' ' THR . . . -109.02 -145.83 11.4 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.353 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -174.35 -82.29 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -88.89 89.99 8.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.337 -0.986 . . . . 10.0 108.337 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 108.08 110.28 3.4 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.511 -1.035 . . . . 10.0 110.511 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -75.6 81.89 2.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.573 0.225 . . . . 10.0 110.916 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.5 t90 67.35 -69.6 0.13 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.145 0.903 . . . . 10.0 111.777 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.33 90.71 3.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.735 0.302 . . . . 10.0 110.749 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -155.42 136.38 13.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.561 -0.29 . . . . 10.0 110.772 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -157.93 34.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.068 -0.715 . . . . 10.0 109.068 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.22 132.13 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.836 -0.62 . . . . 10.0 111.52 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -137.16 15.87 3.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.639 0.733 . . . . 10.0 109.433 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -91.54 84.3 5.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.032 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -66.22 126.21 27.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.955 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.302 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.4 142.04 40.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.242 -0.651 . . . . 10.0 109.242 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.9 m -143.92 126.85 16.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.83 0.348 . . . . 10.0 111.091 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.18 134.95 47.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.405 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' B' ' 265' ' ' LYS . 50.9 mmtt -87.38 -59.39 2.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.451 -0.34 . . . . 10.0 111.776 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' B' ' 266' ' ' THR . 26.0 t70 -146.14 123.94 11.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.481 . . . . 10.0 110.869 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.06 130.61 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.06 113.05 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.455 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 1.3 p -124.06 114.12 19.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.653 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.23 156.05 48.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.971 0.415 . . . . 10.0 111.39 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 60.78 80.19 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.019 -0.991 . . . . 10.0 112.185 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 58.04 37.02 26.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.664 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.74 141.85 30.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 10.0 110.533 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.58 131.21 46.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.747 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.43 133.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.131 0.491 . . . . 10.0 111.093 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.686 ' HB3' HD22 ' B' ' 276' ' ' LEU . 17.1 tm0? -115.98 125.77 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.877 -0.601 . . . . 10.0 109.987 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.529 HD23 HD13 ' A' ' 277' ' ' ILE . 3.0 mm? -112.35 83.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.141 -0.482 . . . . 10.0 111.307 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.93 -177.27 42.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.169 -1.015 . . . . 10.0 112.938 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -90.06 139.63 30.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 10.0 110.201 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 92.7 t -104.6 114.22 43.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.496 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.9 t -119.71 106.5 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.978 0.418 . . . . 10.0 110.028 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 82.5 p -79.66 173.11 12.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.049 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.29 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 10.0 112.096 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.92 -21.59 50.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.784 0.326 . . . . 10.0 110.524 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.474 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . -93.71 17.95 11.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.25 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.69 106.0 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.883 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t60 65.06 82.39 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.954 0.784 . . . . 10.0 111.481 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.6 -135.87 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.915 -0.66 . . . . 10.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.17 127.61 6.14 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.294 -0.722 . . . . 10.0 111.294 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 36.3 mt -119.94 -33.23 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.048 0.451 . . . . 10.0 111.218 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 255' ' ' ARG . . . . . 0.409 ' HD2' ' OD1' ' B' ' 258' ' ' ASP . 1.2 tpt180 -86.19 88.62 7.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.842 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt -120.37 54.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.569 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 m 65.92 38.25 5.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.615 -0.72 . . . . 10.0 110.332 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 258' ' ' ASP . . . . . 0.409 ' OD1' ' HD2' ' B' ' 255' ' ' ARG . 2.0 p-10 -73.96 61.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.226 -0.897 . . . . 10.0 111.541 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -104.8 98.1 7.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.004 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 9.0 t -156.57 148.54 22.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.281 0.562 . . . . 10.0 111.326 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' C' ' 225' ' ' ARG . 0.1 OUTLIER -118.94 98.39 6.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.238 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -88.01 116.29 26.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' C' ' 227' ' ' SER . 0.0 OUTLIER -124.08 135.45 53.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.566 -0.743 . . . . 10.0 111.61 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.18 135.79 49.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.274 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 265' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 0.5 OUTLIER -80.63 -73.93 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.508 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 0.6 OUTLIER -124.15 139.2 54.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.36 121.97 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.167 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.59 119.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.834 0.35 . . . . 10.0 110.984 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.85 117.55 3.19 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -134.45 119.48 18.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.75 0.275 . . . . 10.0 111.364 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.98 87.15 1.08 Allowed Glycine 0 C--N 1.329 0.15 0 C-N-CA 120.863 -0.684 . . . . 10.0 113.474 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 53.04 41.01 32.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.867 0.467 . . . . 10.0 111.51 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.0 t -76.92 154.21 33.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.282 0.563 . . . . 10.0 111.439 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -136.36 106.56 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.912 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.74 126.11 64.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.014 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -117.89 117.3 28.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.35 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.417 HD13 HD23 ' C' ' 241' ' ' LEU . 21.8 mm -108.52 85.32 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.241 0.543 . . . . 10.0 109.776 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.96 168.29 19.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.056 -0.818 . . . . 10.0 111.056 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -88.83 158.55 18.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.223 0.511 . . . . 10.0 110.234 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.42 162.16 24.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.271 0.557 . . . . 10.0 111.039 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.474 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 2.7 t80 -140.35 95.78 2.93 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.047 -0.979 . . . . 10.0 108.862 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -120.9 -122.91 2.96 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.957 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' B' ' 285' ' ' GLY . . . 151.34 -44.17 0.67 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.855 -0.898 . . . . 10.0 110.855 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -82.72 35.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.804 0.812 . . . . 10.0 109.2 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 285' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 283' ' ' GLY . . . 136.23 172.0 12.47 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.42 -1.472 . . . . 10.0 109.42 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -112.98 62.82 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 22.1 t90 71.3 -45.87 0.63 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.103 0.877 . . . . 10.0 110.591 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 288' ' ' ASP . . . . . 0.498 ' OD2' ' HD3' ' C' ' 274' ' ' ARG . 37.5 t70 -101.14 151.17 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.287 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.86 101.23 12.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.418 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 290' ' ' HIS . . . . . 0.637 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 36.0 t60 -131.89 134.88 46.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.423 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -154.38 126.33 7.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.023 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.23 -167.44 2.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.696 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -119.23 127.1 52.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.751 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -70.8 165.77 22.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.775 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.629 -0.7 . . . . 10.0 110.289 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 261' ' ' THR . 20.3 ptt-85 . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 109.876 -0.416 . . . . 10.0 109.876 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -120.56 133.22 55.41 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.247 0.342 . . . . 10.0 110.639 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' B' ' 263' ' ' SER . 67.7 m -139.25 133.28 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.843 0.354 . . . . 10.0 110.558 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.96 51.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.623 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -90.39 -72.72 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.68 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -123.97 121.67 35.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.995 0.426 . . . . 10.0 111.46 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.47 126.71 74.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.856 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.414 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 38.6 ttm-85 -113.62 120.69 41.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.2 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 86.84 2.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 10.0 110.49 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.414 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 5.6 pt-20 -117.17 172.7 7.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.631 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.574 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 48.2 mt-10 65.95 59.74 0.7 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 64.19 15.41 9.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.399 -0.818 . . . . 10.0 112.748 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.63 156.87 32.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.844 0.354 . . . . 10.0 111.462 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.495 HH22 ' CD ' ' C' ' 272' ' ' GLU . 0.2 OUTLIER -137.23 146.62 45.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.31 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.19 140.07 44.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.768 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -125.16 124.66 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.395 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' C' ' 277' ' ' ILE . 4.1 mm? -100.21 97.46 8.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.181 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.77 32.76 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.534 -0.841 . . . . 10.0 112.496 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.49 158.87 15.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 10.0 110.218 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.84 110.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.961 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.47 121.43 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.002 0.43 . . . . 10.0 110.968 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 246' ' ' THR . . . . . 0.449 ' C ' ' H ' ' C' ' 248' ' ' ALA . 11.0 p -87.84 165.88 14.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.917 -0.583 . . . . 10.0 109.734 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.05 26.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.291 0.567 . . . . 10.0 111.975 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 248' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' C' ' 246' ' ' THR . . . -117.75 -10.22 10.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.155 0.502 . . . . 10.0 110.142 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -96.44 73.34 2.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.245 0.545 . . . . 10.0 110.701 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 14.0 mt -109.35 -16.93 13.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.043 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -86.55 76.73 9.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.307 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.75 8.19 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -116.75 164.0 12.41 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 17.1 tt -77.32 128.93 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 10.0 110.57 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -157.29 110.79 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.403 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 5.7 tt -81.99 99.35 5.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.944 0.878 . . . . 10.0 110.379 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -132.97 -176.52 4.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 10.0 110.091 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 258' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 0.2 OUTLIER -64.33 157.14 26.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.836 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.25 138.81 22.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 9.7 t -64.71 127.07 29.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.287 0.565 . . . . 10.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.07 137.18 38.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.528 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' D' ' 241' ' ' LEU . 25.8 t-20 -133.18 132.19 41.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 10.0 110.408 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' D' ' 227' ' ' SER . 17.8 m -151.49 150.2 30.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.737 0.303 . . . . 10.0 110.858 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.34 144.85 25.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 265' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 2.4 mtpt -88.2 -70.76 0.62 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.719 0.637 . . . . 10.0 112.719 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 128.66 51.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.478 0.547 . . . . 10.0 112.478 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.55 118.33 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.588 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 85.5 t -110.05 120.4 61.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.053 0.454 . . . . 10.0 110.928 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 269' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -123.48 122.94 5.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.268 -0.733 . . . . 10.0 111.268 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.516 ' HB2' ' HG2' ' D' ' 234' ' ' GLU . 27.4 mttm -138.43 141.19 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.63 0.252 . . . . 10.0 111.472 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 271' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 71.61 79.77 0.39 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.868 -0.605 . . . . 10.0 113.519 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 272' ' ' GLU . . . . . 0.495 ' CD ' HH22 ' C' ' 238' ' ' ARG . 36.5 mm-40 55.18 39.77 31.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.053 0.454 . . . . 10.0 111.585 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 157.65 23.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 10.0 111.296 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.62 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 1.3 mtm180 -137.7 118.56 14.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.06 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.98 126.7 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.276 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.569 ' HB2' ' CZ3' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -117.42 112.47 20.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.243 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' C' ' 241' ' ' LEU . 34.1 mm -111.32 87.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.14 0.495 . . . . 10.0 110.062 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 162.59 -175.61 38.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.964 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -95.64 145.2 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.091 0.472 . . . . 10.0 110.162 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.47 143.47 37.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -130.1 101.42 5.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.605 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -133.27 -158.1 8.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.673 -0.775 . . . . 10.0 112.509 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.9 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.432 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -72.05 -17.51 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 10.0 111.183 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 285' ' ' GLY . . . . . 0.407 ' HA2' ' HE3' ' D' ' 284' ' ' LYS . . . 168.3 -143.72 8.33 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.803 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -104.53 -160.14 0.75 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.889 -0.412 . . . . 10.0 109.889 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.62 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 9.2 t90 -49.18 -43.79 42.43 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.481 0.488 . . . . 10.0 112.281 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 288' ' ' ASP . . . . . 0.637 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.0 OUTLIER -122.76 168.89 11.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.648 -0.421 . . . . 10.0 111.122 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -120.54 38.56 3.97 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.183 0.808 . . . . 10.0 113.183 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -65.61 -51.19 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.075 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 291' ' ' HIS . . . . . 0.416 ' HB2' HH22 ' D' ' 274' ' ' ARG . 6.0 m170 -130.13 177.28 7.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 71.34 155.73 0.15 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.884 0.74 . . . . 10.0 111.423 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.1 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.205 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -126.94 -176.01 3.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.709 -0.662 . . . . 10.0 110.747 -179.453 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.568 ' HD3' ' OD2' ' D' ' 258' ' ' ASP . 6.0 mpt_? . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.864 0.364 . . . . 10.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -108.95 116.48 32.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 227' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' C' ' 263' ' ' SER . 19.9 m -138.58 132.63 31.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.006 0.431 . . . . 10.0 111.239 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.85 142.11 48.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.73 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 229' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 23.5 tttp -88.78 -71.5 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -118.21 119.74 35.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.723 0.297 . . . . 10.0 111.41 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.47 HG21 HG21 ' D' ' 239' ' ' VAL . 57.1 mt -122.8 118.71 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.041 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -110.61 124.56 52.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.904 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.451 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.6 OUTLIER -135.93 104.89 5.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.039 0.447 . . . . 10.0 110.462 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 234' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' C' ' 270' ' ' LYS . 1.7 mt-10 -128.59 162.13 27.99 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 66.97 72.28 0.36 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.677 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 236' ' ' ARG . . . . . 0.543 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 4.6 mtp180 55.82 32.5 19.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.872 -0.603 . . . . 10.0 111.928 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.26 173.35 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.98 0.419 . . . . 10.0 111.579 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.93 152.36 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.492 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.47 HG21 HG21 ' D' ' 231' ' ' ILE . 1.8 p -143.27 135.97 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.602 . . . . 10.0 110.434 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -124.06 128.63 49.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.19 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.1 mm? -110.66 101.79 10.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.355 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 242' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . 164.31 -108.97 0.35 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.956 -1.116 . . . . 10.0 113.214 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -164.65 158.12 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.13 112.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.987 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.3 t -117.67 128.79 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 10.0 110.088 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.513 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 2.1 p -109.54 161.37 15.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.99 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.84 -2.06 6.59 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.9 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.17 59.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.996 0.427 . . . . 10.0 110.263 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -112.53 102.86 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.952 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.56 -159.88 0.76 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.095 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -71.0 79.45 0.65 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.267 0.556 . . . . 10.0 110.693 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -146.07 39.93 1.1 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.928 -0.869 . . . . 10.0 110.928 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.04 31.15 7.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.412 -0.675 . . . . 10.0 111.412 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.7 tt -74.39 -19.48 17.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.349 . . . . 10.0 111.397 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -78.39 69.51 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.532 0.682 . . . . 10.0 110.117 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.57 -16.73 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.085 . . . . 10.0 111.935 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 257' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 10.5 m 61.67 -127.16 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 258' ' ' ASP . . . . . 0.568 ' OD2' ' HD3' ' D' ' 225' ' ' ARG . 1.1 t0 -125.21 137.88 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 259' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' E' ' 257' ' ' SER . 9.6 tp60 -136.27 -72.43 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.521 -0.472 . . . . 10.0 112.128 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 8.7 t -78.69 151.39 32.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.467 0.651 . . . . 10.0 111.522 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -114.84 90.9 3.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.586 -0.734 . . . . 10.0 109.397 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 7.4 m120 -98.45 112.84 24.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.478 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -129.01 99.71 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.497 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 13.2 p -97.09 142.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 10.0 109.873 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 265' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 1.8 mptt -95.81 -50.45 4.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.75 0.648 . . . . 10.0 112.75 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 11.1 m -133.49 122.61 23.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.638 -0.664 . . . . 10.0 112.281 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.77 117.75 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.991 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.55 110.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.679 -0.237 . . . . 10.0 110.593 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 269' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -118.01 120.12 4.63 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.383 -0.437 . . . . 10.0 112.331 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -135.05 127.39 30.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.829 -0.218 . . . . 10.0 111.525 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.48 83.6 1.12 Allowed Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.174 -0.536 . . . . 10.0 113.631 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 272' ' ' GLU . . . . . 0.543 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 5.8 mp0 53.28 32.96 14.48 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.945 0.498 . . . . 10.0 111.799 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.7 t -75.94 147.98 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.143 0.497 . . . . 10.0 110.85 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 274' ' ' ARG . . . . . 0.416 HH22 ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.89 113.35 15.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.793 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.508 ' HA ' HG13 ' E' ' 239' ' ' VAL . 47.4 t -101.16 110.58 28.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 10.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.87 106.59 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.483 ' HB ' HD13 ' D' ' 241' ' ' LEU . 18.1 mm -105.18 89.98 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 278' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . 158.7 -169.72 35.13 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.875 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -107.98 167.77 9.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.622 0.249 . . . . 10.0 110.715 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.21 140.79 52.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.548 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.06 114.05 13.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.079 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 282' ' ' GLY . . . . . 0.513 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 162.99 163.69 16.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.363 -0.923 . . . . 10.0 112.734 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -97.45 58.38 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.508 -0.854 . . . . 10.0 112.255 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 284' ' ' LYS . . . . . 0.407 ' HE3' ' HA2' ' C' ' 285' ' ' GLY . 39.2 tttm -116.72 12.74 14.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.236 0.541 . . . . 10.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.31 -50.25 4.16 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.665 -0.698 . . . . 10.0 113.077 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 286' ' ' PHE . . . . . 0.483 ' CE1' HG21 ' E' ' 244' ' ' VAL . 1.6 t80 -170.27 157.48 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.53 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 25.3 t90 -60.75 -62.91 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.706 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 288' ' ' ASP . . . . . 0.53 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 7.7 t70 -146.12 124.53 12.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.165 0.507 . . . . 10.0 110.098 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.76 172.45 12.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 10.0 109.847 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -101.33 -51.25 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 111.042 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -156.68 -173.09 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.701 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -100.3 -159.21 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.207 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -76.06 103.37 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 10.0 110.374 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -103.81 175.08 5.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.537 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.574 -0.727 . . . . 10.0 109.57 179.786 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' E' ' 261' ' ' THR . 76.4 mtt180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 226' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 49.8 m-80 -133.02 110.99 10.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.206 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 7.0 m -118.08 145.13 45.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 10.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.76 125.68 25.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.793 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.668 ' HB2' ' O ' ' E' ' 265' ' ' LYS . 42.1 mttm -77.09 -70.14 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.53 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' E' ' 266' ' ' THR . 13.3 t70 -129.73 129.79 44.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.355 -0.384 . . . . 10.0 111.367 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.53 126.08 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.256 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -117.09 110.65 18.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 10.0 110.269 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.441 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 1.4 p -125.14 103.77 8.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.428 -0.805 . . . . 10.0 111.186 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -132.95 154.7 50.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 10.0 111.848 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 235' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' E' ' 271' ' ' GLY . 33.7 tt0 65.45 76.1 0.34 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.469 -0.787 . . . . 10.0 111.067 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 56.59 71.04 0.59 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.221 -0.899 . . . . 10.0 110.455 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -127.49 159.7 33.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.168 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 139.04 38.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.531 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' D' ' 275' ' ' VAL . 2.7 p -132.28 124.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.135 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -126.16 125.34 42.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.541 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mp -119.62 100.64 7.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.395 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.99 -173.38 40.84 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.298 -0.721 . . . . 10.0 111.298 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -103.49 154.53 19.35 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.483 HG21 ' CE1' ' D' ' 286' ' ' PHE . 61.7 t -103.15 129.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.409 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.2 99.15 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 10.0 110.837 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' D' ' 282' ' ' GLY . 7.5 t -69.15 169.64 11.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.202 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.51 -21.09 62.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.822 0.344 . . . . 10.0 111.7 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.09 73.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.998 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.72 -163.46 0.19 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.295 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.46 107.95 20.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.213 -0.449 . . . . 10.0 109.863 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -77.74 81.93 4.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.046 0.45 . . . . 10.0 110.722 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.24 140.98 10.5 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.839 -0.619 . . . . 10.0 112.016 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 119.55 98.47 1.77 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.75 -0.738 . . . . 10.0 111.906 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.67 -27.56 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.266 0.555 . . . . 10.0 110.471 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.05 59.23 5.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.405 0.621 . . . . 10.0 110.148 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 6.0 pt -86.09 123.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 257' ' ' SER . . . . . 0.474 ' HA ' ' NE2' ' D' ' 259' ' ' GLN . 67.0 m -152.96 166.61 31.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.672 -0.24 . . . . 10.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.38 117.76 9.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.851 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -125.49 16.29 8.23 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.35 0.5 . . . . 10.0 112.35 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -152.34 136.86 16.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.09 -0.381 . . . . 10.0 110.932 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 31.4 m -121.97 112.88 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.175 0.512 . . . . 10.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -115.41 114.87 25.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.832 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.1 m -118.82 121.07 39.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 10.0 109.977 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -108.96 147.12 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 10.0 110.112 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 265' ' ' LYS . . . . . 0.668 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 82.6 mttt -85.88 -79.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' E' ' 230' ' ' ASP . 13.0 m -131.07 132.08 44.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.875 0.369 . . . . 10.0 111.143 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 t -121.98 106.21 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.967 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.53 125.89 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.663 -0.244 . . . . 10.0 110.549 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -145.47 136.67 6.6 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.545 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.89 130.37 22.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 271' ' ' GLY . . . . . 0.473 ' H ' ' HB3' ' E' ' 235' ' ' GLU . . . 84.17 85.93 0.89 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.555 -0.831 . . . . 10.0 111.82 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 60.55 60.82 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 10.0 110.85 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.68 136.06 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.701 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.63 104.25 8.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.911 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.28 120.21 58.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.853 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.98 119.94 29.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 28.1 mm -117.75 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 10.0 110.981 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.15 -176.22 34.42 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.499 -0.641 . . . . 10.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -91.63 139.91 30.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.877 -0.416 . . . . 10.0 109.877 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.86 159.83 15.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.333 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -169.64 99.6 0.32 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.275 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.9 -114.56 1.43 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.549 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 283' ' ' GLY . . . . . 0.509 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 166.64 58.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.313 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -137.88 -59.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.443 0.163 . . . . 10.0 110.781 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.62 13.19 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.358 -0.925 . . . . 10.0 113.824 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -152.76 114.35 4.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.161 0.481 . . . . 10.0 109.795 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 73.16 10.92 5.15 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.81 0.814 . . . . 10.0 109.302 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -145.88 -179.9 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.546 -1.206 . . . . 10.0 109.173 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -161.55 137.13 7.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.188 -0.301 . . . . 10.0 110.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 290' ' ' HIS . . . . . 0.509 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 7.3 p-80 -150.33 169.45 21.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.397 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -76.65 -70.76 0.43 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.303 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 292' ' ' HIS . . . . . 0.444 ' HB2' ' NE2' ' E' ' 290' ' ' HIS . 13.7 t60 69.46 153.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.21 0.604 . . . . 10.0 111.615 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -127.08 112.2 14.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.189 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -95.3 -176.25 3.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.761 -0.637 . . . . 10.0 109.807 179.57 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 110.494 -0.188 . . . . 10.0 110.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -117.34 127.16 53.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 263' ' ' SER . 13.4 m -149.16 159.43 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 10.0 111.428 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.15 162.4 35.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.004 -0.544 . . . . 10.0 109.996 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -121.37 -75.46 0.59 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 10.0 111.844 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 266' ' ' THR . 29.0 t70 -113.51 117.47 31.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.866 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 31.8 pt -136.0 144.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.525 -0.307 . . . . 10.0 111.096 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -142.26 126.95 18.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.092 0.472 . . . . 10.0 110.93 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 21.0 p -121.79 113.28 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.271 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.47 158.65 37.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 10.0 111.4 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.49 71.76 0.55 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.427 -0.806 . . . . 10.0 111.908 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 34.9 mtm105 56.63 42.5 26.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 10.0 111.908 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -103.4 153.23 20.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.282 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -134.41 160.49 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.511 -0.313 . . . . 10.0 111.069 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 138.59 23.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -135.3 122.04 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 10.0 109.935 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.47 133.69 53.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.768 0.318 . . . . 10.0 110.253 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 140.97 -119.17 1.49 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.204 -0.522 . . . . 10.0 112.281 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -147.42 143.78 28.17 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.78 107.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.848 0.356 . . . . 10.0 111.362 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.93 120.2 50.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.561 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 m -85.67 151.6 23.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.619 . . . . 10.0 109.907 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.68 -14.89 60.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -87.11 -1.88 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.002 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -119.59 52.99 1.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.265 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.416 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 2.7 mm? 65.96 -158.07 0.26 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.102 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.416 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 44.3 p-80 -93.09 178.91 5.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.995 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -80.62 69.03 3.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.483 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.63 68.33 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.238 -0.745 . . . . 10.0 111.238 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.5 mt 70.51 144.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.259 0.623 . . . . 10.0 112.477 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.19 60.56 1.17 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.3 -0.863 . . . . 10.0 111.153 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.73 -50.75 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.54 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.5 p -128.61 -83.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.848 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.5 t70 54.29 72.56 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.77 0.669 . . . . 10.0 110.615 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -119.18 24.24 10.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.95 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.673 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 4.4 t -139.21 140.91 37.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.35 0.595 . . . . 10.0 112.009 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -91.23 112.46 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.105 -0.952 . . . . 10.0 110.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.441 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 15.6 m-20 -115.46 113.53 23.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 227' ' ' SER . 37.3 m -142.95 124.76 15.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 10.0 110.957 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.8 152.57 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.774 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 -56.88 2.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.83 -0.348 . . . . 10.0 111.48 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 10.5 m -133.75 130.32 37.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.49 124.31 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.919 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 14.8 t -115.92 117.42 55.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.817 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.38 119.32 4.25 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.105 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -134.49 123.32 23.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.925 0.393 . . . . 10.0 111.361 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.91 70.05 1.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.714 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 25.7 tt0 54.83 51.0 14.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.469 0.652 . . . . 10.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.88 144.7 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.508 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -119.03 112.68 19.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.288 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.58 115.14 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.842 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 276' ' ' LEU . 0.8 OUTLIER -111.53 111.05 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.845 0.355 . . . . 10.0 110.251 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.41 ' HA ' ' HB2' ' B' ' 241' ' ' LEU . 15.1 mm -101.94 98.85 7.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.822 0.344 . . . . 10.0 110.147 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.72 161.09 8.59 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.016 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.43 152.06 36.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.639 0.257 . . . . 10.0 110.361 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -175.79 2.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.027 0.441 . . . . 10.0 111.04 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -158.26 97.17 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.459 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.04 -147.8 5.7 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.253 -0.975 . . . . 10.0 114.149 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -175.31 -83.93 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.746 -0.542 . . . . 10.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -81.92 81.39 7.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.248 0.547 . . . . 10.0 109.573 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 120.11 108.12 2.19 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.655 -0.978 . . . . 10.0 110.655 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -74.34 83.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.658 0.266 . . . . 10.0 110.724 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t90 69.11 -65.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.206 -0.906 . . . . 10.0 111.191 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -154.13 91.83 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.959 0.409 . . . . 10.0 110.838 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -156.84 129.8 7.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -147.9 85.9 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -118.25 137.52 52.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.231 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -132.55 14.01 4.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.558 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -89.4 134.52 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.841 -0.6 . . . . 10.0 110.28 179.615 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.673 ' N ' ' HG1' ' A' ' 260' ' ' THR . 25.3 ttm-85 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.069 -0.345 . . . . 10.0 110.069 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -116.89 123.69 47.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.002 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -109.97 90.54 3.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.823 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -94.94 163.8 13.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.165 -0.47 . . . . 10.0 109.962 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' B' ' 265' ' ' LYS . 1.8 ttmm -125.09 -80.71 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.979 -0.288 . . . . 10.0 111.754 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -121.1 117.1 26.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.946 0.403 . . . . 10.0 111.273 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.85 123.16 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -118.28 113.49 21.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.717 0.294 . . . . 10.0 110.515 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.9 OUTLIER -116.71 113.52 22.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.711 -179.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.14 160.53 31.74 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.045 0.45 . . . . 10.0 111.813 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.63 74.35 0.4 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.19 -0.914 . . . . 10.0 112.456 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 21.4 mtm-85 55.06 39.78 31.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.2 0.524 . . . . 10.0 111.099 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -93.81 151.74 19.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.821 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 128.61 23.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.993 -0.549 . . . . 10.0 109.764 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.9 137.67 56.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.127 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -118.96 123.04 43.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 277' ' ' ILE . 4.4 mm? -96.66 87.85 4.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.412 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.441 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . 160.71 -178.63 36.63 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.587 -0.816 . . . . 10.0 112.315 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -89.81 163.33 15.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.597 0.237 . . . . 10.0 110.389 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.3 131.8 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.766 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.39 110.22 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.985 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 33.8 p -88.26 168.63 12.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.671 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.74 -5.1 14.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.512 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.43 -13.17 57.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 10.0 110.573 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.66 3.23 48.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.548 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.96 118.62 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.352 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 65.93 28.38 10.63 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.656 0.597 . . . . 10.0 111.355 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -106.76 -172.41 22.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.012 -0.613 . . . . 10.0 112.543 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.02 121.0 6.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.774 -0.53 . . . . 10.0 111.774 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 12.1 mt -104.27 -23.6 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.754 0.311 . . . . 10.0 111.699 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 255' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' C' ' 253' ' ' GLY . 14.6 tpt180 -93.22 91.59 7.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.909 0.385 . . . . 10.0 110.26 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.35 45.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.335 . . . . 10.0 111.296 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 60.14 33.51 21.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.048 -0.523 . . . . 10.0 111.394 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -63.24 131.95 50.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.383 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -156.81 76.38 0.87 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.206 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 3.7 t -151.95 161.63 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.063 0.459 . . . . 10.0 111.323 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -127.87 123.88 36.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.841 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.406 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 4.7 m120 -97.23 125.21 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 142.71 50.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.239 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.22 148.81 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 265' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 31.7 mttt -104.93 -77.41 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.457 -0.497 . . . . 10.0 111.973 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.17 119.07 38.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.259 0.552 . . . . 10.0 112.293 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.63 109.51 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.432 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 74.8 t -104.83 118.23 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.372 . . . . 10.0 110.658 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.57 133.06 8.19 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.351 -0.699 . . . . 10.0 111.351 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -145.16 122.35 11.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 10.0 111.719 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.28 78.79 1.42 Allowed Glycine 0 C--O 1.238 0.387 0 C-N-CA 120.639 -0.791 . . . . 10.0 113.347 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 55.27 36.48 27.12 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.286 0.565 . . . . 10.0 110.556 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.37 143.31 57.82 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.882 -1.053 . . . . 10.0 111.643 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -125.0 103.85 8.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.497 -0.774 . . . . 10.0 109.595 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.68 115.48 45.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.452 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 112.4 24.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 43.6 mm -101.83 81.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 10.0 110.231 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.18 178.88 33.59 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.007 -0.616 . . . . 10.0 112.336 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -92.93 160.85 14.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.41 172.18 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.961 0.41 . . . . 10.0 110.752 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 4.4 t80 -142.15 76.34 1.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.662 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -90.27 -137.75 6.99 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.677 -0.692 . . . . 10.0 113.248 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 156.42 -50.56 0.44 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.403 -0.679 . . . . 10.0 111.403 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -91.1 1.84 56.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 10.0 109.75 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -177.74 165.33 34.89 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.592 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -108.45 76.55 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.43 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 16.4 t90 70.41 -48.1 0.64 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.017 0.823 . . . . 10.0 111.397 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -117.62 178.24 4.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.91 117.55 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 10.0 110.784 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -139.66 132.46 29.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.438 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 291' ' ' HIS . . . . . 0.435 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 0.1 OUTLIER -157.55 118.23 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.022 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.9 -172.41 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -110.38 137.58 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 10.0 111.764 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -97.87 169.4 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.619 -0.718 . . . . 10.0 111.072 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 48.0 t60 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.629 -0.701 . . . . 10.0 110.416 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.577 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 29.8 ptt180 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.444 0.164 . . . . 10.0 110.678 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -126.52 127.08 44.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.463 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' C' ' 263' ' ' SER . 14.7 m -134.89 132.7 38.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 10.0 111.379 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.17 153.79 47.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.336 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -103.86 -77.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.762 -0.375 . . . . 10.0 111.635 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.1 118.36 35.8 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.254 0.549 . . . . 10.0 111.643 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.83 119.13 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.66 . . . . 10.0 109.985 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -108.03 116.99 32.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.535 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.527 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 0.6 OUTLIER -131.43 102.16 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 10.0 110.781 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -132.91 164.2 27.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.232 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 64.72 71.15 0.47 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.439 -0.801 . . . . 10.0 111.041 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 56.39 65.31 1.45 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 121.327 0.584 . . . . 10.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.75 163.45 25.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.43 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -149.79 143.77 25.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.557 HG23 ' HB ' ' C' ' 275' ' ' VAL . 3.2 p -136.38 135.05 49.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.636 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -118.57 123.11 44.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.584 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.431 HD13 ' HB ' ' C' ' 277' ' ' ILE . 4.2 mm? -96.59 76.58 2.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.578 -0.737 . . . . 10.0 109.632 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' B' ' 262' ' ' ASN . . . 172.55 170.21 36.07 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.252 -0.975 . . . . 10.0 112.212 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -81.6 162.88 22.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.013 -0.366 . . . . 10.0 110.013 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.98 119.67 61.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 10.0 110.736 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.3 t -113.94 109.13 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 39.4 p -80.56 163.73 23.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.541 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 2.67 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.272 0.471 . . . . 10.0 112.272 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.54 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 10.0 110.514 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -84.61 77.3 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.716 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 5.0 mt -112.31 15.36 20.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.387 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -120.89 111.19 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.139 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.42 -113.45 0.3 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.766 -0.73 . . . . 10.0 111.936 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 253' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' B' ' 255' ' ' ARG . . . 128.03 -127.57 5.77 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.812 -0.709 . . . . 10.0 111.498 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.1 tt -152.56 120.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.273 0.559 . . . . 10.0 111.122 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -166.32 133.78 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.639 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -107.22 132.53 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.57 -0.286 . . . . 10.0 110.234 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.43 -169.98 1.74 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.16 141.52 22.97 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.0 0.429 . . . . 10.0 110.951 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.67 146.79 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.716 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 6.1 t -75.77 149.27 38.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.703 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 0.5 OUTLIER -115.83 128.43 55.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.514 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.99 129.72 44.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.786 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' C' ' 227' ' ' SER . 5.7 m -143.26 150.61 39.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.746 0.308 . . . . 10.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.56 144.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.267 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 265' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 23.6 ttmt -88.49 -66.32 0.93 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.424 0.528 . . . . 10.0 112.424 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 23.7 m -130.38 124.9 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.82 123.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.487 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 64.2 t -115.63 114.71 47.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.66 -0.246 . . . . 10.0 111.011 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.24 121.95 5.22 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.955 -0.64 . . . . 10.0 111.906 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -132.99 121.82 23.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 10.0 111.453 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.25 90.86 0.41 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.842 -0.694 . . . . 10.0 113.851 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 56.0 47.45 19.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.923 0.392 . . . . 10.0 111.372 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.25 152.61 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.146 0.498 . . . . 10.0 110.651 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.54 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 0.6 OUTLIER -137.91 117.32 12.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.138 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' C' ' 239' ' ' VAL . 17.3 t -111.73 124.38 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.892 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.503 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -119.58 112.47 19.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.763 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.431 ' HB ' HD13 ' C' ' 241' ' ' LEU . 41.0 mm -106.92 90.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.019 0.437 . . . . 10.0 109.933 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.35 -170.65 35.69 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.222 -0.751 . . . . 10.0 111.222 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.96 155.46 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.96 0.38 . . . . 10.0 110.353 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.94 140.91 51.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.968 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 25.1 t80 -129.86 112.81 13.93 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.304 -0.628 . . . . 10.0 109.304 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -165.85 163.0 36.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.357 -0.925 . . . . 10.0 112.483 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.61 1.89 30.66 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -86.86 36.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.102 0.477 . . . . 10.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.63 -83.43 1.4 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.982 -0.847 . . . . 10.0 110.982 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -164.29 -167.44 1.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.54 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 10.1 t90 -42.29 -48.83 5.06 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.861 0.726 . . . . 10.0 112.687 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 288' ' ' ASP . . . . . 0.494 ' OD1' ' HB2' ' C' ' 290' ' ' HIS . 0.0 OUTLIER -125.89 153.07 44.71 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.49 -0.484 . . . . 10.0 111.215 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 289' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -104.44 82.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.492 0.663 . . . . 10.0 110.787 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 290' ' ' HIS . . . . . 0.494 ' HB2' ' OD1' ' C' ' 288' ' ' ASP . 14.9 t-80 -112.53 -55.94 2.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.453 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 291' ' ' HIS . . . . . 0.445 ' HB2' ' NH2' ' D' ' 274' ' ' ARG . 0.7 OUTLIER -134.11 173.27 11.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 10.0 111.754 -178.419 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 292' ' ' HIS . . . . . 0.467 ' HB2' ' H ' ' D' ' 289' ' ' ASN . 17.1 t-80 52.36 88.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.866 -1.061 . . . . 10.0 113.155 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -94.16 178.7 5.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.298 -0.865 . . . . 10.0 109.377 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -62.24 110.08 1.52 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.987 0.422 . . . . 10.0 111.074 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 37.2 m80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.657 -0.687 . . . . 10.0 109.691 178.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.703 ' N ' ' HG1' ' C' ' 261' ' ' THR . 2.2 mpt_? . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.785 0.326 . . . . 10.0 110.438 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 226' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' D' ' 262' ' ' ASN . 2.7 m-20 -75.47 109.72 9.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.452 . . . . 10.0 110.189 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.66 146.85 52.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.519 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.48 143.2 51.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.164 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 229' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 44.4 tttm -90.06 -73.37 0.52 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.341 -0.391 . . . . 10.0 111.647 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.3 120.56 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.832 0.308 . . . . 10.0 111.832 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.54 121.13 58.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.819 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -116.7 114.04 23.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.662 -0.245 . . . . 10.0 110.51 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.1 p -118.42 100.85 7.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.675 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.38 148.51 42.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.09 0.472 . . . . 10.0 111.922 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 62.56 84.84 0.14 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.076 -0.965 . . . . 10.0 112.218 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 236' ' ' ARG . . . . . 0.484 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 40.8 mtt180 67.92 -8.81 0.51 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.739 1.014 . . . . 10.0 113.739 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -60.6 149.84 33.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.353 0.597 . . . . 10.0 112.314 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -139.25 153.98 47.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.281 -0.872 . . . . 10.0 109.687 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.09 140.17 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.645 0.26 . . . . 10.0 111.679 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -129.5 133.54 47.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.202 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' D' ' 277' ' ' ILE . 2.5 mm? -114.43 95.62 5.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.73 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 242' ' ' GLY . . . . . 0.499 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . 171.39 -119.61 0.8 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.915 -0.659 . . . . 10.0 112.686 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -153.51 158.03 40.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.86 109.91 30.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.247 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 19.3 t -111.48 114.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 68.9 p -78.07 164.89 24.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 10.0 110.816 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.64 -4.51 34.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.034 0.445 . . . . 10.0 111.1 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.5 12.94 13.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 10.0 111.044 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -121.82 105.62 10.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.632 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.44 -162.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.556 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.51 88.27 3.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.071 0.463 . . . . 10.0 111.224 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -157.17 46.88 0.48 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.239 -0.744 . . . . 10.0 111.239 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 105.89 24.09 7.12 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.925 -0.87 . . . . 10.0 110.925 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 6.8 tt -66.95 -19.11 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 112.144 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -92.81 63.16 3.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 10.0 110.388 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.01 -29.59 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 12.9 m 67.07 -168.09 0.2 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.747 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 258' ' ' ASP . . . . . 0.423 ' CG ' ' HD3' ' D' ' 225' ' ' ARG . 11.5 m-20 -78.4 100.84 6.97 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.943 -0.392 . . . . 10.0 109.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 259' ' ' GLN . . . . . 0.639 ' HA ' HE21 ' D' ' 259' ' ' GLN . 0.1 OUTLIER -82.37 -70.55 0.54 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 11.0 t -113.27 160.63 18.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.93 0.395 . . . . 10.0 110.551 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 5.8 m -106.23 96.59 6.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 6.4 t30 -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.83 0.347 . . . . 10.0 110.088 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.21 125.39 40.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.93 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.55 143.53 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 265' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 0.0 OUTLIER -97.1 -50.1 4.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -128.45 122.02 30.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.64 125.16 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.013 -0.54 . . . . 10.0 109.687 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.18 127.45 74.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.812 0.339 . . . . 10.0 110.913 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.4 2.67 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -130.22 121.18 25.7 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.96 0.41 . . . . 10.0 111.281 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.04 66.28 1.04 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.65 -0.786 . . . . 10.0 112.76 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 272' ' ' GLU . . . . . 0.484 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 8.1 tt0 56.81 56.29 5.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.417 0.627 . . . . 10.0 111.552 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 45.7 t -92.13 155.73 17.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.027 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 274' ' ' ARG . . . . . 0.445 ' NH2' ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.31 109.95 12.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.027 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.47 ' HA ' HG13 ' E' ' 239' ' ' VAL . 32.1 t -101.22 113.69 38.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.927 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -116.93 106.39 13.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.035 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.454 ' HB ' HD13 ' D' ' 241' ' ' LEU . 10.7 mm -102.05 71.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.063 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 278' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . -175.12 -167.97 35.06 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.642 -0.79 . . . . 10.0 112.266 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -114.4 166.91 11.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.484 -0.191 . . . . 10.0 110.484 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.71 147.26 48.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 10.0 110.697 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -137.91 105.14 5.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.029 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 282' ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 168.8 173.72 36.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.832 -1.175 . . . . 10.0 113.516 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -96.53 43.84 2.04 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.777 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -91.97 -19.33 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 10.0 109.728 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.91 -45.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.097 -0.801 . . . . 10.0 111.097 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -169.25 143.17 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.244 -0.478 . . . . 10.0 109.762 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -54.98 -64.94 0.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.409 0.443 . . . . 10.0 111.65 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -140.64 108.7 5.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.091 0.472 . . . . 10.0 110.668 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 289' ' ' ASN . . . . . 0.467 ' H ' ' HB2' ' C' ' 292' ' ' HIS . 8.7 t-20 -132.43 165.4 24.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.061 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -92.2 -64.68 1.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.669 0.271 . . . . 10.0 111.072 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -135.94 -170.02 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.688 -0.233 . . . . 10.0 110.419 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -105.28 -158.01 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -74.23 121.36 21.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.717 0.294 . . . . 10.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -133.98 -174.73 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 63.2 m80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.627 -0.701 . . . . 10.0 110.463 179.744 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 226' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 53.6 m-80 -113.65 134.95 54.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 227' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' E' ' 263' ' ' SER . 18.2 m -143.55 137.17 28.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.763 0.316 . . . . 10.0 110.512 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.9 146.11 50.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.19 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' E' ' 265' ' ' LYS . 35.6 tttm -95.71 -69.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.482 -0.326 . . . . 10.0 111.818 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -128.5 124.89 37.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.509 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.4 120.56 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.524 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -116.41 116.25 27.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.165 0.507 . . . . 10.0 111.214 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.683 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 29.2 p -112.68 111.41 22.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.146 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -122.59 138.72 54.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.97 87.2 0.12 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.467 -0.788 . . . . 10.0 112.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 48.81 44.25 21.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.002 -0.999 . . . . 10.0 112.214 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.683 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -98.69 160.39 14.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.172 -0.467 . . . . 10.0 109.921 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 238' ' ' ARG . . . . . 0.407 ' CG ' ' HG3' ' E' ' 274' ' ' ARG . 0.0 OUTLIER -135.29 148.23 49.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.635 -179.117 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' D' ' 275' ' ' VAL . 2.5 p -138.13 120.94 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.445 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -127.03 119.43 26.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.013 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.6 109.49 17.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 242' ' ' GLY . . . . . 0.456 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 161.13 -172.87 37.48 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.253 -0.499 . . . . 10.0 111.914 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -98.87 139.07 35.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 110.932 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -98.64 124.59 51.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.97 118.32 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.361 . . . . 10.0 111.058 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.462 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 14.2 t -72.06 173.66 8.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.076 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.56 70.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 10.0 111.229 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -69.11 -20.49 64.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.953 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.24 -159.98 0.26 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 66.7 mt -96.9 124.16 40.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -80.11 86.86 5.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 10.0 109.679 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 108.76 -152.24 17.01 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.899 -0.881 . . . . 10.0 110.899 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.26 80.06 0.36 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.221 -0.99 . . . . 10.0 111.871 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 52.3 mt -73.3 -29.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.119 0.485 . . . . 10.0 110.157 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.1 74.42 1.09 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.137 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 256' ' ' ILE . . . . . 0.418 ' HB ' ' OE1' ' D' ' 259' ' ' GLN . 9.2 pt -81.21 124.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 14.7 m -142.33 -179.81 6.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.067 0.46 . . . . 10.0 111.786 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.97 130.9 34.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.768 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -130.2 -58.62 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.1 t -69.56 139.18 53.71 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.375 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 35.8 m -113.93 110.81 20.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.719 -0.673 . . . . 10.0 109.797 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.91 120.85 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.081 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 263' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' E' ' 227' ' ' SER . 16.3 m -136.29 131.57 34.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.47 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.43 150.75 29.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.615 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 265' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' E' ' 229' ' ' LYS . 89.9 mttt -88.06 -88.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.788 0.292 . . . . 10.0 111.788 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 10.4 m -110.93 125.5 53.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 10.0 111.49 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 5.8 t -116.1 108.98 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.888 -0.596 . . . . 10.0 109.518 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.54 122.15 62.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.407 -0.36 . . . . 10.0 110.875 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.73 108.96 0.69 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.734 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -120.18 123.61 43.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.344 -0.243 . . . . 10.0 110.344 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.25 74.62 1.28 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.129 -0.558 . . . . 10.0 112.106 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 61.4 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.759 0.79 . . . . 10.0 110.997 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 39.0 m -139.02 141.83 38.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.21 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 274' ' ' ARG . . . . . 0.407 ' HG3' ' CG ' ' E' ' 238' ' ' ARG . 0.0 OUTLIER -114.98 97.76 6.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.154 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.27 104.16 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 10.0 109.708 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.05 114.02 23.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.608 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 34.0 mm -119.41 107.29 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.925 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 278' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 162.74 -125.67 1.44 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.395 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -138.24 129.15 26.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.913 0.387 . . . . 10.0 110.284 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 280' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 0.2 OUTLIER -92.43 138.45 31.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.327 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -171.7 92.99 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.978 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 282' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -132.07 -87.52 0.38 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.255 -0.974 . . . . 10.0 112.829 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 283' ' ' GLY . . . . . 0.454 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 148.18 38.23 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.199 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -121.77 -68.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.732 -0.275 . . . . 10.0 110.744 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.56 9.9 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.175 -1.012 . . . . 10.0 113.802 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 286' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' E' ' 287' ' ' TRP . 17.6 t80 -138.27 108.68 6.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.512 0.656 . . . . 10.0 109.595 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 287' ' ' TRP . . . . . 0.42 ' HB2' ' O ' ' E' ' 286' ' ' PHE . 0.7 OUTLIER 70.59 16.59 6.89 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -177.445 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 288' ' ' ASP . . . . . 0.614 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -161.14 172.81 16.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.089 -1.414 . . . . 10.0 109.357 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -172.3 158.82 4.54 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.746 -0.206 . . . . 10.0 110.539 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 290' ' ' HIS . . . . . 0.454 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 0.6 OUTLIER -155.51 -177.44 6.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -92.53 -70.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 10.0 112.102 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 10.9 t60 71.12 160.42 0.22 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.69 0.619 . . . . 10.0 111.364 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -96.98 119.27 35.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.409 -0.359 . . . . 10.0 110.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -105.66 154.02 21.02 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.613 -0.708 . . . . 10.0 110.847 -179.368 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.58 0.228 . . . . 10.0 110.776 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -112.22 128.43 56.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.799 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.606 ' O ' ' HA ' ' A' ' 263' ' ' SER . 30.1 m -152.15 159.06 43.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 10.0 111.495 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.56 43.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.142 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.54 -61.62 1.37 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.684 0.278 . . . . 10.0 111.262 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.74 131.84 33.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.833 0.349 . . . . 10.0 111.058 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.8 mt -127.07 128.32 70.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.835 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -114.75 99.26 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.214 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.7 122.09 46.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.731 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.705 0.288 . . . . 10.0 111.417 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.58 ' HB3' ' H ' ' A' ' 271' ' ' GLY . 7.6 tp10 63.89 72.06 0.47 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.455 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 236' ' ' ARG . 29.5 mtm-85 55.91 32.73 20.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.439 -0.8 . . . . 10.0 111.713 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.65 159.24 17.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.337 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -137.31 147.97 46.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.623 -0.262 . . . . 10.0 110.575 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.57 141.72 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.518 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -134.86 138.3 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.6 tp -125.14 128.79 48.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.932 0.396 . . . . 10.0 110.99 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.35 -110.09 0.75 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.856 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -156.76 156.6 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.5 t -125.47 121.78 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.798 0.333 . . . . 10.0 110.611 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.06 101.61 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.689 -0.485 . . . . 10.0 109.689 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 248' ' ' ALA . 94.2 m -74.09 145.37 44.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.23 8.66 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.685 ' H ' HG22 ' A' ' 246' ' ' THR . . . -80.29 -6.59 58.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.846 0.355 . . . . 10.0 110.935 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -121.05 38.82 3.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.327 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.3 mm? 72.81 -167.65 0.12 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.249 -0.887 . . . . 10.0 111.067 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -78.54 -174.61 3.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.615 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.92 71.07 2.64 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.487 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.15 -45.54 96.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.905 -0.665 . . . . 10.0 111.542 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 75.5 mt 70.33 138.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.314 0.646 . . . . 10.0 111.752 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 66.87 90.1 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.687 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.87 -45.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.813 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 -86.75 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 55.4 t0 60.22 79.64 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.389 0.614 . . . . 10.0 109.978 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.49 24.1 10.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.925 -0.579 . . . . 10.0 111.563 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 7.7 t -148.94 148.11 29.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.496 . . . . 10.0 111.476 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 118.54 30.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.849 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -115.09 105.82 13.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.389 -0.368 . . . . 10.0 110.157 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 227' ' ' SER . 70.7 m -140.32 135.16 31.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 10.0 110.78 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.93 145.99 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.766 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.17 -70.87 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.03 0.381 . . . . 10.0 112.03 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 125.29 47.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 10.0 112.581 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 16.9 t -121.15 119.81 60.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.657 . . . . 10.0 109.579 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.88 119.89 60.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.701 0.286 . . . . 10.0 110.95 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.48 107.29 0.91 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.557 -0.617 . . . . 10.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -126.9 124.77 40.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.091 0.472 . . . . 10.0 111.187 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.58 ' H ' ' HB3' ' A' ' 235' ' ' GLU . . . 93.32 73.83 1.24 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.872 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 54.66 36.63 26.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.594 0.358 . . . . 10.0 111.846 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 8.1 m -86.46 150.18 24.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.226 0.536 . . . . 10.0 110.876 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -119.85 124.82 47.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.646 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.24 113.74 44.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.235 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.38 111.54 22.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.755 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.06 86.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.962 0.41 . . . . 10.0 109.919 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.23 170.92 22.67 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.216 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -92.99 151.83 19.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.737 0.303 . . . . 10.0 110.51 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.22 158.71 25.47 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.056 0.455 . . . . 10.0 110.817 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.11 101.27 5.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 10.0 108.942 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -151.22 165.91 30.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.789 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -137.92 -16.99 0.65 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.163 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -72.67 -37.0 68.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.252 0.548 . . . . 10.0 110.035 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -164.98 156.53 28.56 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.671 -0.972 . . . . 10.0 110.671 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -80.86 74.95 7.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.393 0.596 . . . . 10.0 110.671 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 21.4 t90 69.59 -58.36 0.52 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.089 0.868 . . . . 10.0 111.71 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -142.65 96.29 2.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.864 0.364 . . . . 10.0 110.646 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -166.3 125.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.085 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -150.56 21.11 0.82 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.511 0.672 . . . . 10.0 109.853 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -75.56 144.12 42.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.633 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.12 32.23 3.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.528 -0.76 . . . . 10.0 109.326 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -103.32 120.56 41.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.265 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -95.26 142.84 27.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.821 0.343 . . . . 10.0 110.425 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 p80 . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.051 179.361 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' B' ' 261' ' ' THR . 39.3 ttm180 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.481 HD21 ' HA2' ' B' ' 278' ' ' GLY . 85.0 m-20 -117.89 152.94 34.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 10.0 110.807 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 48.9 m -147.13 91.96 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.122 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -97.04 161.75 13.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' B' ' 265' ' ' LYS . 14.4 mttm -123.2 -72.53 0.68 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.008 -0.277 . . . . 10.0 111.741 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -127.74 114.19 16.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.148 0.499 . . . . 10.0 111.13 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 77.6 mt -118.62 123.83 72.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.886 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -118.67 124.27 46.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.419 0.628 . . . . 10.0 111.451 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 1.0 OUTLIER -123.58 123.26 40.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.948 -1.023 . . . . 10.0 110.135 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -138.48 162.95 33.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 10.0 110.904 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.71 62.77 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.249 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 60.16 26.62 16.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -78.62 157.57 28.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.037 0.446 . . . . 10.0 110.923 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 135.48 35.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.522 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.16 138.92 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.972 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -126.4 131.77 51.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.093 0.473 . . . . 10.0 110.166 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.1 100.7 10.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.73 -177.99 29.29 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -95.8 157.96 15.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.401 . . . . 10.0 110.531 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.17 122.61 69.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.978 0.418 . . . . 10.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.25 124.71 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 72.8 p -93.75 174.02 7.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 10.0 112.022 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.17 -20.06 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.546 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.8 -19.33 57.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.284 0.564 . . . . 10.0 110.249 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -86.68 -4.05 59.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.342 -0.845 . . . . 10.0 110.398 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.62 118.14 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.739 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.84 62.47 1.05 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.839 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -135.19 -142.89 4.65 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.924 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.12 91.2 0.6 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.344 -0.702 . . . . 10.0 111.344 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 16.6 mt -79.59 -27.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.277 0.473 . . . . 10.0 112.277 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -116.55 111.24 19.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.944 0.402 . . . . 10.0 111.099 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 14.7 pt -137.03 40.83 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.23 50.1 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.428 -0.806 . . . . 10.0 111.44 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -84.98 63.85 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.554 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -92.69 103.72 16.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.574 . . . . 10.0 110.385 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.567 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 13.4 t -167.45 150.44 6.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 10.0 111.571 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 31.7 m -118.56 117.96 30.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.141 -0.936 . . . . 10.0 108.908 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -99.4 100.9 12.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.212 0.529 . . . . 10.0 110.387 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.5 m -106.12 143.32 34.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.931 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' C' ' 228' ' ' ALA . 12.2 p -148.67 144.28 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.642 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 265' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 20.6 mttt -94.41 -80.1 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.38 0.511 . . . . 10.0 112.38 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 125.59 53.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.592 0.59 . . . . 10.0 112.592 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 87.5 t -118.58 123.71 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.652 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 5.5 t -109.74 126.46 66.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.305 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.36 98.48 0.34 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -122.36 124.18 43.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 10.0 111.258 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 98.36 58.92 0.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.565 -0.826 . . . . 10.0 112.849 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 57.07 37.68 28.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.051 0.541 . . . . 10.0 111.984 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 19.6 m -77.57 150.78 34.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.454 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.62 124.13 49.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.874 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.18 122.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.778 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -118.82 108.27 14.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.218 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.72 92.56 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.106 0.479 . . . . 10.0 110.004 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' B' ' 226' ' ' ASN . . . 155.93 -178.82 32.28 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.493 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -99.35 161.33 13.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.42 158.97 33.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.167 0.508 . . . . 10.0 111.091 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 1.0 OUTLIER -139.4 81.44 1.83 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.13 -0.941 . . . . 10.0 108.668 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.439 ' HA2' ' OG1' ' B' ' 246' ' ' THR . . . -118.77 -98.54 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.749 -0.66 . . . . 10.0 113.067 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.02 -37.33 2.71 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.929 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -90.45 53.72 2.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.231 0.539 . . . . 10.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.97 132.92 4.95 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.543 ' CD2' HG11 ' C' ' 244' ' ' VAL . 16.6 m-85 -82.4 76.0 9.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.41 0.148 . . . . 10.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.442 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 18.9 t90 70.55 -51.28 0.66 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.06 0.85 . . . . 10.0 111.529 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.61 -172.07 1.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.5 0.19 . . . . 10.0 110.797 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.21 118.71 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.217 0.532 . . . . 10.0 111.287 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 290' ' ' HIS . . . . . 0.487 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 40.0 t60 -138.9 128.72 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 291' ' ' HIS . . . . . 0.517 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 1.0 OUTLIER -152.51 116.75 4.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.26 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -133.29 -176.14 4.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 10.0 111.832 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -118.03 126.34 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.568 -0.742 . . . . 10.0 109.813 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -80.78 -139.6 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.469 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 295' ' ' HIS . . . . . 0.452 ' HB2' ' CE1' ' C' ' 291' ' ' HIS . 47.6 t60 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.404 -0.807 . . . . 10.0 110.013 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.567 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 13.8 ptt-85 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 6.4 m120 -128.22 141.04 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.039 0.447 . . . . 10.0 110.593 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.4 m -145.98 132.66 19.92 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -130.45 149.69 52.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.375 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' B' ' 265' ' ' LYS . 16.0 tttm -101.64 -67.34 0.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.241 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -124.24 120.33 31.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.835 0.35 . . . . 10.0 111.616 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.02 117.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.141 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.527 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 4.7 ttm180 -110.45 119.66 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.467 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.46 104.03 7.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.485 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.527 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 13.3 pt-20 -128.03 173.05 10.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.119 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 42.9 mt-10 62.36 64.26 0.97 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.532 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' C' ' 272' ' ' GLU . 7.3 ttp180 57.23 42.91 24.6 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.268 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.41 168.76 10.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.503 -0.317 . . . . 10.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.442 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 1.1 ptp180 -149.89 138.91 21.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.83 0.347 . . . . 10.0 110.387 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.5 138.13 52.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.286 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' B' ' 276' ' ' LEU . 2.8 tt0 -125.16 127.29 46.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.222 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' C' ' 277' ' ' ILE . 1.3 mm? -105.68 85.56 2.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.333 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.33 -169.65 42.41 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.225 -0.988 . . . . 10.0 112.34 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -100.19 155.06 17.96 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.099 -0.334 . . . . 10.0 110.099 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.543 HG11 ' CD2' ' B' ' 286' ' ' PHE . 41.3 t -109.77 118.64 57.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.2 t -111.74 110.51 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -81.81 166.35 20.07 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.976 -0.29 . . . . 10.0 110.43 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.78 5.1 1.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.68 -18.91 20.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.897 0.38 . . . . 10.0 110.335 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.52 88.07 5.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 10.0 110.172 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 31.1 mt -127.25 8.59 6.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.747 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -124.46 105.36 9.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.238 0.542 . . . . 10.0 110.939 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -173.35 154.3 19.93 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.341 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.0 -171.19 13.13 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.564 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.0 tt -98.05 107.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.3 0.572 . . . . 10.0 110.398 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -139.94 118.74 12.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.804 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 tt -89.73 112.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 23.1 m -143.98 -172.7 3.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.065 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.0 146.53 39.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.072 0.463 . . . . 10.0 110.606 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.08 140.09 52.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.507 ' HA ' ' OD1' ' D' ' 258' ' ' ASP . 0.4 OUTLIER -60.29 139.52 57.57 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.611 0.72 . . . . 10.0 111.25 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.645 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 0.7 OUTLIER -99.13 106.54 18.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.402 -0.817 . . . . 10.0 110.64 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.7 t-20 -115.23 126.15 54.2 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -143.68 145.78 32.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.904 0.383 . . . . 10.0 111.14 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.52 143.67 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.258 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 265' ' ' LYS . . . . . 0.605 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 3.4 ttmt -85.57 -61.85 1.67 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.8 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 21.3 m -135.54 131.3 35.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.07 118.31 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.474 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' C' ' 232' ' ' ARG . 20.6 t -113.86 107.21 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.754 0.311 . . . . 10.0 110.555 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 269' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -110.3 130.05 9.67 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.16 -0.543 . . . . 10.0 112.066 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -135.02 124.52 24.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.809 0.338 . . . . 10.0 111.397 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 271' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 91.54 77.39 1.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 10.0 113.121 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 272' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' C' ' 236' ' ' ARG . 2.0 mt-10 52.33 33.82 13.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.904 0.482 . . . . 10.0 111.753 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.82 147.82 48.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.241 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -125.46 121.06 32.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.205 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.94 120.63 61.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.845 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.447 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -116.01 105.12 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.483 ' HB ' HD13 ' C' ' 241' ' ' LEU . 32.2 mm -101.55 91.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.167 0.508 . . . . 10.0 109.86 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.9 -173.05 35.17 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.303 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.47 149.23 22.92 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.075 -0.342 . . . . 10.0 110.075 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.9 138.59 48.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.935 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 1.9 t80 -120.39 102.02 8.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -141.77 173.57 23.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.54 -0.838 . . . . 10.0 112.538 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -126.39 -28.43 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.694 -0.765 . . . . 10.0 112.394 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -94.18 76.27 4.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 10.0 109.962 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 84.87 -113.77 3.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.154 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -151.48 -157.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 11.8 t90 -43.65 -53.47 5.72 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.598 0.561 . . . . 10.0 111.66 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 288' ' ' ASP . . . . . 0.487 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.4 OUTLIER -122.54 171.0 9.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.575 -0.45 . . . . 10.0 110.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 289' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -121.3 85.82 2.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.513 0.673 . . . . 10.0 111.064 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -117.93 -44.34 2.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.397 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 291' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' B' ' 295' ' ' HIS . 1.6 t-80 -142.55 171.3 14.24 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.906 0.335 . . . . 10.0 111.906 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 54.56 96.43 0.02 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.759 -1.11 . . . . 10.0 112.688 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -101.55 -164.83 1.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.386 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -71.02 146.28 49.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.452 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 63.1 m170 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.674 -0.679 . . . . 10.0 110.361 -179.585 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.645 ' N ' ' HG1' ' C' ' 261' ' ' THR . 1.1 tpm_? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.042 0.448 . . . . 10.0 110.488 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -104.12 135.52 45.45 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 227' ' ' SER . . . . . 0.459 ' HB3' ' CAF' ' B' ' 301' ' ' 3LS . 27.6 m -145.71 135.45 23.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.783 0.325 . . . . 10.0 111.014 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.47 131.46 43.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.011 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 229' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' C' ' 265' ' ' LYS . 85.2 tttt -81.52 -69.98 0.57 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.737 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 124.75 39.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.437 . . . . 10.0 111.824 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.47 126.78 71.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.368 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 232' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' D' ' 232' ' ' ARG . 3.7 mmm180 -118.21 121.04 39.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.6 -0.273 . . . . 10.0 110.384 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.452 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 2.2 p -125.27 117.14 23.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.745 0.307 . . . . 10.0 110.635 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -129.34 149.04 51.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 10.0 111.8 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 67.21 80.6 0.21 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.116 -0.947 . . . . 10.0 112.658 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 57.51 16.25 3.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.397 -0.82 . . . . 10.0 112.731 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 237' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -76.42 152.53 36.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.662 0.268 . . . . 10.0 111.022 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.86 154.32 48.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.199 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' D' ' 275' ' ' VAL . 2.4 p -139.57 136.21 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.875 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -122.95 129.4 51.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.403 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.509 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.6 mm? -112.42 90.73 3.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.597 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 177.5 -106.95 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.187 -1.006 . . . . 10.0 112.67 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -171.67 158.02 4.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.72 108.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.0 0.428 . . . . 10.0 111.335 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 17.6 t -104.72 108.39 24.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.581 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 72.6 p -87.05 162.05 17.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.009 -0.541 . . . . 10.0 111.983 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.62 -5.34 42.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.687 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.386 0.612 . . . . 10.0 110.075 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -93.17 166.77 12.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.274 -0.876 . . . . 10.0 110.001 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' D' ' 250' ' ' LEU . 6.3 tp -155.09 -169.8 3.29 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -76.77 70.59 3.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 10.0 110.924 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -166.78 74.82 0.14 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 99.95 0.02 56.25 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.505 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.23 -24.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.028 0.442 . . . . 10.0 111.505 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.81 70.67 9.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.498 . . . . 10.0 110.178 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 14.5 tt -58.42 -25.62 28.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.334 -0.848 . . . . 10.0 111.558 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m 63.38 -153.33 0.33 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.541 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 258' ' ' ASP . . . . . 0.639 ' CG ' ' HD2' ' D' ' 225' ' ' ARG . 1.3 m-20 -107.89 111.33 23.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 10.0 110.139 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -111.6 -87.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.2 t -87.59 159.37 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.067 0.46 . . . . 10.0 111.455 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 17.1 m -110.25 123.14 49.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.866 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -114.5 107.89 16.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 263' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' D' ' 227' ' ' SER . 18.1 m -125.9 116.29 21.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.837 0.351 . . . . 10.0 110.862 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.52 143.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 265' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 17.4 mmtp -95.88 -52.92 3.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.048 0.759 . . . . 10.0 113.048 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.14 121.96 36.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.74 113.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.683 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.28 125.29 74.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.832 0.349 . . . . 10.0 110.835 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 269' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -135.86 129.31 4.92 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.963 -0.562 . . . . 10.0 112.047 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -139.38 130.32 26.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.026 0.441 . . . . 10.0 111.433 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.34 81.39 0.79 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.294 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 272' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' E' ' 236' ' ' ARG . 1.4 tm-20 58.13 74.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.332 0.587 . . . . 10.0 110.193 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 273' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 4.0 m -125.85 140.38 52.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.437 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.77 121.4 36.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.402 ' HB ' HG23 ' D' ' 239' ' ' VAL . 58.8 t -104.75 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.064 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' D' ' 276' ' ' LEU . 0.6 OUTLIER -115.75 105.77 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.147 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.509 ' HB ' HD13 ' D' ' 241' ' ' LEU . 19.2 mm -108.61 95.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.883 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.7 -177.89 33.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.102 -0.57 . . . . 10.0 112.18 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.59 164.24 12.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.635 0.255 . . . . 10.0 110.404 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.71 134.22 50.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -125.4 118.36 25.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.543 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 282' ' ' GLY . . . . . 0.581 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 153.92 -178.13 31.0 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.282 -0.961 . . . . 10.0 113.405 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.21 47.75 1.01 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.766 -0.534 . . . . 10.0 111.766 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -92.82 4.84 53.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.461 0.648 . . . . 10.0 109.881 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 83.86 -56.52 5.05 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 286' ' ' PHE . . . . . 0.469 ' CE1' HG21 ' E' ' 244' ' ' VAL . 0.8 OUTLIER -172.88 143.0 1.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.488 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 44.0 t90 -48.75 -66.73 0.35 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.252 0.345 . . . . 10.0 111.787 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 288' ' ' ASP . . . . . 0.488 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 16.9 t0 -149.32 115.04 5.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.109 0.48 . . . . 10.0 110.302 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 289' ' ' ASN . . . . . 0.41 HD21 ' HB2' ' E' ' 287' ' ' TRP . 8.6 t-20 -136.02 173.8 11.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.671 . . . . 10.0 109.187 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -85.44 -56.95 3.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.528 0.204 . . . . 10.0 110.803 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -159.4 -168.52 2.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 10.0 111.216 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -92.54 -165.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.169 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -66.73 123.32 19.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 10.0 110.378 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -108.43 160.24 16.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.309 -0.853 . . . . 10.0 109.797 179.595 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.565 0.221 . . . . 10.0 110.484 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -119.61 120.84 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.083 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.89 149.04 50.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.549 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 133.44 24.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.148 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -68.83 0.76 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.622 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' E' ' 266' ' ' THR . 28.4 t70 -124.69 125.3 43.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 10.0 112.098 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 62.4 mt -128.49 124.05 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.113 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -120.76 121.02 37.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.781 0.324 . . . . 10.0 110.336 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.601 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 3.1 p -129.99 108.85 10.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.665 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.53 152.92 46.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.967 0.358 . . . . 10.0 111.967 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 66.18 79.89 0.23 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.527 -0.761 . . . . 10.0 112.114 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 236' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' D' ' 272' ' ' GLU . 13.2 ttp180 53.35 67.02 1.07 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.165 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' D' ' 273' ' ' SER . . . -129.99 162.28 29.04 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.169 -0.923 . . . . 10.0 110.675 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.54 146.77 28.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.349 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.44 HG22 HD12 ' E' ' 241' ' ' LEU . 4.4 p -127.28 122.99 61.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.359 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -120.52 118.51 30.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.775 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.44 HD12 HG22 ' E' ' 239' ' ' VAL . 1.1 mp -114.75 100.18 8.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.019 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 242' ' ' GLY . . . . . 0.55 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 169.73 -173.71 43.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 243' ' ' ASN . . . . . 0.579 ' HB2' ' OD1' ' E' ' 279' ' ' ASN . 5.7 p-10 -111.02 144.21 40.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.87 0.367 . . . . 10.0 110.262 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.469 HG21 ' CE1' ' D' ' 286' ' ' PHE . 55.1 t -98.5 130.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.987 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.77 110.6 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.529 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -61.0 164.05 5.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.011 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.12 -19.9 63.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.374 0.509 . . . . 10.0 112.374 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.29 -11.66 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.843 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.89 -155.56 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.943 -0.571 . . . . 10.0 111.137 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.34 142.56 27.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -82.36 62.59 6.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.44 0.638 . . . . 10.0 109.779 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 106.44 -170.23 16.2 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.1 80.55 1.54 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.477 -0.868 . . . . 10.0 111.901 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.54 -0.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.421 0.629 . . . . 10.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.26 73.32 0.98 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 10.0 110.489 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.8 pt -81.63 96.01 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 10.9 m -127.18 150.33 49.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.528 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.49 125.42 31.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.432 0.634 . . . . 10.0 110.245 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -124.94 46.12 2.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.575 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.1 t -149.21 141.47 24.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.002 0.429 . . . . 10.0 110.713 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 8.1 m -114.93 111.69 21.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.097 -0.502 . . . . 10.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -128.82 98.9 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.403 . . . . 10.0 110.465 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 9.9 m -107.83 117.55 34.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.173 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 15.5 t -100.32 126.57 53.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.415 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 265' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -82.61 -73.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.675 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' E' ' 230' ' ' ASP . 88.9 m -144.9 120.39 10.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.944 0.402 . . . . 10.0 111.435 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.15 121.38 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.088 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.3 t -116.08 128.85 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.146 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.26 124.37 3.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.047 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -124.91 111.75 15.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.032 0.444 . . . . 10.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.4 92.77 1.73 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.342 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.62 55.69 2.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.217 0.532 . . . . 10.0 110.38 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 127.1 42.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 274' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' E' ' 274' ' ' ARG . 5.8 mtm105 -119.8 106.96 12.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.003 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.1 111.67 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.37 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.68 106.58 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.125 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.4 mm -114.52 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.222 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 278' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 168.45 -135.3 3.56 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.381 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 279' ' ' ASN . . . . . 0.579 ' OD1' ' HB2' ' E' ' 243' ' ' ASN . 0.1 OUTLIER -118.97 137.57 53.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.722 0.296 . . . . 10.0 110.814 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 280' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 4.4 pt-20 -97.41 126.64 42.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 281' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' E' ' 244' ' ' VAL . 24.1 t80 -164.6 93.24 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.33 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.01 -90.8 0.4 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.279 -0.962 . . . . 10.0 112.964 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 283' ' ' GLY . . . . . 0.54 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 153.03 28.55 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.172 -0.537 . . . . 10.0 112.316 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.79 -65.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 10.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.95 23.47 1.16 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.373 -0.918 . . . . 10.0 113.219 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -152.31 106.76 3.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.41 ' HB2' HD21 ' D' ' 289' ' ' ASN . 0.8 OUTLIER 73.43 7.87 5.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.244 1.021 . . . . 10.0 108.345 -177.121 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 288' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.7 OUTLIER -154.14 169.69 22.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.619 -1.628 . . . . 10.0 107.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -159.62 163.93 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.764 0.316 . . . . 10.0 110.846 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 290' ' ' HIS . . . . . 0.54 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 1.6 p-80 -158.37 -179.76 8.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.505 -0.771 . . . . 10.0 109.784 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -85.88 -73.0 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 64.6 t60 70.9 155.52 0.15 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.953 0.783 . . . . 10.0 111.392 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -111.63 128.46 56.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.578 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.98 142.25 31.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.888 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 . . . . . 0 C--O 1.246 0.884 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.33 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 301' ' ' 3LS . . . . . 0.651 ' SAK' ' OAA' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.986 -0.375 . . . . 10.0 109.986 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -114.03 136.72 52.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.029 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.06 132.75 28.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 10.0 110.946 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.3 164.32 17.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.192 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 265' ' ' LYS . 47.4 tttm -125.59 -69.09 0.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.848 0.356 . . . . 10.0 111.169 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -128.36 124.37 36.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.055 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.1 mt -136.72 131.55 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.334 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -129.38 111.69 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.206 0.527 . . . . 10.0 110.485 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -109.94 124.36 51.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.382 -0.826 . . . . 10.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -140.69 157.39 45.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.823 0.344 . . . . 10.0 111.375 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.8 72.64 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.484 -0.78 . . . . 10.0 111.514 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 56.57 35.97 26.87 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.315 -0.857 . . . . 10.0 111.703 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.6 149.24 22.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.121 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -132.97 145.71 51.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.922 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 2.6 p -136.81 125.29 34.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.194 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -125.57 130.96 52.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.868 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.21 122.74 48.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.416 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.515 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 144.64 -165.17 27.63 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.67 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -95.69 142.98 27.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 10.0 110.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.36 98.5 6.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.364 0.602 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.38 121.01 46.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.181 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 m -97.06 151.21 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.578 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.71 -12.89 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.112 0.482 . . . . 10.0 111.428 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -81.94 4.22 23.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.803 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -141.24 59.09 1.52 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.703 -0.68 . . . . 10.0 109.918 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 2.0 mm? 70.04 -160.12 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.425 -0.807 . . . . 10.0 111.415 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.4 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 29.5 p-80 -95.45 -174.42 3.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.54 2.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.294 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.71 -43.36 99.36 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.812 -0.515 . . . . 10.0 111.812 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 70.5 mt 71.98 133.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 122.996 0.519 . . . . 10.0 111.734 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 62.9 88.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.377 -0.828 . . . . 10.0 111.619 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.18 -56.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.773 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.1 p -118.33 -86.45 0.64 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.04 0.385 . . . . 10.0 112.04 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.6 t70 63.06 84.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.716 0.635 . . . . 10.0 110.289 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -129.16 13.51 6.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.081 -0.508 . . . . 10.0 111.342 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.74 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 4.9 t -145.29 134.98 23.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.377 0.608 . . . . 10.0 111.549 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -85.37 116.57 23.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.712 . . . . 10.0 109.58 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.409 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 61.9 m-20 -100.03 120.56 40.02 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.813 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.0 p -137.21 128.22 27.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.087 0.47 . . . . 10.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.93 136.21 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 229' ' ' LYS . 71.6 mmtt -93.12 -56.79 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.811 0.671 . . . . 10.0 112.811 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.77 128.91 44.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.706 0.632 . . . . 10.0 112.706 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.04 129.07 67.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.306 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.7 124.07 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.374 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.34 118.15 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.191 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -134.89 115.27 13.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.15 79.65 1.47 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.697 -0.763 . . . . 10.0 113.485 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 59.0 29.28 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.487 0.551 . . . . 10.0 112.487 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 5.5 m -77.94 141.65 38.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.402 0.62 . . . . 10.0 111.563 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -119.26 120.23 36.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.761 . . . . 10.0 109.505 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 48.5 t -113.92 118.02 57.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.242 -0.436 . . . . 10.0 110.68 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.436 ' HA ' HD22 ' A' ' 276' ' ' LEU . 0.7 OUTLIER -117.93 116.55 27.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.404 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.24 95.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.75 160.39 9.48 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.686 -0.768 . . . . 10.0 112.069 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -77.18 148.94 35.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.74 0.305 . . . . 10.0 110.934 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 164.58 14.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.112 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -139.89 106.36 5.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.617 -0.719 . . . . 10.0 109.772 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -166.15 148.55 13.81 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.59 -0.814 . . . . 10.0 113.158 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -129.5 7.27 6.25 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.655 -0.784 . . . . 10.0 112.661 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -97.55 -13.35 21.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.674 . . . . 10.0 110.031 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.0 145.55 5.08 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.679 -0.968 . . . . 10.0 110.679 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -77.83 96.1 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.694 0.247 . . . . 10.0 110.618 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.407 ' CZ3' ' HB2' ' B' ' 238' ' ' ARG . 7.0 t90 67.9 -70.52 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.859 0.724 . . . . 10.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -167.07 96.22 0.5 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.667 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -162.67 119.24 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.318 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -122.36 106.01 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.701 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -116.55 143.57 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.288 -0.414 . . . . 10.0 109.948 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -153.55 21.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.835 -0.166 . . . . 10.0 111.359 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -127.53 124.85 39.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 10.0 111.581 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 154.48 41.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.288 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' HIS . . . . . 0.408 ' HB2' ' NH2' ' D' ' 236' ' ' ARG . 20.3 p-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.129 -0.939 . . . . 10.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.74 ' N ' ' HG1' ' A' ' 260' ' ' THR . 35.2 ttm180 . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -120.6 133.77 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.233 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' B' ' 263' ' ' SER . 16.3 m -130.85 111.33 12.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.915 0.388 . . . . 10.0 111.301 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -110.16 130.29 55.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.629 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.519 ' HE3' ' OBG' ' B' ' 301' ' ' 3LS . 0.0 OUTLIER -86.36 -68.92 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.92 120.43 16.05 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.964 0.412 . . . . 10.0 111.196 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.81 131.12 67.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 10.0 111.141 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' B' ' 232' ' ' ARG . 12.1 mmt85 -114.53 112.4 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.245 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.501 HG22 ' HB1' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -121.42 112.47 18.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.721 0.296 . . . . 10.0 110.974 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -133.13 150.72 52.02 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.507 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 67.89 81.04 0.2 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.443 -0.799 . . . . 10.0 113.128 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 32.8 mtm-85 54.99 22.95 4.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.196 0.598 . . . . 10.0 112.082 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.501 ' HB1' HG22 ' B' ' 233' ' ' THR . . . -80.08 154.27 28.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.338 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.407 ' HB2' ' CZ3' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -137.49 138.25 39.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.925 -0.579 . . . . 10.0 110.379 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.413 HG23 ' HB ' ' B' ' 275' ' ' VAL . 3.6 p -133.74 131.37 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.112 0.482 . . . . 10.0 110.662 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -120.97 131.17 54.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.345 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.487 HD13 ' HB ' ' B' ' 277' ' ' ILE . 3.4 mm? -104.88 104.6 14.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.474 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.409 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . 145.98 178.33 21.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.35 -0.929 . . . . 10.0 112.673 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -93.26 147.54 22.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.728 0.299 . . . . 10.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.54 131.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.675 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.44 113.46 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.104 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 44.4 p -90.28 171.37 9.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.381 . . . . 10.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.9 -10.23 51.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.2 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.82 -14.21 60.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.06 -6.71 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.221 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.38 114.11 3.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.535 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 23.4 t60 60.18 56.86 3.15 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.841 0.713 . . . . 10.0 110.533 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -136.34 -111.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.624 -0.717 . . . . 10.0 111.462 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.57 166.9 24.69 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.22 -0.752 . . . . 10.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 117.059 0.429 . . . . 10.0 111.057 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.416 ' HD2' ' OD2' ' B' ' 258' ' ' ASP . 0.6 OUTLIER -97.25 106.92 19.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.89 0.376 . . . . 10.0 110.639 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.4 HD11 HG11 ' C' ' 245' ' ' VAL . 4.3 pt -136.5 61.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.298 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.9 m 67.34 29.52 7.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.213 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.416 ' OD2' ' HD2' ' B' ' 255' ' ' ARG . 3.4 p-10 -81.14 79.41 7.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.569 0.699 . . . . 10.0 111.027 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -123.89 85.81 2.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.622 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.9 t -138.17 176.82 8.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.032 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.9 m -140.02 113.27 8.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.144 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -100.59 121.74 42.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.901 0.382 . . . . 10.0 110.695 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 227' ' ' SER . 1.9 m -134.54 137.03 43.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.48 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.6 p -137.41 138.87 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.347 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 265' ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 23.4 mttt -86.46 -80.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.82 120.77 42.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.2 t -115.99 105.32 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.538 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.24 113.19 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.464 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.07 134.09 9.05 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.44 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -144.81 141.06 28.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.317 -0.253 . . . . 10.0 110.317 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.73 69.07 1.43 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.198 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 59.87 42.18 16.81 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.797 0.439 . . . . 10.0 111.659 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.5 t -69.41 137.52 52.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.185 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -115.66 102.16 9.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.015 -0.539 . . . . 10.0 109.63 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' B' ' 239' ' ' VAL . 7.7 t -102.06 122.26 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.843 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.437 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -119.77 115.25 23.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.268 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.487 ' HB ' HD13 ' B' ' 241' ' ' LEU . 13.0 mm -104.5 83.57 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.819 0.342 . . . . 10.0 110.634 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.03 174.34 27.61 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.285 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -90.22 164.7 14.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.61 165.27 19.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.899 0.38 . . . . 10.0 110.099 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 2.4 t80 -143.58 78.94 1.61 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.334 -0.848 . . . . 10.0 108.834 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -112.62 -122.75 4.05 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.694 -0.765 . . . . 10.0 113.162 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 155.31 -61.95 0.36 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.303 -0.719 . . . . 10.0 111.303 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -83.67 74.49 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.58 121.15 3.85 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.388 -1.085 . . . . 10.0 110.388 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -83.49 79.27 9.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.939 0.37 . . . . 10.0 111.327 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.437 ' CZ2' ' HB2' ' B' ' 276' ' ' LEU . 21.0 t90 71.28 -48.28 0.67 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.199 0.937 . . . . 10.0 112.255 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -127.7 -175.62 3.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.899 0.381 . . . . 10.0 110.432 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -92.71 131.84 37.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.998 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -164.34 91.24 0.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.12 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -130.09 130.14 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.03 -0.532 . . . . 10.0 109.632 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.93 -173.08 4.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.588 0.232 . . . . 10.0 111.133 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -111.81 132.45 54.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.98 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -87.15 -177.01 5.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.437 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.285 -0.864 . . . . 10.0 110.134 179.731 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.582 0.229 . . . . 10.0 110.409 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.441 ' HB3' HG22 ' C' ' 277' ' ' ILE . 15.5 m120 -126.51 103.4 7.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 133.51 52.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.13 0.491 . . . . 10.0 111.871 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -130.11 122.28 27.97 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.037 -0.727 . . . . 10.0 109.037 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' C' ' 265' ' ' LYS . 48.8 tttm -82.69 -80.87 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.395 0.517 . . . . 10.0 112.395 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' C' ' 266' ' ' THR . 0.2 OUTLIER -109.39 122.27 47.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.268 0.556 . . . . 10.0 111.835 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.442 HD11 ' HB1' ' C' ' 228' ' ' ALA . 88.4 mt -127.65 137.76 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.474 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.472 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 40.0 ttm-85 -128.76 119.51 24.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.402 ' C ' ' HB3' ' C' ' 237' ' ' ALA . 0.7 OUTLIER -127.92 93.57 3.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.049 0.452 . . . . 10.0 110.355 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.472 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 6.1 pt-20 -120.01 158.68 26.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.743 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 65.68 73.17 0.4 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 10.0 111.354 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 59.31 36.62 23.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.262 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.402 ' HB3' ' C ' ' C' ' 233' ' ' THR . . . -100.3 156.47 17.21 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.276 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -145.82 150.56 36.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.664 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 131.16 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.418 ' HB3' HD22 ' C' ' 276' ' ' LEU . 8.6 tt0 -115.81 127.16 54.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 10.0 109.958 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.478 HD23 HD13 ' B' ' 277' ' ' ILE . 3.7 mm? -102.11 88.25 3.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.774 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.48 171.6 31.89 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.168 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -84.34 152.58 24.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.779 0.323 . . . . 10.0 110.324 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.12 118.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.791 0.329 . . . . 10.0 110.939 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 46.6 t -121.06 110.91 29.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.031 0.443 . . . . 10.0 110.2 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.9 p -82.6 160.4 22.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.827 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.89 -4.74 7.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.76 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.41 -15.87 44.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.188 0.518 . . . . 10.0 110.242 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -100.01 94.15 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.496 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.02 20.97 13.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.338 0.59 . . . . 10.0 109.834 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -111.15 144.18 40.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.04 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.18 134.4 3.31 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.086 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.55 171.74 14.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.921 -0.657 . . . . 10.0 111.493 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.3 tp -87.17 115.74 28.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.146 0.498 . . . . 10.0 109.746 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -160.28 149.81 17.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.005 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 tt -95.32 130.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.416 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 35.3 m -153.31 169.49 22.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.792 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 258' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' D' ' 257' ' ' SER . 0.5 OUTLIER -94.53 130.11 41.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.044 0.449 . . . . 10.0 110.108 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -115.72 145.45 42.76 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.345 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.5 t -55.24 135.84 49.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.317 0.579 . . . . 10.0 111.013 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 56.0 m -96.41 139.28 32.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.951 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 20.7 t-20 -133.65 140.34 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.674 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -154.01 139.17 17.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.802 0.334 . . . . 10.0 110.126 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.39 147.15 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 265' ' ' LYS . . . . . 0.647 ' HE3' ' OBK' ' B' ' 301' ' ' 3LS . 1.1 mtpt -85.46 -58.84 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.432 . . . . 10.0 112.097 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 39.9 m -141.58 128.0 20.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.25 117.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.638 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.24 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.107 0.48 . . . . 10.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.51 138.81 15.02 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.797 -0.716 . . . . 10.0 111.667 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.25 125.6 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.912 0.356 . . . . 10.0 111.493 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.44 82.99 0.99 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.921 -0.656 . . . . 10.0 113.465 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 60.55 23.68 13.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.86 0.362 . . . . 10.0 111.377 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.18 136.82 57.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.204 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -128.07 109.91 11.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.525 -0.761 . . . . 10.0 109.825 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 37.7 t -100.45 133.82 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.759 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.4 OUTLIER -127.71 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.088 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.441 HG22 ' HB3' ' C' ' 226' ' ' ASN . 35.3 mm -105.04 95.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.379 . . . . 10.0 110.221 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.67 -171.23 33.65 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.254 -0.738 . . . . 10.0 111.254 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.24 148.1 30.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 10.0 109.801 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -106.95 142.32 36.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 111.084 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -129.31 104.32 7.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.501 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -173.93 175.83 46.45 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.684 -0.77 . . . . 10.0 112.134 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.29 -8.71 24.9 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.541 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.67 63.58 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.166 0.508 . . . . 10.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.48 -84.74 1.07 Allowed Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.064 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.42 -51.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.417 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 8.6 t90 -144.85 -67.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 288' ' ' ASP . . . . . 0.443 ' OD2' ' HD2' ' D' ' 238' ' ' ARG . 2.1 p30 -107.13 165.28 11.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.066 -0.516 . . . . 10.0 109.784 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -114.65 50.65 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.916 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -79.85 -53.19 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.473 . . . . 10.0 111.811 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.13 172.24 10.7 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.954 -0.298 . . . . 10.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 66.53 173.8 0.24 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -177.85 -153.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.347 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -76.22 157.85 32.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.607 179.346 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' D' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.315 0.579 . . . . 10.0 110.372 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 226' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 19.4 m-80 -99.23 138.8 35.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 227' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' D' ' 263' ' ' SER . 18.3 m -154.27 148.46 25.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.071 0.462 . . . . 10.0 111.086 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.45 134.09 31.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.802 -0.635 . . . . 10.0 109.732 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 229' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' C' ' 265' ' ' LYS . 12.6 tmtt? -86.13 -64.78 1.1 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.064 -0.255 . . . . 10.0 111.382 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.8 124.18 45.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.004 0.372 . . . . 10.0 112.004 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.45 HG21 HG21 ' D' ' 239' ' ' VAL . 55.3 mt -131.3 122.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -121.57 120.43 34.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.274 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -120.06 115.23 23.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.534 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.915 0.388 . . . . 10.0 112.029 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 62.18 90.01 0.08 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.981 1.104 . . . . 10.0 113.981 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 236' ' ' ARG . . . . . 0.671 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 29.8 mtt180 62.57 3.17 1.05 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.602 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.95 142.56 49.42 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.987 0.422 . . . . 10.0 111.408 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 238' ' ' ARG . . . . . 0.443 ' HD2' ' OD2' ' C' ' 288' ' ' ASP . 0.3 OUTLIER -133.68 150.07 51.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.412 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.45 HG21 HG21 ' D' ' 231' ' ' ILE . 2.5 p -136.55 137.21 47.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.883 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -115.57 140.7 48.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.375 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.459 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.9 mm? -123.7 75.77 1.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.054 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 242' ' ' GLY . . . . . 0.575 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . -171.19 -138.79 2.6 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.223 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -139.57 132.54 29.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.87 113.86 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.117 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.4 t -117.88 106.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.516 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 0.6 OUTLIER -81.52 158.69 24.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.229 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.87 -0.97 8.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.149 0.5 . . . . 10.0 111.38 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.95 -10.5 57.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.161 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.67 113.57 26.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.049 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 6.6 mp -111.35 -166.29 1.06 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.61 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -63.13 129.64 41.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.508 0.194 . . . . 10.0 110.6 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 133.66 50.6 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.026 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.39 18.18 8.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.432 -0.89 . . . . 10.0 112.593 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -74.26 -17.52 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.094 0.473 . . . . 10.0 111.314 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -104.69 88.48 2.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 10.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 20.0 tt -82.59 -10.59 12.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.883 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 257' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' C' ' 258' ' ' ASP . 37.7 m 61.06 -133.72 0.67 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.042 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 258' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' D' ' 225' ' ' ARG . 2.0 t0 -122.98 137.09 55.05 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -138.57 -83.65 0.29 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.507 -0.477 . . . . 10.0 112.033 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 12.9 t -79.29 156.31 28.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.198 0.523 . . . . 10.0 111.657 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' D' ' 225' ' ' ARG . 23.3 m -111.24 118.94 37.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.231 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 4.0 m120 -120.52 106.41 11.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 263' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' D' ' 227' ' ' SER . 23.1 m -127.61 132.58 49.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.475 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' E' ' 228' ' ' ALA . 10.1 p -120.86 144.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.638 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 265' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 19.5 mmtp -82.86 -51.65 7.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.802 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 50.1 m -142.54 122.22 13.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.09 122.16 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.334 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.85 123.13 67.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.135 0.493 . . . . 10.0 111.083 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.49 134.32 10.27 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -138.4 115.05 10.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.202 0.501 . . . . 10.0 111.474 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.17 93.12 0.79 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.967 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 272' ' ' GLU . . . . . 0.671 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 52.8 mm-40 54.94 33.3 19.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.214 0.53 . . . . 10.0 111.527 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -75.78 144.54 41.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.737 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -127.49 103.25 7.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.248 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 62.4 t -98.73 117.89 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.49 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.456 ' HB2' ' CH2' ' D' ' 287' ' ' TRP . 0.6 OUTLIER -114.08 106.16 14.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.531 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.459 ' HB ' HD13 ' D' ' 241' ' ' LEU . 30.6 mm -102.43 86.36 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 278' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . 162.21 -171.41 38.09 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.527 -0.844 . . . . 10.0 112.365 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -113.02 162.74 15.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.275 -0.268 . . . . 10.0 110.275 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.77 142.97 49.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 10.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -135.19 116.27 14.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.209 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 282' ' ' GLY . . . . . 0.516 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 152.29 166.28 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.481 -0.866 . . . . 10.0 112.422 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -83.98 71.57 2.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -117.1 -5.72 11.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.095 0.474 . . . . 10.0 110.292 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.94 -54.6 4.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.069 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -163.07 144.9 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.151 -0.315 . . . . 10.0 110.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' D' ' 276' ' ' LEU . 34.6 t90 -59.52 -63.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.244 0.34 . . . . 10.0 111.25 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 288' ' ' ASP . . . . . 0.495 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 60.1 t0 -146.03 115.29 7.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 10.0 109.97 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -142.87 161.83 37.08 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.93 -51.92 7.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.673 0.273 . . . . 10.0 110.7 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -156.57 -175.44 5.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.444 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -91.93 -151.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.851 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.18 119.55 10.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.807 0.337 . . . . 10.0 110.757 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -113.28 154.59 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.168 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.656 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' E' ' 261' ' ' THR . 93.3 mtt180 . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 226' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' E' ' 262' ' ' ASN . 22.0 m-80 -130.84 120.66 24.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.945 0.402 . . . . 10.0 111.14 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 227' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' E' ' 263' ' ' SER . 1.3 m -118.74 141.9 48.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' D' ' 264' ' ' VAL . . . -132.17 133.26 44.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.167 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' E' ' 265' ' ' LYS . 1.1 ttmm -91.25 -77.72 0.41 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.899 -0.32 . . . . 10.0 111.143 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.7 126.78 51.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 10.0 111.666 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 66.5 mt -132.82 124.03 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -122.15 109.82 14.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.537 . . . . 10.0 110.3 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.5 p -113.53 96.82 6.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.358 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 234' ' ' GLU . . . . . 0.401 ' HG3' ' HG2' ' E' ' 270' ' ' LYS . 5.3 pt-20 -117.07 152.22 35.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.441 . . . . 10.0 112.103 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 65.15 81.5 0.21 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.741 -1.118 . . . . 10.0 111.441 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 50.82 63.69 2.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.07 -0.968 . . . . 10.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.78 155.28 45.4 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.985 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 238' ' ' ARG . . . . . 0.495 ' HE ' ' CG ' ' D' ' 288' ' ' ASP . 0.1 OUTLIER -136.48 149.35 48.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.885 -178.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.09 127.12 32.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.92 -0.582 . . . . 10.0 109.982 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -120.75 128.11 52.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.589 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.4 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 1.0 OUTLIER -116.47 92.42 3.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.751 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 242' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 167.53 -165.31 38.56 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.765 -0.731 . . . . 10.0 112.172 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -103.44 150.18 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.953 0.406 . . . . 10.0 110.783 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.81 110.93 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.911 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.17 112.09 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.096 0.474 . . . . 10.0 110.431 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.693 HG23 ' H ' ' E' ' 248' ' ' ALA . 14.5 t -76.02 179.4 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.72 -7.53 11.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.035 0.754 . . . . 10.0 113.035 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 248' ' ' ALA . . . . . 0.693 ' H ' HG23 ' E' ' 246' ' ' THR . . . -67.49 -30.85 70.65 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.754 -0.461 . . . . 10.0 109.754 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.96 -173.59 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.072 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 60.9 mt -89.48 123.51 33.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.889 -0.596 . . . . 10.0 109.618 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -63.96 -28.41 69.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.81 -167.48 25.45 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.003 -0.839 . . . . 10.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 85.88 92.56 0.85 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 10.0 112.238 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 35.0 mt -78.75 -31.77 15.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.626 . . . . 10.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 255' ' ' ARG . . . . . 0.416 ' HA ' ' NE ' ' E' ' 255' ' ' ARG . 0.4 OUTLIER -84.74 83.53 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.777 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.29 109.75 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 10.0 110.075 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 35.5 m -143.13 140.82 31.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.055 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.79 130.94 35.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.262 0.553 . . . . 10.0 110.338 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -108.42 -52.8 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.67 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.4 t -67.79 133.69 49.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.465 0.65 . . . . 10.0 111.319 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 94.9 m -121.69 113.11 19.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.694 -0.684 . . . . 10.0 109.889 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 262' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' E' ' 226' ' ' ASN . 11.2 m120 -115.86 141.25 48.35 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.52 -0.764 . . . . 10.0 110.281 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 263' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' E' ' 227' ' ' SER . 73.3 m -142.22 133.34 26.07 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.34 138.31 49.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.183 0.516 . . . . 10.0 110.411 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 265' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' E' ' 229' ' ' LYS . 80.8 mttt -84.18 -60.79 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.211 -0.449 . . . . 10.0 112.144 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.5 m -135.92 123.71 22.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 t -120.23 111.23 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.403 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -114.39 110.51 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.758 0.313 . . . . 10.0 111.029 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.0 117.43 3.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.014 -0.613 . . . . 10.0 111.7 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 270' ' ' LYS . . . . . 0.401 ' HG2' ' HG3' ' E' ' 234' ' ' GLU . 0.0 OUTLIER -120.02 114.07 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.748 0.309 . . . . 10.0 111.519 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.0 90.54 0.4 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.819 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 60.76 85.77 0.11 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.178 0.513 . . . . 10.0 111.319 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.41 136.1 48.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.94 104.26 10.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.35 117.89 51.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.024 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.03 113.08 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.139 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' E' ' 226' ' ' ASN . 38.3 mm -107.65 87.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 278' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 166.56 -156.39 28.25 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.901 -0.666 . . . . 10.0 111.948 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -110.18 145.58 37.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.97 0.414 . . . . 10.0 110.293 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 280' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' E' ' 288' ' ' ASP . 0.7 OUTLIER -106.21 146.71 29.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.541 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -159.17 84.49 0.79 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.045 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.36 -104.92 1.31 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.239 -0.981 . . . . 10.0 113.19 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 283' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 154.36 59.95 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.204 -0.522 . . . . 10.0 111.916 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -135.45 -59.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.516 0.198 . . . . 10.0 110.726 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.5 19.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.55 -0.833 . . . . 10.0 113.65 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -156.13 113.86 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.397 0.599 . . . . 10.0 109.944 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 68.24 16.29 9.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.086 0.946 . . . . 10.0 108.799 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 288' ' ' ASP . . . . . 0.466 ' HA ' ' HG3' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -154.97 168.53 26.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.993 -1.458 . . . . 10.0 108.14 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -153.32 143.43 22.24 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.852 -0.339 . . . . 10.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 290' ' ' HIS . . . . . 0.424 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 2.2 p-80 -149.34 178.65 8.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.979 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -105.12 -62.96 1.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.679 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 t60 66.65 168.35 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.758 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -108.32 107.07 17.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.997 0.427 . . . . 10.0 110.003 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.02 132.31 42.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.72 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.773 0 CA-C-O 118.49 -0.767 . . . . 10.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' 3LS . . . . . 0.795 ' SAK' ' OBK' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.206 -0.294 . . . . 10.0 110.206 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -105.21 142.4 35.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.9 m -147.15 137.47 23.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.781 0.324 . . . . 10.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -140.87 151.93 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.321 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -112.46 -56.84 2.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -137.02 121.32 18.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.853 0.359 . . . . 10.0 111.378 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 54.2 mt -128.14 119.01 49.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.084 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -127.84 110.83 12.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.309 0.576 . . . . 10.0 110.532 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.95 127.16 51.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.555 -0.748 . . . . 10.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.73 176.94 8.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.426 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 60.53 66.9 0.88 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.077 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 57.8 65.44 1.32 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.901 -1.045 . . . . 10.0 110.94 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -131.81 178.68 6.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 238' ' ' ARG . 6.2 ptp180 -159.18 155.12 26.55 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.026 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.18 136.74 59.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.471 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -129.21 134.41 47.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.994 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.53 138.12 51.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.278 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.74 -123.1 2.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.312 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -143.91 141.71 30.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 41.8 t -105.41 110.52 31.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.216 0.531 . . . . 10.0 111.56 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.12 108.51 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.647 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.418 ' HB ' ' HA2' ' A' ' 282' ' ' GLY . 12.0 m -84.62 149.72 25.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.183 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.3 -14.17 16.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.64 -13.3 56.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 10.0 110.904 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -106.94 25.31 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.431 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 3.9 mm? 70.95 -159.64 0.13 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.258 -0.883 . . . . 10.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.41 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 48.8 p-80 -76.86 169.63 17.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.235 0.541 . . . . 10.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -77.58 80.13 1.33 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.3 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.04 -36.6 93.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.218 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.8 mt 72.72 146.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.547 0.792 . . . . 10.0 111.68 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 61.85 87.54 0.1 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.286 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 20.7 mt -123.38 -67.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.96 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 p -101.34 -90.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.861 -0.154 . . . . 10.0 111.408 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.1 t0 56.1 69.1 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.706 0.628 . . . . 10.0 110.932 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -121.07 2.65 10.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 10.0 110.623 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -136.38 152.0 50.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.38 127.85 42.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.345 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -101.77 83.61 2.43 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -108.81 116.69 32.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.602 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 228' ' ' ALA . 14.2 p -119.81 140.31 44.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.7 mttm -91.84 -79.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.179 0.437 . . . . 10.0 112.179 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 128.73 54.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.06 119.54 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.456 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.73 125.27 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.774 0.321 . . . . 10.0 111.491 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -128.91 129.31 6.11 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.197 -0.525 . . . . 10.0 111.934 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -145.01 111.87 5.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.901 0.382 . . . . 10.0 111.339 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.16 82.57 1.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.867 -0.683 . . . . 10.0 112.952 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 52.17 50.59 18.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.506 0.669 . . . . 10.0 110.996 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 m -102.26 141.64 34.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.966 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -121.15 119.43 32.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.32 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 55.2 t -103.31 119.07 51.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.918 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 276' ' ' LEU . 1.4 tm? -114.15 103.6 11.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.36 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.529 HD13 HD23 ' B' ' 241' ' ' LEU . 8.8 mm -96.98 101.54 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.358 -0.383 . . . . 10.0 109.992 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 142.44 179.24 19.14 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.847 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.15 159.95 15.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.846 0.323 . . . . 10.0 110.642 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.96 156.86 39.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.447 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.86 86.97 2.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.325 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.418 ' HA2' ' HB ' ' A' ' 246' ' ' THR . . . -109.02 -145.83 11.4 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.353 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -174.35 -82.29 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -88.89 89.99 8.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.337 -0.986 . . . . 10.0 108.337 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 108.08 110.28 3.4 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.511 -1.035 . . . . 10.0 110.511 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -75.6 81.89 2.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.573 0.225 . . . . 10.0 110.916 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.5 t90 67.35 -69.6 0.13 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.145 0.903 . . . . 10.0 111.777 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.33 90.71 3.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.735 0.302 . . . . 10.0 110.749 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -155.42 136.38 13.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.561 -0.29 . . . . 10.0 110.772 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -157.93 34.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.068 -0.715 . . . . 10.0 109.068 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.22 132.13 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.836 -0.62 . . . . 10.0 111.52 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -137.16 15.87 3.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.639 0.733 . . . . 10.0 109.433 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -91.54 84.3 5.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.032 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -66.22 126.21 27.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.955 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.302 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.4 142.04 40.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.242 -0.651 . . . . 10.0 109.242 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.9 m -143.92 126.85 16.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.83 0.348 . . . . 10.0 111.091 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.18 134.95 47.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.405 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' B' ' 265' ' ' LYS . 50.9 mmtt -87.38 -59.39 2.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.451 -0.34 . . . . 10.0 111.776 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' B' ' 266' ' ' THR . 26.0 t70 -146.14 123.94 11.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.481 . . . . 10.0 110.869 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.06 130.61 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.06 113.05 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.455 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 1.3 p -124.06 114.12 19.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.653 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.23 156.05 48.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.971 0.415 . . . . 10.0 111.39 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 60.78 80.19 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.019 -0.991 . . . . 10.0 112.185 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 58.04 37.02 26.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.664 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.74 141.85 30.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 10.0 110.533 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.58 131.21 46.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.747 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.43 133.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.131 0.491 . . . . 10.0 111.093 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.686 ' HB3' HD22 ' B' ' 276' ' ' LEU . 17.1 tm0? -115.98 125.77 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.877 -0.601 . . . . 10.0 109.987 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.529 HD23 HD13 ' A' ' 277' ' ' ILE . 3.0 mm? -112.35 83.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.141 -0.482 . . . . 10.0 111.307 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.93 -177.27 42.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.169 -1.015 . . . . 10.0 112.938 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -90.06 139.63 30.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 10.0 110.201 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 92.7 t -104.6 114.22 43.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.496 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.9 t -119.71 106.5 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.978 0.418 . . . . 10.0 110.028 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 82.5 p -79.66 173.11 12.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.049 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.29 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 10.0 112.096 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.92 -21.59 50.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.784 0.326 . . . . 10.0 110.524 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.474 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . -93.71 17.95 11.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.25 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.69 106.0 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.883 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t60 65.06 82.39 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.954 0.784 . . . . 10.0 111.481 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.6 -135.87 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.915 -0.66 . . . . 10.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.17 127.61 6.14 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.294 -0.722 . . . . 10.0 111.294 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 36.3 mt -119.94 -33.23 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.048 0.451 . . . . 10.0 111.218 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.409 ' HD2' ' OD1' ' B' ' 258' ' ' ASP . 1.2 tpt180 -86.19 88.62 7.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.842 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt -120.37 54.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.569 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 m 65.92 38.25 5.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.615 -0.72 . . . . 10.0 110.332 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.409 ' OD1' ' HD2' ' B' ' 255' ' ' ARG . 2.0 p-10 -73.96 61.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.226 -0.897 . . . . 10.0 111.541 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -104.8 98.1 7.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.004 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 9.0 t -156.57 148.54 22.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.281 0.562 . . . . 10.0 111.326 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' C' ' 225' ' ' ARG . 0.1 OUTLIER -118.94 98.39 6.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.238 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -88.01 116.29 26.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' C' ' 227' ' ' SER . 0.0 OUTLIER -124.08 135.45 53.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.566 -0.743 . . . . 10.0 111.61 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.18 135.79 49.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.274 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 265' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 0.5 OUTLIER -80.63 -73.93 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.508 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 0.6 OUTLIER -124.15 139.2 54.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.36 121.97 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.167 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.59 119.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.834 0.35 . . . . 10.0 110.984 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.85 117.55 3.19 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -134.45 119.48 18.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.75 0.275 . . . . 10.0 111.364 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.98 87.15 1.08 Allowed Glycine 0 C--N 1.329 0.15 0 C-N-CA 120.863 -0.684 . . . . 10.0 113.474 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 53.04 41.01 32.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.867 0.467 . . . . 10.0 111.51 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.0 t -76.92 154.21 33.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.282 0.563 . . . . 10.0 111.439 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -136.36 106.56 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.912 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.74 126.11 64.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.014 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -117.89 117.3 28.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.35 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.417 HD13 HD23 ' C' ' 241' ' ' LEU . 21.8 mm -108.52 85.32 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.241 0.543 . . . . 10.0 109.776 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.96 168.29 19.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.056 -0.818 . . . . 10.0 111.056 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -88.83 158.55 18.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.223 0.511 . . . . 10.0 110.234 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.42 162.16 24.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.271 0.557 . . . . 10.0 111.039 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.474 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 2.7 t80 -140.35 95.78 2.93 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.047 -0.979 . . . . 10.0 108.862 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -120.9 -122.91 2.96 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.957 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' B' ' 285' ' ' GLY . . . 151.34 -44.17 0.67 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.855 -0.898 . . . . 10.0 110.855 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -82.72 35.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.804 0.812 . . . . 10.0 109.2 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 285' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 283' ' ' GLY . . . 136.23 172.0 12.47 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.42 -1.472 . . . . 10.0 109.42 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -112.98 62.82 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 22.1 t90 71.3 -45.87 0.63 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.103 0.877 . . . . 10.0 110.591 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 288' ' ' ASP . . . . . 0.498 ' OD2' ' HD3' ' C' ' 274' ' ' ARG . 37.5 t70 -101.14 151.17 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.287 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.86 101.23 12.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.418 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 290' ' ' HIS . . . . . 0.637 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 36.0 t60 -131.89 134.88 46.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.423 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -154.38 126.33 7.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.023 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.23 -167.44 2.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.696 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -119.23 127.1 52.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.751 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -70.8 165.77 22.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.775 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.629 -0.7 . . . . 10.0 110.289 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 261' ' ' THR . 20.3 ptt-85 . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 109.876 -0.416 . . . . 10.0 109.876 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -120.56 133.22 55.41 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.247 0.342 . . . . 10.0 110.639 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' B' ' 263' ' ' SER . 67.7 m -139.25 133.28 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.843 0.354 . . . . 10.0 110.558 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.96 51.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.623 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.462 ' HB2' ' OBK' ' B' ' 301' ' ' 3LS . 8.3 tttt -90.39 -72.72 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.68 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -123.97 121.67 35.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.995 0.426 . . . . 10.0 111.46 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.47 126.71 74.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.856 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.414 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 38.6 ttm-85 -113.62 120.69 41.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.2 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 86.84 2.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 10.0 110.49 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.414 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 5.6 pt-20 -117.17 172.7 7.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.631 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.574 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 48.2 mt-10 65.95 59.74 0.7 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 64.19 15.41 9.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.399 -0.818 . . . . 10.0 112.748 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.63 156.87 32.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.844 0.354 . . . . 10.0 111.462 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.495 HH22 ' CD ' ' C' ' 272' ' ' GLU . 0.2 OUTLIER -137.23 146.62 45.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.31 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.19 140.07 44.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.768 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -125.16 124.66 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.395 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' C' ' 277' ' ' ILE . 4.1 mm? -100.21 97.46 8.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.181 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.77 32.76 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.534 -0.841 . . . . 10.0 112.496 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.49 158.87 15.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 10.0 110.218 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.84 110.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.961 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.47 121.43 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.002 0.43 . . . . 10.0 110.968 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 246' ' ' THR . . . . . 0.449 ' C ' ' H ' ' C' ' 248' ' ' ALA . 11.0 p -87.84 165.88 14.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.917 -0.583 . . . . 10.0 109.734 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.05 26.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.291 0.567 . . . . 10.0 111.975 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 248' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' C' ' 246' ' ' THR . . . -117.75 -10.22 10.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.155 0.502 . . . . 10.0 110.142 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -96.44 73.34 2.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.245 0.545 . . . . 10.0 110.701 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 14.0 mt -109.35 -16.93 13.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.043 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -86.55 76.73 9.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.307 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.75 8.19 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -116.75 164.0 12.41 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 17.1 tt -77.32 128.93 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 10.0 110.57 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -157.29 110.79 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.403 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 5.7 tt -81.99 99.35 5.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.944 0.878 . . . . 10.0 110.379 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -132.97 -176.52 4.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 10.0 110.091 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 258' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 0.2 OUTLIER -64.33 157.14 26.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.836 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.25 138.81 22.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 9.7 t -64.71 127.07 29.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.287 0.565 . . . . 10.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.07 137.18 38.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.528 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' D' ' 241' ' ' LEU . 25.8 t-20 -133.18 132.19 41.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 10.0 110.408 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' D' ' 227' ' ' SER . 17.8 m -151.49 150.2 30.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.737 0.303 . . . . 10.0 110.858 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.34 144.85 25.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 265' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 2.4 mtpt -88.2 -70.76 0.62 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.719 0.637 . . . . 10.0 112.719 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 128.66 51.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.478 0.547 . . . . 10.0 112.478 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.55 118.33 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.588 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 85.5 t -110.05 120.4 61.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.053 0.454 . . . . 10.0 110.928 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 269' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -123.48 122.94 5.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.268 -0.733 . . . . 10.0 111.268 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.516 ' HB2' ' HG2' ' D' ' 234' ' ' GLU . 27.4 mttm -138.43 141.19 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.63 0.252 . . . . 10.0 111.472 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 271' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 71.61 79.77 0.39 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.868 -0.605 . . . . 10.0 113.519 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 272' ' ' GLU . . . . . 0.495 ' CD ' HH22 ' C' ' 238' ' ' ARG . 36.5 mm-40 55.18 39.77 31.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.053 0.454 . . . . 10.0 111.585 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 157.65 23.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 10.0 111.296 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.62 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 1.3 mtm180 -137.7 118.56 14.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.06 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.98 126.7 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.276 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.569 ' HB2' ' CZ3' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -117.42 112.47 20.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.243 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' C' ' 241' ' ' LEU . 34.1 mm -111.32 87.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.14 0.495 . . . . 10.0 110.062 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 162.59 -175.61 38.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.964 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -95.64 145.2 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.091 0.472 . . . . 10.0 110.162 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.47 143.47 37.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -130.1 101.42 5.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.605 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -133.27 -158.1 8.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.673 -0.775 . . . . 10.0 112.509 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.9 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.432 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -72.05 -17.51 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 10.0 111.183 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 285' ' ' GLY . . . . . 0.407 ' HA2' ' HE3' ' D' ' 284' ' ' LYS . . . 168.3 -143.72 8.33 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.803 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -104.53 -160.14 0.75 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.889 -0.412 . . . . 10.0 109.889 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.62 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 9.2 t90 -49.18 -43.79 42.43 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.481 0.488 . . . . 10.0 112.281 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 288' ' ' ASP . . . . . 0.637 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.0 OUTLIER -122.76 168.89 11.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.648 -0.421 . . . . 10.0 111.122 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -120.54 38.56 3.97 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.183 0.808 . . . . 10.0 113.183 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -65.61 -51.19 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.075 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 291' ' ' HIS . . . . . 0.416 ' HB2' HH22 ' D' ' 274' ' ' ARG . 6.0 m170 -130.13 177.28 7.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 71.34 155.73 0.15 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.884 0.74 . . . . 10.0 111.423 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.1 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.205 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -126.94 -176.01 3.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.709 -0.662 . . . . 10.0 110.747 -179.453 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.568 ' HD3' ' OD2' ' D' ' 258' ' ' ASP . 6.0 mpt_? . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.864 0.364 . . . . 10.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -108.95 116.48 32.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 227' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' C' ' 263' ' ' SER . 19.9 m -138.58 132.63 31.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.006 0.431 . . . . 10.0 111.239 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.85 142.11 48.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.73 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 229' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 23.5 tttp -88.78 -71.5 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -118.21 119.74 35.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.723 0.297 . . . . 10.0 111.41 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.47 HG21 HG21 ' D' ' 239' ' ' VAL . 57.1 mt -122.8 118.71 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.041 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -110.61 124.56 52.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.904 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.451 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.6 OUTLIER -135.93 104.89 5.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.039 0.447 . . . . 10.0 110.462 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 234' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' C' ' 270' ' ' LYS . 1.7 mt-10 -128.59 162.13 27.99 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 66.97 72.28 0.36 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.677 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 236' ' ' ARG . . . . . 0.543 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 4.6 mtp180 55.82 32.5 19.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.872 -0.603 . . . . 10.0 111.928 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.26 173.35 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.98 0.419 . . . . 10.0 111.579 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.93 152.36 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.492 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.47 HG21 HG21 ' D' ' 231' ' ' ILE . 1.8 p -143.27 135.97 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.602 . . . . 10.0 110.434 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -124.06 128.63 49.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.19 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.1 mm? -110.66 101.79 10.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.355 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 242' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . 164.31 -108.97 0.35 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.956 -1.116 . . . . 10.0 113.214 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -164.65 158.12 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.13 112.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.987 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.3 t -117.67 128.79 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 10.0 110.088 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.513 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 2.1 p -109.54 161.37 15.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.99 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.84 -2.06 6.59 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.9 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.17 59.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.996 0.427 . . . . 10.0 110.263 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -112.53 102.86 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.952 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.56 -159.88 0.76 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.095 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -71.0 79.45 0.65 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.267 0.556 . . . . 10.0 110.693 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -146.07 39.93 1.1 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.928 -0.869 . . . . 10.0 110.928 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.04 31.15 7.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.412 -0.675 . . . . 10.0 111.412 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.7 tt -74.39 -19.48 17.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.349 . . . . 10.0 111.397 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -78.39 69.51 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.532 0.682 . . . . 10.0 110.117 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.57 -16.73 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.085 . . . . 10.0 111.935 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 257' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 10.5 m 61.67 -127.16 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 258' ' ' ASP . . . . . 0.568 ' OD2' ' HD3' ' D' ' 225' ' ' ARG . 1.1 t0 -125.21 137.88 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 259' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' E' ' 257' ' ' SER . 9.6 tp60 -136.27 -72.43 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.521 -0.472 . . . . 10.0 112.128 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 8.7 t -78.69 151.39 32.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.467 0.651 . . . . 10.0 111.522 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -114.84 90.9 3.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.586 -0.734 . . . . 10.0 109.397 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 7.4 m120 -98.45 112.84 24.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.478 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -129.01 99.71 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.497 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 13.2 p -97.09 142.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 10.0 109.873 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 265' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 1.8 mptt -95.81 -50.45 4.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.75 0.648 . . . . 10.0 112.75 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 11.1 m -133.49 122.61 23.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.638 -0.664 . . . . 10.0 112.281 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.77 117.75 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.991 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.55 110.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.679 -0.237 . . . . 10.0 110.593 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 269' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -118.01 120.12 4.63 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.383 -0.437 . . . . 10.0 112.331 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -135.05 127.39 30.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.829 -0.218 . . . . 10.0 111.525 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.48 83.6 1.12 Allowed Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.174 -0.536 . . . . 10.0 113.631 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 272' ' ' GLU . . . . . 0.543 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 5.8 mp0 53.28 32.96 14.48 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.945 0.498 . . . . 10.0 111.799 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.7 t -75.94 147.98 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.143 0.497 . . . . 10.0 110.85 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 274' ' ' ARG . . . . . 0.416 HH22 ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.89 113.35 15.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.793 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.508 ' HA ' HG13 ' E' ' 239' ' ' VAL . 47.4 t -101.16 110.58 28.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 10.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.87 106.59 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.483 ' HB ' HD13 ' D' ' 241' ' ' LEU . 18.1 mm -105.18 89.98 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 278' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . 158.7 -169.72 35.13 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.875 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -107.98 167.77 9.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.622 0.249 . . . . 10.0 110.715 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.21 140.79 52.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.548 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.06 114.05 13.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.079 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 282' ' ' GLY . . . . . 0.513 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 162.99 163.69 16.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.363 -0.923 . . . . 10.0 112.734 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -97.45 58.38 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.508 -0.854 . . . . 10.0 112.255 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 284' ' ' LYS . . . . . 0.407 ' HE3' ' HA2' ' C' ' 285' ' ' GLY . 39.2 tttm -116.72 12.74 14.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.236 0.541 . . . . 10.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.31 -50.25 4.16 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.665 -0.698 . . . . 10.0 113.077 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 286' ' ' PHE . . . . . 0.483 ' CE1' HG21 ' E' ' 244' ' ' VAL . 1.6 t80 -170.27 157.48 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.53 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 25.3 t90 -60.75 -62.91 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.706 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 288' ' ' ASP . . . . . 0.53 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 7.7 t70 -146.12 124.53 12.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.165 0.507 . . . . 10.0 110.098 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.76 172.45 12.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 10.0 109.847 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -101.33 -51.25 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 111.042 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -156.68 -173.09 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.701 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -100.3 -159.21 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.207 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -76.06 103.37 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 10.0 110.374 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -103.81 175.08 5.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.537 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.574 -0.727 . . . . 10.0 109.57 179.786 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' E' ' 261' ' ' THR . 76.4 mtt180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 226' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 49.8 m-80 -133.02 110.99 10.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.206 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 7.0 m -118.08 145.13 45.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 10.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.76 125.68 25.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.793 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.668 ' HB2' ' O ' ' E' ' 265' ' ' LYS . 42.1 mttm -77.09 -70.14 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.53 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' E' ' 266' ' ' THR . 13.3 t70 -129.73 129.79 44.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.355 -0.384 . . . . 10.0 111.367 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.53 126.08 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.256 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -117.09 110.65 18.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 10.0 110.269 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.441 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 1.4 p -125.14 103.77 8.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.428 -0.805 . . . . 10.0 111.186 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -132.95 154.7 50.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 10.0 111.848 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 235' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' E' ' 271' ' ' GLY . 33.7 tt0 65.45 76.1 0.34 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.469 -0.787 . . . . 10.0 111.067 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 56.59 71.04 0.59 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.221 -0.899 . . . . 10.0 110.455 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -127.49 159.7 33.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.168 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 139.04 38.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.531 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' D' ' 275' ' ' VAL . 2.7 p -132.28 124.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.135 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -126.16 125.34 42.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.541 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mp -119.62 100.64 7.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.395 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.99 -173.38 40.84 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.298 -0.721 . . . . 10.0 111.298 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -103.49 154.53 19.35 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.483 HG21 ' CE1' ' D' ' 286' ' ' PHE . 61.7 t -103.15 129.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.409 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.2 99.15 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 10.0 110.837 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' D' ' 282' ' ' GLY . 7.5 t -69.15 169.64 11.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.202 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.51 -21.09 62.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.822 0.344 . . . . 10.0 111.7 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.09 73.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.998 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.72 -163.46 0.19 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.295 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.46 107.95 20.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.213 -0.449 . . . . 10.0 109.863 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -77.74 81.93 4.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.046 0.45 . . . . 10.0 110.722 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.24 140.98 10.5 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.839 -0.619 . . . . 10.0 112.016 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 119.55 98.47 1.77 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.75 -0.738 . . . . 10.0 111.906 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.67 -27.56 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.266 0.555 . . . . 10.0 110.471 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.05 59.23 5.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.405 0.621 . . . . 10.0 110.148 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 6.0 pt -86.09 123.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 257' ' ' SER . . . . . 0.474 ' HA ' ' NE2' ' D' ' 259' ' ' GLN . 67.0 m -152.96 166.61 31.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.672 -0.24 . . . . 10.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.38 117.76 9.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.851 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -125.49 16.29 8.23 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.35 0.5 . . . . 10.0 112.35 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -152.34 136.86 16.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.09 -0.381 . . . . 10.0 110.932 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 31.4 m -121.97 112.88 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.175 0.512 . . . . 10.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -115.41 114.87 25.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.832 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.1 m -118.82 121.07 39.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 10.0 109.977 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -108.96 147.12 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 10.0 110.112 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 265' ' ' LYS . . . . . 0.668 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 82.6 mttt -85.88 -79.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' E' ' 230' ' ' ASP . 13.0 m -131.07 132.08 44.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.875 0.369 . . . . 10.0 111.143 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 t -121.98 106.21 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.967 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.53 125.89 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.663 -0.244 . . . . 10.0 110.549 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -145.47 136.67 6.6 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.545 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.89 130.37 22.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 271' ' ' GLY . . . . . 0.473 ' H ' ' HB3' ' E' ' 235' ' ' GLU . . . 84.17 85.93 0.89 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.555 -0.831 . . . . 10.0 111.82 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 60.55 60.82 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 10.0 110.85 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.68 136.06 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.701 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.63 104.25 8.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.911 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.28 120.21 58.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.853 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.98 119.94 29.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 28.1 mm -117.75 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 10.0 110.981 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.15 -176.22 34.42 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.499 -0.641 . . . . 10.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -91.63 139.91 30.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.877 -0.416 . . . . 10.0 109.877 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.86 159.83 15.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.333 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -169.64 99.6 0.32 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.275 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.9 -114.56 1.43 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.549 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 283' ' ' GLY . . . . . 0.509 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 166.64 58.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.313 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -137.88 -59.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.443 0.163 . . . . 10.0 110.781 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.62 13.19 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.358 -0.925 . . . . 10.0 113.824 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -152.76 114.35 4.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.161 0.481 . . . . 10.0 109.795 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 73.16 10.92 5.15 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.81 0.814 . . . . 10.0 109.302 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -145.88 -179.9 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.546 -1.206 . . . . 10.0 109.173 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -161.55 137.13 7.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.188 -0.301 . . . . 10.0 110.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 290' ' ' HIS . . . . . 0.509 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 7.3 p-80 -150.33 169.45 21.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.397 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -76.65 -70.76 0.43 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.303 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 292' ' ' HIS . . . . . 0.444 ' HB2' ' NE2' ' E' ' 290' ' ' HIS . 13.7 t60 69.46 153.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.21 0.604 . . . . 10.0 111.615 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -127.08 112.2 14.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.189 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -95.3 -176.25 3.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.761 -0.637 . . . . 10.0 109.807 179.57 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 301' ' ' 3LS . . . . . 0.775 ' SAK' ' OAA' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 110.494 -0.188 . . . . 10.0 110.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -117.34 127.16 53.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 263' ' ' SER . 13.4 m -149.16 159.43 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 10.0 111.428 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.15 162.4 35.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.004 -0.544 . . . . 10.0 109.996 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -121.37 -75.46 0.59 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 10.0 111.844 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 266' ' ' THR . 29.0 t70 -113.51 117.47 31.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.866 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 31.8 pt -136.0 144.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.525 -0.307 . . . . 10.0 111.096 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -142.26 126.95 18.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.092 0.472 . . . . 10.0 110.93 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 21.0 p -121.79 113.28 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.271 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.47 158.65 37.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 10.0 111.4 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.49 71.76 0.55 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.427 -0.806 . . . . 10.0 111.908 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 34.9 mtm105 56.63 42.5 26.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 10.0 111.908 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -103.4 153.23 20.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.282 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -134.41 160.49 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.511 -0.313 . . . . 10.0 111.069 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 138.59 23.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -135.3 122.04 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 10.0 109.935 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.47 133.69 53.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.768 0.318 . . . . 10.0 110.253 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 140.97 -119.17 1.49 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.204 -0.522 . . . . 10.0 112.281 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -147.42 143.78 28.17 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.78 107.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.848 0.356 . . . . 10.0 111.362 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.93 120.2 50.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.561 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 m -85.67 151.6 23.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.619 . . . . 10.0 109.907 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.68 -14.89 60.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -87.11 -1.88 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.002 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -119.59 52.99 1.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.265 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.416 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 2.7 mm? 65.96 -158.07 0.26 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.102 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.416 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 44.3 p-80 -93.09 178.91 5.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.995 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -80.62 69.03 3.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.483 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.63 68.33 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.238 -0.745 . . . . 10.0 111.238 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.5 mt 70.51 144.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.259 0.623 . . . . 10.0 112.477 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.19 60.56 1.17 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.3 -0.863 . . . . 10.0 111.153 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.73 -50.75 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.54 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.5 p -128.61 -83.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.848 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.5 t70 54.29 72.56 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.77 0.669 . . . . 10.0 110.615 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -119.18 24.24 10.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.95 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.673 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 4.4 t -139.21 140.91 37.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.35 0.595 . . . . 10.0 112.009 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -91.23 112.46 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.105 -0.952 . . . . 10.0 110.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.441 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 15.6 m-20 -115.46 113.53 23.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 227' ' ' SER . 37.3 m -142.95 124.76 15.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 10.0 110.957 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.8 152.57 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.774 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 -56.88 2.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.83 -0.348 . . . . 10.0 111.48 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 10.5 m -133.75 130.32 37.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.49 124.31 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.919 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 14.8 t -115.92 117.42 55.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.817 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.38 119.32 4.25 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.105 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -134.49 123.32 23.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.925 0.393 . . . . 10.0 111.361 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.91 70.05 1.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.714 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 25.7 tt0 54.83 51.0 14.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.469 0.652 . . . . 10.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.88 144.7 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.508 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -119.03 112.68 19.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.288 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.58 115.14 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.842 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 276' ' ' LEU . 0.8 OUTLIER -111.53 111.05 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.845 0.355 . . . . 10.0 110.251 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.41 ' HA ' ' HB2' ' B' ' 241' ' ' LEU . 15.1 mm -101.94 98.85 7.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.822 0.344 . . . . 10.0 110.147 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.72 161.09 8.59 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.016 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.43 152.06 36.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.639 0.257 . . . . 10.0 110.361 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -175.79 2.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.027 0.441 . . . . 10.0 111.04 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -158.26 97.17 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.459 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.04 -147.8 5.7 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.253 -0.975 . . . . 10.0 114.149 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -175.31 -83.93 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.746 -0.542 . . . . 10.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -81.92 81.39 7.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.248 0.547 . . . . 10.0 109.573 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 120.11 108.12 2.19 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.655 -0.978 . . . . 10.0 110.655 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -74.34 83.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.658 0.266 . . . . 10.0 110.724 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t90 69.11 -65.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.206 -0.906 . . . . 10.0 111.191 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -154.13 91.83 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.959 0.409 . . . . 10.0 110.838 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -156.84 129.8 7.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -147.9 85.9 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -118.25 137.52 52.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.231 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -132.55 14.01 4.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.558 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -89.4 134.52 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.841 -0.6 . . . . 10.0 110.28 179.615 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.673 ' N ' ' HG1' ' A' ' 260' ' ' THR . 25.3 ttm-85 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.069 -0.345 . . . . 10.0 110.069 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -116.89 123.69 47.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.002 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -109.97 90.54 3.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.823 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -94.94 163.8 13.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.165 -0.47 . . . . 10.0 109.962 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.421 ' HE3' ' OAT' ' B' ' 301' ' ' 3LS . 1.8 ttmm -125.09 -80.71 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.979 -0.288 . . . . 10.0 111.754 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -121.1 117.1 26.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.946 0.403 . . . . 10.0 111.273 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.85 123.16 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -118.28 113.49 21.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.717 0.294 . . . . 10.0 110.515 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.9 OUTLIER -116.71 113.52 22.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.711 -179.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.14 160.53 31.74 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.045 0.45 . . . . 10.0 111.813 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.63 74.35 0.4 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.19 -0.914 . . . . 10.0 112.456 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 21.4 mtm-85 55.06 39.78 31.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.2 0.524 . . . . 10.0 111.099 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -93.81 151.74 19.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.821 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 128.61 23.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.993 -0.549 . . . . 10.0 109.764 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.9 137.67 56.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.127 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -118.96 123.04 43.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 277' ' ' ILE . 4.4 mm? -96.66 87.85 4.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.412 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.441 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . 160.71 -178.63 36.63 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.587 -0.816 . . . . 10.0 112.315 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -89.81 163.33 15.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.597 0.237 . . . . 10.0 110.389 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.3 131.8 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.766 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.39 110.22 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.985 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 33.8 p -88.26 168.63 12.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.671 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.74 -5.1 14.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.512 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.43 -13.17 57.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 10.0 110.573 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.66 3.23 48.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.548 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.96 118.62 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.352 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 65.93 28.38 10.63 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.656 0.597 . . . . 10.0 111.355 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -106.76 -172.41 22.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.012 -0.613 . . . . 10.0 112.543 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.02 121.0 6.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.774 -0.53 . . . . 10.0 111.774 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 12.1 mt -104.27 -23.6 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.754 0.311 . . . . 10.0 111.699 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' C' ' 253' ' ' GLY . 14.6 tpt180 -93.22 91.59 7.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.909 0.385 . . . . 10.0 110.26 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.35 45.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.335 . . . . 10.0 111.296 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 60.14 33.51 21.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.048 -0.523 . . . . 10.0 111.394 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -63.24 131.95 50.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.383 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -156.81 76.38 0.87 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.206 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 3.7 t -151.95 161.63 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.063 0.459 . . . . 10.0 111.323 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -127.87 123.88 36.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.841 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.406 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 4.7 m120 -97.23 125.21 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 142.71 50.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.239 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.22 148.81 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 265' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 31.7 mttt -104.93 -77.41 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.457 -0.497 . . . . 10.0 111.973 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.17 119.07 38.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.259 0.552 . . . . 10.0 112.293 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.63 109.51 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.432 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 74.8 t -104.83 118.23 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.372 . . . . 10.0 110.658 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.57 133.06 8.19 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.351 -0.699 . . . . 10.0 111.351 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -145.16 122.35 11.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 10.0 111.719 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.28 78.79 1.42 Allowed Glycine 0 C--O 1.238 0.387 0 C-N-CA 120.639 -0.791 . . . . 10.0 113.347 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 55.27 36.48 27.12 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.286 0.565 . . . . 10.0 110.556 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.37 143.31 57.82 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.882 -1.053 . . . . 10.0 111.643 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -125.0 103.85 8.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.497 -0.774 . . . . 10.0 109.595 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.68 115.48 45.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.452 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 112.4 24.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 43.6 mm -101.83 81.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 10.0 110.231 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.18 178.88 33.59 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.007 -0.616 . . . . 10.0 112.336 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -92.93 160.85 14.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.41 172.18 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.961 0.41 . . . . 10.0 110.752 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 4.4 t80 -142.15 76.34 1.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.662 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -90.27 -137.75 6.99 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.677 -0.692 . . . . 10.0 113.248 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 156.42 -50.56 0.44 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.403 -0.679 . . . . 10.0 111.403 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -91.1 1.84 56.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 10.0 109.75 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -177.74 165.33 34.89 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.592 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -108.45 76.55 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.43 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 16.4 t90 70.41 -48.1 0.64 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.017 0.823 . . . . 10.0 111.397 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -117.62 178.24 4.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.91 117.55 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 10.0 110.784 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -139.66 132.46 29.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.438 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 291' ' ' HIS . . . . . 0.435 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 0.1 OUTLIER -157.55 118.23 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.022 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.9 -172.41 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -110.38 137.58 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 10.0 111.764 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -97.87 169.4 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.619 -0.718 . . . . 10.0 111.072 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 48.0 t60 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.629 -0.701 . . . . 10.0 110.416 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.577 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 29.8 ptt180 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.444 0.164 . . . . 10.0 110.678 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -126.52 127.08 44.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.463 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' C' ' 263' ' ' SER . 14.7 m -134.89 132.7 38.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 10.0 111.379 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.17 153.79 47.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.336 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -103.86 -77.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.762 -0.375 . . . . 10.0 111.635 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.1 118.36 35.8 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.254 0.549 . . . . 10.0 111.643 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.83 119.13 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.66 . . . . 10.0 109.985 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -108.03 116.99 32.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.535 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.527 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 0.6 OUTLIER -131.43 102.16 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 10.0 110.781 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -132.91 164.2 27.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.232 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 64.72 71.15 0.47 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.439 -0.801 . . . . 10.0 111.041 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 56.39 65.31 1.45 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 121.327 0.584 . . . . 10.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.75 163.45 25.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.43 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -149.79 143.77 25.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.557 HG23 ' HB ' ' C' ' 275' ' ' VAL . 3.2 p -136.38 135.05 49.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.636 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -118.57 123.11 44.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.584 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.431 HD13 ' HB ' ' C' ' 277' ' ' ILE . 4.2 mm? -96.59 76.58 2.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.578 -0.737 . . . . 10.0 109.632 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' B' ' 262' ' ' ASN . . . 172.55 170.21 36.07 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.252 -0.975 . . . . 10.0 112.212 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -81.6 162.88 22.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.013 -0.366 . . . . 10.0 110.013 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.98 119.67 61.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 10.0 110.736 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.3 t -113.94 109.13 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 39.4 p -80.56 163.73 23.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.541 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 2.67 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.272 0.471 . . . . 10.0 112.272 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.54 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 10.0 110.514 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -84.61 77.3 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.716 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 5.0 mt -112.31 15.36 20.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.387 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -120.89 111.19 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.139 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.42 -113.45 0.3 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.766 -0.73 . . . . 10.0 111.936 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 253' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' B' ' 255' ' ' ARG . . . 128.03 -127.57 5.77 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.812 -0.709 . . . . 10.0 111.498 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.1 tt -152.56 120.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.273 0.559 . . . . 10.0 111.122 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -166.32 133.78 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.639 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -107.22 132.53 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.57 -0.286 . . . . 10.0 110.234 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.43 -169.98 1.74 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.16 141.52 22.97 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.0 0.429 . . . . 10.0 110.951 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.67 146.79 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.716 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 6.1 t -75.77 149.27 38.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.703 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 0.5 OUTLIER -115.83 128.43 55.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.514 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.99 129.72 44.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.786 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' C' ' 227' ' ' SER . 5.7 m -143.26 150.61 39.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.746 0.308 . . . . 10.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.56 144.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.267 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 265' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 23.6 ttmt -88.49 -66.32 0.93 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.424 0.528 . . . . 10.0 112.424 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 23.7 m -130.38 124.9 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.82 123.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.487 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 64.2 t -115.63 114.71 47.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.66 -0.246 . . . . 10.0 111.011 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.24 121.95 5.22 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.955 -0.64 . . . . 10.0 111.906 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -132.99 121.82 23.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 10.0 111.453 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.25 90.86 0.41 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.842 -0.694 . . . . 10.0 113.851 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 56.0 47.45 19.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.923 0.392 . . . . 10.0 111.372 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.25 152.61 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.146 0.498 . . . . 10.0 110.651 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.54 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 0.6 OUTLIER -137.91 117.32 12.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.138 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' C' ' 239' ' ' VAL . 17.3 t -111.73 124.38 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.892 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.503 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -119.58 112.47 19.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.763 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.431 ' HB ' HD13 ' C' ' 241' ' ' LEU . 41.0 mm -106.92 90.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.019 0.437 . . . . 10.0 109.933 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.35 -170.65 35.69 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.222 -0.751 . . . . 10.0 111.222 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.96 155.46 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.96 0.38 . . . . 10.0 110.353 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.94 140.91 51.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.968 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 25.1 t80 -129.86 112.81 13.93 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.304 -0.628 . . . . 10.0 109.304 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -165.85 163.0 36.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.357 -0.925 . . . . 10.0 112.483 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.61 1.89 30.66 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -86.86 36.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.102 0.477 . . . . 10.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.63 -83.43 1.4 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.982 -0.847 . . . . 10.0 110.982 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -164.29 -167.44 1.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.54 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 10.1 t90 -42.29 -48.83 5.06 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.861 0.726 . . . . 10.0 112.687 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 288' ' ' ASP . . . . . 0.494 ' OD1' ' HB2' ' C' ' 290' ' ' HIS . 0.0 OUTLIER -125.89 153.07 44.71 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.49 -0.484 . . . . 10.0 111.215 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 289' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -104.44 82.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.492 0.663 . . . . 10.0 110.787 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 290' ' ' HIS . . . . . 0.494 ' HB2' ' OD1' ' C' ' 288' ' ' ASP . 14.9 t-80 -112.53 -55.94 2.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.453 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 291' ' ' HIS . . . . . 0.445 ' HB2' ' NH2' ' D' ' 274' ' ' ARG . 0.7 OUTLIER -134.11 173.27 11.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 10.0 111.754 -178.419 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 292' ' ' HIS . . . . . 0.467 ' HB2' ' H ' ' D' ' 289' ' ' ASN . 17.1 t-80 52.36 88.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.866 -1.061 . . . . 10.0 113.155 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -94.16 178.7 5.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.298 -0.865 . . . . 10.0 109.377 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -62.24 110.08 1.52 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.987 0.422 . . . . 10.0 111.074 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 37.2 m80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.657 -0.687 . . . . 10.0 109.691 178.973 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.703 ' N ' ' HG1' ' C' ' 261' ' ' THR . 2.2 mpt_? . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.785 0.326 . . . . 10.0 110.438 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 226' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' D' ' 262' ' ' ASN . 2.7 m-20 -75.47 109.72 9.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.452 . . . . 10.0 110.189 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.66 146.85 52.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.519 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.48 143.2 51.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.164 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 229' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 44.4 tttm -90.06 -73.37 0.52 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.341 -0.391 . . . . 10.0 111.647 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.3 120.56 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.832 0.308 . . . . 10.0 111.832 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.54 121.13 58.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.819 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -116.7 114.04 23.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.662 -0.245 . . . . 10.0 110.51 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.1 p -118.42 100.85 7.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.675 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.38 148.51 42.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.09 0.472 . . . . 10.0 111.922 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 62.56 84.84 0.14 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.076 -0.965 . . . . 10.0 112.218 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 236' ' ' ARG . . . . . 0.484 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 40.8 mtt180 67.92 -8.81 0.51 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.739 1.014 . . . . 10.0 113.739 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -60.6 149.84 33.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.353 0.597 . . . . 10.0 112.314 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -139.25 153.98 47.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.281 -0.872 . . . . 10.0 109.687 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.09 140.17 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.645 0.26 . . . . 10.0 111.679 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -129.5 133.54 47.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.202 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' D' ' 277' ' ' ILE . 2.5 mm? -114.43 95.62 5.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.73 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 242' ' ' GLY . . . . . 0.499 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . 171.39 -119.61 0.8 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.915 -0.659 . . . . 10.0 112.686 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -153.51 158.03 40.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.86 109.91 30.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.247 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 19.3 t -111.48 114.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 68.9 p -78.07 164.89 24.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 10.0 110.816 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.64 -4.51 34.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.034 0.445 . . . . 10.0 111.1 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.5 12.94 13.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 10.0 111.044 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -121.82 105.62 10.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.632 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.44 -162.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.556 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.51 88.27 3.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.071 0.463 . . . . 10.0 111.224 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -157.17 46.88 0.48 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.239 -0.744 . . . . 10.0 111.239 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 105.89 24.09 7.12 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.925 -0.87 . . . . 10.0 110.925 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 6.8 tt -66.95 -19.11 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 112.144 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -92.81 63.16 3.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 10.0 110.388 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.01 -29.59 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 12.9 m 67.07 -168.09 0.2 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.747 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 258' ' ' ASP . . . . . 0.423 ' CG ' ' HD3' ' D' ' 225' ' ' ARG . 11.5 m-20 -78.4 100.84 6.97 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.943 -0.392 . . . . 10.0 109.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 259' ' ' GLN . . . . . 0.639 ' HA ' HE21 ' D' ' 259' ' ' GLN . 0.1 OUTLIER -82.37 -70.55 0.54 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 11.0 t -113.27 160.63 18.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.93 0.395 . . . . 10.0 110.551 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 5.8 m -106.23 96.59 6.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 6.4 t30 -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.83 0.347 . . . . 10.0 110.088 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.21 125.39 40.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.93 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.55 143.53 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 265' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 0.0 OUTLIER -97.1 -50.1 4.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -128.45 122.02 30.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.64 125.16 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.013 -0.54 . . . . 10.0 109.687 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.18 127.45 74.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.812 0.339 . . . . 10.0 110.913 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.4 2.67 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -130.22 121.18 25.7 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.96 0.41 . . . . 10.0 111.281 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.04 66.28 1.04 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.65 -0.786 . . . . 10.0 112.76 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 272' ' ' GLU . . . . . 0.484 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 8.1 tt0 56.81 56.29 5.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.417 0.627 . . . . 10.0 111.552 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 45.7 t -92.13 155.73 17.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.027 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 274' ' ' ARG . . . . . 0.445 ' NH2' ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.31 109.95 12.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.027 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.47 ' HA ' HG13 ' E' ' 239' ' ' VAL . 32.1 t -101.22 113.69 38.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.927 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -116.93 106.39 13.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.035 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.454 ' HB ' HD13 ' D' ' 241' ' ' LEU . 10.7 mm -102.05 71.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.063 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 278' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . -175.12 -167.97 35.06 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.642 -0.79 . . . . 10.0 112.266 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -114.4 166.91 11.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.484 -0.191 . . . . 10.0 110.484 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.71 147.26 48.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 10.0 110.697 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -137.91 105.14 5.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.029 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 282' ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 168.8 173.72 36.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.832 -1.175 . . . . 10.0 113.516 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -96.53 43.84 2.04 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.777 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -91.97 -19.33 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 10.0 109.728 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.91 -45.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.097 -0.801 . . . . 10.0 111.097 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -169.25 143.17 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.244 -0.478 . . . . 10.0 109.762 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -54.98 -64.94 0.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.409 0.443 . . . . 10.0 111.65 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -140.64 108.7 5.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.091 0.472 . . . . 10.0 110.668 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 289' ' ' ASN . . . . . 0.467 ' H ' ' HB2' ' C' ' 292' ' ' HIS . 8.7 t-20 -132.43 165.4 24.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.061 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -92.2 -64.68 1.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.669 0.271 . . . . 10.0 111.072 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -135.94 -170.02 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.688 -0.233 . . . . 10.0 110.419 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -105.28 -158.01 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -74.23 121.36 21.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.717 0.294 . . . . 10.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -133.98 -174.73 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 63.2 m80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.627 -0.701 . . . . 10.0 110.463 179.744 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 226' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 53.6 m-80 -113.65 134.95 54.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 227' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' E' ' 263' ' ' SER . 18.2 m -143.55 137.17 28.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.763 0.316 . . . . 10.0 110.512 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.9 146.11 50.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.19 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' E' ' 265' ' ' LYS . 35.6 tttm -95.71 -69.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.482 -0.326 . . . . 10.0 111.818 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -128.5 124.89 37.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.509 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.4 120.56 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.524 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -116.41 116.25 27.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.165 0.507 . . . . 10.0 111.214 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.683 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 29.2 p -112.68 111.41 22.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.146 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -122.59 138.72 54.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.97 87.2 0.12 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.467 -0.788 . . . . 10.0 112.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 48.81 44.25 21.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.002 -0.999 . . . . 10.0 112.214 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.683 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -98.69 160.39 14.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.172 -0.467 . . . . 10.0 109.921 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 238' ' ' ARG . . . . . 0.407 ' CG ' ' HG3' ' E' ' 274' ' ' ARG . 0.0 OUTLIER -135.29 148.23 49.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.635 -179.117 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' D' ' 275' ' ' VAL . 2.5 p -138.13 120.94 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.445 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -127.03 119.43 26.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.013 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.6 109.49 17.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 242' ' ' GLY . . . . . 0.456 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 161.13 -172.87 37.48 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.253 -0.499 . . . . 10.0 111.914 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -98.87 139.07 35.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 110.932 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -98.64 124.59 51.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.97 118.32 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.361 . . . . 10.0 111.058 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.462 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 14.2 t -72.06 173.66 8.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.076 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.56 70.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 10.0 111.229 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -69.11 -20.49 64.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.953 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.24 -159.98 0.26 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 66.7 mt -96.9 124.16 40.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -80.11 86.86 5.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 10.0 109.679 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 108.76 -152.24 17.01 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.899 -0.881 . . . . 10.0 110.899 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.26 80.06 0.36 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.221 -0.99 . . . . 10.0 111.871 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 52.3 mt -73.3 -29.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.119 0.485 . . . . 10.0 110.157 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.1 74.42 1.09 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.137 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 256' ' ' ILE . . . . . 0.418 ' HB ' ' OE1' ' D' ' 259' ' ' GLN . 9.2 pt -81.21 124.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 14.7 m -142.33 -179.81 6.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.067 0.46 . . . . 10.0 111.786 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.97 130.9 34.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.768 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -130.2 -58.62 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.1 t -69.56 139.18 53.71 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.375 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 35.8 m -113.93 110.81 20.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.719 -0.673 . . . . 10.0 109.797 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.91 120.85 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.081 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 263' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' E' ' 227' ' ' SER . 16.3 m -136.29 131.57 34.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.47 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.43 150.75 29.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.615 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 265' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' E' ' 229' ' ' LYS . 89.9 mttt -88.06 -88.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.788 0.292 . . . . 10.0 111.788 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 10.4 m -110.93 125.5 53.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 10.0 111.49 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 5.8 t -116.1 108.98 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.888 -0.596 . . . . 10.0 109.518 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.54 122.15 62.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.407 -0.36 . . . . 10.0 110.875 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.73 108.96 0.69 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.734 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -120.18 123.61 43.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.344 -0.243 . . . . 10.0 110.344 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.25 74.62 1.28 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.129 -0.558 . . . . 10.0 112.106 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 61.4 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.759 0.79 . . . . 10.0 110.997 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 39.0 m -139.02 141.83 38.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.21 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 274' ' ' ARG . . . . . 0.407 ' HG3' ' CG ' ' E' ' 238' ' ' ARG . 0.0 OUTLIER -114.98 97.76 6.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.154 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.27 104.16 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 10.0 109.708 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.05 114.02 23.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.608 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 34.0 mm -119.41 107.29 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.925 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 278' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 162.74 -125.67 1.44 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.395 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -138.24 129.15 26.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.913 0.387 . . . . 10.0 110.284 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 280' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 0.2 OUTLIER -92.43 138.45 31.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.327 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -171.7 92.99 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.978 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 282' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -132.07 -87.52 0.38 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.255 -0.974 . . . . 10.0 112.829 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 283' ' ' GLY . . . . . 0.454 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 148.18 38.23 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.199 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -121.77 -68.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.732 -0.275 . . . . 10.0 110.744 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.56 9.9 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.175 -1.012 . . . . 10.0 113.802 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 286' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' E' ' 287' ' ' TRP . 17.6 t80 -138.27 108.68 6.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.512 0.656 . . . . 10.0 109.595 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.42 ' HB2' ' O ' ' E' ' 286' ' ' PHE . 0.7 OUTLIER 70.59 16.59 6.89 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -177.445 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 288' ' ' ASP . . . . . 0.614 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -161.14 172.81 16.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.089 -1.414 . . . . 10.0 109.357 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -172.3 158.82 4.54 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.746 -0.206 . . . . 10.0 110.539 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 290' ' ' HIS . . . . . 0.454 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 0.6 OUTLIER -155.51 -177.44 6.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -92.53 -70.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 10.0 112.102 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 10.9 t60 71.12 160.42 0.22 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.69 0.619 . . . . 10.0 111.364 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -96.98 119.27 35.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.409 -0.359 . . . . 10.0 110.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -105.66 154.02 21.02 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.613 -0.708 . . . . 10.0 110.847 -179.368 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 301' ' ' 3LS . . . . . 0.661 ' CBI' ' SAK' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.58 0.228 . . . . 10.0 110.776 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -112.22 128.43 56.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.799 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.606 ' O ' ' HA ' ' A' ' 263' ' ' SER . 30.1 m -152.15 159.06 43.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 10.0 111.495 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.56 43.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.142 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.54 -61.62 1.37 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.684 0.278 . . . . 10.0 111.262 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.74 131.84 33.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.833 0.349 . . . . 10.0 111.058 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.8 mt -127.07 128.32 70.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.835 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -114.75 99.26 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.214 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.7 122.09 46.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.731 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.705 0.288 . . . . 10.0 111.417 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.58 ' HB3' ' H ' ' A' ' 271' ' ' GLY . 7.6 tp10 63.89 72.06 0.47 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.455 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 236' ' ' ARG . 29.5 mtm-85 55.91 32.73 20.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.439 -0.8 . . . . 10.0 111.713 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.65 159.24 17.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.337 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -137.31 147.97 46.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.623 -0.262 . . . . 10.0 110.575 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.57 141.72 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.518 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -134.86 138.3 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.6 tp -125.14 128.79 48.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.932 0.396 . . . . 10.0 110.99 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.35 -110.09 0.75 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.856 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -156.76 156.6 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.5 t -125.47 121.78 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.798 0.333 . . . . 10.0 110.611 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.06 101.61 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.689 -0.485 . . . . 10.0 109.689 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 248' ' ' ALA . 94.2 m -74.09 145.37 44.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.23 8.66 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.685 ' H ' HG22 ' A' ' 246' ' ' THR . . . -80.29 -6.59 58.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.846 0.355 . . . . 10.0 110.935 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -121.05 38.82 3.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.327 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.3 mm? 72.81 -167.65 0.12 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.249 -0.887 . . . . 10.0 111.067 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -78.54 -174.61 3.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.615 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.92 71.07 2.64 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.487 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.15 -45.54 96.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.905 -0.665 . . . . 10.0 111.542 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 75.5 mt 70.33 138.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.314 0.646 . . . . 10.0 111.752 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 66.87 90.1 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.687 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.87 -45.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.813 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 -86.75 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 55.4 t0 60.22 79.64 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.389 0.614 . . . . 10.0 109.978 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.49 24.1 10.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.925 -0.579 . . . . 10.0 111.563 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 7.7 t -148.94 148.11 29.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.496 . . . . 10.0 111.476 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 118.54 30.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.849 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -115.09 105.82 13.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.389 -0.368 . . . . 10.0 110.157 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 227' ' ' SER . 70.7 m -140.32 135.16 31.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 10.0 110.78 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.93 145.99 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.766 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.17 -70.87 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.03 0.381 . . . . 10.0 112.03 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 125.29 47.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 10.0 112.581 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 16.9 t -121.15 119.81 60.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.657 . . . . 10.0 109.579 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.88 119.89 60.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.701 0.286 . . . . 10.0 110.95 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.48 107.29 0.91 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.557 -0.617 . . . . 10.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -126.9 124.77 40.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.091 0.472 . . . . 10.0 111.187 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.58 ' H ' ' HB3' ' A' ' 235' ' ' GLU . . . 93.32 73.83 1.24 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.872 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 54.66 36.63 26.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.594 0.358 . . . . 10.0 111.846 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 8.1 m -86.46 150.18 24.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.226 0.536 . . . . 10.0 110.876 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -119.85 124.82 47.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.646 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.24 113.74 44.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.235 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.38 111.54 22.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.755 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.06 86.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.962 0.41 . . . . 10.0 109.919 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.23 170.92 22.67 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.216 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -92.99 151.83 19.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.737 0.303 . . . . 10.0 110.51 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.22 158.71 25.47 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.056 0.455 . . . . 10.0 110.817 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.11 101.27 5.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 10.0 108.942 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -151.22 165.91 30.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.789 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -137.92 -16.99 0.65 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.163 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -72.67 -37.0 68.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.252 0.548 . . . . 10.0 110.035 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -164.98 156.53 28.56 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.671 -0.972 . . . . 10.0 110.671 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -80.86 74.95 7.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.393 0.596 . . . . 10.0 110.671 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 21.4 t90 69.59 -58.36 0.52 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.089 0.868 . . . . 10.0 111.71 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -142.65 96.29 2.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.864 0.364 . . . . 10.0 110.646 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -166.3 125.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.085 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -150.56 21.11 0.82 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.511 0.672 . . . . 10.0 109.853 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -75.56 144.12 42.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.633 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.12 32.23 3.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.528 -0.76 . . . . 10.0 109.326 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -103.32 120.56 41.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.265 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -95.26 142.84 27.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.821 0.343 . . . . 10.0 110.425 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 p80 . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.051 179.361 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' B' ' 261' ' ' THR . 39.3 ttm180 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.481 HD21 ' HA2' ' B' ' 278' ' ' GLY . 85.0 m-20 -117.89 152.94 34.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 10.0 110.807 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 48.9 m -147.13 91.96 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.122 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -97.04 161.75 13.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' B' ' 265' ' ' LYS . 14.4 mttm -123.2 -72.53 0.68 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.008 -0.277 . . . . 10.0 111.741 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -127.74 114.19 16.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.148 0.499 . . . . 10.0 111.13 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 77.6 mt -118.62 123.83 72.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.886 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -118.67 124.27 46.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.419 0.628 . . . . 10.0 111.451 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 1.0 OUTLIER -123.58 123.26 40.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.948 -1.023 . . . . 10.0 110.135 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -138.48 162.95 33.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 10.0 110.904 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.71 62.77 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.249 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 60.16 26.62 16.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -78.62 157.57 28.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.037 0.446 . . . . 10.0 110.923 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 135.48 35.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.522 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.16 138.92 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.972 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -126.4 131.77 51.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.093 0.473 . . . . 10.0 110.166 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.1 100.7 10.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.73 -177.99 29.29 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -95.8 157.96 15.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.401 . . . . 10.0 110.531 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.17 122.61 69.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.978 0.418 . . . . 10.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.25 124.71 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 72.8 p -93.75 174.02 7.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 10.0 112.022 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.17 -20.06 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.546 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.8 -19.33 57.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.284 0.564 . . . . 10.0 110.249 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -86.68 -4.05 59.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.342 -0.845 . . . . 10.0 110.398 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.62 118.14 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.739 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.84 62.47 1.05 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.839 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -135.19 -142.89 4.65 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.924 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.12 91.2 0.6 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.344 -0.702 . . . . 10.0 111.344 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 16.6 mt -79.59 -27.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.277 0.473 . . . . 10.0 112.277 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -116.55 111.24 19.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.944 0.402 . . . . 10.0 111.099 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 14.7 pt -137.03 40.83 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.23 50.1 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.428 -0.806 . . . . 10.0 111.44 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -84.98 63.85 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.554 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -92.69 103.72 16.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.574 . . . . 10.0 110.385 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.567 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 13.4 t -167.45 150.44 6.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 10.0 111.571 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 31.7 m -118.56 117.96 30.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.141 -0.936 . . . . 10.0 108.908 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -99.4 100.9 12.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.212 0.529 . . . . 10.0 110.387 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.5 m -106.12 143.32 34.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.931 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' C' ' 228' ' ' ALA . 12.2 p -148.67 144.28 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.642 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 20.6 mttt -94.41 -80.1 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.38 0.511 . . . . 10.0 112.38 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 125.59 53.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.592 0.59 . . . . 10.0 112.592 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 87.5 t -118.58 123.71 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.652 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 5.5 t -109.74 126.46 66.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.305 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.36 98.48 0.34 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -122.36 124.18 43.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 10.0 111.258 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 98.36 58.92 0.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.565 -0.826 . . . . 10.0 112.849 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 57.07 37.68 28.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.051 0.541 . . . . 10.0 111.984 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 19.6 m -77.57 150.78 34.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.454 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.62 124.13 49.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.874 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.18 122.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.778 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -118.82 108.27 14.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.218 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.72 92.56 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.106 0.479 . . . . 10.0 110.004 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' B' ' 226' ' ' ASN . . . 155.93 -178.82 32.28 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.493 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -99.35 161.33 13.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.42 158.97 33.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.167 0.508 . . . . 10.0 111.091 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 1.0 OUTLIER -139.4 81.44 1.83 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.13 -0.941 . . . . 10.0 108.668 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.439 ' HA2' ' OG1' ' B' ' 246' ' ' THR . . . -118.77 -98.54 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.749 -0.66 . . . . 10.0 113.067 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.02 -37.33 2.71 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.929 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -90.45 53.72 2.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.231 0.539 . . . . 10.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.97 132.92 4.95 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.543 ' CD2' HG11 ' C' ' 244' ' ' VAL . 16.6 m-85 -82.4 76.0 9.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.41 0.148 . . . . 10.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.442 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 18.9 t90 70.55 -51.28 0.66 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.06 0.85 . . . . 10.0 111.529 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.61 -172.07 1.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.5 0.19 . . . . 10.0 110.797 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.21 118.71 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.217 0.532 . . . . 10.0 111.287 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 290' ' ' HIS . . . . . 0.487 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 40.0 t60 -138.9 128.72 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 291' ' ' HIS . . . . . 0.517 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 15.5 t-160 -152.51 116.75 4.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.26 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -133.29 -176.14 4.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 10.0 111.832 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -118.03 126.34 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.568 -0.742 . . . . 10.0 109.813 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 294' ' ' HIS . . . . . 0.49 ' CD2' ' H ' ' B' ' 294' ' ' HIS . 9.1 p80 -80.78 -139.6 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.469 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 295' ' ' HIS . . . . . 0.452 ' HB2' ' CE1' ' C' ' 291' ' ' HIS . 47.6 t60 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.404 -0.807 . . . . 10.0 110.013 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.567 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 13.8 ptt-85 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 6.4 m120 -128.22 141.04 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.039 0.447 . . . . 10.0 110.593 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.4 m -145.98 132.66 19.92 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -130.45 149.69 52.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.375 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' B' ' 265' ' ' LYS . 16.0 tttm -101.64 -67.34 0.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.241 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -124.24 120.33 31.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.835 0.35 . . . . 10.0 111.616 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.02 117.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.141 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.527 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 4.7 ttm180 -110.45 119.66 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.467 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.46 104.03 7.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.485 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.527 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 13.3 pt-20 -128.03 173.05 10.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.119 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 42.9 mt-10 62.36 64.26 0.97 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.532 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' C' ' 272' ' ' GLU . 7.3 ttp180 57.23 42.91 24.6 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.268 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.41 168.76 10.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.503 -0.317 . . . . 10.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.442 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 1.1 ptp180 -149.89 138.91 21.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.83 0.347 . . . . 10.0 110.387 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.5 138.13 52.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.286 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' B' ' 276' ' ' LEU . 2.8 tt0 -125.16 127.29 46.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.222 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' C' ' 277' ' ' ILE . 1.3 mm? -105.68 85.56 2.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.333 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.33 -169.65 42.41 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.225 -0.988 . . . . 10.0 112.34 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -100.19 155.06 17.96 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.099 -0.334 . . . . 10.0 110.099 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.543 HG11 ' CD2' ' B' ' 286' ' ' PHE . 41.3 t -109.77 118.64 57.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.2 t -111.74 110.51 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -81.81 166.35 20.07 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.976 -0.29 . . . . 10.0 110.43 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.78 5.1 1.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.68 -18.91 20.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.897 0.38 . . . . 10.0 110.335 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.52 88.07 5.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 10.0 110.172 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 31.1 mt -127.25 8.59 6.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.747 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -124.46 105.36 9.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.238 0.542 . . . . 10.0 110.939 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -173.35 154.3 19.93 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.341 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.0 -171.19 13.13 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.564 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.0 tt -98.05 107.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.3 0.572 . . . . 10.0 110.398 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -139.94 118.74 12.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.804 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 tt -89.73 112.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 23.1 m -143.98 -172.7 3.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.065 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.0 146.53 39.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.072 0.463 . . . . 10.0 110.606 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.08 140.09 52.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.507 ' HA ' ' OD1' ' D' ' 258' ' ' ASP . 0.4 OUTLIER -60.29 139.52 57.57 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.611 0.72 . . . . 10.0 111.25 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.645 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 0.7 OUTLIER -99.13 106.54 18.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.402 -0.817 . . . . 10.0 110.64 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.7 t-20 -115.23 126.15 54.2 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -143.68 145.78 32.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.904 0.383 . . . . 10.0 111.14 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.52 143.67 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.258 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 265' ' ' LYS . . . . . 0.605 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 3.4 ttmt -85.57 -61.85 1.67 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.8 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 21.3 m -135.54 131.3 35.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.07 118.31 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.474 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' C' ' 232' ' ' ARG . 20.6 t -113.86 107.21 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.754 0.311 . . . . 10.0 110.555 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -110.3 130.05 9.67 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.16 -0.543 . . . . 10.0 112.066 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -135.02 124.52 24.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.809 0.338 . . . . 10.0 111.397 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 91.54 77.39 1.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 10.0 113.121 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' C' ' 236' ' ' ARG . 2.0 mt-10 52.33 33.82 13.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.904 0.482 . . . . 10.0 111.753 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.82 147.82 48.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.241 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -125.46 121.06 32.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.205 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.94 120.63 61.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.845 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.447 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -116.01 105.12 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.483 ' HB ' HD13 ' C' ' 241' ' ' LEU . 32.2 mm -101.55 91.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.167 0.508 . . . . 10.0 109.86 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.9 -173.05 35.17 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.303 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.47 149.23 22.92 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.075 -0.342 . . . . 10.0 110.075 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.9 138.59 48.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.935 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 1.9 t80 -120.39 102.02 8.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -141.77 173.57 23.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.54 -0.838 . . . . 10.0 112.538 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -126.39 -28.43 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.694 -0.765 . . . . 10.0 112.394 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -94.18 76.27 4.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 10.0 109.962 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 84.87 -113.77 3.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.154 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -151.48 -157.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 11.8 t90 -43.65 -53.47 5.72 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.598 0.561 . . . . 10.0 111.66 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 288' ' ' ASP . . . . . 0.487 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.4 OUTLIER -122.54 171.0 9.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.575 -0.45 . . . . 10.0 110.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 289' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -121.3 85.82 2.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.513 0.673 . . . . 10.0 111.064 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -117.93 -44.34 2.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.397 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 291' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' B' ' 295' ' ' HIS . 1.6 t-80 -142.55 171.3 14.24 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.906 0.335 . . . . 10.0 111.906 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 54.56 96.43 0.02 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.759 -1.11 . . . . 10.0 112.688 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -101.55 -164.83 1.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.386 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -71.02 146.28 49.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.452 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 63.1 m170 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.674 -0.679 . . . . 10.0 110.361 -179.585 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.645 ' N ' ' HG1' ' C' ' 261' ' ' THR . 1.1 tpm_? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.042 0.448 . . . . 10.0 110.488 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' D' ' 262' ' ' ASN . 15.7 m120 -104.12 135.52 45.45 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' D' ' 263' ' ' SER . 27.6 m -145.71 135.45 23.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.783 0.325 . . . . 10.0 111.014 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.47 131.46 43.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.011 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' C' ' 265' ' ' LYS . 85.2 tttt -81.52 -69.98 0.57 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.737 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 124.75 39.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.437 . . . . 10.0 111.824 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.47 126.78 71.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.368 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' D' ' 232' ' ' ARG . 3.7 mmm180 -118.21 121.04 39.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.6 -0.273 . . . . 10.0 110.384 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.452 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 2.2 p -125.27 117.14 23.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.745 0.307 . . . . 10.0 110.635 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -129.34 149.04 51.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 10.0 111.8 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 67.21 80.6 0.21 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.116 -0.947 . . . . 10.0 112.658 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 57.51 16.25 3.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.397 -0.82 . . . . 10.0 112.731 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -76.42 152.53 36.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.662 0.268 . . . . 10.0 111.022 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.86 154.32 48.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.199 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' D' ' 275' ' ' VAL . 2.4 p -139.57 136.21 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.875 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -122.95 129.4 51.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.403 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.509 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.6 mm? -112.42 90.73 3.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.597 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 177.5 -106.95 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.187 -1.006 . . . . 10.0 112.67 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -171.67 158.02 4.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.72 108.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.0 0.428 . . . . 10.0 111.335 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 17.6 t -104.72 108.39 24.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.581 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 72.6 p -87.05 162.05 17.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.009 -0.541 . . . . 10.0 111.983 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.62 -5.34 42.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.687 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.386 0.612 . . . . 10.0 110.075 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -93.17 166.77 12.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.274 -0.876 . . . . 10.0 110.001 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 250' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' D' ' 250' ' ' LEU . 6.3 tp -155.09 -169.8 3.29 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -76.77 70.59 3.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 10.0 110.924 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -166.78 74.82 0.14 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 99.95 0.02 56.25 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.505 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.23 -24.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.028 0.442 . . . . 10.0 111.505 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.81 70.67 9.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.498 . . . . 10.0 110.178 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 14.5 tt -58.42 -25.62 28.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.334 -0.848 . . . . 10.0 111.558 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m 63.38 -153.33 0.33 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.541 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 258' ' ' ASP . . . . . 0.639 ' CG ' ' HD2' ' D' ' 225' ' ' ARG . 1.3 m-20 -107.89 111.33 23.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 10.0 110.139 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -111.6 -87.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.2 t -87.59 159.37 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.067 0.46 . . . . 10.0 111.455 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 17.1 m -110.25 123.14 49.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.866 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.491 ' HB2' ' ND2' ' D' ' 226' ' ' ASN . 15.2 m120 -114.5 107.89 16.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' D' ' 227' ' ' SER . 18.1 m -125.9 116.29 21.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.837 0.351 . . . . 10.0 110.862 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.52 143.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 265' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 17.4 mmtp -95.88 -52.92 3.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.048 0.759 . . . . 10.0 113.048 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.14 121.96 36.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.74 113.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.683 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.28 125.29 74.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.832 0.349 . . . . 10.0 110.835 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -135.86 129.31 4.92 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.963 -0.562 . . . . 10.0 112.047 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -139.38 130.32 26.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.026 0.441 . . . . 10.0 111.433 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.34 81.39 0.79 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.294 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' E' ' 236' ' ' ARG . 1.4 tm-20 58.13 74.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.332 0.587 . . . . 10.0 110.193 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 4.0 m -125.85 140.38 52.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.437 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.77 121.4 36.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.402 ' HB ' HG23 ' D' ' 239' ' ' VAL . 58.8 t -104.75 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.064 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' D' ' 276' ' ' LEU . 0.6 OUTLIER -115.75 105.77 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.147 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.509 ' HB ' HD13 ' D' ' 241' ' ' LEU . 19.2 mm -108.61 95.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.883 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.7 -177.89 33.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.102 -0.57 . . . . 10.0 112.18 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.59 164.24 12.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.635 0.255 . . . . 10.0 110.404 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.71 134.22 50.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -125.4 118.36 25.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.543 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . 0.581 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 153.92 -178.13 31.0 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.282 -0.961 . . . . 10.0 113.405 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.21 47.75 1.01 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.766 -0.534 . . . . 10.0 111.766 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -92.82 4.84 53.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.461 0.648 . . . . 10.0 109.881 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 83.86 -56.52 5.05 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . 0.469 ' CE1' HG21 ' E' ' 244' ' ' VAL . 0.8 OUTLIER -172.88 143.0 1.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.488 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 44.0 t90 -48.75 -66.73 0.35 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.252 0.345 . . . . 10.0 111.787 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 288' ' ' ASP . . . . . 0.488 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 16.9 t0 -149.32 115.04 5.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.109 0.48 . . . . 10.0 110.302 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 289' ' ' ASN . . . . . 0.41 HD21 ' HB2' ' E' ' 287' ' ' TRP . 8.6 t-20 -136.02 173.8 11.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.671 . . . . 10.0 109.187 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -85.44 -56.95 3.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.528 0.204 . . . . 10.0 110.803 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -159.4 -168.52 2.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 10.0 111.216 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -92.54 -165.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.169 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -66.73 123.32 19.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 10.0 110.378 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -108.43 160.24 16.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.309 -0.853 . . . . 10.0 109.797 179.595 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.565 0.221 . . . . 10.0 110.484 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -119.61 120.84 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.083 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.89 149.04 50.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.549 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 133.44 24.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.148 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -68.83 0.76 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.622 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' E' ' 266' ' ' THR . 28.4 t70 -124.69 125.3 43.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 10.0 112.098 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 62.4 mt -128.49 124.05 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.113 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -120.76 121.02 37.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.781 0.324 . . . . 10.0 110.336 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.601 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 3.1 p -129.99 108.85 10.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.665 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.53 152.92 46.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.967 0.358 . . . . 10.0 111.967 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 66.18 79.89 0.23 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.527 -0.761 . . . . 10.0 112.114 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' D' ' 272' ' ' GLU . 13.2 ttp180 53.35 67.02 1.07 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.165 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' D' ' 273' ' ' SER . . . -129.99 162.28 29.04 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.169 -0.923 . . . . 10.0 110.675 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.54 146.77 28.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.349 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.44 HG22 HD12 ' E' ' 241' ' ' LEU . 4.4 p -127.28 122.99 61.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.359 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -120.52 118.51 30.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.775 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.44 HD12 HG22 ' E' ' 239' ' ' VAL . 1.1 mp -114.75 100.18 8.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.019 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . 0.55 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 169.73 -173.71 43.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . 0.579 ' HB2' ' OD1' ' E' ' 279' ' ' ASN . 5.7 p-10 -111.02 144.21 40.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.87 0.367 . . . . 10.0 110.262 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.469 HG21 ' CE1' ' D' ' 286' ' ' PHE . 55.1 t -98.5 130.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.987 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.77 110.6 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.529 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -61.0 164.05 5.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.011 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.12 -19.9 63.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.374 0.509 . . . . 10.0 112.374 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.29 -11.66 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.843 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.89 -155.56 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.943 -0.571 . . . . 10.0 111.137 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.34 142.56 27.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -82.36 62.59 6.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.44 0.638 . . . . 10.0 109.779 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 106.44 -170.23 16.2 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.1 80.55 1.54 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.477 -0.868 . . . . 10.0 111.901 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.54 -0.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.421 0.629 . . . . 10.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.26 73.32 0.98 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 10.0 110.489 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.8 pt -81.63 96.01 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 10.9 m -127.18 150.33 49.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.528 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.49 125.42 31.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.432 0.634 . . . . 10.0 110.245 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -124.94 46.12 2.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.575 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.1 t -149.21 141.47 24.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.002 0.429 . . . . 10.0 110.713 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 8.1 m -114.93 111.69 21.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.097 -0.502 . . . . 10.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -128.82 98.9 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.403 . . . . 10.0 110.465 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 9.9 m -107.83 117.55 34.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.173 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 15.5 t -100.32 126.57 53.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.415 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 265' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -82.61 -73.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.675 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' E' ' 230' ' ' ASP . 88.9 m -144.9 120.39 10.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.944 0.402 . . . . 10.0 111.435 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.15 121.38 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.088 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.3 t -116.08 128.85 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.146 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.26 124.37 3.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.047 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -124.91 111.75 15.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.032 0.444 . . . . 10.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.4 92.77 1.73 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.342 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.62 55.69 2.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.217 0.532 . . . . 10.0 110.38 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 127.1 42.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' E' ' 274' ' ' ARG . 5.8 mtm105 -119.8 106.96 12.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.003 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.1 111.67 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.37 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.68 106.58 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.125 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.4 mm -114.52 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.222 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 168.45 -135.3 3.56 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.381 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . 0.579 ' OD1' ' HB2' ' E' ' 243' ' ' ASN . 0.1 OUTLIER -118.97 137.57 53.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.722 0.296 . . . . 10.0 110.814 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 4.4 pt-20 -97.41 126.64 42.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' E' ' 244' ' ' VAL . 24.1 t80 -164.6 93.24 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.33 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.01 -90.8 0.4 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.279 -0.962 . . . . 10.0 112.964 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 283' ' ' GLY . . . . . 0.54 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 153.03 28.55 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.172 -0.537 . . . . 10.0 112.316 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.79 -65.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 10.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.95 23.47 1.16 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.373 -0.918 . . . . 10.0 113.219 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -152.31 106.76 3.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 287' ' ' TRP . . . . . 0.41 ' HB2' HD21 ' D' ' 289' ' ' ASN . 0.8 OUTLIER 73.43 7.87 5.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.244 1.021 . . . . 10.0 108.345 -177.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 288' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.7 OUTLIER -154.14 169.69 22.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.619 -1.628 . . . . 10.0 107.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -159.62 163.93 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.764 0.316 . . . . 10.0 110.846 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 290' ' ' HIS . . . . . 0.54 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 1.6 p-80 -158.37 -179.76 8.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.505 -0.771 . . . . 10.0 109.784 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -85.88 -73.0 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 64.6 t60 70.9 155.52 0.15 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.953 0.783 . . . . 10.0 111.392 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -111.63 128.46 56.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.578 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.98 142.25 31.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.888 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 . . . . . 0 C--O 1.246 0.884 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.33 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.986 -0.375 . . . . 10.0 109.986 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -114.03 136.72 52.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.029 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.06 132.75 28.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 10.0 110.946 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.3 164.32 17.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.192 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 265' ' ' LYS . 47.4 tttm -125.59 -69.09 0.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.848 0.356 . . . . 10.0 111.169 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -128.36 124.37 36.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.055 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.1 mt -136.72 131.55 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.334 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -129.38 111.69 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.206 0.527 . . . . 10.0 110.485 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -109.94 124.36 51.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.382 -0.826 . . . . 10.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -140.69 157.39 45.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.823 0.344 . . . . 10.0 111.375 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.8 72.64 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.484 -0.78 . . . . 10.0 111.514 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 56.57 35.97 26.87 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.315 -0.857 . . . . 10.0 111.703 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.6 149.24 22.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.121 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -132.97 145.71 51.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.922 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 2.6 p -136.81 125.29 34.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.194 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -125.57 130.96 52.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.868 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.21 122.74 48.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.416 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.515 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 144.64 -165.17 27.63 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.67 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -95.69 142.98 27.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 10.0 110.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.36 98.5 6.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.364 0.602 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.38 121.01 46.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.181 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 m -97.06 151.21 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.578 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.71 -12.89 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.112 0.482 . . . . 10.0 111.428 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -81.94 4.22 23.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.803 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -141.24 59.09 1.52 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.703 -0.68 . . . . 10.0 109.918 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 2.0 mm? 70.04 -160.12 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.425 -0.807 . . . . 10.0 111.415 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.4 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 29.5 p-80 -95.45 -174.42 3.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.54 2.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.294 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.71 -43.36 99.36 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.812 -0.515 . . . . 10.0 111.812 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 70.5 mt 71.98 133.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 122.996 0.519 . . . . 10.0 111.734 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 62.9 88.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.377 -0.828 . . . . 10.0 111.619 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.18 -56.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.773 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.1 p -118.33 -86.45 0.64 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.04 0.385 . . . . 10.0 112.04 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.6 t70 63.06 84.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.716 0.635 . . . . 10.0 110.289 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -129.16 13.51 6.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.081 -0.508 . . . . 10.0 111.342 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.74 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 4.9 t -145.29 134.98 23.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.377 0.608 . . . . 10.0 111.549 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -85.37 116.57 23.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.712 . . . . 10.0 109.58 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.409 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 61.9 m-20 -100.03 120.56 40.02 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.813 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.0 p -137.21 128.22 27.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.087 0.47 . . . . 10.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.93 136.21 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 229' ' ' LYS . 71.6 mmtt -93.12 -56.79 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.811 0.671 . . . . 10.0 112.811 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.77 128.91 44.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.706 0.632 . . . . 10.0 112.706 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.04 129.07 67.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.306 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.7 124.07 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.374 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.34 118.15 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.191 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -134.89 115.27 13.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.15 79.65 1.47 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.697 -0.763 . . . . 10.0 113.485 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 59.0 29.28 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.487 0.551 . . . . 10.0 112.487 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 5.5 m -77.94 141.65 38.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.402 0.62 . . . . 10.0 111.563 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -119.26 120.23 36.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.761 . . . . 10.0 109.505 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 48.5 t -113.92 118.02 57.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.242 -0.436 . . . . 10.0 110.68 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.436 ' HA ' HD22 ' A' ' 276' ' ' LEU . 0.7 OUTLIER -117.93 116.55 27.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.404 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.24 95.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.75 160.39 9.48 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.686 -0.768 . . . . 10.0 112.069 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -77.18 148.94 35.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.74 0.305 . . . . 10.0 110.934 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 164.58 14.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.112 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -139.89 106.36 5.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.617 -0.719 . . . . 10.0 109.772 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -166.15 148.55 13.81 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.59 -0.814 . . . . 10.0 113.158 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -129.5 7.27 6.25 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.655 -0.784 . . . . 10.0 112.661 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -97.55 -13.35 21.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.674 . . . . 10.0 110.031 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.0 145.55 5.08 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.679 -0.968 . . . . 10.0 110.679 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -77.83 96.1 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.694 0.247 . . . . 10.0 110.618 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.407 ' CZ3' ' HB2' ' B' ' 238' ' ' ARG . 7.0 t90 67.9 -70.52 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.859 0.724 . . . . 10.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -167.07 96.22 0.5 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.667 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -162.67 119.24 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.318 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -122.36 106.01 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.701 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -116.55 143.57 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.288 -0.414 . . . . 10.0 109.948 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -153.55 21.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.835 -0.166 . . . . 10.0 111.359 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -127.53 124.85 39.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 10.0 111.581 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 154.48 41.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.288 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' HIS . . . . . 0.408 ' HB2' ' NH2' ' D' ' 236' ' ' ARG . 20.3 p-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.129 -0.939 . . . . 10.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.74 ' N ' ' HG1' ' A' ' 260' ' ' THR . 35.2 ttm180 . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -120.6 133.77 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.233 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' B' ' 263' ' ' SER . 16.3 m -130.85 111.33 12.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.915 0.388 . . . . 10.0 111.301 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -110.16 130.29 55.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.629 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' B' ' 265' ' ' LYS . 0.0 OUTLIER -86.36 -68.92 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.92 120.43 16.05 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.964 0.412 . . . . 10.0 111.196 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.81 131.12 67.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 10.0 111.141 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' B' ' 232' ' ' ARG . 12.1 mmt85 -114.53 112.4 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.245 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.501 HG22 ' HB1' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -121.42 112.47 18.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.721 0.296 . . . . 10.0 110.974 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -133.13 150.72 52.02 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.507 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 67.89 81.04 0.2 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.443 -0.799 . . . . 10.0 113.128 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 32.8 mtm-85 54.99 22.95 4.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.196 0.598 . . . . 10.0 112.082 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.501 ' HB1' HG22 ' B' ' 233' ' ' THR . . . -80.08 154.27 28.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.338 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.407 ' HB2' ' CZ3' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -137.49 138.25 39.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.925 -0.579 . . . . 10.0 110.379 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.413 HG23 ' HB ' ' B' ' 275' ' ' VAL . 3.6 p -133.74 131.37 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.112 0.482 . . . . 10.0 110.662 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -120.97 131.17 54.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.345 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.487 HD13 ' HB ' ' B' ' 277' ' ' ILE . 3.4 mm? -104.88 104.6 14.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.474 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.409 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . 145.98 178.33 21.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.35 -0.929 . . . . 10.0 112.673 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -93.26 147.54 22.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.728 0.299 . . . . 10.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.54 131.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.675 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.44 113.46 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.104 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 44.4 p -90.28 171.37 9.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.381 . . . . 10.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.9 -10.23 51.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.2 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.82 -14.21 60.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.06 -6.71 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.221 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.38 114.11 3.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.535 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 23.4 t60 60.18 56.86 3.15 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.841 0.713 . . . . 10.0 110.533 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -136.34 -111.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.624 -0.717 . . . . 10.0 111.462 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.57 166.9 24.69 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.22 -0.752 . . . . 10.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 117.059 0.429 . . . . 10.0 111.057 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . 0.416 ' HD2' ' OD2' ' B' ' 258' ' ' ASP . 0.6 OUTLIER -97.25 106.92 19.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.89 0.376 . . . . 10.0 110.639 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' ILE . . . . . 0.4 HD11 HG11 ' C' ' 245' ' ' VAL . 4.3 pt -136.5 61.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.298 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.9 m 67.34 29.52 7.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.213 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . 0.416 ' OD2' ' HD2' ' B' ' 255' ' ' ARG . 3.4 p-10 -81.14 79.41 7.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.569 0.699 . . . . 10.0 111.027 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.89 85.81 2.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.622 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.9 t -138.17 176.82 8.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.032 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.9 m -140.02 113.27 8.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.144 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -100.59 121.74 42.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.901 0.382 . . . . 10.0 110.695 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 227' ' ' SER . 1.9 m -134.54 137.03 43.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.48 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.6 p -137.41 138.87 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.347 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 23.4 mttt -86.46 -80.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.82 120.77 42.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.2 t -115.99 105.32 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.538 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.24 113.19 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.464 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.07 134.09 9.05 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.44 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -144.81 141.06 28.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.317 -0.253 . . . . 10.0 110.317 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.73 69.07 1.43 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.198 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 59.87 42.18 16.81 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.797 0.439 . . . . 10.0 111.659 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.5 t -69.41 137.52 52.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.185 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -115.66 102.16 9.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.015 -0.539 . . . . 10.0 109.63 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' B' ' 239' ' ' VAL . 7.7 t -102.06 122.26 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.843 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.437 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -119.77 115.25 23.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.268 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.487 ' HB ' HD13 ' B' ' 241' ' ' LEU . 13.0 mm -104.5 83.57 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.819 0.342 . . . . 10.0 110.634 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.03 174.34 27.61 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.285 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -90.22 164.7 14.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.61 165.27 19.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.899 0.38 . . . . 10.0 110.099 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 2.4 t80 -143.58 78.94 1.61 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.334 -0.848 . . . . 10.0 108.834 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -112.62 -122.75 4.05 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.694 -0.765 . . . . 10.0 113.162 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 155.31 -61.95 0.36 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.303 -0.719 . . . . 10.0 111.303 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -83.67 74.49 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.58 121.15 3.85 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.388 -1.085 . . . . 10.0 110.388 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -83.49 79.27 9.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.939 0.37 . . . . 10.0 111.327 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.437 ' CZ2' ' HB2' ' B' ' 276' ' ' LEU . 21.0 t90 71.28 -48.28 0.67 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.199 0.937 . . . . 10.0 112.255 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -127.7 -175.62 3.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.899 0.381 . . . . 10.0 110.432 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -92.71 131.84 37.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.998 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -164.34 91.24 0.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.12 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -130.09 130.14 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.03 -0.532 . . . . 10.0 109.632 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.93 -173.08 4.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.588 0.232 . . . . 10.0 111.133 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -111.81 132.45 54.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.98 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -87.15 -177.01 5.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.437 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.285 -0.864 . . . . 10.0 110.134 179.731 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.582 0.229 . . . . 10.0 110.409 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.441 ' HB3' HG22 ' C' ' 277' ' ' ILE . 15.5 m120 -126.51 103.4 7.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 133.51 52.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.13 0.491 . . . . 10.0 111.871 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -130.11 122.28 27.97 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.037 -0.727 . . . . 10.0 109.037 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' C' ' 265' ' ' LYS . 48.8 tttm -82.69 -80.87 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.395 0.517 . . . . 10.0 112.395 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' C' ' 266' ' ' THR . 0.2 OUTLIER -109.39 122.27 47.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.268 0.556 . . . . 10.0 111.835 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.442 HD11 ' HB1' ' C' ' 228' ' ' ALA . 88.4 mt -127.65 137.76 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.474 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.472 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 40.0 ttm-85 -128.76 119.51 24.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.402 ' C ' ' HB3' ' C' ' 237' ' ' ALA . 0.7 OUTLIER -127.92 93.57 3.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.049 0.452 . . . . 10.0 110.355 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.472 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 6.1 pt-20 -120.01 158.68 26.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.743 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 65.68 73.17 0.4 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 10.0 111.354 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 59.31 36.62 23.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.262 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.402 ' HB3' ' C ' ' C' ' 233' ' ' THR . . . -100.3 156.47 17.21 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.276 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -145.82 150.56 36.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.664 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 131.16 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.418 ' HB3' HD22 ' C' ' 276' ' ' LEU . 8.6 tt0 -115.81 127.16 54.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 10.0 109.958 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.478 HD23 HD13 ' B' ' 277' ' ' ILE . 3.7 mm? -102.11 88.25 3.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.774 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.48 171.6 31.89 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.168 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -84.34 152.58 24.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.779 0.323 . . . . 10.0 110.324 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.12 118.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.791 0.329 . . . . 10.0 110.939 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 46.6 t -121.06 110.91 29.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.031 0.443 . . . . 10.0 110.2 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.9 p -82.6 160.4 22.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.827 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.89 -4.74 7.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.76 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.41 -15.87 44.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.188 0.518 . . . . 10.0 110.242 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -100.01 94.15 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.496 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.02 20.97 13.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.338 0.59 . . . . 10.0 109.834 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -111.15 144.18 40.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.04 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.18 134.4 3.31 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.086 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.55 171.74 14.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.921 -0.657 . . . . 10.0 111.493 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.3 tp -87.17 115.74 28.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.146 0.498 . . . . 10.0 109.746 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -160.28 149.81 17.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.005 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 tt -95.32 130.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.416 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 35.3 m -153.31 169.49 22.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.792 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 258' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' D' ' 257' ' ' SER . 0.5 OUTLIER -94.53 130.11 41.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.044 0.449 . . . . 10.0 110.108 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -115.72 145.45 42.76 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.345 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.5 t -55.24 135.84 49.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.317 0.579 . . . . 10.0 111.013 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 56.0 m -96.41 139.28 32.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.951 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 20.7 t-20 -133.65 140.34 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.674 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -154.01 139.17 17.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.802 0.334 . . . . 10.0 110.126 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.39 147.15 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 265' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 1.1 mtpt -85.46 -58.84 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.432 . . . . 10.0 112.097 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 39.9 m -141.58 128.0 20.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.25 117.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.638 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.24 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.107 0.48 . . . . 10.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.51 138.81 15.02 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.797 -0.716 . . . . 10.0 111.667 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.25 125.6 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.912 0.356 . . . . 10.0 111.493 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.44 82.99 0.99 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.921 -0.656 . . . . 10.0 113.465 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 60.55 23.68 13.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.86 0.362 . . . . 10.0 111.377 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.18 136.82 57.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.204 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -128.07 109.91 11.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.525 -0.761 . . . . 10.0 109.825 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 37.7 t -100.45 133.82 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.759 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.4 OUTLIER -127.71 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.088 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.441 HG22 ' HB3' ' C' ' 226' ' ' ASN . 35.3 mm -105.04 95.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.379 . . . . 10.0 110.221 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.67 -171.23 33.65 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.254 -0.738 . . . . 10.0 111.254 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.24 148.1 30.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 10.0 109.801 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -106.95 142.32 36.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 111.084 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -129.31 104.32 7.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.501 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -173.93 175.83 46.45 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.684 -0.77 . . . . 10.0 112.134 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.29 -8.71 24.9 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.541 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.67 63.58 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.166 0.508 . . . . 10.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.48 -84.74 1.07 Allowed Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.064 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.42 -51.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.417 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 8.6 t90 -144.85 -67.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 288' ' ' ASP . . . . . 0.443 ' OD2' ' HD2' ' D' ' 238' ' ' ARG . 2.1 p30 -107.13 165.28 11.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.066 -0.516 . . . . 10.0 109.784 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -114.65 50.65 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.916 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -79.85 -53.19 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.473 . . . . 10.0 111.811 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.13 172.24 10.7 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.954 -0.298 . . . . 10.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 66.53 173.8 0.24 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -177.85 -153.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.347 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -76.22 157.85 32.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.607 179.346 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' D' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.315 0.579 . . . . 10.0 110.372 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 12.5 m120 -99.23 138.8 35.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' D' ' 263' ' ' SER . 18.3 m -154.27 148.46 25.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.071 0.462 . . . . 10.0 111.086 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.45 134.09 31.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.802 -0.635 . . . . 10.0 109.732 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' C' ' 265' ' ' LYS . 12.6 tmtt? -86.13 -64.78 1.1 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.064 -0.255 . . . . 10.0 111.382 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.8 124.18 45.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.004 0.372 . . . . 10.0 112.004 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.45 HG21 HG21 ' D' ' 239' ' ' VAL . 55.3 mt -131.3 122.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -121.57 120.43 34.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.274 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -120.06 115.23 23.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.534 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.915 0.388 . . . . 10.0 112.029 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 62.18 90.01 0.08 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.981 1.104 . . . . 10.0 113.981 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . 0.671 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 29.8 mtt180 62.57 3.17 1.05 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.602 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.95 142.56 49.42 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.987 0.422 . . . . 10.0 111.408 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . 0.443 ' HD2' ' OD2' ' C' ' 288' ' ' ASP . 0.3 OUTLIER -133.68 150.07 51.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.412 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.45 HG21 HG21 ' D' ' 231' ' ' ILE . 2.5 p -136.55 137.21 47.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.883 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -115.57 140.7 48.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.375 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.459 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.9 mm? -123.7 75.77 1.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.054 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . 0.575 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . -171.19 -138.79 2.6 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.223 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -139.57 132.54 29.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.87 113.86 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.117 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.4 t -117.88 106.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.516 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 0.6 OUTLIER -81.52 158.69 24.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.229 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.87 -0.97 8.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.149 0.5 . . . . 10.0 111.38 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.95 -10.5 57.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.161 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.67 113.57 26.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.049 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 6.6 mp -111.35 -166.29 1.06 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.61 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -63.13 129.64 41.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.508 0.194 . . . . 10.0 110.6 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 133.66 50.6 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.026 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.39 18.18 8.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.432 -0.89 . . . . 10.0 112.593 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -74.26 -17.52 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.094 0.473 . . . . 10.0 111.314 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -104.69 88.48 2.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 10.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 20.0 tt -82.59 -10.59 12.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.883 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 257' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' C' ' 258' ' ' ASP . 37.7 m 61.06 -133.72 0.67 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.042 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 258' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' D' ' 225' ' ' ARG . 2.0 t0 -122.98 137.09 55.05 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -138.57 -83.65 0.29 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.507 -0.477 . . . . 10.0 112.033 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 12.9 t -79.29 156.31 28.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.198 0.523 . . . . 10.0 111.657 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' D' ' 225' ' ' ARG . 23.3 m -111.24 118.94 37.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.231 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 4.0 m120 -120.52 106.41 11.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' D' ' 227' ' ' SER . 23.1 m -127.61 132.58 49.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.475 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' E' ' 228' ' ' ALA . 10.1 p -120.86 144.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.638 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 265' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 19.5 mmtp -82.86 -51.65 7.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.802 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 50.1 m -142.54 122.22 13.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.09 122.16 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.334 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.85 123.13 67.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.135 0.493 . . . . 10.0 111.083 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.49 134.32 10.27 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -138.4 115.05 10.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.202 0.501 . . . . 10.0 111.474 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.17 93.12 0.79 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.967 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . 0.671 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 52.8 mm-40 54.94 33.3 19.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.214 0.53 . . . . 10.0 111.527 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -75.78 144.54 41.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.737 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -127.49 103.25 7.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.248 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 62.4 t -98.73 117.89 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.49 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.456 ' HB2' ' CH2' ' D' ' 287' ' ' TRP . 0.6 OUTLIER -114.08 106.16 14.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.531 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.459 ' HB ' HD13 ' D' ' 241' ' ' LEU . 30.6 mm -102.43 86.36 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . 162.21 -171.41 38.09 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.527 -0.844 . . . . 10.0 112.365 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -113.02 162.74 15.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.275 -0.268 . . . . 10.0 110.275 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.77 142.97 49.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 10.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -135.19 116.27 14.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.209 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . 0.516 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 152.29 166.28 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.481 -0.866 . . . . 10.0 112.422 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -83.98 71.57 2.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -117.1 -5.72 11.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.095 0.474 . . . . 10.0 110.292 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.94 -54.6 4.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.069 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -163.07 144.9 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.151 -0.315 . . . . 10.0 110.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' D' ' 276' ' ' LEU . 34.6 t90 -59.52 -63.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.244 0.34 . . . . 10.0 111.25 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 288' ' ' ASP . . . . . 0.495 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 60.1 t0 -146.03 115.29 7.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 10.0 109.97 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -142.87 161.83 37.08 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.93 -51.92 7.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.673 0.273 . . . . 10.0 110.7 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -156.57 -175.44 5.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.444 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -91.93 -151.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.851 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.18 119.55 10.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.807 0.337 . . . . 10.0 110.757 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -113.28 154.59 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.168 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.656 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' E' ' 261' ' ' THR . 93.3 mtt180 . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . 0.476 ' ND2' ' HB2' ' E' ' 262' ' ' ASN . 9.5 m120 -130.84 120.66 24.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.945 0.402 . . . . 10.0 111.14 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' E' ' 263' ' ' SER . 1.3 m -118.74 141.9 48.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' D' ' 264' ' ' VAL . . . -132.17 133.26 44.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.167 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' E' ' 265' ' ' LYS . 1.1 ttmm -91.25 -77.72 0.41 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.899 -0.32 . . . . 10.0 111.143 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.7 126.78 51.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 10.0 111.666 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 66.5 mt -132.82 124.03 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -122.15 109.82 14.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.537 . . . . 10.0 110.3 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.5 p -113.53 96.82 6.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.358 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . 0.401 ' HG3' ' HG2' ' E' ' 270' ' ' LYS . 5.3 pt-20 -117.07 152.22 35.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.441 . . . . 10.0 112.103 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 65.15 81.5 0.21 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.741 -1.118 . . . . 10.0 111.441 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 50.82 63.69 2.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.07 -0.968 . . . . 10.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.78 155.28 45.4 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.985 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . 0.495 ' HE ' ' CG ' ' D' ' 288' ' ' ASP . 0.1 OUTLIER -136.48 149.35 48.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.885 -178.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.09 127.12 32.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.92 -0.582 . . . . 10.0 109.982 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -120.75 128.11 52.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.589 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.4 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 1.0 OUTLIER -116.47 92.42 3.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.751 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 167.53 -165.31 38.56 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.765 -0.731 . . . . 10.0 112.172 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . 0.423 HD22 HG23 ' E' ' 245' ' ' VAL . 3.2 p-10 -103.44 150.18 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.953 0.406 . . . . 10.0 110.783 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.81 110.93 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.911 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . 0.423 HG23 HD22 ' E' ' 243' ' ' ASN . 86.3 t -123.17 112.09 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.096 0.474 . . . . 10.0 110.431 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.693 HG23 ' H ' ' E' ' 248' ' ' ALA . 14.5 t -76.02 179.4 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.72 -7.53 11.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.035 0.754 . . . . 10.0 113.035 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . 0.693 ' H ' HG23 ' E' ' 246' ' ' THR . . . -67.49 -30.85 70.65 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.754 -0.461 . . . . 10.0 109.754 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.96 -173.59 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.072 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 60.9 mt -89.48 123.51 33.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.889 -0.596 . . . . 10.0 109.618 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -63.96 -28.41 69.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.81 -167.48 25.45 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.003 -0.839 . . . . 10.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 85.88 92.56 0.85 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 10.0 112.238 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 35.0 mt -78.75 -31.77 15.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.626 . . . . 10.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 255' ' ' ARG . . . . . 0.416 ' HA ' ' NE ' ' E' ' 255' ' ' ARG . 0.4 OUTLIER -84.74 83.53 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.777 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.29 109.75 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 10.0 110.075 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 35.5 m -143.13 140.82 31.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.055 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.79 130.94 35.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.262 0.553 . . . . 10.0 110.338 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -108.42 -52.8 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.67 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.4 t -67.79 133.69 49.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.465 0.65 . . . . 10.0 111.319 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 94.9 m -121.69 113.11 19.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.694 -0.684 . . . . 10.0 109.889 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . 0.476 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 11.2 m120 -115.86 141.25 48.35 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.52 -0.764 . . . . 10.0 110.281 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' E' ' 227' ' ' SER . 73.3 m -142.22 133.34 26.07 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.34 138.31 49.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.183 0.516 . . . . 10.0 110.411 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 265' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' E' ' 229' ' ' LYS . 80.8 mttt -84.18 -60.79 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.211 -0.449 . . . . 10.0 112.144 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.5 m -135.92 123.71 22.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 t -120.23 111.23 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.403 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -114.39 110.51 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.758 0.313 . . . . 10.0 111.029 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.0 117.43 3.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.014 -0.613 . . . . 10.0 111.7 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . 0.401 ' HG2' ' HG3' ' E' ' 234' ' ' GLU . 0.0 OUTLIER -120.02 114.07 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.748 0.309 . . . . 10.0 111.519 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.0 90.54 0.4 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.819 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 60.76 85.77 0.11 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.178 0.513 . . . . 10.0 111.319 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.41 136.1 48.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.94 104.26 10.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.35 117.89 51.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.024 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.03 113.08 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.139 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' E' ' 226' ' ' ASN . 38.3 mm -107.65 87.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 166.56 -156.39 28.25 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.901 -0.666 . . . . 10.0 111.948 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -110.18 145.58 37.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.97 0.414 . . . . 10.0 110.293 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' E' ' 288' ' ' ASP . 0.7 OUTLIER -106.21 146.71 29.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.541 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -159.17 84.49 0.79 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.045 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.36 -104.92 1.31 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.239 -0.981 . . . . 10.0 113.19 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 283' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 154.36 59.95 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.204 -0.522 . . . . 10.0 111.916 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -135.45 -59.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.516 0.198 . . . . 10.0 110.726 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.5 19.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.55 -0.833 . . . . 10.0 113.65 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -156.13 113.86 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.397 0.599 . . . . 10.0 109.944 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 68.24 16.29 9.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.086 0.946 . . . . 10.0 108.799 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 288' ' ' ASP . . . . . 0.466 ' HA ' ' HG3' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -154.97 168.53 26.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.993 -1.458 . . . . 10.0 108.14 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -153.32 143.43 22.24 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.852 -0.339 . . . . 10.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 290' ' ' HIS . . . . . 0.424 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 2.2 p-80 -149.34 178.65 8.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.979 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -105.12 -62.96 1.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.679 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 t60 66.65 168.35 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.758 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -108.32 107.07 17.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.997 0.427 . . . . 10.0 110.003 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.02 132.31 42.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.72 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.773 0 CA-C-O 118.49 -0.767 . . . . 10.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.206 -0.294 . . . . 10.0 110.206 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -105.21 142.4 35.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.9 m -147.15 137.47 23.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.781 0.324 . . . . 10.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -140.87 151.93 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.321 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -112.46 -56.84 2.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -137.02 121.32 18.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.853 0.359 . . . . 10.0 111.378 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 54.2 mt -128.14 119.01 49.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.084 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -127.84 110.83 12.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.309 0.576 . . . . 10.0 110.532 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.95 127.16 51.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.555 -0.748 . . . . 10.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.73 176.94 8.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.426 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 60.53 66.9 0.88 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.077 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 57.8 65.44 1.32 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.901 -1.045 . . . . 10.0 110.94 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -131.81 178.68 6.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 238' ' ' ARG . 6.2 ptp180 -159.18 155.12 26.55 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.026 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.18 136.74 59.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.471 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -129.21 134.41 47.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.994 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.53 138.12 51.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.278 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.74 -123.1 2.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.312 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -143.91 141.71 30.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 41.8 t -105.41 110.52 31.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.216 0.531 . . . . 10.0 111.56 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.12 108.51 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.647 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.418 ' HB ' ' HA2' ' A' ' 282' ' ' GLY . 12.0 m -84.62 149.72 25.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.183 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.3 -14.17 16.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.64 -13.3 56.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 10.0 110.904 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -106.94 25.31 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.431 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 3.9 mm? 70.95 -159.64 0.13 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.258 -0.883 . . . . 10.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.41 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 48.8 p-80 -76.86 169.63 17.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.235 0.541 . . . . 10.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -77.58 80.13 1.33 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.3 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.04 -36.6 93.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.218 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.8 mt 72.72 146.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.547 0.792 . . . . 10.0 111.68 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 61.85 87.54 0.1 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.286 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 20.7 mt -123.38 -67.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.96 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 p -101.34 -90.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.861 -0.154 . . . . 10.0 111.408 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.1 t0 56.1 69.1 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.706 0.628 . . . . 10.0 110.932 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -121.07 2.65 10.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 10.0 110.623 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -136.38 152.0 50.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.38 127.85 42.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.345 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -101.77 83.61 2.43 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -108.81 116.69 32.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.602 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 228' ' ' ALA . 14.2 p -119.81 140.31 44.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.7 mttm -91.84 -79.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.179 0.437 . . . . 10.0 112.179 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 128.73 54.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.06 119.54 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.456 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.73 125.27 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.774 0.321 . . . . 10.0 111.491 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -128.91 129.31 6.11 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.197 -0.525 . . . . 10.0 111.934 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -145.01 111.87 5.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.901 0.382 . . . . 10.0 111.339 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.16 82.57 1.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.867 -0.683 . . . . 10.0 112.952 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 52.17 50.59 18.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.506 0.669 . . . . 10.0 110.996 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 m -102.26 141.64 34.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.966 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -121.15 119.43 32.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.32 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 55.2 t -103.31 119.07 51.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.918 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 276' ' ' LEU . 1.4 tm? -114.15 103.6 11.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.36 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.529 HD13 HD23 ' B' ' 241' ' ' LEU . 8.8 mm -96.98 101.54 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.358 -0.383 . . . . 10.0 109.992 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 142.44 179.24 19.14 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.847 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.15 159.95 15.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.846 0.323 . . . . 10.0 110.642 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.96 156.86 39.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.447 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.86 86.97 2.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.325 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.418 ' HA2' ' HB ' ' A' ' 246' ' ' THR . . . -109.02 -145.83 11.4 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.353 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -174.35 -82.29 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -88.89 89.99 8.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.337 -0.986 . . . . 10.0 108.337 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 108.08 110.28 3.4 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.511 -1.035 . . . . 10.0 110.511 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -75.6 81.89 2.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.573 0.225 . . . . 10.0 110.916 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.5 t90 67.35 -69.6 0.13 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.145 0.903 . . . . 10.0 111.777 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.33 90.71 3.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.735 0.302 . . . . 10.0 110.749 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -155.42 136.38 13.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.561 -0.29 . . . . 10.0 110.772 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -157.93 34.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.068 -0.715 . . . . 10.0 109.068 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.22 132.13 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.836 -0.62 . . . . 10.0 111.52 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -137.16 15.87 3.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.639 0.733 . . . . 10.0 109.433 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -91.54 84.3 5.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.032 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -66.22 126.21 27.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.955 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.302 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.4 142.04 40.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.242 -0.651 . . . . 10.0 109.242 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.9 m -143.92 126.85 16.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.83 0.348 . . . . 10.0 111.091 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.18 134.95 47.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.405 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' B' ' 265' ' ' LYS . 50.9 mmtt -87.38 -59.39 2.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.451 -0.34 . . . . 10.0 111.776 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' B' ' 266' ' ' THR . 26.0 t70 -146.14 123.94 11.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.481 . . . . 10.0 110.869 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.06 130.61 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.06 113.05 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.455 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 1.3 p -124.06 114.12 19.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.653 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.23 156.05 48.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.971 0.415 . . . . 10.0 111.39 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 60.78 80.19 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.019 -0.991 . . . . 10.0 112.185 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 58.04 37.02 26.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.664 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.74 141.85 30.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 10.0 110.533 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.58 131.21 46.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.747 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.43 133.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.131 0.491 . . . . 10.0 111.093 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.686 ' HB3' HD22 ' B' ' 276' ' ' LEU . 17.1 tm0? -115.98 125.77 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.877 -0.601 . . . . 10.0 109.987 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.529 HD23 HD13 ' A' ' 277' ' ' ILE . 3.0 mm? -112.35 83.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.141 -0.482 . . . . 10.0 111.307 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.93 -177.27 42.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.169 -1.015 . . . . 10.0 112.938 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -90.06 139.63 30.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 10.0 110.201 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 92.7 t -104.6 114.22 43.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.496 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.9 t -119.71 106.5 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.978 0.418 . . . . 10.0 110.028 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 82.5 p -79.66 173.11 12.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.049 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.29 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 10.0 112.096 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.92 -21.59 50.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.784 0.326 . . . . 10.0 110.524 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.474 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . -93.71 17.95 11.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.25 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.69 106.0 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.883 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t60 65.06 82.39 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.954 0.784 . . . . 10.0 111.481 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.6 -135.87 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.915 -0.66 . . . . 10.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.17 127.61 6.14 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.294 -0.722 . . . . 10.0 111.294 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 36.3 mt -119.94 -33.23 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.048 0.451 . . . . 10.0 111.218 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . 0.409 ' HD2' ' OD1' ' B' ' 258' ' ' ASP . 1.2 tpt180 -86.19 88.62 7.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.842 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt -120.37 54.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.569 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 m 65.92 38.25 5.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.615 -0.72 . . . . 10.0 110.332 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . 0.409 ' OD1' ' HD2' ' B' ' 255' ' ' ARG . 2.0 p-10 -73.96 61.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.226 -0.897 . . . . 10.0 111.541 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -104.8 98.1 7.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.004 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 9.0 t -156.57 148.54 22.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.281 0.562 . . . . 10.0 111.326 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' C' ' 225' ' ' ARG . 0.1 OUTLIER -118.94 98.39 6.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.238 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -88.01 116.29 26.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' C' ' 227' ' ' SER . 0.0 OUTLIER -124.08 135.45 53.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.566 -0.743 . . . . 10.0 111.61 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.18 135.79 49.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.274 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 0.5 OUTLIER -80.63 -73.93 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.508 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 0.6 OUTLIER -124.15 139.2 54.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.36 121.97 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.167 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.59 119.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.834 0.35 . . . . 10.0 110.984 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.85 117.55 3.19 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -134.45 119.48 18.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.75 0.275 . . . . 10.0 111.364 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.98 87.15 1.08 Allowed Glycine 0 C--N 1.329 0.15 0 C-N-CA 120.863 -0.684 . . . . 10.0 113.474 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 53.04 41.01 32.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.867 0.467 . . . . 10.0 111.51 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.0 t -76.92 154.21 33.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.282 0.563 . . . . 10.0 111.439 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -136.36 106.56 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.912 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.74 126.11 64.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.014 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -117.89 117.3 28.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.35 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.417 HD13 HD23 ' C' ' 241' ' ' LEU . 21.8 mm -108.52 85.32 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.241 0.543 . . . . 10.0 109.776 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.96 168.29 19.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.056 -0.818 . . . . 10.0 111.056 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -88.83 158.55 18.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.223 0.511 . . . . 10.0 110.234 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.42 162.16 24.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.271 0.557 . . . . 10.0 111.039 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.474 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 2.7 t80 -140.35 95.78 2.93 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.047 -0.979 . . . . 10.0 108.862 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -120.9 -122.91 2.96 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.957 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' B' ' 285' ' ' GLY . . . 151.34 -44.17 0.67 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.855 -0.898 . . . . 10.0 110.855 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -82.72 35.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.804 0.812 . . . . 10.0 109.2 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 283' ' ' GLY . . . 136.23 172.0 12.47 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.42 -1.472 . . . . 10.0 109.42 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -112.98 62.82 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 22.1 t90 71.3 -45.87 0.63 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.103 0.877 . . . . 10.0 110.591 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 288' ' ' ASP . . . . . 0.498 ' OD2' ' HD3' ' C' ' 274' ' ' ARG . 37.5 t70 -101.14 151.17 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.287 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.86 101.23 12.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.418 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 290' ' ' HIS . . . . . 0.637 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 36.0 t60 -131.89 134.88 46.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.423 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -154.38 126.33 7.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.023 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.23 -167.44 2.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.696 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -119.23 127.1 52.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.751 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -70.8 165.77 22.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.775 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.629 -0.7 . . . . 10.0 110.289 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 261' ' ' THR . 20.3 ptt-85 . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 109.876 -0.416 . . . . 10.0 109.876 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -120.56 133.22 55.41 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.247 0.342 . . . . 10.0 110.639 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' B' ' 263' ' ' SER . 67.7 m -139.25 133.28 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.843 0.354 . . . . 10.0 110.558 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.96 51.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.623 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -90.39 -72.72 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.68 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -123.97 121.67 35.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.995 0.426 . . . . 10.0 111.46 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.47 126.71 74.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.856 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.414 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 38.6 ttm-85 -113.62 120.69 41.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.2 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 86.84 2.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 10.0 110.49 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.414 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 5.6 pt-20 -117.17 172.7 7.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.631 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.574 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 48.2 mt-10 65.95 59.74 0.7 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 64.19 15.41 9.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.399 -0.818 . . . . 10.0 112.748 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.63 156.87 32.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.844 0.354 . . . . 10.0 111.462 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.495 HH22 ' CD ' ' C' ' 272' ' ' GLU . 0.2 OUTLIER -137.23 146.62 45.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.31 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.19 140.07 44.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.768 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -125.16 124.66 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.395 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' C' ' 277' ' ' ILE . 4.1 mm? -100.21 97.46 8.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.181 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.77 32.76 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.534 -0.841 . . . . 10.0 112.496 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.49 158.87 15.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 10.0 110.218 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.84 110.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.961 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.47 121.43 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.002 0.43 . . . . 10.0 110.968 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . 0.449 ' C ' ' H ' ' C' ' 248' ' ' ALA . 11.0 p -87.84 165.88 14.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.917 -0.583 . . . . 10.0 109.734 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.05 26.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.291 0.567 . . . . 10.0 111.975 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' C' ' 246' ' ' THR . . . -117.75 -10.22 10.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.155 0.502 . . . . 10.0 110.142 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -96.44 73.34 2.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.245 0.545 . . . . 10.0 110.701 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 14.0 mt -109.35 -16.93 13.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.043 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -86.55 76.73 9.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.307 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.75 8.19 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -116.75 164.0 12.41 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 17.1 tt -77.32 128.93 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 10.0 110.57 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -157.29 110.79 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.403 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 5.7 tt -81.99 99.35 5.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.944 0.878 . . . . 10.0 110.379 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -132.97 -176.52 4.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 10.0 110.091 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 258' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 0.2 OUTLIER -64.33 157.14 26.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.836 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.25 138.81 22.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 9.7 t -64.71 127.07 29.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.287 0.565 . . . . 10.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.07 137.18 38.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.528 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' D' ' 241' ' ' LEU . 25.8 t-20 -133.18 132.19 41.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 10.0 110.408 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' D' ' 227' ' ' SER . 17.8 m -151.49 150.2 30.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.737 0.303 . . . . 10.0 110.858 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.34 144.85 25.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 265' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 2.4 mtpt -88.2 -70.76 0.62 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.719 0.637 . . . . 10.0 112.719 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 128.66 51.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.478 0.547 . . . . 10.0 112.478 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.55 118.33 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.588 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 85.5 t -110.05 120.4 61.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.053 0.454 . . . . 10.0 110.928 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -123.48 122.94 5.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.268 -0.733 . . . . 10.0 111.268 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.516 ' HB2' ' HG2' ' D' ' 234' ' ' GLU . 27.4 mttm -138.43 141.19 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.63 0.252 . . . . 10.0 111.472 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 71.61 79.77 0.39 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.868 -0.605 . . . . 10.0 113.519 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . 0.495 ' CD ' HH22 ' C' ' 238' ' ' ARG . 36.5 mm-40 55.18 39.77 31.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.053 0.454 . . . . 10.0 111.585 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 157.65 23.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 10.0 111.296 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.62 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 1.3 mtm180 -137.7 118.56 14.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.06 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.98 126.7 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.276 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.569 ' HB2' ' CZ3' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -117.42 112.47 20.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.243 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' C' ' 241' ' ' LEU . 34.1 mm -111.32 87.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.14 0.495 . . . . 10.0 110.062 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 162.59 -175.61 38.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.964 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -95.64 145.2 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.091 0.472 . . . . 10.0 110.162 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.47 143.47 37.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -130.1 101.42 5.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.605 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -133.27 -158.1 8.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.673 -0.775 . . . . 10.0 112.509 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.9 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.432 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -72.05 -17.51 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 10.0 111.183 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . 0.407 ' HA2' ' HE3' ' D' ' 284' ' ' LYS . . . 168.3 -143.72 8.33 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.803 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -104.53 -160.14 0.75 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.889 -0.412 . . . . 10.0 109.889 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.62 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 9.2 t90 -49.18 -43.79 42.43 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.481 0.488 . . . . 10.0 112.281 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 288' ' ' ASP . . . . . 0.637 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.0 OUTLIER -122.76 168.89 11.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.648 -0.421 . . . . 10.0 111.122 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -120.54 38.56 3.97 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.183 0.808 . . . . 10.0 113.183 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -65.61 -51.19 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.075 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 291' ' ' HIS . . . . . 0.416 ' HB2' HH22 ' D' ' 274' ' ' ARG . 6.0 m170 -130.13 177.28 7.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 71.34 155.73 0.15 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.884 0.74 . . . . 10.0 111.423 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.1 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.205 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -126.94 -176.01 3.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.709 -0.662 . . . . 10.0 110.747 -179.453 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.568 ' HD3' ' OD2' ' D' ' 258' ' ' ASP . 6.0 mpt_? . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.864 0.364 . . . . 10.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -108.95 116.48 32.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' C' ' 263' ' ' SER . 19.9 m -138.58 132.63 31.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.006 0.431 . . . . 10.0 111.239 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.85 142.11 48.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.73 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 23.5 tttp -88.78 -71.5 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -118.21 119.74 35.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.723 0.297 . . . . 10.0 111.41 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.47 HG21 HG21 ' D' ' 239' ' ' VAL . 57.1 mt -122.8 118.71 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.041 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -110.61 124.56 52.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.904 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.451 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.6 OUTLIER -135.93 104.89 5.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.039 0.447 . . . . 10.0 110.462 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' C' ' 270' ' ' LYS . 1.7 mt-10 -128.59 162.13 27.99 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 66.97 72.28 0.36 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.677 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . 0.543 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 4.6 mtp180 55.82 32.5 19.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.872 -0.603 . . . . 10.0 111.928 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.26 173.35 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.98 0.419 . . . . 10.0 111.579 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.93 152.36 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.492 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.47 HG21 HG21 ' D' ' 231' ' ' ILE . 1.8 p -143.27 135.97 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.602 . . . . 10.0 110.434 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -124.06 128.63 49.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.19 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.1 mm? -110.66 101.79 10.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.355 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . 164.31 -108.97 0.35 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.956 -1.116 . . . . 10.0 113.214 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -164.65 158.12 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.13 112.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.987 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.3 t -117.67 128.79 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 10.0 110.088 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.513 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 2.1 p -109.54 161.37 15.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.99 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.84 -2.06 6.59 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.9 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.17 59.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.996 0.427 . . . . 10.0 110.263 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -112.53 102.86 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.952 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.56 -159.88 0.76 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.095 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -71.0 79.45 0.65 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.267 0.556 . . . . 10.0 110.693 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -146.07 39.93 1.1 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.928 -0.869 . . . . 10.0 110.928 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.04 31.15 7.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.412 -0.675 . . . . 10.0 111.412 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.7 tt -74.39 -19.48 17.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.349 . . . . 10.0 111.397 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -78.39 69.51 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.532 0.682 . . . . 10.0 110.117 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.57 -16.73 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.085 . . . . 10.0 111.935 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 257' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 10.5 m 61.67 -127.16 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 258' ' ' ASP . . . . . 0.568 ' OD2' ' HD3' ' D' ' 225' ' ' ARG . 1.1 t0 -125.21 137.88 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 259' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' E' ' 257' ' ' SER . 9.6 tp60 -136.27 -72.43 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.521 -0.472 . . . . 10.0 112.128 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 8.7 t -78.69 151.39 32.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.467 0.651 . . . . 10.0 111.522 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -114.84 90.9 3.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.586 -0.734 . . . . 10.0 109.397 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 7.4 m120 -98.45 112.84 24.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.478 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -129.01 99.71 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.497 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 13.2 p -97.09 142.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 10.0 109.873 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 265' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 1.8 mptt -95.81 -50.45 4.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.75 0.648 . . . . 10.0 112.75 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 11.1 m -133.49 122.61 23.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.638 -0.664 . . . . 10.0 112.281 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.77 117.75 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.991 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.55 110.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.679 -0.237 . . . . 10.0 110.593 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -118.01 120.12 4.63 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.383 -0.437 . . . . 10.0 112.331 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -135.05 127.39 30.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.829 -0.218 . . . . 10.0 111.525 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.48 83.6 1.12 Allowed Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.174 -0.536 . . . . 10.0 113.631 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . 0.543 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 5.8 mp0 53.28 32.96 14.48 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.945 0.498 . . . . 10.0 111.799 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.7 t -75.94 147.98 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.143 0.497 . . . . 10.0 110.85 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . 0.416 HH22 ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.89 113.35 15.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.793 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.508 ' HA ' HG13 ' E' ' 239' ' ' VAL . 47.4 t -101.16 110.58 28.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 10.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.87 106.59 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.483 ' HB ' HD13 ' D' ' 241' ' ' LEU . 18.1 mm -105.18 89.98 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . 158.7 -169.72 35.13 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.875 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -107.98 167.77 9.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.622 0.249 . . . . 10.0 110.715 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.21 140.79 52.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.548 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.06 114.05 13.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.079 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . 0.513 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 162.99 163.69 16.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.363 -0.923 . . . . 10.0 112.734 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -97.45 58.38 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.508 -0.854 . . . . 10.0 112.255 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . 0.407 ' HE3' ' HA2' ' C' ' 285' ' ' GLY . 39.2 tttm -116.72 12.74 14.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.236 0.541 . . . . 10.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.31 -50.25 4.16 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.665 -0.698 . . . . 10.0 113.077 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . 0.483 ' CE1' HG21 ' E' ' 244' ' ' VAL . 1.6 t80 -170.27 157.48 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.53 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 25.3 t90 -60.75 -62.91 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.706 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 288' ' ' ASP . . . . . 0.53 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 7.7 t70 -146.12 124.53 12.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.165 0.507 . . . . 10.0 110.098 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.76 172.45 12.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 10.0 109.847 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -101.33 -51.25 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 111.042 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -156.68 -173.09 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.701 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -100.3 -159.21 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.207 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -76.06 103.37 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 10.0 110.374 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -103.81 175.08 5.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.537 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.574 -0.727 . . . . 10.0 109.57 179.786 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' E' ' 261' ' ' THR . 76.4 mtt180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 18.6 m120 -133.02 110.99 10.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.206 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 7.0 m -118.08 145.13 45.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 10.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.76 125.68 25.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.793 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.668 ' HB2' ' O ' ' E' ' 265' ' ' LYS . 42.1 mttm -77.09 -70.14 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.53 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' E' ' 266' ' ' THR . 13.3 t70 -129.73 129.79 44.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.355 -0.384 . . . . 10.0 111.367 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.53 126.08 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.256 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -117.09 110.65 18.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 10.0 110.269 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.441 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 1.4 p -125.14 103.77 8.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.428 -0.805 . . . . 10.0 111.186 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -132.95 154.7 50.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 10.0 111.848 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' E' ' 271' ' ' GLY . 33.7 tt0 65.45 76.1 0.34 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.469 -0.787 . . . . 10.0 111.067 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 56.59 71.04 0.59 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.221 -0.899 . . . . 10.0 110.455 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -127.49 159.7 33.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.168 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 139.04 38.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.531 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' D' ' 275' ' ' VAL . 2.7 p -132.28 124.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.135 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -126.16 125.34 42.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.541 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mp -119.62 100.64 7.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.395 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.99 -173.38 40.84 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.298 -0.721 . . . . 10.0 111.298 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -103.49 154.53 19.35 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.483 HG21 ' CE1' ' D' ' 286' ' ' PHE . 61.7 t -103.15 129.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.409 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.2 99.15 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 10.0 110.837 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' D' ' 282' ' ' GLY . 7.5 t -69.15 169.64 11.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.202 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.51 -21.09 62.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.822 0.344 . . . . 10.0 111.7 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.09 73.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.998 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.72 -163.46 0.19 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.295 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.46 107.95 20.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.213 -0.449 . . . . 10.0 109.863 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -77.74 81.93 4.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.046 0.45 . . . . 10.0 110.722 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.24 140.98 10.5 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.839 -0.619 . . . . 10.0 112.016 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 119.55 98.47 1.77 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.75 -0.738 . . . . 10.0 111.906 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.67 -27.56 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.266 0.555 . . . . 10.0 110.471 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.05 59.23 5.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.405 0.621 . . . . 10.0 110.148 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 6.0 pt -86.09 123.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 257' ' ' SER . . . . . 0.474 ' HA ' ' NE2' ' D' ' 259' ' ' GLN . 67.0 m -152.96 166.61 31.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.672 -0.24 . . . . 10.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.38 117.76 9.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.851 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.49 16.29 8.23 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.35 0.5 . . . . 10.0 112.35 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -152.34 136.86 16.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.09 -0.381 . . . . 10.0 110.932 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 31.4 m -121.97 112.88 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.175 0.512 . . . . 10.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . 0.434 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 15.7 m120 -115.41 114.87 25.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.832 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.1 m -118.82 121.07 39.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 10.0 109.977 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -108.96 147.12 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 10.0 110.112 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 265' ' ' LYS . . . . . 0.668 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 82.6 mttt -85.88 -79.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' E' ' 230' ' ' ASP . 13.0 m -131.07 132.08 44.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.875 0.369 . . . . 10.0 111.143 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 t -121.98 106.21 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.967 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.53 125.89 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.663 -0.244 . . . . 10.0 110.549 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -145.47 136.67 6.6 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.545 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.89 130.37 22.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . 0.473 ' H ' ' HB3' ' E' ' 235' ' ' GLU . . . 84.17 85.93 0.89 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.555 -0.831 . . . . 10.0 111.82 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 60.55 60.82 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 10.0 110.85 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.68 136.06 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.701 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.63 104.25 8.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.911 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.28 120.21 58.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.853 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.98 119.94 29.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 28.1 mm -117.75 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 10.0 110.981 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.15 -176.22 34.42 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.499 -0.641 . . . . 10.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -91.63 139.91 30.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.877 -0.416 . . . . 10.0 109.877 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.86 159.83 15.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.333 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -169.64 99.6 0.32 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.275 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.9 -114.56 1.43 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.549 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 283' ' ' GLY . . . . . 0.509 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 166.64 58.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.313 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -137.88 -59.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.443 0.163 . . . . 10.0 110.781 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.62 13.19 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.358 -0.925 . . . . 10.0 113.824 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -152.76 114.35 4.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.161 0.481 . . . . 10.0 109.795 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 73.16 10.92 5.15 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.81 0.814 . . . . 10.0 109.302 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -145.88 -179.9 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.546 -1.206 . . . . 10.0 109.173 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -161.55 137.13 7.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.188 -0.301 . . . . 10.0 110.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 290' ' ' HIS . . . . . 0.509 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 7.3 p-80 -150.33 169.45 21.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.397 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -76.65 -70.76 0.43 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.303 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 292' ' ' HIS . . . . . 0.444 ' HB2' ' NE2' ' E' ' 290' ' ' HIS . 13.7 t60 69.46 153.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.21 0.604 . . . . 10.0 111.615 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -127.08 112.2 14.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.189 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -95.3 -176.25 3.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.761 -0.637 . . . . 10.0 109.807 179.57 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 110.494 -0.188 . . . . 10.0 110.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -117.34 127.16 53.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 263' ' ' SER . 13.4 m -149.16 159.43 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 10.0 111.428 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.15 162.4 35.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.004 -0.544 . . . . 10.0 109.996 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -121.37 -75.46 0.59 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 10.0 111.844 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 266' ' ' THR . 29.0 t70 -113.51 117.47 31.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.866 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 31.8 pt -136.0 144.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.525 -0.307 . . . . 10.0 111.096 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -142.26 126.95 18.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.092 0.472 . . . . 10.0 110.93 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 21.0 p -121.79 113.28 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.271 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.47 158.65 37.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 10.0 111.4 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.49 71.76 0.55 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.427 -0.806 . . . . 10.0 111.908 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 34.9 mtm105 56.63 42.5 26.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 10.0 111.908 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -103.4 153.23 20.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.282 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -134.41 160.49 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.511 -0.313 . . . . 10.0 111.069 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 138.59 23.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -135.3 122.04 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 10.0 109.935 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.47 133.69 53.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.768 0.318 . . . . 10.0 110.253 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 140.97 -119.17 1.49 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.204 -0.522 . . . . 10.0 112.281 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -147.42 143.78 28.17 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.78 107.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.848 0.356 . . . . 10.0 111.362 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.93 120.2 50.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.561 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 m -85.67 151.6 23.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.619 . . . . 10.0 109.907 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.68 -14.89 60.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -87.11 -1.88 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.002 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -119.59 52.99 1.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.265 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.416 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 2.7 mm? 65.96 -158.07 0.26 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.102 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.416 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 44.3 p-80 -93.09 178.91 5.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.995 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -80.62 69.03 3.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.483 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.63 68.33 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.238 -0.745 . . . . 10.0 111.238 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.5 mt 70.51 144.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.259 0.623 . . . . 10.0 112.477 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.19 60.56 1.17 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.3 -0.863 . . . . 10.0 111.153 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.73 -50.75 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.54 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.5 p -128.61 -83.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.848 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.5 t70 54.29 72.56 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.77 0.669 . . . . 10.0 110.615 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -119.18 24.24 10.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.95 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.673 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 4.4 t -139.21 140.91 37.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.35 0.595 . . . . 10.0 112.009 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -91.23 112.46 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.105 -0.952 . . . . 10.0 110.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.441 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 15.6 m-20 -115.46 113.53 23.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 227' ' ' SER . 37.3 m -142.95 124.76 15.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 10.0 110.957 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.8 152.57 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.774 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 -56.88 2.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.83 -0.348 . . . . 10.0 111.48 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 10.5 m -133.75 130.32 37.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.49 124.31 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.919 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 14.8 t -115.92 117.42 55.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.817 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.38 119.32 4.25 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.105 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -134.49 123.32 23.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.925 0.393 . . . . 10.0 111.361 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.91 70.05 1.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.714 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 25.7 tt0 54.83 51.0 14.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.469 0.652 . . . . 10.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.88 144.7 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.508 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -119.03 112.68 19.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.288 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.58 115.14 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.842 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 276' ' ' LEU . 0.8 OUTLIER -111.53 111.05 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.845 0.355 . . . . 10.0 110.251 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.41 ' HA ' ' HB2' ' B' ' 241' ' ' LEU . 15.1 mm -101.94 98.85 7.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.822 0.344 . . . . 10.0 110.147 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.72 161.09 8.59 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.016 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.43 152.06 36.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.639 0.257 . . . . 10.0 110.361 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -175.79 2.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.027 0.441 . . . . 10.0 111.04 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -158.26 97.17 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.459 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.04 -147.8 5.7 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.253 -0.975 . . . . 10.0 114.149 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -175.31 -83.93 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.746 -0.542 . . . . 10.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -81.92 81.39 7.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.248 0.547 . . . . 10.0 109.573 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 120.11 108.12 2.19 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.655 -0.978 . . . . 10.0 110.655 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -74.34 83.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.658 0.266 . . . . 10.0 110.724 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t90 69.11 -65.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.206 -0.906 . . . . 10.0 111.191 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -154.13 91.83 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.959 0.409 . . . . 10.0 110.838 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -156.84 129.8 7.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -147.9 85.9 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -118.25 137.52 52.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.231 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -132.55 14.01 4.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.558 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -89.4 134.52 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.841 -0.6 . . . . 10.0 110.28 179.615 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.673 ' N ' ' HG1' ' A' ' 260' ' ' THR . 25.3 ttm-85 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.069 -0.345 . . . . 10.0 110.069 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.415 HD21 ' HA2' ' B' ' 278' ' ' GLY . 33.2 m-20 -116.89 123.69 47.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.002 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -109.97 90.54 3.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.823 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -94.94 163.8 13.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.165 -0.47 . . . . 10.0 109.962 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' B' ' 265' ' ' LYS . 1.8 ttmm -125.09 -80.71 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.979 -0.288 . . . . 10.0 111.754 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -121.1 117.1 26.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.946 0.403 . . . . 10.0 111.273 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.85 123.16 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -118.28 113.49 21.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.717 0.294 . . . . 10.0 110.515 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.9 OUTLIER -116.71 113.52 22.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.711 -179.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.14 160.53 31.74 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.045 0.45 . . . . 10.0 111.813 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.63 74.35 0.4 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.19 -0.914 . . . . 10.0 112.456 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 21.4 mtm-85 55.06 39.78 31.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.2 0.524 . . . . 10.0 111.099 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -93.81 151.74 19.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.821 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 128.61 23.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.993 -0.549 . . . . 10.0 109.764 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.9 137.67 56.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.127 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -118.96 123.04 43.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 277' ' ' ILE . 4.4 mm? -96.66 87.85 4.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.412 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.441 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . 160.71 -178.63 36.63 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.587 -0.816 . . . . 10.0 112.315 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -89.81 163.33 15.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.597 0.237 . . . . 10.0 110.389 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.3 131.8 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.766 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.39 110.22 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.985 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 33.8 p -88.26 168.63 12.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.671 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.74 -5.1 14.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.512 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.43 -13.17 57.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 10.0 110.573 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.66 3.23 48.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.548 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.96 118.62 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.352 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 65.93 28.38 10.63 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.656 0.597 . . . . 10.0 111.355 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -106.76 -172.41 22.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.012 -0.613 . . . . 10.0 112.543 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.02 121.0 6.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.774 -0.53 . . . . 10.0 111.774 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 12.1 mt -104.27 -23.6 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.754 0.311 . . . . 10.0 111.699 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' C' ' 253' ' ' GLY . 14.6 tpt180 -93.22 91.59 7.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.909 0.385 . . . . 10.0 110.26 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.35 45.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.335 . . . . 10.0 111.296 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 60.14 33.51 21.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.048 -0.523 . . . . 10.0 111.394 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -63.24 131.95 50.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.383 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -156.81 76.38 0.87 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.206 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 3.7 t -151.95 161.63 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.063 0.459 . . . . 10.0 111.323 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -127.87 123.88 36.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.841 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.406 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 4.7 m120 -97.23 125.21 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 142.71 50.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.239 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.22 148.81 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 31.7 mttt -104.93 -77.41 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.457 -0.497 . . . . 10.0 111.973 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.17 119.07 38.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.259 0.552 . . . . 10.0 112.293 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.63 109.51 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.432 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 74.8 t -104.83 118.23 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.372 . . . . 10.0 110.658 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.57 133.06 8.19 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.351 -0.699 . . . . 10.0 111.351 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -145.16 122.35 11.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 10.0 111.719 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.28 78.79 1.42 Allowed Glycine 0 C--O 1.238 0.387 0 C-N-CA 120.639 -0.791 . . . . 10.0 113.347 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 55.27 36.48 27.12 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.286 0.565 . . . . 10.0 110.556 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.37 143.31 57.82 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.882 -1.053 . . . . 10.0 111.643 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -125.0 103.85 8.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.497 -0.774 . . . . 10.0 109.595 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.68 115.48 45.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.452 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 112.4 24.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 43.6 mm -101.83 81.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 10.0 110.231 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.415 ' HA2' HD21 ' B' ' 226' ' ' ASN . . . 159.18 178.88 33.59 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.007 -0.616 . . . . 10.0 112.336 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -92.93 160.85 14.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.41 172.18 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.961 0.41 . . . . 10.0 110.752 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 4.4 t80 -142.15 76.34 1.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.662 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -90.27 -137.75 6.99 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.677 -0.692 . . . . 10.0 113.248 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 156.42 -50.56 0.44 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.403 -0.679 . . . . 10.0 111.403 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -91.1 1.84 56.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 10.0 109.75 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -177.74 165.33 34.89 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.592 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -108.45 76.55 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.43 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 16.4 t90 70.41 -48.1 0.64 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.017 0.823 . . . . 10.0 111.397 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -117.62 178.24 4.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.91 117.55 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 10.0 110.784 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -139.66 132.46 29.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.438 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 291' ' ' HIS . . . . . 0.435 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 0.1 OUTLIER -157.55 118.23 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.022 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.9 -172.41 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -110.38 137.58 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 10.0 111.764 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 294' ' ' HIS . . . . . 0.411 ' CD2' ' H ' ' B' ' 294' ' ' HIS . 7.4 p80 -97.87 169.4 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.619 -0.718 . . . . 10.0 111.072 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 48.0 t60 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.629 -0.701 . . . . 10.0 110.416 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.577 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 29.8 ptt180 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.444 0.164 . . . . 10.0 110.678 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -126.52 127.08 44.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.463 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' C' ' 263' ' ' SER . 14.7 m -134.89 132.7 38.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 10.0 111.379 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.17 153.79 47.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.336 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -103.86 -77.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.762 -0.375 . . . . 10.0 111.635 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.1 118.36 35.8 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.254 0.549 . . . . 10.0 111.643 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.83 119.13 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.66 . . . . 10.0 109.985 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -108.03 116.99 32.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.535 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.527 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 0.6 OUTLIER -131.43 102.16 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 10.0 110.781 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -132.91 164.2 27.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.232 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 64.72 71.15 0.47 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.439 -0.801 . . . . 10.0 111.041 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 56.39 65.31 1.45 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 121.327 0.584 . . . . 10.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.75 163.45 25.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.43 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -149.79 143.77 25.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.557 HG23 ' HB ' ' C' ' 275' ' ' VAL . 3.2 p -136.38 135.05 49.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.636 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -118.57 123.11 44.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.584 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.431 HD13 ' HB ' ' C' ' 277' ' ' ILE . 4.2 mm? -96.59 76.58 2.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.578 -0.737 . . . . 10.0 109.632 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' B' ' 262' ' ' ASN . . . 172.55 170.21 36.07 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.252 -0.975 . . . . 10.0 112.212 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -81.6 162.88 22.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.013 -0.366 . . . . 10.0 110.013 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.98 119.67 61.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 10.0 110.736 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.3 t -113.94 109.13 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 39.4 p -80.56 163.73 23.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.541 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 2.67 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.272 0.471 . . . . 10.0 112.272 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.54 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 10.0 110.514 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -84.61 77.3 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.716 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 5.0 mt -112.31 15.36 20.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.387 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -120.89 111.19 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.139 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.42 -113.45 0.3 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.766 -0.73 . . . . 10.0 111.936 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 253' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' B' ' 255' ' ' ARG . . . 128.03 -127.57 5.77 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.812 -0.709 . . . . 10.0 111.498 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.1 tt -152.56 120.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.273 0.559 . . . . 10.0 111.122 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -166.32 133.78 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.639 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -107.22 132.53 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.57 -0.286 . . . . 10.0 110.234 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.43 -169.98 1.74 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.16 141.52 22.97 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.0 0.429 . . . . 10.0 110.951 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.67 146.79 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.716 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 6.1 t -75.77 149.27 38.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.703 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 0.5 OUTLIER -115.83 128.43 55.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.514 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.99 129.72 44.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.786 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' C' ' 227' ' ' SER . 5.7 m -143.26 150.61 39.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.746 0.308 . . . . 10.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.56 144.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.267 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 265' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 23.6 ttmt -88.49 -66.32 0.93 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.424 0.528 . . . . 10.0 112.424 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 23.7 m -130.38 124.9 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.82 123.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.487 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 64.2 t -115.63 114.71 47.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.66 -0.246 . . . . 10.0 111.011 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.24 121.95 5.22 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.955 -0.64 . . . . 10.0 111.906 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -132.99 121.82 23.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 10.0 111.453 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.25 90.86 0.41 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.842 -0.694 . . . . 10.0 113.851 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 56.0 47.45 19.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.923 0.392 . . . . 10.0 111.372 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.25 152.61 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.146 0.498 . . . . 10.0 110.651 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.54 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 0.6 OUTLIER -137.91 117.32 12.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.138 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' C' ' 239' ' ' VAL . 17.3 t -111.73 124.38 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.892 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.503 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -119.58 112.47 19.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.763 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.431 ' HB ' HD13 ' C' ' 241' ' ' LEU . 41.0 mm -106.92 90.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.019 0.437 . . . . 10.0 109.933 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.35 -170.65 35.69 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.222 -0.751 . . . . 10.0 111.222 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.96 155.46 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.96 0.38 . . . . 10.0 110.353 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.94 140.91 51.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.968 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 25.1 t80 -129.86 112.81 13.93 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.304 -0.628 . . . . 10.0 109.304 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -165.85 163.0 36.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.357 -0.925 . . . . 10.0 112.483 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.61 1.89 30.66 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -86.86 36.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.102 0.477 . . . . 10.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.63 -83.43 1.4 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.982 -0.847 . . . . 10.0 110.982 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -164.29 -167.44 1.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.54 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 10.1 t90 -42.29 -48.83 5.06 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.861 0.726 . . . . 10.0 112.687 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 288' ' ' ASP . . . . . 0.494 ' OD1' ' HB2' ' C' ' 290' ' ' HIS . 0.0 OUTLIER -125.89 153.07 44.71 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.49 -0.484 . . . . 10.0 111.215 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 289' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -104.44 82.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.492 0.663 . . . . 10.0 110.787 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 290' ' ' HIS . . . . . 0.494 ' HB2' ' OD1' ' C' ' 288' ' ' ASP . 14.9 t-80 -112.53 -55.94 2.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.453 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 291' ' ' HIS . . . . . 0.445 ' HB2' ' NH2' ' D' ' 274' ' ' ARG . 0.7 OUTLIER -134.11 173.27 11.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 10.0 111.754 -178.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 292' ' ' HIS . . . . . 0.467 ' HB2' ' H ' ' D' ' 289' ' ' ASN . 17.1 t-80 52.36 88.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.866 -1.061 . . . . 10.0 113.155 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -94.16 178.7 5.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.298 -0.865 . . . . 10.0 109.377 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -62.24 110.08 1.52 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.987 0.422 . . . . 10.0 111.074 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 37.2 m80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.657 -0.687 . . . . 10.0 109.691 178.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.703 ' N ' ' HG1' ' C' ' 261' ' ' THR . 2.2 mpt_? . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.785 0.326 . . . . 10.0 110.438 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' D' ' 262' ' ' ASN . 2.7 m-20 -75.47 109.72 9.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.452 . . . . 10.0 110.189 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.66 146.85 52.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.519 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.48 143.2 51.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.164 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 44.4 tttm -90.06 -73.37 0.52 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.341 -0.391 . . . . 10.0 111.647 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.3 120.56 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.832 0.308 . . . . 10.0 111.832 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.54 121.13 58.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.819 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -116.7 114.04 23.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.662 -0.245 . . . . 10.0 110.51 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.1 p -118.42 100.85 7.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.675 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.38 148.51 42.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.09 0.472 . . . . 10.0 111.922 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 62.56 84.84 0.14 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.076 -0.965 . . . . 10.0 112.218 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . 0.484 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 40.8 mtt180 67.92 -8.81 0.51 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.739 1.014 . . . . 10.0 113.739 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -60.6 149.84 33.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.353 0.597 . . . . 10.0 112.314 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -139.25 153.98 47.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.281 -0.872 . . . . 10.0 109.687 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.09 140.17 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.645 0.26 . . . . 10.0 111.679 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -129.5 133.54 47.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.202 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' D' ' 277' ' ' ILE . 2.5 mm? -114.43 95.62 5.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.73 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . 0.499 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . 171.39 -119.61 0.8 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.915 -0.659 . . . . 10.0 112.686 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -153.51 158.03 40.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.86 109.91 30.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.247 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 19.3 t -111.48 114.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 68.9 p -78.07 164.89 24.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 10.0 110.816 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.64 -4.51 34.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.034 0.445 . . . . 10.0 111.1 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.5 12.94 13.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 10.0 111.044 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -121.82 105.62 10.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.632 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.44 -162.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.556 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.51 88.27 3.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.071 0.463 . . . . 10.0 111.224 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -157.17 46.88 0.48 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.239 -0.744 . . . . 10.0 111.239 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 105.89 24.09 7.12 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.925 -0.87 . . . . 10.0 110.925 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 6.8 tt -66.95 -19.11 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 112.144 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -92.81 63.16 3.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 10.0 110.388 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.01 -29.59 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 12.9 m 67.07 -168.09 0.2 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.747 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 258' ' ' ASP . . . . . 0.423 ' CG ' ' HD3' ' D' ' 225' ' ' ARG . 11.5 m-20 -78.4 100.84 6.97 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.943 -0.392 . . . . 10.0 109.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 259' ' ' GLN . . . . . 0.639 ' HA ' HE21 ' D' ' 259' ' ' GLN . 0.1 OUTLIER -82.37 -70.55 0.54 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 11.0 t -113.27 160.63 18.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.93 0.395 . . . . 10.0 110.551 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 5.8 m -106.23 96.59 6.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 6.4 t30 -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.83 0.347 . . . . 10.0 110.088 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.21 125.39 40.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.93 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.55 143.53 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 265' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 0.0 OUTLIER -97.1 -50.1 4.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -128.45 122.02 30.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.64 125.16 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.013 -0.54 . . . . 10.0 109.687 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.18 127.45 74.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.812 0.339 . . . . 10.0 110.913 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.4 2.67 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -130.22 121.18 25.7 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.96 0.41 . . . . 10.0 111.281 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.04 66.28 1.04 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.65 -0.786 . . . . 10.0 112.76 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . 0.484 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 8.1 tt0 56.81 56.29 5.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.417 0.627 . . . . 10.0 111.552 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 45.7 t -92.13 155.73 17.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.027 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . 0.445 ' NH2' ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.31 109.95 12.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.027 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.47 ' HA ' HG13 ' E' ' 239' ' ' VAL . 32.1 t -101.22 113.69 38.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.927 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -116.93 106.39 13.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.035 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.454 ' HB ' HD13 ' D' ' 241' ' ' LEU . 10.7 mm -102.05 71.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.063 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . -175.12 -167.97 35.06 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.642 -0.79 . . . . 10.0 112.266 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -114.4 166.91 11.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.484 -0.191 . . . . 10.0 110.484 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.71 147.26 48.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 10.0 110.697 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -137.91 105.14 5.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.029 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 168.8 173.72 36.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.832 -1.175 . . . . 10.0 113.516 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -96.53 43.84 2.04 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.777 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -91.97 -19.33 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 10.0 109.728 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.91 -45.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.097 -0.801 . . . . 10.0 111.097 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -169.25 143.17 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.244 -0.478 . . . . 10.0 109.762 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -54.98 -64.94 0.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.409 0.443 . . . . 10.0 111.65 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -140.64 108.7 5.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.091 0.472 . . . . 10.0 110.668 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 289' ' ' ASN . . . . . 0.467 ' H ' ' HB2' ' C' ' 292' ' ' HIS . 8.7 t-20 -132.43 165.4 24.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.061 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -92.2 -64.68 1.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.669 0.271 . . . . 10.0 111.072 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -135.94 -170.02 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.688 -0.233 . . . . 10.0 110.419 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -105.28 -158.01 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -74.23 121.36 21.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.717 0.294 . . . . 10.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -133.98 -174.73 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 63.2 m80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.627 -0.701 . . . . 10.0 110.463 179.744 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 23.4 m120 -113.65 134.95 54.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' E' ' 263' ' ' SER . 18.2 m -143.55 137.17 28.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.763 0.316 . . . . 10.0 110.512 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.9 146.11 50.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.19 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' E' ' 265' ' ' LYS . 35.6 tttm -95.71 -69.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.482 -0.326 . . . . 10.0 111.818 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -128.5 124.89 37.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.509 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.4 120.56 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.524 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -116.41 116.25 27.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.165 0.507 . . . . 10.0 111.214 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.683 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 29.2 p -112.68 111.41 22.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.146 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -122.59 138.72 54.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.97 87.2 0.12 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.467 -0.788 . . . . 10.0 112.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 48.81 44.25 21.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.002 -0.999 . . . . 10.0 112.214 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.683 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -98.69 160.39 14.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.172 -0.467 . . . . 10.0 109.921 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . 0.407 ' CG ' ' HG3' ' E' ' 274' ' ' ARG . 0.0 OUTLIER -135.29 148.23 49.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.635 -179.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' D' ' 275' ' ' VAL . 2.5 p -138.13 120.94 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.445 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -127.03 119.43 26.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.013 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.6 109.49 17.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . 0.456 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 161.13 -172.87 37.48 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.253 -0.499 . . . . 10.0 111.914 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -98.87 139.07 35.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 110.932 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -98.64 124.59 51.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.97 118.32 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.361 . . . . 10.0 111.058 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.462 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 14.2 t -72.06 173.66 8.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.076 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.56 70.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 10.0 111.229 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -69.11 -20.49 64.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.953 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.24 -159.98 0.26 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 66.7 mt -96.9 124.16 40.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -80.11 86.86 5.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 10.0 109.679 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 108.76 -152.24 17.01 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.899 -0.881 . . . . 10.0 110.899 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.26 80.06 0.36 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.221 -0.99 . . . . 10.0 111.871 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 52.3 mt -73.3 -29.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.119 0.485 . . . . 10.0 110.157 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.1 74.42 1.09 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.137 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 256' ' ' ILE . . . . . 0.418 ' HB ' ' OE1' ' D' ' 259' ' ' GLN . 9.2 pt -81.21 124.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 14.7 m -142.33 -179.81 6.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.067 0.46 . . . . 10.0 111.786 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.97 130.9 34.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.768 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -130.2 -58.62 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.1 t -69.56 139.18 53.71 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.375 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 35.8 m -113.93 110.81 20.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.719 -0.673 . . . . 10.0 109.797 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.91 120.85 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.081 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' E' ' 227' ' ' SER . 16.3 m -136.29 131.57 34.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.47 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.43 150.75 29.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.615 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 265' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' E' ' 229' ' ' LYS . 89.9 mttt -88.06 -88.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.788 0.292 . . . . 10.0 111.788 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 10.4 m -110.93 125.5 53.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 10.0 111.49 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 5.8 t -116.1 108.98 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.888 -0.596 . . . . 10.0 109.518 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.54 122.15 62.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.407 -0.36 . . . . 10.0 110.875 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.73 108.96 0.69 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.734 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -120.18 123.61 43.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.344 -0.243 . . . . 10.0 110.344 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.25 74.62 1.28 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.129 -0.558 . . . . 10.0 112.106 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 61.4 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.759 0.79 . . . . 10.0 110.997 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 39.0 m -139.02 141.83 38.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.21 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . 0.407 ' HG3' ' CG ' ' E' ' 238' ' ' ARG . 0.0 OUTLIER -114.98 97.76 6.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.154 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.27 104.16 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 10.0 109.708 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.05 114.02 23.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.608 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 34.0 mm -119.41 107.29 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.925 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 162.74 -125.67 1.44 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.395 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -138.24 129.15 26.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.913 0.387 . . . . 10.0 110.284 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 0.2 OUTLIER -92.43 138.45 31.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.327 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -171.7 92.99 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.978 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -132.07 -87.52 0.38 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.255 -0.974 . . . . 10.0 112.829 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 283' ' ' GLY . . . . . 0.454 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 148.18 38.23 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.199 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -121.77 -68.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.732 -0.275 . . . . 10.0 110.744 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.56 9.9 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.175 -1.012 . . . . 10.0 113.802 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 286' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' E' ' 287' ' ' TRP . 17.6 t80 -138.27 108.68 6.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.512 0.656 . . . . 10.0 109.595 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 287' ' ' TRP . . . . . 0.42 ' HB2' ' O ' ' E' ' 286' ' ' PHE . 0.7 OUTLIER 70.59 16.59 6.89 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -177.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 288' ' ' ASP . . . . . 0.614 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -161.14 172.81 16.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.089 -1.414 . . . . 10.0 109.357 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -172.3 158.82 4.54 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.746 -0.206 . . . . 10.0 110.539 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 290' ' ' HIS . . . . . 0.454 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 0.6 OUTLIER -155.51 -177.44 6.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -92.53 -70.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 10.0 112.102 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 10.9 t60 71.12 160.42 0.22 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.69 0.619 . . . . 10.0 111.364 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -96.98 119.27 35.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.409 -0.359 . . . . 10.0 110.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -105.66 154.02 21.02 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.613 -0.708 . . . . 10.0 110.847 -179.368 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.58 0.228 . . . . 10.0 110.776 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -112.22 128.43 56.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.799 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.606 ' O ' ' HA ' ' A' ' 263' ' ' SER . 30.1 m -152.15 159.06 43.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 10.0 111.495 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.56 43.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.142 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -102.54 -61.62 1.37 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.684 0.278 . . . . 10.0 111.262 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -136.74 131.84 33.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.833 0.349 . . . . 10.0 111.058 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.8 mt -127.07 128.32 70.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.835 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -114.75 99.26 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.214 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.7 122.09 46.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.731 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.84 160.81 41.83 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.705 0.288 . . . . 10.0 111.417 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.58 ' HB3' ' H ' ' A' ' 271' ' ' GLY . 7.6 tp10 63.89 72.06 0.47 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.455 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 236' ' ' ARG . 29.5 mtm-85 55.91 32.73 20.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.439 -0.8 . . . . 10.0 111.713 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.65 159.24 17.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.337 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -137.31 147.97 46.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.623 -0.262 . . . . 10.0 110.575 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.57 141.72 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.518 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -134.86 138.3 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.6 tp -125.14 128.79 48.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.932 0.396 . . . . 10.0 110.99 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.35 -110.09 0.75 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.63 -0.795 . . . . 10.0 112.856 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -156.76 156.6 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 57.5 t -125.47 121.78 61.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.798 0.333 . . . . 10.0 110.611 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.06 101.61 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.689 -0.485 . . . . 10.0 109.689 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 248' ' ' ALA . 94.2 m -74.09 145.37 44.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.823 -0.436 . . . . 10.0 109.823 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.23 8.66 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.685 ' H ' HG22 ' A' ' 246' ' ' THR . . . -80.29 -6.59 58.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.846 0.355 . . . . 10.0 110.935 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -121.05 38.82 3.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.327 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.3 mm? 72.81 -167.65 0.12 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.249 -0.887 . . . . 10.0 111.067 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -78.54 -174.61 3.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.615 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.92 71.07 2.64 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.995 -0.622 . . . . 10.0 112.487 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.15 -45.54 96.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.905 -0.665 . . . . 10.0 111.542 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 75.5 mt 70.33 138.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.314 0.646 . . . . 10.0 111.752 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 66.87 90.1 0.1 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.687 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.87 -45.04 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.813 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.89 -86.75 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 55.4 t0 60.22 79.64 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.389 0.614 . . . . 10.0 109.978 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.49 24.1 10.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.925 -0.579 . . . . 10.0 111.563 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 7.7 t -148.94 148.11 29.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.143 0.496 . . . . 10.0 111.476 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 118.54 30.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.849 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -115.09 105.82 13.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.389 -0.368 . . . . 10.0 110.157 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 227' ' ' SER . 70.7 m -140.32 135.16 31.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 10.0 110.78 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.93 145.99 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.766 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.17 -70.87 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.03 0.381 . . . . 10.0 112.03 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 125.29 47.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 10.0 112.581 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 16.9 t -121.15 119.81 60.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.756 -0.657 . . . . 10.0 109.579 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.88 119.89 60.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.701 0.286 . . . . 10.0 110.95 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.48 107.29 0.91 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.557 -0.617 . . . . 10.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -126.9 124.77 40.33 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.091 0.472 . . . . 10.0 111.187 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.58 ' H ' ' HB3' ' A' ' 235' ' ' GLU . . . 93.32 73.83 1.24 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.872 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 54.66 36.63 26.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.594 0.358 . . . . 10.0 111.846 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 8.1 m -86.46 150.18 24.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.226 0.536 . . . . 10.0 110.876 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -119.85 124.82 47.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.646 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.24 113.74 44.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.235 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.38 111.54 22.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.755 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.06 86.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.962 0.41 . . . . 10.0 109.919 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.23 170.92 22.67 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.216 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -92.99 151.83 19.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.737 0.303 . . . . 10.0 110.51 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.22 158.71 25.47 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.056 0.455 . . . . 10.0 110.817 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.11 101.27 5.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 10.0 108.942 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -151.22 165.91 30.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.789 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -137.92 -16.99 0.65 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.151 -0.547 . . . . 10.0 112.163 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -72.67 -37.0 68.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.252 0.548 . . . . 10.0 110.035 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -164.98 156.53 28.56 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.671 -0.972 . . . . 10.0 110.671 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -80.86 74.95 7.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.393 0.596 . . . . 10.0 110.671 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 21.4 t90 69.59 -58.36 0.52 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.089 0.868 . . . . 10.0 111.71 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -142.65 96.29 2.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.864 0.364 . . . . 10.0 110.646 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -166.3 125.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.085 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -150.56 21.11 0.82 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.511 0.672 . . . . 10.0 109.853 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -75.56 144.12 42.04 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.633 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.12 32.23 3.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.528 -0.76 . . . . 10.0 109.326 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -103.32 120.56 41.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.265 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -95.26 142.84 27.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.821 0.343 . . . . 10.0 110.425 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 p80 . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.051 179.361 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' B' ' 261' ' ' THR . 39.3 ttm180 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.481 HD21 ' HA2' ' B' ' 278' ' ' GLY . 85.0 m-20 -117.89 152.94 34.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 10.0 110.807 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 48.9 m -147.13 91.96 2.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.122 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -97.04 161.75 13.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' B' ' 265' ' ' LYS . 14.4 mttm -123.2 -72.53 0.68 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.008 -0.277 . . . . 10.0 111.741 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -127.74 114.19 16.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.148 0.499 . . . . 10.0 111.13 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 77.6 mt -118.62 123.83 72.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.886 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -118.67 124.27 46.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.419 0.628 . . . . 10.0 111.451 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 1.0 OUTLIER -123.58 123.26 40.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.948 -1.023 . . . . 10.0 110.135 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -138.48 162.95 33.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.472 -0.331 . . . . 10.0 110.904 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.71 62.77 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.249 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 60.16 26.62 16.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.607 0.595 . . . . 10.0 112.607 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -78.62 157.57 28.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.037 0.446 . . . . 10.0 110.923 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 135.48 35.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.522 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.16 138.92 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.972 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -126.4 131.77 51.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.093 0.473 . . . . 10.0 110.166 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.1 100.7 10.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.988 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.73 -177.99 29.29 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.299 -0.953 . . . . 10.0 112.477 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -95.8 157.96 15.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.401 . . . . 10.0 110.531 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.17 122.61 69.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.978 0.418 . . . . 10.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.25 124.71 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 72.8 p -93.75 174.02 7.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 10.0 112.022 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.17 -20.06 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.546 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.8 -19.33 57.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.284 0.564 . . . . 10.0 110.249 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -86.68 -4.05 59.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.342 -0.845 . . . . 10.0 110.398 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.62 118.14 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.739 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.84 62.47 1.05 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.839 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -135.19 -142.89 4.65 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.924 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.12 91.2 0.6 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.344 -0.702 . . . . 10.0 111.344 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 16.6 mt -79.59 -27.65 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.277 0.473 . . . . 10.0 112.277 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -116.55 111.24 19.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.944 0.402 . . . . 10.0 111.099 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 14.7 pt -137.03 40.83 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.23 50.1 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.428 -0.806 . . . . 10.0 111.44 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -84.98 63.85 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.554 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -92.69 103.72 16.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.574 . . . . 10.0 110.385 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.567 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 13.4 t -167.45 150.44 6.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 10.0 111.571 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 31.7 m -118.56 117.96 30.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.141 -0.936 . . . . 10.0 108.908 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -99.4 100.9 12.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.212 0.529 . . . . 10.0 110.387 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.5 m -106.12 143.32 34.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.931 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' C' ' 228' ' ' ALA . 12.2 p -148.67 144.28 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.642 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 20.6 mttt -94.41 -80.1 0.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.38 0.511 . . . . 10.0 112.38 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.06 125.59 53.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.592 0.59 . . . . 10.0 112.592 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 87.5 t -118.58 123.71 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.652 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 5.5 t -109.74 126.46 66.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.305 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.36 98.48 0.34 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.489 -0.645 . . . . 10.0 111.489 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -122.36 124.18 43.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.778 0.323 . . . . 10.0 111.258 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 98.36 58.92 0.94 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.565 -0.826 . . . . 10.0 112.849 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 57.07 37.68 28.77 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.051 0.541 . . . . 10.0 111.984 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 19.6 m -77.57 150.78 34.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.454 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.62 124.13 49.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 10.0 109.874 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.18 122.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.778 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -118.82 108.27 14.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.218 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.72 92.56 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.106 0.479 . . . . 10.0 110.004 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' B' ' 226' ' ' ASN . . . 155.93 -178.82 32.28 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.493 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -99.35 161.33 13.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.42 158.97 33.03 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.167 0.508 . . . . 10.0 111.091 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 1.0 OUTLIER -139.4 81.44 1.83 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.13 -0.941 . . . . 10.0 108.668 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.439 ' HA2' ' OG1' ' B' ' 246' ' ' THR . . . -118.77 -98.54 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.749 -0.66 . . . . 10.0 113.067 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.02 -37.33 2.71 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.929 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -90.45 53.72 2.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.231 0.539 . . . . 10.0 109.688 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.97 132.92 4.95 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.799 -0.92 . . . . 10.0 110.799 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.543 ' CD2' HG11 ' C' ' 244' ' ' VAL . 16.6 m-85 -82.4 76.0 9.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.41 0.148 . . . . 10.0 111.075 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.442 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 18.9 t90 70.55 -51.28 0.66 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 124.06 0.85 . . . . 10.0 111.529 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.61 -172.07 1.96 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.5 0.19 . . . . 10.0 110.797 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.21 118.71 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.217 0.532 . . . . 10.0 111.287 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . 0.487 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 40.0 t60 -138.9 128.72 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . 0.517 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 15.5 t-160 -152.51 116.75 4.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.26 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -133.29 -176.14 4.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.082 0.468 . . . . 10.0 111.832 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -118.03 126.34 52.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.568 -0.742 . . . . 10.0 109.813 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . 0.49 ' CD2' ' H ' ' B' ' 294' ' ' HIS . 9.1 p80 -80.78 -139.6 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.469 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . 0.452 ' HB2' ' CE1' ' C' ' 291' ' ' HIS . 47.6 t60 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.404 -0.807 . . . . 10.0 110.013 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.567 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 13.8 ptt-85 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 6.4 m120 -128.22 141.04 51.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.039 0.447 . . . . 10.0 110.593 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.4 m -145.98 132.66 19.92 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -130.45 149.69 52.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.375 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' B' ' 265' ' ' LYS . 16.0 tttm -101.64 -67.34 0.87 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.241 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -124.24 120.33 31.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.835 0.35 . . . . 10.0 111.616 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.02 117.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.141 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.527 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 4.7 ttm180 -110.45 119.66 39.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.467 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.46 104.03 7.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.485 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.527 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 13.3 pt-20 -128.03 173.05 10.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.119 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 42.9 mt-10 62.36 64.26 0.97 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.489 -0.778 . . . . 10.0 110.532 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' C' ' 272' ' ' GLU . 7.3 ttp180 57.23 42.91 24.6 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.268 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.41 168.76 10.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.503 -0.317 . . . . 10.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.442 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 1.1 ptp180 -149.89 138.91 21.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.83 0.347 . . . . 10.0 110.387 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.5 138.13 52.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.286 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' B' ' 276' ' ' LEU . 2.8 tt0 -125.16 127.29 46.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.222 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' C' ' 277' ' ' ILE . 1.3 mm? -105.68 85.56 2.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.333 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.33 -169.65 42.41 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.225 -0.988 . . . . 10.0 112.34 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -100.19 155.06 17.96 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.099 -0.334 . . . . 10.0 110.099 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.543 HG11 ' CD2' ' B' ' 286' ' ' PHE . 41.3 t -109.77 118.64 57.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.456 -0.338 . . . . 10.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.2 t -111.74 110.51 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -81.81 166.35 20.07 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.976 -0.29 . . . . 10.0 110.43 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.78 5.1 1.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.68 -18.91 20.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.897 0.38 . . . . 10.0 110.335 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.52 88.07 5.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.104 0.478 . . . . 10.0 110.172 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 31.1 mt -127.25 8.59 6.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.747 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -124.46 105.36 9.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.238 0.542 . . . . 10.0 110.939 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -173.35 154.3 19.93 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.341 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.0 -171.19 13.13 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.564 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.0 tt -98.05 107.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.3 0.572 . . . . 10.0 110.398 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -139.94 118.74 12.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.804 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 tt -89.73 112.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 23.1 m -143.98 -172.7 3.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.065 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.0 146.53 39.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.072 0.463 . . . . 10.0 110.606 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.08 140.09 52.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.494 -0.775 . . . . 10.0 109.052 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.507 ' HA ' ' OD1' ' D' ' 258' ' ' ASP . 0.4 OUTLIER -60.29 139.52 57.57 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.611 0.72 . . . . 10.0 111.25 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.645 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 0.7 OUTLIER -99.13 106.54 18.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.402 -0.817 . . . . 10.0 110.64 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.7 t-20 -115.23 126.15 54.2 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -143.68 145.78 32.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.904 0.383 . . . . 10.0 111.14 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 p -127.52 143.67 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.258 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 265' ' ' LYS . . . . . 0.605 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 3.4 ttmt -85.57 -61.85 1.67 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.8 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 21.3 m -135.54 131.3 35.82 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.07 118.31 49.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.474 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' C' ' 232' ' ' ARG . 20.6 t -113.86 107.21 22.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.754 0.311 . . . . 10.0 110.555 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -110.3 130.05 9.67 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.16 -0.543 . . . . 10.0 112.066 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -135.02 124.52 24.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.809 0.338 . . . . 10.0 111.397 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 91.54 77.39 1.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 10.0 113.121 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' C' ' 236' ' ' ARG . 2.0 mt-10 52.33 33.82 13.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.904 0.482 . . . . 10.0 111.753 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.82 147.82 48.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.701 -0.682 . . . . 10.0 110.241 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -125.46 121.06 32.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.205 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.94 120.63 61.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.845 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.447 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -116.01 105.12 12.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.483 ' HB ' HD13 ' C' ' 241' ' ' LEU . 32.2 mm -101.55 91.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.167 0.508 . . . . 10.0 109.86 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.9 -173.05 35.17 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.303 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.47 149.23 22.92 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.075 -0.342 . . . . 10.0 110.075 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.9 138.59 48.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.935 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 1.9 t80 -120.39 102.02 8.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -141.77 173.57 23.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.54 -0.838 . . . . 10.0 112.538 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -126.39 -28.43 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.694 -0.765 . . . . 10.0 112.394 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -94.18 76.27 4.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 10.0 109.962 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 84.87 -113.77 3.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.154 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -151.48 -157.28 0.79 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 11.8 t90 -43.65 -53.47 5.72 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.598 0.561 . . . . 10.0 111.66 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . 0.487 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.4 OUTLIER -122.54 171.0 9.43 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.575 -0.45 . . . . 10.0 110.674 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -121.3 85.82 2.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.513 0.673 . . . . 10.0 111.064 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -117.93 -44.34 2.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.397 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' B' ' 295' ' ' HIS . 1.6 t-80 -142.55 171.3 14.24 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.906 0.335 . . . . 10.0 111.906 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 54.56 96.43 0.02 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.759 -1.11 . . . . 10.0 112.688 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -101.55 -164.83 1.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.386 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -71.02 146.28 49.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.452 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 63.1 m170 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.674 -0.679 . . . . 10.0 110.361 -179.585 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.645 ' N ' ' HG1' ' C' ' 261' ' ' THR . 1.1 tpm_? . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 121.042 0.448 . . . . 10.0 110.488 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' D' ' 262' ' ' ASN . 15.7 m120 -104.12 135.52 45.45 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.853 -0.795 . . . . 10.0 108.853 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . 0.459 ' HB3' ' CAF' ' B' ' 301' ' ' 3LS . 27.6 m -145.71 135.45 23.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.783 0.325 . . . . 10.0 111.014 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.47 131.46 43.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.011 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' C' ' 265' ' ' LYS . 85.2 tttt -81.52 -69.98 0.57 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.737 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 124.75 39.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.437 . . . . 10.0 111.824 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.47 126.78 71.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.368 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' D' ' 232' ' ' ARG . 3.7 mmm180 -118.21 121.04 39.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.6 -0.273 . . . . 10.0 110.384 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.452 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 2.2 p -125.27 117.14 23.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.745 0.307 . . . . 10.0 110.635 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -129.34 149.04 51.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.383 . . . . 10.0 111.8 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 67.21 80.6 0.21 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.116 -0.947 . . . . 10.0 112.658 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? 57.51 16.25 3.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.397 -0.82 . . . . 10.0 112.731 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -76.42 152.53 36.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.662 0.268 . . . . 10.0 111.022 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.86 154.32 48.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.199 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' D' ' 275' ' ' VAL . 2.4 p -139.57 136.21 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.875 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -122.95 129.4 51.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.403 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.509 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.6 mm? -112.42 90.73 3.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.597 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 177.5 -106.95 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.187 -1.006 . . . . 10.0 112.67 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -171.67 158.02 4.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.72 108.93 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.0 0.428 . . . . 10.0 111.335 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 17.6 t -104.72 108.39 24.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.581 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 72.6 p -87.05 162.05 17.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.009 -0.541 . . . . 10.0 111.983 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.62 -5.34 42.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.687 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -76.59 -9.21 58.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.386 0.612 . . . . 10.0 110.075 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -93.17 166.77 12.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.274 -0.876 . . . . 10.0 110.001 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' D' ' 250' ' ' LEU . 6.3 tp -155.09 -169.8 3.29 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -76.77 70.59 3.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 10.0 110.924 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -166.78 74.82 0.14 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 99.95 0.02 56.25 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.505 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.1 tt -62.23 -24.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.028 0.442 . . . . 10.0 111.505 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.81 70.67 9.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.498 . . . . 10.0 110.178 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 14.5 tt -58.42 -25.62 28.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.334 -0.848 . . . . 10.0 111.558 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m 63.38 -153.33 0.33 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.541 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . 0.639 ' CG ' ' HD2' ' D' ' 225' ' ' ARG . 1.3 m-20 -107.89 111.33 23.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.139 -0.319 . . . . 10.0 110.139 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -111.6 -87.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.332 0.493 . . . . 10.0 112.332 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.2 t -87.59 159.37 18.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.067 0.46 . . . . 10.0 111.455 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 17.1 m -110.25 123.14 49.26 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.866 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.491 ' HB2' ' ND2' ' D' ' 226' ' ' ASN . 15.2 m120 -114.5 107.89 16.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.77 -0.455 . . . . 10.0 109.77 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' D' ' 227' ' ' SER . 18.1 m -125.9 116.29 21.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.837 0.351 . . . . 10.0 110.862 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.52 143.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 265' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 17.4 mmtp -95.88 -52.92 3.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.048 0.759 . . . . 10.0 113.048 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.14 121.96 36.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.515 0.561 . . . . 10.0 112.515 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.74 113.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.683 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.28 125.29 74.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.832 0.349 . . . . 10.0 110.835 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -135.86 129.31 4.92 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.963 -0.562 . . . . 10.0 112.047 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -139.38 130.32 26.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.026 0.441 . . . . 10.0 111.433 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.34 81.39 0.79 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.294 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' E' ' 236' ' ' ARG . 1.4 tm-20 58.13 74.99 0.4 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.332 0.587 . . . . 10.0 110.193 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 4.0 m -125.85 140.38 52.7 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.437 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.77 121.4 36.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.402 ' HB ' HG23 ' D' ' 239' ' ' VAL . 58.8 t -104.75 114.35 44.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.932 -0.576 . . . . 10.0 110.064 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' D' ' 276' ' ' LEU . 0.6 OUTLIER -115.75 105.77 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.147 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.509 ' HB ' HD13 ' D' ' 241' ' ' LEU . 19.2 mm -108.61 95.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.883 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.7 -177.89 33.42 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.102 -0.57 . . . . 10.0 112.18 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.59 164.24 12.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.635 0.255 . . . . 10.0 110.404 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -126.71 134.22 50.73 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -125.4 118.36 25.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.543 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . 0.581 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 153.92 -178.13 31.0 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.282 -0.961 . . . . 10.0 113.405 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.21 47.75 1.01 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.766 -0.534 . . . . 10.0 111.766 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -92.82 4.84 53.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.461 0.648 . . . . 10.0 109.881 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 83.86 -56.52 5.05 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . 0.469 ' CE1' HG21 ' E' ' 244' ' ' VAL . 0.8 OUTLIER -172.88 143.0 1.17 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.488 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 44.0 t90 -48.75 -66.73 0.35 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.252 0.345 . . . . 10.0 111.787 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . 0.488 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 16.9 t0 -149.32 115.04 5.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.109 0.48 . . . . 10.0 110.302 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . 0.41 HD21 ' HB2' ' E' ' 287' ' ' TRP . 8.6 t-20 -136.02 173.8 11.31 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.671 . . . . 10.0 109.187 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -85.44 -56.95 3.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.528 0.204 . . . . 10.0 110.803 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -159.4 -168.52 2.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 10.0 111.216 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -92.54 -165.69 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.169 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -66.73 123.32 19.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.951 0.405 . . . . 10.0 110.378 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -108.43 160.24 16.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.309 -0.853 . . . . 10.0 109.797 179.595 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.565 0.221 . . . . 10.0 110.484 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -119.61 120.84 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.083 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.89 149.04 50.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.381 -0.372 . . . . 10.0 110.549 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 133.44 24.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.148 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -68.83 0.76 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.508 -0.315 . . . . 10.0 111.622 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' E' ' 266' ' ' THR . 28.4 t70 -124.69 125.3 43.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.098 0.407 . . . . 10.0 112.098 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 62.4 mt -128.49 124.05 61.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.113 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -120.76 121.02 37.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.781 0.324 . . . . 10.0 110.336 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.601 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 3.1 p -129.99 108.85 10.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.665 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.53 152.92 46.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.967 0.358 . . . . 10.0 111.967 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 66.18 79.89 0.23 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.527 -0.761 . . . . 10.0 112.114 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' D' ' 272' ' ' GLU . 13.2 ttp180 53.35 67.02 1.07 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.165 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' D' ' 273' ' ' SER . . . -129.99 162.28 29.04 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.169 -0.923 . . . . 10.0 110.675 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.54 146.77 28.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.349 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.44 HG22 HD12 ' E' ' 241' ' ' LEU . 4.4 p -127.28 122.99 61.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.359 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -120.52 118.51 30.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.775 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.44 HD12 HG22 ' E' ' 239' ' ' VAL . 1.1 mp -114.75 100.18 8.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.019 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . 0.55 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 169.73 -173.71 43.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . 0.579 ' HB2' ' OD1' ' E' ' 279' ' ' ASN . 5.7 p-10 -111.02 144.21 40.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.87 0.367 . . . . 10.0 110.262 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.469 HG21 ' CE1' ' D' ' 286' ' ' PHE . 55.1 t -98.5 130.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.987 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.77 110.6 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.529 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -61.0 164.05 5.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.011 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.12 -19.9 63.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.374 0.509 . . . . 10.0 112.374 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.29 -11.66 54.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.843 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.89 -155.56 0.29 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.943 -0.571 . . . . 10.0 111.137 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.34 142.56 27.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -82.36 62.59 6.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.44 0.638 . . . . 10.0 109.779 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 106.44 -170.23 16.2 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.1 80.55 1.54 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.477 -0.868 . . . . 10.0 111.901 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.54 -0.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.421 0.629 . . . . 10.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.26 73.32 0.98 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 10.0 110.489 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.8 pt -81.63 96.01 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 10.9 m -127.18 150.33 49.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.528 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.49 125.42 31.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.432 0.634 . . . . 10.0 110.245 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -124.94 46.12 2.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.575 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.1 t -149.21 141.47 24.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.002 0.429 . . . . 10.0 110.713 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 8.1 m -114.93 111.69 21.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.097 -0.502 . . . . 10.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -128.82 98.9 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.403 . . . . 10.0 110.465 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 9.9 m -107.83 117.55 34.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.173 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 15.5 t -100.32 126.57 53.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.415 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 265' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -82.61 -73.94 0.37 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.675 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' E' ' 230' ' ' ASP . 88.9 m -144.9 120.39 10.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.944 0.402 . . . . 10.0 111.435 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.15 121.38 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.088 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.3 t -116.08 128.85 73.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.146 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.26 124.37 3.04 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.047 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -124.91 111.75 15.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.032 0.444 . . . . 10.0 111.06 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.4 92.77 1.73 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.342 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 62.62 55.69 2.14 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.217 0.532 . . . . 10.0 110.38 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 127.1 42.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' E' ' 274' ' ' ARG . 5.8 mtm105 -119.8 106.96 12.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.003 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.1 111.67 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.37 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.68 106.58 11.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.125 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.4 mm -114.52 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.222 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 168.45 -135.3 3.56 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.381 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . 0.579 ' OD1' ' HB2' ' E' ' 243' ' ' ASN . 0.1 OUTLIER -118.97 137.57 53.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.722 0.296 . . . . 10.0 110.814 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 4.4 pt-20 -97.41 126.64 42.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' E' ' 244' ' ' VAL . 24.1 t80 -164.6 93.24 0.65 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.33 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.01 -90.8 0.4 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.279 -0.962 . . . . 10.0 112.964 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . 0.54 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 153.03 28.55 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.172 -0.537 . . . . 10.0 112.316 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.79 -65.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 10.0 110.862 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.95 23.47 1.16 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.373 -0.918 . . . . 10.0 113.219 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -152.31 106.76 3.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.143 -0.688 . . . . 10.0 109.143 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.41 ' HB2' HD21 ' D' ' 289' ' ' ASN . 0.8 OUTLIER 73.43 7.87 5.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.244 1.021 . . . . 10.0 108.345 -177.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.7 OUTLIER -154.14 169.69 22.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 113.619 -1.628 . . . . 10.0 107.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -159.62 163.93 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.764 0.316 . . . . 10.0 110.846 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . 0.54 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 1.6 p-80 -158.37 -179.76 8.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.505 -0.771 . . . . 10.0 109.784 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -85.88 -73.0 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 64.6 t60 70.9 155.52 0.15 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 123.953 0.783 . . . . 10.0 111.392 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -111.63 128.46 56.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.578 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.98 142.25 31.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.888 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 . . . . . 0 C--O 1.246 0.884 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.33 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' 3LS . . . . . 0.651 ' SAK' ' OAA' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.986 -0.375 . . . . 10.0 109.986 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -114.03 136.72 52.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.029 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.06 132.75 28.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.759 0.314 . . . . 10.0 110.946 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.3 164.32 17.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.192 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 265' ' ' LYS . 47.4 tttm -125.59 -69.09 0.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.848 0.356 . . . . 10.0 111.169 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -128.36 124.37 36.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.055 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.1 mt -136.72 131.55 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.334 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -129.38 111.69 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.206 0.527 . . . . 10.0 110.485 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -109.94 124.36 51.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.382 -0.826 . . . . 10.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -140.69 157.39 45.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.823 0.344 . . . . 10.0 111.375 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.8 72.64 0.44 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.484 -0.78 . . . . 10.0 111.514 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 56.57 35.97 26.87 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.315 -0.857 . . . . 10.0 111.703 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.6 149.24 22.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.121 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -132.97 145.71 51.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.922 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 2.6 p -136.81 125.29 34.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.194 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -125.57 130.96 52.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.868 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.21 122.74 48.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.416 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.515 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 144.64 -165.17 27.63 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.67 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -95.69 142.98 27.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 10.0 110.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.36 98.5 6.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.364 0.602 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.38 121.01 46.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 10.0 110.181 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 m -97.06 151.21 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.046 -0.525 . . . . 10.0 110.578 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.71 -12.89 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.112 0.482 . . . . 10.0 111.428 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -81.94 4.22 23.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.803 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -141.24 59.09 1.52 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.703 -0.68 . . . . 10.0 109.918 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 2.0 mm? 70.04 -160.12 0.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.425 -0.807 . . . . 10.0 111.415 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.4 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 29.5 p-80 -95.45 -174.42 3.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.54 2.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 10.0 112.294 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -61.71 -43.36 99.36 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.812 -0.515 . . . . 10.0 111.812 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 70.5 mt 71.98 133.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 122.996 0.519 . . . . 10.0 111.734 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 62.9 88.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.377 -0.828 . . . . 10.0 111.619 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.18 -56.31 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.773 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 3.1 p -118.33 -86.45 0.64 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.04 0.385 . . . . 10.0 112.04 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.6 t70 63.06 84.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.716 0.635 . . . . 10.0 110.289 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -129.16 13.51 6.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.081 -0.508 . . . . 10.0 111.342 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.74 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 4.9 t -145.29 134.98 23.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.377 0.608 . . . . 10.0 111.549 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -85.37 116.57 23.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.712 . . . . 10.0 109.58 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.409 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 61.9 m-20 -100.03 120.56 40.02 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.813 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.0 p -137.21 128.22 27.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.087 0.47 . . . . 10.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.93 136.21 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.809 -0.811 . . . . 10.0 108.809 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 229' ' ' LYS . 71.6 mmtt -93.12 -56.79 2.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.811 0.671 . . . . 10.0 112.811 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.77 128.91 44.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.706 0.632 . . . . 10.0 112.706 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.04 129.07 67.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.306 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.7 124.07 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.374 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.34 118.15 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.191 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -134.89 115.27 13.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.984 0.421 . . . . 10.0 111.15 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.15 79.65 1.47 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.697 -0.763 . . . . 10.0 113.485 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 59.0 29.28 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.487 0.551 . . . . 10.0 112.487 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 5.5 m -77.94 141.65 38.87 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.402 0.62 . . . . 10.0 111.563 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -119.26 120.23 36.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.761 . . . . 10.0 109.505 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 48.5 t -113.92 118.02 57.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.242 -0.436 . . . . 10.0 110.68 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.436 ' HA ' HD22 ' A' ' 276' ' ' LEU . 0.7 OUTLIER -117.93 116.55 27.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.404 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.24 95.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.75 160.39 9.48 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.686 -0.768 . . . . 10.0 112.069 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -77.18 148.94 35.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.74 0.305 . . . . 10.0 110.934 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 164.58 14.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.112 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -139.89 106.36 5.31 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.617 -0.719 . . . . 10.0 109.772 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -166.15 148.55 13.81 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.59 -0.814 . . . . 10.0 113.158 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -129.5 7.27 6.25 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.655 -0.784 . . . . 10.0 112.661 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -97.55 -13.35 21.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.516 0.674 . . . . 10.0 110.031 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.0 145.55 5.08 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.679 -0.968 . . . . 10.0 110.679 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -77.83 96.1 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.694 0.247 . . . . 10.0 110.618 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.407 ' CZ3' ' HB2' ' B' ' 238' ' ' ARG . 7.0 t90 67.9 -70.52 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.859 0.724 . . . . 10.0 111.158 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -167.07 96.22 0.5 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.667 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -162.67 119.24 1.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.318 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -122.36 106.01 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.996 -0.547 . . . . 10.0 109.701 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -116.55 143.57 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.288 -0.414 . . . . 10.0 109.948 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -153.55 21.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.835 -0.166 . . . . 10.0 111.359 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -127.53 124.85 39.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 10.0 111.581 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 154.48 41.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.288 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . 0.408 ' HB2' ' NH2' ' D' ' 236' ' ' ARG . 20.3 p-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.129 -0.939 . . . . 10.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.74 ' N ' ' HG1' ' A' ' 260' ' ' THR . 35.2 ttm180 . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.28 -0.267 . . . . 10.0 110.28 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -120.6 133.77 55.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.233 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' B' ' 263' ' ' SER . 16.3 m -130.85 111.33 12.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.915 0.388 . . . . 10.0 111.301 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -110.16 130.29 55.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.038 -0.528 . . . . 10.0 109.629 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.519 ' HE3' ' OBG' ' B' ' 301' ' ' 3LS . 0.0 OUTLIER -86.36 -68.92 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.92 120.43 16.05 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.964 0.412 . . . . 10.0 111.196 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.81 131.12 67.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 10.0 111.141 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' B' ' 232' ' ' ARG . 12.1 mmt85 -114.53 112.4 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.245 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.501 HG22 ' HB1' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -121.42 112.47 18.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.721 0.296 . . . . 10.0 110.974 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -133.13 150.72 52.02 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.439 -0.346 . . . . 10.0 111.507 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 67.89 81.04 0.2 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.443 -0.799 . . . . 10.0 113.128 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 32.8 mtm-85 54.99 22.95 4.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.196 0.598 . . . . 10.0 112.082 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.501 ' HB1' HG22 ' B' ' 233' ' ' THR . . . -80.08 154.27 28.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.043 -0.526 . . . . 10.0 111.338 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.407 ' HB2' ' CZ3' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -137.49 138.25 39.52 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.925 -0.579 . . . . 10.0 110.379 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.413 HG23 ' HB ' ' B' ' 275' ' ' VAL . 3.6 p -133.74 131.37 56.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.112 0.482 . . . . 10.0 110.662 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -120.97 131.17 54.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.345 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.487 HD13 ' HB ' ' B' ' 277' ' ' ILE . 3.4 mm? -104.88 104.6 14.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.474 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.409 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . 145.98 178.33 21.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.35 -0.929 . . . . 10.0 112.673 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -93.26 147.54 22.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.728 0.299 . . . . 10.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.54 131.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.675 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.44 113.46 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.104 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 44.4 p -90.28 171.37 9.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.381 . . . . 10.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.9 -10.23 51.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.2 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.82 -14.21 60.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.885 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.06 -6.71 57.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.221 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.38 114.11 3.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.535 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 23.4 t60 60.18 56.86 3.15 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.841 0.713 . . . . 10.0 110.533 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -136.34 -111.38 1.1 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.624 -0.717 . . . . 10.0 111.462 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -136.57 166.9 24.69 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.22 -0.752 . . . . 10.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 117.059 0.429 . . . . 10.0 111.057 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.416 ' HD2' ' OD2' ' B' ' 258' ' ' ASP . 0.6 OUTLIER -97.25 106.92 19.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.89 0.376 . . . . 10.0 110.639 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.4 HD11 HG11 ' C' ' 245' ' ' VAL . 4.3 pt -136.5 61.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.298 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.9 m 67.34 29.52 7.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.492 -0.776 . . . . 10.0 111.213 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.416 ' OD2' ' HD2' ' B' ' 255' ' ' ARG . 3.4 p-10 -81.14 79.41 7.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.569 0.699 . . . . 10.0 111.027 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.89 85.81 2.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.622 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.9 t -138.17 176.82 8.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.032 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.9 m -140.02 113.27 8.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.284 -0.416 . . . . 10.0 110.144 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -100.59 121.74 42.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.901 0.382 . . . . 10.0 110.695 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 227' ' ' SER . 1.9 m -134.54 137.03 43.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.48 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.6 p -137.41 138.87 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.505 -0.316 . . . . 10.0 110.347 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 23.4 mttt -86.46 -80.9 0.23 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.82 120.77 42.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.928 0.714 . . . . 10.0 112.928 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.2 t -115.99 105.32 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.538 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.24 113.19 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.464 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.07 134.09 9.05 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.44 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -144.81 141.06 28.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.317 -0.253 . . . . 10.0 110.317 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.73 69.07 1.43 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.198 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 59.87 42.18 16.81 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.797 0.439 . . . . 10.0 111.659 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.5 t -69.41 137.52 52.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.185 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -115.66 102.16 9.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.015 -0.539 . . . . 10.0 109.63 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' B' ' 239' ' ' VAL . 7.7 t -102.06 122.26 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.843 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.437 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -119.77 115.25 23.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.268 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.487 ' HB ' HD13 ' B' ' 241' ' ' LEU . 13.0 mm -104.5 83.57 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.819 0.342 . . . . 10.0 110.634 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.03 174.34 27.61 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.285 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -90.22 164.7 14.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.61 165.27 19.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.899 0.38 . . . . 10.0 110.099 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 2.4 t80 -143.58 78.94 1.61 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.334 -0.848 . . . . 10.0 108.834 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -112.62 -122.75 4.05 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.694 -0.765 . . . . 10.0 113.162 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 155.31 -61.95 0.36 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.303 -0.719 . . . . 10.0 111.303 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -83.67 74.49 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.58 121.15 3.85 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.388 -1.085 . . . . 10.0 110.388 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -83.49 79.27 9.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.939 0.37 . . . . 10.0 111.327 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.437 ' CZ2' ' HB2' ' B' ' 276' ' ' LEU . 21.0 t90 71.28 -48.28 0.67 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.199 0.937 . . . . 10.0 112.255 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -127.7 -175.62 3.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.899 0.381 . . . . 10.0 110.432 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -92.71 131.84 37.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.998 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -164.34 91.24 0.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.12 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -130.09 130.14 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.03 -0.532 . . . . 10.0 109.632 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.93 -173.08 4.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.588 0.232 . . . . 10.0 111.133 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -111.81 132.45 54.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.98 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -87.15 -177.01 5.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.437 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.285 -0.864 . . . . 10.0 110.134 179.731 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.582 0.229 . . . . 10.0 110.409 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.441 ' HB3' HG22 ' C' ' 277' ' ' ILE . 15.5 m120 -126.51 103.4 7.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 133.51 52.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.13 0.491 . . . . 10.0 111.871 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -130.11 122.28 27.97 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.037 -0.727 . . . . 10.0 109.037 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' C' ' 265' ' ' LYS . 48.8 tttm -82.69 -80.87 0.16 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.395 0.517 . . . . 10.0 112.395 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' C' ' 266' ' ' THR . 0.2 OUTLIER -109.39 122.27 47.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.268 0.556 . . . . 10.0 111.835 -178.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.442 HD11 ' HB1' ' C' ' 228' ' ' ALA . 88.4 mt -127.65 137.76 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.811 -0.632 . . . . 10.0 110.474 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.472 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 40.0 ttm-85 -128.76 119.51 24.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.402 ' C ' ' HB3' ' C' ' 237' ' ' ALA . 0.7 OUTLIER -127.92 93.57 3.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.049 0.452 . . . . 10.0 110.355 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.472 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 6.1 pt-20 -120.01 158.68 26.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.743 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 65.68 73.17 0.4 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 10.0 111.354 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 59.31 36.62 23.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.262 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.402 ' HB3' ' C ' ' C' ' 233' ' ' THR . . . -100.3 156.47 17.21 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.276 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -145.82 150.56 36.4 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.664 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.56 131.16 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.828 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.418 ' HB3' HD22 ' C' ' 276' ' ' LEU . 8.6 tt0 -115.81 127.16 54.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 10.0 109.958 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.478 HD23 HD13 ' B' ' 277' ' ' ILE . 3.7 mm? -102.11 88.25 3.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.808 -0.633 . . . . 10.0 109.774 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.48 171.6 31.89 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.168 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -84.34 152.58 24.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.779 0.323 . . . . 10.0 110.324 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.12 118.26 56.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.791 0.329 . . . . 10.0 110.939 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 46.6 t -121.06 110.91 29.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.031 0.443 . . . . 10.0 110.2 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.9 p -82.6 160.4 22.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.827 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.89 -4.74 7.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.495 -0.321 . . . . 10.0 111.76 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.41 -15.87 44.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.188 0.518 . . . . 10.0 110.242 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -100.01 94.15 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.496 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.02 20.97 13.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.338 0.59 . . . . 10.0 109.834 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -111.15 144.18 40.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.04 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.18 134.4 3.31 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.086 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.55 171.74 14.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.921 -0.657 . . . . 10.0 111.493 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.3 tp -87.17 115.74 28.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.146 0.498 . . . . 10.0 109.746 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -160.28 149.81 17.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.005 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 tt -95.32 130.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.131 0.491 . . . . 10.0 110.416 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 35.3 m -153.31 169.49 22.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.792 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' D' ' 257' ' ' SER . 0.5 OUTLIER -94.53 130.11 41.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.044 0.449 . . . . 10.0 110.108 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -115.72 145.45 42.76 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.345 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.5 t -55.24 135.84 49.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.317 0.579 . . . . 10.0 111.013 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 56.0 m -96.41 139.28 32.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.951 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 20.7 t-20 -133.65 140.34 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.674 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -154.01 139.17 17.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.802 0.334 . . . . 10.0 110.126 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.39 147.15 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 265' ' ' LYS . . . . . 0.647 ' HE3' ' OBK' ' B' ' 301' ' ' 3LS . 1.1 mtpt -85.46 -58.84 2.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.432 . . . . 10.0 112.097 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 39.9 m -141.58 128.0 20.01 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.464 0.542 . . . . 10.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.25 117.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.638 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.24 109.51 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.107 0.48 . . . . 10.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.51 138.81 15.02 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.797 -0.716 . . . . 10.0 111.667 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -147.25 125.6 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.912 0.356 . . . . 10.0 111.493 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.44 82.99 0.99 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.921 -0.656 . . . . 10.0 113.465 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 60.55 23.68 13.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.86 0.362 . . . . 10.0 111.377 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.18 136.82 57.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.204 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -128.07 109.91 11.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.525 -0.761 . . . . 10.0 109.825 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 37.7 t -100.45 133.82 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.759 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.4 OUTLIER -127.71 111.14 13.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.088 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.441 HG22 ' HB3' ' C' ' 226' ' ' ASN . 35.3 mm -105.04 95.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.379 . . . . 10.0 110.221 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.67 -171.23 33.65 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.254 -0.738 . . . . 10.0 111.254 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.24 148.1 30.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 10.0 109.801 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -106.95 142.32 36.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 111.084 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -129.31 104.32 7.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.501 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -173.93 175.83 46.45 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.684 -0.77 . . . . 10.0 112.134 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.29 -8.71 24.9 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.541 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.67 63.58 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.166 0.508 . . . . 10.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.48 -84.74 1.07 Allowed Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.892 -0.595 . . . . 10.0 112.064 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -168.42 -51.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.417 ' CH2' ' HB2' ' C' ' 276' ' ' LEU . 8.6 t90 -144.85 -67.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . 0.443 ' OD2' ' HD2' ' D' ' 238' ' ' ARG . 2.1 p30 -107.13 165.28 11.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.066 -0.516 . . . . 10.0 109.784 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -114.65 50.65 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.916 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -79.85 -53.19 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.473 . . . . 10.0 111.811 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.13 172.24 10.7 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.954 -0.298 . . . . 10.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 66.53 173.8 0.24 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.022 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -177.85 -153.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.347 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -76.22 157.85 32.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.607 179.346 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' D' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.315 0.579 . . . . 10.0 110.372 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 12.5 m120 -99.23 138.8 35.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' D' ' 263' ' ' SER . 18.3 m -154.27 148.46 25.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.071 0.462 . . . . 10.0 111.086 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.45 134.09 31.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.802 -0.635 . . . . 10.0 109.732 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' C' ' 265' ' ' LYS . 12.6 tmtt? -86.13 -64.78 1.1 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.064 -0.255 . . . . 10.0 111.382 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.8 124.18 45.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.004 0.372 . . . . 10.0 112.004 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.45 HG21 HG21 ' D' ' 239' ' ' VAL . 55.3 mt -131.3 122.93 52.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -121.57 120.43 34.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.274 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.1 p -120.06 115.23 23.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.534 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -122.44 141.22 51.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.915 0.388 . . . . 10.0 112.029 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 62.18 90.01 0.08 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.981 1.104 . . . . 10.0 113.981 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . 0.671 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 29.8 mtt180 62.57 3.17 1.05 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.795 -0.639 . . . . 10.0 112.602 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.95 142.56 49.42 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.987 0.422 . . . . 10.0 111.408 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . 0.443 ' HD2' ' OD2' ' C' ' 288' ' ' ASP . 0.3 OUTLIER -133.68 150.07 51.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.412 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.45 HG21 HG21 ' D' ' 231' ' ' ILE . 2.5 p -136.55 137.21 47.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.883 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -115.57 140.7 48.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.375 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.459 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.9 mm? -123.7 75.77 1.37 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.054 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . 0.575 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . -171.19 -138.79 2.6 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.223 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -139.57 132.54 29.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.87 113.86 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.117 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.4 t -117.88 106.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.516 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 0.6 OUTLIER -81.52 158.69 24.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.229 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.87 -0.97 8.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.149 0.5 . . . . 10.0 111.38 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.95 -10.5 57.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.161 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.67 113.57 26.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.049 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 6.6 mp -111.35 -166.29 1.06 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.61 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -63.13 129.64 41.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.508 0.194 . . . . 10.0 110.6 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 133.66 50.6 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.026 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.39 18.18 8.26 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.432 -0.89 . . . . 10.0 112.593 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -74.26 -17.52 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.094 0.473 . . . . 10.0 111.314 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -104.69 88.48 2.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.976 0.417 . . . . 10.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 20.0 tt -82.59 -10.59 12.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.883 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' C' ' 258' ' ' ASP . 37.7 m 61.06 -133.72 0.67 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.042 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' D' ' 225' ' ' ARG . 2.0 t0 -122.98 137.09 55.05 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -138.57 -83.65 0.29 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.507 -0.477 . . . . 10.0 112.033 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 12.9 t -79.29 156.31 28.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.198 0.523 . . . . 10.0 111.657 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' D' ' 225' ' ' ARG . 23.3 m -111.24 118.94 37.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.231 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 4.0 m120 -120.52 106.41 11.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' D' ' 227' ' ' SER . 23.1 m -127.61 132.58 49.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 10.0 110.475 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' E' ' 228' ' ' ALA . 10.1 p -120.86 144.51 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.638 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 265' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 19.5 mmtp -82.86 -51.65 7.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.802 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 50.1 m -142.54 122.22 13.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.09 122.16 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.334 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.85 123.13 67.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.135 0.493 . . . . 10.0 111.083 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.49 134.32 10.27 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -138.4 115.05 10.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.202 0.501 . . . . 10.0 111.474 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.17 93.12 0.79 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.088 -0.577 . . . . 10.0 113.967 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . 0.671 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 52.8 mm-40 54.94 33.3 19.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.214 0.53 . . . . 10.0 111.527 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -75.78 144.54 41.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.737 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -127.49 103.25 7.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.248 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 62.4 t -98.73 117.89 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.49 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.456 ' HB2' ' CH2' ' D' ' 287' ' ' TRP . 0.6 OUTLIER -114.08 106.16 14.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.531 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.459 ' HB ' HD13 ' D' ' 241' ' ' LEU . 30.6 mm -102.43 86.36 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . 162.21 -171.41 38.09 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.527 -0.844 . . . . 10.0 112.365 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -113.02 162.74 15.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.275 -0.268 . . . . 10.0 110.275 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.77 142.97 49.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.362 . . . . 10.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -135.19 116.27 14.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.209 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . 0.516 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 152.29 166.28 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.481 -0.866 . . . . 10.0 112.422 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -83.98 71.57 2.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.52 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -117.1 -5.72 11.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.095 0.474 . . . . 10.0 110.292 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.94 -54.6 4.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.069 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -163.07 144.9 9.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.151 -0.315 . . . . 10.0 110.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' D' ' 276' ' ' LEU . 34.6 t90 -59.52 -63.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.244 0.34 . . . . 10.0 111.25 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . 0.495 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 60.1 t0 -146.03 115.29 7.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 10.0 109.97 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -142.87 161.83 37.08 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.146 -0.687 . . . . 10.0 109.146 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.93 -51.92 7.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.673 0.273 . . . . 10.0 110.7 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -156.57 -175.44 5.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.444 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -91.93 -151.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.851 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -64.18 119.55 10.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.807 0.337 . . . . 10.0 110.757 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -113.28 154.59 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.168 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.656 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' E' ' 261' ' ' THR . 93.3 mtt180 . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . 0.476 ' ND2' ' HB2' ' E' ' 262' ' ' ASN . 9.5 m120 -130.84 120.66 24.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.945 0.402 . . . . 10.0 111.14 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' E' ' 263' ' ' SER . 1.3 m -118.74 141.9 48.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.275 -0.42 . . . . 10.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' D' ' 264' ' ' VAL . . . -132.17 133.26 44.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.167 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' E' ' 265' ' ' LYS . 1.1 ttmm -91.25 -77.72 0.41 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.899 -0.32 . . . . 10.0 111.143 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.7 126.78 51.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 10.0 111.666 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 66.5 mt -132.82 124.03 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -122.15 109.82 14.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.537 . . . . 10.0 110.3 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.5 p -113.53 96.82 6.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.358 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . 0.401 ' HG3' ' HG2' ' E' ' 270' ' ' LYS . 5.3 pt-20 -117.07 152.22 35.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.025 0.441 . . . . 10.0 112.103 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 65.15 81.5 0.21 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.741 -1.118 . . . . 10.0 111.441 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 50.82 63.69 2.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.07 -0.968 . . . . 10.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.78 155.28 45.4 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.66 -0.7 . . . . 10.0 109.985 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . 0.495 ' HE ' ' CG ' ' D' ' 288' ' ' ASP . 0.1 OUTLIER -136.48 149.35 48.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.885 -178.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.09 127.12 32.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.92 -0.582 . . . . 10.0 109.982 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -120.75 128.11 52.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.589 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.4 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 1.0 OUTLIER -116.47 92.42 3.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.751 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 167.53 -165.31 38.56 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.765 -0.731 . . . . 10.0 112.172 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . 0.423 HD22 HG23 ' E' ' 245' ' ' VAL . 3.2 p-10 -103.44 150.18 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.953 0.406 . . . . 10.0 110.783 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.81 110.93 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.911 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . 0.423 HG23 HD22 ' E' ' 243' ' ' ASN . 86.3 t -123.17 112.09 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.096 0.474 . . . . 10.0 110.431 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.693 HG23 ' H ' ' E' ' 248' ' ' ALA . 14.5 t -76.02 179.4 5.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.72 -7.53 11.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.035 0.754 . . . . 10.0 113.035 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . 0.693 ' H ' HG23 ' E' ' 246' ' ' THR . . . -67.49 -30.85 70.65 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.754 -0.461 . . . . 10.0 109.754 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.96 -173.59 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.072 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 60.9 mt -89.48 123.51 33.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.889 -0.596 . . . . 10.0 109.618 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -63.96 -28.41 69.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.81 -167.48 25.45 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.003 -0.839 . . . . 10.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 85.88 92.56 0.85 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 10.0 112.238 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 35.0 mt -78.75 -31.77 15.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.626 . . . . 10.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . 0.416 ' HA ' ' NE ' ' E' ' 255' ' ' ARG . 0.4 OUTLIER -84.74 83.53 8.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.777 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.29 109.75 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 10.0 110.075 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 35.5 m -143.13 140.82 31.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.055 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -81.79 130.94 35.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.262 0.553 . . . . 10.0 110.338 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -108.42 -52.8 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.67 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.4 t -67.79 133.69 49.68 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.465 0.65 . . . . 10.0 111.319 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 94.9 m -121.69 113.11 19.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.694 -0.684 . . . . 10.0 109.889 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . 0.476 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 11.2 m120 -115.86 141.25 48.35 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.52 -0.764 . . . . 10.0 110.281 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' E' ' 227' ' ' SER . 73.3 m -142.22 133.34 26.07 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.34 138.31 49.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.183 0.516 . . . . 10.0 110.411 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 265' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' E' ' 229' ' ' LYS . 80.8 mttt -84.18 -60.79 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.211 -0.449 . . . . 10.0 112.144 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.5 m -135.92 123.71 22.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 t -120.23 111.23 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.403 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -114.39 110.51 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.758 0.313 . . . . 10.0 111.029 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.0 117.43 3.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.014 -0.613 . . . . 10.0 111.7 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . 0.401 ' HG2' ' HG3' ' E' ' 234' ' ' GLU . 0.0 OUTLIER -120.02 114.07 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.748 0.309 . . . . 10.0 111.519 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.0 90.54 0.4 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.819 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 60.76 85.77 0.11 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.178 0.513 . . . . 10.0 111.319 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.41 136.1 48.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.94 104.26 10.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.386 -0.598 . . . . 10.0 109.386 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.35 117.89 51.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.546 -0.297 . . . . 10.0 111.024 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.03 113.08 19.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.139 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' E' ' 226' ' ' ASN . 38.3 mm -107.65 87.5 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 166.56 -156.39 28.25 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.901 -0.666 . . . . 10.0 111.948 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -110.18 145.58 37.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.97 0.414 . . . . 10.0 110.293 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' E' ' 288' ' ' ASP . 0.7 OUTLIER -106.21 146.71 29.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.541 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -159.17 84.49 0.79 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.045 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.36 -104.92 1.31 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.239 -0.981 . . . . 10.0 113.19 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 154.36 59.95 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.204 -0.522 . . . . 10.0 111.916 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -135.45 -59.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.516 0.198 . . . . 10.0 110.726 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.5 19.1 1.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.55 -0.833 . . . . 10.0 113.65 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -156.13 113.86 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.397 0.599 . . . . 10.0 109.944 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 68.24 16.29 9.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.086 0.946 . . . . 10.0 108.799 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . 0.466 ' HA ' ' HG3' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -154.97 168.53 26.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.993 -1.458 . . . . 10.0 108.14 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -153.32 143.43 22.24 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.852 -0.339 . . . . 10.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . 0.424 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 2.2 p-80 -149.34 178.65 8.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.979 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -105.12 -62.96 1.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.679 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 t60 66.65 168.35 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.758 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -108.32 107.07 17.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.997 0.427 . . . . 10.0 110.003 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.02 132.31 42.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.765 -0.652 . . . . 10.0 110.72 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.773 0 CA-C-O 118.49 -0.767 . . . . 10.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' 3LS . . . . . 0.795 ' SAK' ' OBK' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.206 -0.294 . . . . 10.0 110.206 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -105.21 142.4 35.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.9 m -147.15 137.47 23.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.781 0.324 . . . . 10.0 110.624 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -140.87 151.93 44.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.321 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -112.46 -56.84 2.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -137.02 121.32 18.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.853 0.359 . . . . 10.0 111.378 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 54.2 mt -128.14 119.01 49.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.084 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -127.84 110.83 12.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.309 0.576 . . . . 10.0 110.532 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.95 127.16 51.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.555 -0.748 . . . . 10.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.73 176.94 8.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.426 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 60.53 66.9 0.88 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.077 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 57.8 65.44 1.32 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.901 -1.045 . . . . 10.0 110.94 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -131.81 178.68 6.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 238' ' ' ARG . 6.2 ptp180 -159.18 155.12 26.55 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.026 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.18 136.74 59.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.471 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -129.21 134.41 47.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 10.0 109.994 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.53 138.12 51.16 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.278 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.74 -123.1 2.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.312 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -143.91 141.71 30.4 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.556 -0.535 . . . . 10.0 109.556 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 41.8 t -105.41 110.52 31.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.216 0.531 . . . . 10.0 111.56 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.12 108.51 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.812 -0.631 . . . . 10.0 109.647 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.418 ' HB ' ' HA2' ' A' ' 282' ' ' GLY . 12.0 m -84.62 149.72 25.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.183 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.3 -14.17 16.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.282 0.475 . . . . 10.0 112.282 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.64 -13.3 56.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 10.0 110.904 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -106.94 25.31 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.431 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 3.9 mm? 70.95 -159.64 0.13 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.258 -0.883 . . . . 10.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.41 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 48.8 p-80 -76.86 169.63 17.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.235 0.541 . . . . 10.0 110.919 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -77.58 80.13 1.33 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.3 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.04 -36.6 93.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.218 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.8 mt 72.72 146.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.547 0.792 . . . . 10.0 111.68 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 61.85 87.54 0.1 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.984 -0.553 . . . . 10.0 111.286 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 20.7 mt -123.38 -67.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.96 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 p -101.34 -90.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.861 -0.154 . . . . 10.0 111.408 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.1 t0 56.1 69.1 0.77 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.706 0.628 . . . . 10.0 110.932 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -121.07 2.65 10.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 10.0 110.623 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -136.38 152.0 50.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.839 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.38 127.85 42.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.345 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -101.77 83.61 2.43 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -108.81 116.69 32.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.602 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 228' ' ' ALA . 14.2 p -119.81 140.31 44.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.7 mttm -91.84 -79.48 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.179 0.437 . . . . 10.0 112.179 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 128.73 54.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.06 119.54 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.456 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.7 t -117.73 125.27 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.774 0.321 . . . . 10.0 111.491 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -128.91 129.31 6.11 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.197 -0.525 . . . . 10.0 111.934 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -145.01 111.87 5.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.901 0.382 . . . . 10.0 111.339 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 99.16 82.57 1.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.867 -0.683 . . . . 10.0 112.952 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 52.17 50.59 18.11 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.506 0.669 . . . . 10.0 110.996 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 m -102.26 141.64 34.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.966 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -121.15 119.43 32.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.32 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 55.2 t -103.31 119.07 51.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.918 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 276' ' ' LEU . 1.4 tm? -114.15 103.6 11.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.36 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.529 HD13 HD23 ' B' ' 241' ' ' LEU . 8.8 mm -96.98 101.54 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.358 -0.383 . . . . 10.0 109.992 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 142.44 179.24 19.14 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.66 -0.781 . . . . 10.0 111.847 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.15 159.95 15.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.846 0.323 . . . . 10.0 110.642 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.96 156.86 39.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.447 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.86 86.97 2.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.325 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.418 ' HA2' ' HB ' ' A' ' 246' ' ' THR . . . -109.02 -145.83 11.4 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.353 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -174.35 -82.29 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -88.89 89.99 8.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.337 -0.986 . . . . 10.0 108.337 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 108.08 110.28 3.4 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.511 -1.035 . . . . 10.0 110.511 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -75.6 81.89 2.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.573 0.225 . . . . 10.0 110.916 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.5 t90 67.35 -69.6 0.13 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.145 0.903 . . . . 10.0 111.777 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.33 90.71 3.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.735 0.302 . . . . 10.0 110.749 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -155.42 136.38 13.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.561 -0.29 . . . . 10.0 110.772 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -157.93 34.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.068 -0.715 . . . . 10.0 109.068 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.22 132.13 36.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.836 -0.62 . . . . 10.0 111.52 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -137.16 15.87 3.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.639 0.733 . . . . 10.0 109.433 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -91.54 84.3 5.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.032 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -66.22 126.21 27.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.955 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.687 -0.673 . . . . 10.0 111.302 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.4 142.04 40.92 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.242 -0.651 . . . . 10.0 109.242 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.9 m -143.92 126.85 16.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.83 0.348 . . . . 10.0 111.091 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.18 134.95 47.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.405 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' B' ' 265' ' ' LYS . 50.9 mmtt -87.38 -59.39 2.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.451 -0.34 . . . . 10.0 111.776 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' B' ' 266' ' ' THR . 26.0 t70 -146.14 123.94 11.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.481 . . . . 10.0 110.869 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.06 130.61 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.06 113.05 24.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.455 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 1.3 p -124.06 114.12 19.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.653 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.23 156.05 48.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.971 0.415 . . . . 10.0 111.39 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 60.78 80.19 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.019 -0.991 . . . . 10.0 112.185 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 58.04 37.02 26.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.664 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.74 141.85 30.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 10.0 110.533 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.58 131.21 46.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.747 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.43 133.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.131 0.491 . . . . 10.0 111.093 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.686 ' HB3' HD22 ' B' ' 276' ' ' LEU . 17.1 tm0? -115.98 125.77 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.877 -0.601 . . . . 10.0 109.987 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.529 HD23 HD13 ' A' ' 277' ' ' ILE . 3.0 mm? -112.35 83.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.141 -0.482 . . . . 10.0 111.307 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 167.93 -177.27 42.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.169 -1.015 . . . . 10.0 112.938 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -90.06 139.63 30.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 10.0 110.201 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 92.7 t -104.6 114.22 43.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.496 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.9 t -119.71 106.5 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.978 0.418 . . . . 10.0 110.028 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 82.5 p -79.66 173.11 12.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.049 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.29 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 10.0 112.096 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.92 -21.59 50.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.784 0.326 . . . . 10.0 110.524 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.474 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . -93.71 17.95 11.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.25 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.69 106.0 3.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.883 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t60 65.06 82.39 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.954 0.784 . . . . 10.0 111.481 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -164.6 -135.87 1.9 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.915 -0.66 . . . . 10.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.17 127.61 6.14 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.294 -0.722 . . . . 10.0 111.294 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 36.3 mt -119.94 -33.23 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.048 0.451 . . . . 10.0 111.218 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.409 ' HD2' ' OD1' ' B' ' 258' ' ' ASP . 1.2 tpt180 -86.19 88.62 7.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.842 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt -120.37 54.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.569 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 m 65.92 38.25 5.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.615 -0.72 . . . . 10.0 110.332 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.409 ' OD1' ' HD2' ' B' ' 255' ' ' ARG . 2.0 p-10 -73.96 61.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.226 -0.897 . . . . 10.0 111.541 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -104.8 98.1 7.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.004 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 9.0 t -156.57 148.54 22.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.281 0.562 . . . . 10.0 111.326 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' C' ' 225' ' ' ARG . 0.1 OUTLIER -118.94 98.39 6.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.238 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -88.01 116.29 26.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' C' ' 227' ' ' SER . 0.0 OUTLIER -124.08 135.45 53.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.566 -0.743 . . . . 10.0 111.61 -178.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.18 135.79 49.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.274 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 0.5 OUTLIER -80.63 -73.93 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.508 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 0.6 OUTLIER -124.15 139.2 54.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 7.5 t -129.36 121.97 54.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.167 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.59 119.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.834 0.35 . . . . 10.0 110.984 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.85 117.55 3.19 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -134.45 119.48 18.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.75 0.275 . . . . 10.0 111.364 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.98 87.15 1.08 Allowed Glycine 0 C--N 1.329 0.15 0 C-N-CA 120.863 -0.684 . . . . 10.0 113.474 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 53.04 41.01 32.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.867 0.467 . . . . 10.0 111.51 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.0 t -76.92 154.21 33.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.282 0.563 . . . . 10.0 111.439 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -136.36 106.56 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.235 -0.893 . . . . 10.0 109.912 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.74 126.11 64.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.014 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -117.89 117.3 28.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.35 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.417 HD13 HD23 ' C' ' 241' ' ' LEU . 21.8 mm -108.52 85.32 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.241 0.543 . . . . 10.0 109.776 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.96 168.29 19.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.056 -0.818 . . . . 10.0 111.056 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -88.83 158.55 18.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.223 0.511 . . . . 10.0 110.234 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.42 162.16 24.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.271 0.557 . . . . 10.0 111.039 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.474 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 2.7 t80 -140.35 95.78 2.93 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.047 -0.979 . . . . 10.0 108.862 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -120.9 -122.91 2.96 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.957 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' B' ' 285' ' ' GLY . . . 151.34 -44.17 0.67 Allowed Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.855 -0.898 . . . . 10.0 110.855 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mtpp -82.72 35.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.804 0.812 . . . . 10.0 109.2 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 283' ' ' GLY . . . 136.23 172.0 12.47 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 109.42 -1.472 . . . . 10.0 109.42 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -112.98 62.82 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 22.1 t90 71.3 -45.87 0.63 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.103 0.877 . . . . 10.0 110.591 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . 0.498 ' OD2' ' HD3' ' C' ' 274' ' ' ARG . 37.5 t70 -101.14 151.17 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.287 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.86 101.23 12.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.418 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . 0.637 ' CD2' ' HB2' ' C' ' 288' ' ' ASP . 36.0 t60 -131.89 134.88 46.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.423 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -154.38 126.33 7.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.023 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.23 -167.44 2.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.696 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -119.23 127.1 52.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.751 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -70.8 165.77 22.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.775 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.629 -0.7 . . . . 10.0 110.289 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 261' ' ' THR . 20.3 ptt-85 . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 109.876 -0.416 . . . . 10.0 109.876 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -120.56 133.22 55.41 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.247 0.342 . . . . 10.0 110.639 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' B' ' 263' ' ' SER . 67.7 m -139.25 133.28 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.843 0.354 . . . . 10.0 110.558 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.07 144.96 51.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.623 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.462 ' HB2' ' OBK' ' B' ' 301' ' ' 3LS . 8.3 tttt -90.39 -72.72 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.68 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -123.97 121.67 35.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.995 0.426 . . . . 10.0 111.46 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.47 126.71 74.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.856 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.414 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 38.6 ttm-85 -113.62 120.69 41.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.2 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.07 86.84 2.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 10.0 110.49 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.414 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 5.6 pt-20 -117.17 172.7 7.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.631 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.574 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 48.2 mt-10 65.95 59.74 0.7 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.777 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 64.19 15.41 9.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.399 -0.818 . . . . 10.0 112.748 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.63 156.87 32.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.844 0.354 . . . . 10.0 111.462 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.495 HH22 ' CD ' ' C' ' 272' ' ' GLU . 0.2 OUTLIER -137.23 146.62 45.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.31 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.19 140.07 44.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.768 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -125.16 124.66 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 10.0 110.395 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' C' ' 277' ' ' ILE . 4.1 mm? -100.21 97.46 8.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.181 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.37 -169.77 32.76 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.534 -0.841 . . . . 10.0 112.496 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.49 158.87 15.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.735 0.302 . . . . 10.0 110.218 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.84 110.47 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.961 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.47 121.43 63.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.002 0.43 . . . . 10.0 110.968 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . 0.449 ' C ' ' H ' ' C' ' 248' ' ' ALA . 11.0 p -87.84 165.88 14.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.917 -0.583 . . . . 10.0 109.734 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.05 26.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.291 0.567 . . . . 10.0 111.975 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' C' ' 246' ' ' THR . . . -117.75 -10.22 10.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.155 0.502 . . . . 10.0 110.142 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -96.44 73.34 2.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.245 0.545 . . . . 10.0 110.701 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 14.0 mt -109.35 -16.93 13.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.043 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -86.55 76.73 9.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.307 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.75 8.19 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.461 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -116.75 164.0 12.41 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 17.1 tt -77.32 128.93 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 10.0 110.57 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -157.29 110.79 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.403 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 5.7 tt -81.99 99.35 5.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.944 0.878 . . . . 10.0 110.379 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -132.97 -176.52 4.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 10.0 110.091 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 0.2 OUTLIER -64.33 157.14 26.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.836 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.25 138.81 22.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 9.7 t -64.71 127.07 29.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.287 0.565 . . . . 10.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.07 137.18 38.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.528 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' D' ' 241' ' ' LEU . 25.8 t-20 -133.18 132.19 41.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 10.0 110.408 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' D' ' 227' ' ' SER . 17.8 m -151.49 150.2 30.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.737 0.303 . . . . 10.0 110.858 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.34 144.85 25.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 265' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 2.4 mtpt -88.2 -70.76 0.62 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.719 0.637 . . . . 10.0 112.719 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.42 128.66 51.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.478 0.547 . . . . 10.0 112.478 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.55 118.33 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.62 -0.718 . . . . 10.0 109.588 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 85.5 t -110.05 120.4 61.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.053 0.454 . . . . 10.0 110.928 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -123.48 122.94 5.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.268 -0.733 . . . . 10.0 111.268 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.516 ' HB2' ' HG2' ' D' ' 234' ' ' GLU . 27.4 mttm -138.43 141.19 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.63 0.252 . . . . 10.0 111.472 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 71.61 79.77 0.39 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.868 -0.605 . . . . 10.0 113.519 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . 0.495 ' CD ' HH22 ' C' ' 238' ' ' ARG . 36.5 mm-40 55.18 39.77 31.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.053 0.454 . . . . 10.0 111.585 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 157.65 23.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 10.0 111.296 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.62 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 1.3 mtm180 -137.7 118.56 14.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.06 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.98 126.7 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.276 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.569 ' HB2' ' CZ3' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -117.42 112.47 20.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.243 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' C' ' 241' ' ' LEU . 34.1 mm -111.32 87.72 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.14 0.495 . . . . 10.0 110.062 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 162.59 -175.61 38.99 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.964 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -95.64 145.2 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.091 0.472 . . . . 10.0 110.162 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.47 143.47 37.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -130.1 101.42 5.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.605 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -133.27 -158.1 8.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.673 -0.775 . . . . 10.0 112.509 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -150.9 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.432 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -72.05 -17.51 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 10.0 111.183 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . 0.407 ' HA2' ' HE3' ' D' ' 284' ' ' LYS . . . 168.3 -143.72 8.33 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.803 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -104.53 -160.14 0.75 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.889 -0.412 . . . . 10.0 109.889 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.62 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 9.2 t90 -49.18 -43.79 42.43 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.481 0.488 . . . . 10.0 112.281 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . 0.637 ' HB2' ' CD2' ' B' ' 290' ' ' HIS . 0.0 OUTLIER -122.76 168.89 11.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.648 -0.421 . . . . 10.0 111.122 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -120.54 38.56 3.97 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.183 0.808 . . . . 10.0 113.183 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -65.61 -51.19 61.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.075 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . 0.416 ' HB2' HH22 ' D' ' 274' ' ' ARG . 6.0 m170 -130.13 177.28 7.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 71.34 155.73 0.15 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.884 0.74 . . . . 10.0 111.423 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.1 -88.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.205 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -126.94 -176.01 3.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.709 -0.662 . . . . 10.0 110.747 -179.453 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.568 ' HD3' ' OD2' ' D' ' 258' ' ' ASP . 6.0 mpt_? . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.864 0.364 . . . . 10.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -108.95 116.48 32.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' C' ' 263' ' ' SER . 19.9 m -138.58 132.63 31.37 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.006 0.431 . . . . 10.0 111.239 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.85 142.11 48.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.73 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 23.5 tttp -88.78 -71.5 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -118.21 119.74 35.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.723 0.297 . . . . 10.0 111.41 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.47 HG21 HG21 ' D' ' 239' ' ' VAL . 57.1 mt -122.8 118.71 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.041 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -110.61 124.56 52.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.904 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.451 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.6 OUTLIER -135.93 104.89 5.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.039 0.447 . . . . 10.0 110.462 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' C' ' 270' ' ' LYS . 1.7 mt-10 -128.59 162.13 27.99 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.358 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 66.97 72.28 0.36 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.677 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . 0.543 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 4.6 mtp180 55.82 32.5 19.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.872 -0.603 . . . . 10.0 111.928 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.26 173.35 8.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.98 0.419 . . . . 10.0 111.579 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.93 152.36 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.492 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.47 HG21 HG21 ' D' ' 231' ' ' ILE . 1.8 p -143.27 135.97 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.602 . . . . 10.0 110.434 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -124.06 128.63 49.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.19 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.1 mm? -110.66 101.79 10.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.355 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . 164.31 -108.97 0.35 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 119.956 -1.116 . . . . 10.0 113.214 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -164.65 158.12 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.13 112.7 41.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.987 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 38.3 t -117.67 128.79 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 10.0 110.088 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.513 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 2.1 p -109.54 161.37 15.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.99 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.84 -2.06 6.59 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.9 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -84.19 -8.17 59.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.996 0.427 . . . . 10.0 110.263 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -112.53 102.86 10.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.952 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 2.3 mp -100.56 -159.88 0.76 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.095 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -71.0 79.45 0.65 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.267 0.556 . . . . 10.0 110.693 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -146.07 39.93 1.1 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.928 -0.869 . . . . 10.0 110.928 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.04 31.15 7.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.412 -0.675 . . . . 10.0 111.412 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 11.7 tt -74.39 -19.48 17.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.834 0.349 . . . . 10.0 111.397 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -78.39 69.51 4.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.532 0.682 . . . . 10.0 110.117 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.57 -16.73 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.085 . . . . 10.0 111.935 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 10.5 m 61.67 -127.16 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . 0.568 ' OD2' ' HD3' ' D' ' 225' ' ' ARG . 1.1 t0 -125.21 137.88 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' E' ' 257' ' ' SER . 9.6 tp60 -136.27 -72.43 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.521 -0.472 . . . . 10.0 112.128 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 8.7 t -78.69 151.39 32.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.467 0.651 . . . . 10.0 111.522 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.0 m -114.84 90.9 3.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.586 -0.734 . . . . 10.0 109.397 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 7.4 m120 -98.45 112.84 24.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.478 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -129.01 99.71 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.497 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 13.2 p -97.09 142.57 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 10.0 109.873 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 265' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 1.8 mptt -95.81 -50.45 4.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.75 0.648 . . . . 10.0 112.75 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 11.1 m -133.49 122.61 23.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.638 -0.664 . . . . 10.0 112.281 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.77 117.75 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.991 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 25.8 t -110.55 110.62 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.679 -0.237 . . . . 10.0 110.593 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -118.01 120.12 4.63 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.383 -0.437 . . . . 10.0 112.331 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -135.05 127.39 30.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.829 -0.218 . . . . 10.0 111.525 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.48 83.6 1.12 Allowed Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.174 -0.536 . . . . 10.0 113.631 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . 0.543 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 5.8 mp0 53.28 32.96 14.48 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.945 0.498 . . . . 10.0 111.799 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.7 t -75.94 147.98 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.143 0.497 . . . . 10.0 110.85 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . 0.416 HH22 ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.89 113.35 15.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.793 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.508 ' HA ' HG13 ' E' ' 239' ' ' VAL . 47.4 t -101.16 110.58 28.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.872 0.367 . . . . 10.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.87 106.59 16.93 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.483 ' HB ' HD13 ' D' ' 241' ' ' LEU . 18.1 mm -105.18 89.98 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.656 -0.498 . . . . 10.0 109.656 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . 158.7 -169.72 35.13 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.875 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -107.98 167.77 9.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.622 0.249 . . . . 10.0 110.715 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.21 140.79 52.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.548 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.06 114.05 13.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 10.0 110.079 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . 0.513 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 162.99 163.69 16.25 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.363 -0.923 . . . . 10.0 112.734 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -97.45 58.38 1.14 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.508 -0.854 . . . . 10.0 112.255 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . 0.407 ' HE3' ' HA2' ' C' ' 285' ' ' GLY . 39.2 tttm -116.72 12.74 14.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.236 0.541 . . . . 10.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.31 -50.25 4.16 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.665 -0.698 . . . . 10.0 113.077 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . 0.483 ' CE1' HG21 ' E' ' 244' ' ' VAL . 1.6 t80 -170.27 157.48 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.53 ' CE3' ' HB3' ' D' ' 288' ' ' ASP . 25.3 t90 -60.75 -62.91 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.706 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . 0.53 ' HB3' ' CE3' ' D' ' 287' ' ' TRP . 7.7 t70 -146.12 124.53 12.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.165 0.507 . . . . 10.0 110.098 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.76 172.45 12.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 10.0 109.847 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -101.33 -51.25 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 111.042 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -156.68 -173.09 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.701 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -100.3 -159.21 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.207 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -76.06 103.37 6.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.002 0.43 . . . . 10.0 110.374 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -103.81 175.08 5.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.537 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.574 -0.727 . . . . 10.0 109.57 179.786 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' E' ' 261' ' ' THR . 76.4 mtt180 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 18.6 m120 -133.02 110.99 10.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.206 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 7.0 m -118.08 145.13 45.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 10.0 111.341 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.76 125.68 25.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.673 -0.694 . . . . 10.0 109.793 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.668 ' HB2' ' O ' ' E' ' 265' ' ' LYS . 42.1 mttm -77.09 -70.14 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.53 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' E' ' 266' ' ' THR . 13.3 t70 -129.73 129.79 44.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.355 -0.384 . . . . 10.0 111.367 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 80.7 mt -123.53 126.08 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.256 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -117.09 110.65 18.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 10.0 110.269 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.441 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 1.4 p -125.14 103.77 8.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.428 -0.805 . . . . 10.0 111.186 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -132.95 154.7 50.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 10.0 111.848 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' E' ' 271' ' ' GLY . 33.7 tt0 65.45 76.1 0.34 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.469 -0.787 . . . . 10.0 111.067 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 56.59 71.04 0.59 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.221 -0.899 . . . . 10.0 110.455 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -127.49 159.7 33.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.168 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 139.04 38.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.531 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' D' ' 275' ' ' VAL . 2.7 p -132.28 124.03 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.135 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -126.16 125.34 42.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.541 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mp -119.62 100.64 7.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.395 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.99 -173.38 40.84 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.298 -0.721 . . . . 10.0 111.298 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -103.49 154.53 19.35 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.483 HG21 ' CE1' ' D' ' 286' ' ' PHE . 61.7 t -103.15 129.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.409 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.2 99.15 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 10.0 110.837 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' D' ' 282' ' ' GLY . 7.5 t -69.15 169.64 11.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.202 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.51 -21.09 62.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.822 0.344 . . . . 10.0 111.7 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -68.46 -33.09 73.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.998 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.72 -163.46 0.19 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.402 -0.817 . . . . 10.0 111.295 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.46 107.95 20.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.213 -0.449 . . . . 10.0 109.863 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -77.74 81.93 4.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.046 0.45 . . . . 10.0 110.722 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 105.24 140.98 10.5 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.839 -0.619 . . . . 10.0 112.016 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 119.55 98.47 1.77 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.75 -0.738 . . . . 10.0 111.906 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 21.3 mt -94.67 -27.56 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.266 0.555 . . . . 10.0 110.471 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.05 59.23 5.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.405 0.621 . . . . 10.0 110.148 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 6.0 pt -86.09 123.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . 0.474 ' HA ' ' NE2' ' D' ' 259' ' ' GLN . 67.0 m -152.96 166.61 31.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.672 -0.24 . . . . 10.0 110.685 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.38 117.76 9.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.851 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.49 16.29 8.23 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.35 0.5 . . . . 10.0 112.35 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -152.34 136.86 16.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.09 -0.381 . . . . 10.0 110.932 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' E' ' 225' ' ' ARG . 31.4 m -121.97 112.88 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.175 0.512 . . . . 10.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . 0.434 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 15.7 m120 -115.41 114.87 25.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.832 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.1 m -118.82 121.07 39.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 10.0 109.977 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -108.96 147.12 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 10.0 110.112 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 265' ' ' LYS . . . . . 0.668 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 82.6 mttt -85.88 -79.74 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.472 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' E' ' 230' ' ' ASP . 13.0 m -131.07 132.08 44.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.875 0.369 . . . . 10.0 111.143 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 t -121.98 106.21 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.837 -0.62 . . . . 10.0 109.967 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.53 125.89 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.663 -0.244 . . . . 10.0 110.549 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -145.47 136.67 6.6 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.545 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.89 130.37 22.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . 0.473 ' H ' ' HB3' ' E' ' 235' ' ' GLU . . . 84.17 85.93 0.89 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.555 -0.831 . . . . 10.0 111.82 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 60.55 60.82 1.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 10.0 110.85 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.68 136.06 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.701 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.63 104.25 8.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.911 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.28 120.21 58.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.853 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.98 119.94 29.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 28.1 mm -117.75 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 10.0 110.981 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.15 -176.22 34.42 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.499 -0.641 . . . . 10.0 111.499 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -91.63 139.91 30.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.877 -0.416 . . . . 10.0 109.877 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.86 159.83 15.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.333 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -169.64 99.6 0.32 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.275 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.9 -114.56 1.43 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.549 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . 0.509 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 166.64 58.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.084 -0.579 . . . . 10.0 112.313 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -137.88 -59.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.443 0.163 . . . . 10.0 110.781 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.62 13.19 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.358 -0.925 . . . . 10.0 113.824 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -152.76 114.35 4.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.161 0.481 . . . . 10.0 109.795 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 73.16 10.92 5.15 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.81 0.814 . . . . 10.0 109.302 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -145.88 -179.9 7.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.546 -1.206 . . . . 10.0 109.173 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -161.55 137.13 7.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.188 -0.301 . . . . 10.0 110.188 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . 0.509 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 7.3 p-80 -150.33 169.45 21.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.397 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -76.65 -70.76 0.43 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.303 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . 0.444 ' HB2' ' NE2' ' E' ' 290' ' ' HIS . 13.7 t60 69.46 153.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.21 0.604 . . . . 10.0 111.615 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -127.08 112.2 14.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.211 -0.449 . . . . 10.0 110.189 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -95.3 -176.25 3.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.761 -0.637 . . . . 10.0 109.807 179.57 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' 3LS . . . . . 0.775 ' SAK' ' OAA' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 110.494 -0.188 . . . . 10.0 110.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -117.34 127.16 53.78 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 263' ' ' SER . 13.4 m -149.16 159.43 44.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 10.0 111.428 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.15 162.4 35.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.004 -0.544 . . . . 10.0 109.996 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -121.37 -75.46 0.59 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.059 0.457 . . . . 10.0 111.844 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 266' ' ' THR . 29.0 t70 -113.51 117.47 31.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.866 -178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 31.8 pt -136.0 144.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.525 -0.307 . . . . 10.0 111.096 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -142.26 126.95 18.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.092 0.472 . . . . 10.0 110.93 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 21.0 p -121.79 113.28 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.271 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.47 158.65 37.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 10.0 111.4 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.49 71.76 0.55 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.427 -0.806 . . . . 10.0 111.908 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 34.9 mtm105 56.63 42.5 26.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 10.0 111.908 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -103.4 153.23 20.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.282 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -134.41 160.49 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.511 -0.313 . . . . 10.0 111.069 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 138.59 23.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -135.3 122.04 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 10.0 109.935 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.47 133.69 53.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.768 0.318 . . . . 10.0 110.253 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 140.97 -119.17 1.49 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.204 -0.522 . . . . 10.0 112.281 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -147.42 143.78 28.17 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.78 107.15 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.848 0.356 . . . . 10.0 111.362 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.93 120.2 50.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.561 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 m -85.67 151.6 23.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.837 -0.619 . . . . 10.0 109.907 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.68 -14.89 60.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -87.11 -1.88 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.002 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -119.59 52.99 1.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.265 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.416 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 2.7 mm? 65.96 -158.07 0.26 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.511 -0.768 . . . . 10.0 111.102 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.416 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 44.3 p-80 -93.09 178.91 5.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.995 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -80.62 69.03 3.26 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.483 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.63 68.33 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.238 -0.745 . . . . 10.0 111.238 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.5 mt 70.51 144.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.259 0.623 . . . . 10.0 112.477 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 63.19 60.56 1.17 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.3 -0.863 . . . . 10.0 111.153 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.73 -50.75 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.54 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.5 p -128.61 -83.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.848 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.5 t70 54.29 72.56 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.77 0.669 . . . . 10.0 110.615 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -119.18 24.24 10.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.95 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.673 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 4.4 t -139.21 140.91 37.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.35 0.595 . . . . 10.0 112.009 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -91.23 112.46 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.105 -0.952 . . . . 10.0 110.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.441 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 15.6 m-20 -115.46 113.53 23.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.469 -0.567 . . . . 10.0 109.469 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 227' ' ' SER . 37.3 m -142.95 124.76 15.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 10.0 110.957 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.8 152.57 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.774 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.48 -56.88 2.65 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.83 -0.348 . . . . 10.0 111.48 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 10.5 m -133.75 130.32 37.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.089 0.403 . . . . 10.0 112.089 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.49 124.31 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.985 -0.552 . . . . 10.0 109.919 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 14.8 t -115.92 117.42 55.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.817 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.38 119.32 4.25 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.646 -0.788 . . . . 10.0 112.105 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -134.49 123.32 23.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.925 0.393 . . . . 10.0 111.361 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.91 70.05 1.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.684 -0.769 . . . . 10.0 112.714 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 25.7 tt0 54.83 51.0 14.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.469 0.652 . . . . 10.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.88 144.7 26.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.508 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -119.03 112.68 19.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.288 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.58 115.14 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.842 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 276' ' ' LEU . 0.8 OUTLIER -111.53 111.05 21.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.845 0.355 . . . . 10.0 110.251 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.41 ' HA ' ' HB2' ' B' ' 241' ' ' LEU . 15.1 mm -101.94 98.85 7.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.822 0.344 . . . . 10.0 110.147 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.72 161.09 8.59 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.016 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.43 152.06 36.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.639 0.257 . . . . 10.0 110.361 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -175.79 2.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.027 0.441 . . . . 10.0 111.04 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -158.26 97.17 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.013 -0.994 . . . . 10.0 108.459 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -134.04 -147.8 5.7 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.253 -0.975 . . . . 10.0 114.149 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -175.31 -83.93 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.746 -0.542 . . . . 10.0 111.746 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -81.92 81.39 7.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.248 0.547 . . . . 10.0 109.573 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 120.11 108.12 2.19 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.655 -0.978 . . . . 10.0 110.655 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -74.34 83.4 1.92 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.658 0.266 . . . . 10.0 110.724 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t90 69.11 -65.34 0.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.206 -0.906 . . . . 10.0 111.191 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -154.13 91.83 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.959 0.409 . . . . 10.0 110.838 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -156.84 129.8 7.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -147.9 85.9 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -118.25 137.52 52.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.231 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -132.55 14.01 4.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.558 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -89.4 134.52 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.841 -0.6 . . . . 10.0 110.28 179.615 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.673 ' N ' ' HG1' ' A' ' 260' ' ' THR . 25.3 ttm-85 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.069 -0.345 . . . . 10.0 110.069 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.415 HD21 ' HA2' ' B' ' 278' ' ' GLY . 33.2 m-20 -116.89 123.69 47.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.002 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -109.97 90.54 3.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.823 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -94.94 163.8 13.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.165 -0.47 . . . . 10.0 109.962 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.421 ' HE3' ' OAT' ' B' ' 301' ' ' 3LS . 1.8 ttmm -125.09 -80.71 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.979 -0.288 . . . . 10.0 111.754 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -121.1 117.1 26.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.946 0.403 . . . . 10.0 111.273 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.85 123.16 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.141 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -118.28 113.49 21.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.717 0.294 . . . . 10.0 110.515 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.9 OUTLIER -116.71 113.52 22.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.711 -179.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.14 160.53 31.74 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.045 0.45 . . . . 10.0 111.813 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.63 74.35 0.4 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.19 -0.914 . . . . 10.0 112.456 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 21.4 mtm-85 55.06 39.78 31.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.2 0.524 . . . . 10.0 111.099 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -93.81 151.74 19.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.821 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 128.61 23.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.993 -0.549 . . . . 10.0 109.764 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.9 137.67 56.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.127 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -118.96 123.04 43.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 277' ' ' ILE . 4.4 mm? -96.66 87.85 4.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.412 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.441 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . 160.71 -178.63 36.63 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.587 -0.816 . . . . 10.0 112.315 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -89.81 163.33 15.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.597 0.237 . . . . 10.0 110.389 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.3 131.8 65.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.766 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.39 110.22 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.985 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 33.8 p -88.26 168.63 12.55 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.671 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.74 -5.1 14.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.512 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -82.43 -13.17 57.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.973 0.416 . . . . 10.0 110.573 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.66 3.23 48.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.778 -0.646 . . . . 10.0 110.548 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.3 tp -65.96 118.62 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.352 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 65.93 28.38 10.63 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.656 0.597 . . . . 10.0 111.355 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -106.76 -172.41 22.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.012 -0.613 . . . . 10.0 112.543 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.02 121.0 6.87 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.774 -0.53 . . . . 10.0 111.774 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 12.1 mt -104.27 -23.6 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.754 0.311 . . . . 10.0 111.699 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' C' ' 253' ' ' GLY . 14.6 tpt180 -93.22 91.59 7.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.909 0.385 . . . . 10.0 110.26 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.35 45.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.335 . . . . 10.0 111.296 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 60.14 33.51 21.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.048 -0.523 . . . . 10.0 111.394 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -63.24 131.95 50.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.383 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -156.81 76.38 0.87 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.206 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' C' ' 225' ' ' ARG . 3.7 t -151.95 161.63 42.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.063 0.459 . . . . 10.0 111.323 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -127.87 123.88 36.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.841 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.406 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 4.7 m120 -97.23 125.21 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 142.71 50.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.239 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.22 148.81 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 31.7 mttt -104.93 -77.41 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.457 -0.497 . . . . 10.0 111.973 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.17 119.07 38.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.259 0.552 . . . . 10.0 112.293 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.63 109.51 28.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.432 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 74.8 t -104.83 118.23 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.372 . . . . 10.0 110.658 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.57 133.06 8.19 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.351 -0.699 . . . . 10.0 111.351 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -145.16 122.35 11.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 10.0 111.719 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.28 78.79 1.42 Allowed Glycine 0 C--O 1.238 0.387 0 C-N-CA 120.639 -0.791 . . . . 10.0 113.347 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 55.27 36.48 27.12 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.286 0.565 . . . . 10.0 110.556 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.37 143.31 57.82 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.882 -1.053 . . . . 10.0 111.643 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -125.0 103.85 8.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.497 -0.774 . . . . 10.0 109.595 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.68 115.48 45.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.452 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 112.4 24.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 43.6 mm -101.83 81.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 10.0 110.231 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.415 ' HA2' HD21 ' B' ' 226' ' ' ASN . . . 159.18 178.88 33.59 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.007 -0.616 . . . . 10.0 112.336 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -92.93 160.85 14.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.41 172.18 8.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.961 0.41 . . . . 10.0 110.752 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 4.4 t80 -142.15 76.34 1.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.662 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -90.27 -137.75 6.99 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.677 -0.692 . . . . 10.0 113.248 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 156.42 -50.56 0.44 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.403 -0.679 . . . . 10.0 111.403 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -91.1 1.84 56.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 10.0 109.75 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -177.74 165.33 34.89 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.592 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -108.45 76.55 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.478 -0.564 . . . . 10.0 109.478 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.43 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 16.4 t90 70.41 -48.1 0.64 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.017 0.823 . . . . 10.0 111.397 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -117.62 178.24 4.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.092 -0.336 . . . . 10.0 110.092 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.91 117.55 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 10.0 110.784 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -139.66 132.46 29.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.438 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . 0.435 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 0.1 OUTLIER -157.55 118.23 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.022 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.9 -172.41 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -110.38 137.58 47.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 10.0 111.764 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . 0.411 ' CD2' ' H ' ' B' ' 294' ' ' HIS . 7.4 p80 -97.87 169.4 9.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.619 -0.718 . . . . 10.0 111.072 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 48.0 t60 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.629 -0.701 . . . . 10.0 110.416 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.577 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 29.8 ptt180 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.444 0.164 . . . . 10.0 110.678 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -126.52 127.08 44.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.463 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' C' ' 263' ' ' SER . 14.7 m -134.89 132.7 38.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 10.0 111.379 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.17 153.79 47.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.336 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -103.86 -77.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.762 -0.375 . . . . 10.0 111.635 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.1 118.36 35.8 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.254 0.549 . . . . 10.0 111.643 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.83 119.13 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.66 . . . . 10.0 109.985 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -108.03 116.99 32.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.535 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.527 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 0.6 OUTLIER -131.43 102.16 5.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.219 0.533 . . . . 10.0 110.781 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -132.91 164.2 27.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.232 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 64.72 71.15 0.47 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.439 -0.801 . . . . 10.0 111.041 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 56.39 65.31 1.45 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 121.327 0.584 . . . . 10.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -128.75 163.45 25.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.43 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -149.79 143.77 25.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.557 HG23 ' HB ' ' C' ' 275' ' ' VAL . 3.2 p -136.38 135.05 49.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.636 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -118.57 123.11 44.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.584 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.431 HD13 ' HB ' ' C' ' 277' ' ' ILE . 4.2 mm? -96.59 76.58 2.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.578 -0.737 . . . . 10.0 109.632 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' B' ' 262' ' ' ASN . . . 172.55 170.21 36.07 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.252 -0.975 . . . . 10.0 112.212 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -81.6 162.88 22.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.013 -0.366 . . . . 10.0 110.013 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.98 119.67 61.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 10.0 110.736 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 15.3 t -113.94 109.13 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 39.4 p -80.56 163.73 23.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.541 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.08 2.67 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.272 0.471 . . . . 10.0 112.272 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.54 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 10.0 110.514 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -84.61 77.3 10.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.716 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 5.0 mt -112.31 15.36 20.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.387 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -120.89 111.19 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.139 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.42 -113.45 0.3 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.766 -0.73 . . . . 10.0 111.936 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' B' ' 255' ' ' ARG . . . 128.03 -127.57 5.77 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.812 -0.709 . . . . 10.0 111.498 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.1 tt -152.56 120.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.273 0.559 . . . . 10.0 111.122 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -166.32 133.78 2.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.639 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -107.22 132.53 54.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.57 -0.286 . . . . 10.0 110.234 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.43 -169.98 1.74 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.16 141.52 22.97 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.0 0.429 . . . . 10.0 110.951 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.67 146.79 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.716 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 6.1 t -75.77 149.27 38.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.548 -0.538 . . . . 10.0 109.548 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.703 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 0.5 OUTLIER -115.83 128.43 55.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.514 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.99 129.72 44.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.786 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' C' ' 227' ' ' SER . 5.7 m -143.26 150.61 39.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.746 0.308 . . . . 10.0 111.12 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.56 144.86 27.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.267 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 265' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' D' ' 229' ' ' LYS . 23.6 ttmt -88.49 -66.32 0.93 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.424 0.528 . . . . 10.0 112.424 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 23.7 m -130.38 124.9 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.82 123.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.439 -0.8 . . . . 10.0 109.487 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 64.2 t -115.63 114.71 47.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.66 -0.246 . . . . 10.0 111.011 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.24 121.95 5.22 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.955 -0.64 . . . . 10.0 111.906 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -132.99 121.82 23.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 10.0 111.453 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.25 90.86 0.41 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.842 -0.694 . . . . 10.0 113.851 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 56.0 47.45 19.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.923 0.392 . . . . 10.0 111.372 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.25 152.61 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.146 0.498 . . . . 10.0 110.651 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.54 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 0.6 OUTLIER -137.91 117.32 12.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.138 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' C' ' 239' ' ' VAL . 17.3 t -111.73 124.38 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.892 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.503 ' HB2' ' CH2' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -119.58 112.47 19.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.763 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.431 ' HB ' HD13 ' C' ' 241' ' ' LEU . 41.0 mm -106.92 90.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.019 0.437 . . . . 10.0 109.933 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.35 -170.65 35.69 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.222 -0.751 . . . . 10.0 111.222 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.96 155.46 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.96 0.38 . . . . 10.0 110.353 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.94 140.91 51.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.968 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 25.1 t80 -129.86 112.81 13.93 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.304 -0.628 . . . . 10.0 109.304 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -165.85 163.0 36.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.357 -0.925 . . . . 10.0 112.483 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -109.61 1.89 30.66 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -86.86 36.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.102 0.477 . . . . 10.0 110.586 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.63 -83.43 1.4 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.982 -0.847 . . . . 10.0 110.982 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -164.29 -167.44 1.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.54 ' CH2' ' HB3' ' C' ' 274' ' ' ARG . 10.1 t90 -42.29 -48.83 5.06 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.861 0.726 . . . . 10.0 112.687 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . 0.494 ' OD1' ' HB2' ' C' ' 290' ' ' HIS . 0.0 OUTLIER -125.89 153.07 44.71 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.49 -0.484 . . . . 10.0 111.215 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 3.9 p30 -104.44 82.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.492 0.663 . . . . 10.0 110.787 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . 0.494 ' HB2' ' OD1' ' C' ' 288' ' ' ASP . 14.9 t-80 -112.53 -55.94 2.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.453 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . 0.445 ' HB2' ' NH2' ' D' ' 274' ' ' ARG . 0.7 OUTLIER -134.11 173.27 11.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 10.0 111.754 -178.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . 0.467 ' HB2' ' H ' ' D' ' 289' ' ' ASN . 17.1 t-80 52.36 88.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.866 -1.061 . . . . 10.0 113.155 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -94.16 178.7 5.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.298 -0.865 . . . . 10.0 109.377 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -62.24 110.08 1.52 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.987 0.422 . . . . 10.0 111.074 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 37.2 m80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.657 -0.687 . . . . 10.0 109.691 178.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.703 ' N ' ' HG1' ' C' ' 261' ' ' THR . 2.2 mpt_? . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.785 0.326 . . . . 10.0 110.438 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' D' ' 262' ' ' ASN . 2.7 m-20 -75.47 109.72 9.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.452 . . . . 10.0 110.189 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.66 146.85 52.4 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.519 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.48 143.2 51.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.164 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' D' ' 265' ' ' LYS . 44.4 tttm -90.06 -73.37 0.52 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.341 -0.391 . . . . 10.0 111.647 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -115.3 120.56 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.832 0.308 . . . . 10.0 111.832 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.54 121.13 58.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.097 -0.502 . . . . 10.0 109.819 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -116.7 114.04 23.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.662 -0.245 . . . . 10.0 110.51 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.1 p -118.42 100.85 7.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.675 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.38 148.51 42.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.09 0.472 . . . . 10.0 111.922 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 62.56 84.84 0.14 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.076 -0.965 . . . . 10.0 112.218 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . 0.484 ' HD3' ' OE2' ' D' ' 272' ' ' GLU . 40.8 mtt180 67.92 -8.81 0.51 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.739 1.014 . . . . 10.0 113.739 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -60.6 149.84 33.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.353 0.597 . . . . 10.0 112.314 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -139.25 153.98 47.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.281 -0.872 . . . . 10.0 109.687 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.09 140.17 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.645 0.26 . . . . 10.0 111.679 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.1 OUTLIER -129.5 133.54 47.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.202 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' D' ' 277' ' ' ILE . 2.5 mm? -114.43 95.62 5.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.73 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . 0.499 ' O ' ' HA3' ' D' ' 278' ' ' GLY . . . 171.39 -119.61 0.8 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.915 -0.659 . . . . 10.0 112.686 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -153.51 158.03 40.69 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.86 109.91 30.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.247 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 19.3 t -111.48 114.32 46.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 68.9 p -78.07 164.89 24.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 10.0 110.816 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.64 -4.51 34.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.034 0.445 . . . . 10.0 111.1 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.5 12.94 13.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 10.0 111.044 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -121.82 105.62 10.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.632 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.44 -162.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.556 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.51 88.27 3.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.071 0.463 . . . . 10.0 111.224 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -157.17 46.88 0.48 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.239 -0.744 . . . . 10.0 111.239 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 105.89 24.09 7.12 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.925 -0.87 . . . . 10.0 110.925 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 6.8 tt -66.95 -19.11 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 112.144 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -92.81 63.16 3.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.988 0.423 . . . . 10.0 110.388 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.01 -29.59 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.626 -0.716 . . . . 10.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 12.9 m 67.07 -168.09 0.2 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.747 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . 0.423 ' CG ' ' HD3' ' D' ' 225' ' ' ARG . 11.5 m-20 -78.4 100.84 6.97 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.943 -0.392 . . . . 10.0 109.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . 0.639 ' HA ' HE21 ' D' ' 259' ' ' GLN . 0.1 OUTLIER -82.37 -70.55 0.54 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 11.0 t -113.27 160.63 18.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.93 0.395 . . . . 10.0 110.551 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 5.8 m -106.23 96.59 6.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' E' ' 226' ' ' ASN . 6.4 t30 -96.68 121.46 38.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.83 0.347 . . . . 10.0 110.088 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.21 125.39 40.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.93 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.55 143.53 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.419 -0.586 . . . . 10.0 109.419 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 265' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 0.0 OUTLIER -97.1 -50.1 4.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -128.45 122.02 30.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.64 125.16 64.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.013 -0.54 . . . . 10.0 109.687 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.18 127.45 74.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.812 0.339 . . . . 10.0 110.913 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.17 118.4 2.67 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -130.22 121.18 25.7 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.96 0.41 . . . . 10.0 111.281 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.04 66.28 1.04 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.65 -0.786 . . . . 10.0 112.76 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . 0.484 ' OE2' ' HD3' ' D' ' 236' ' ' ARG . 8.1 tt0 56.81 56.29 5.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.417 0.627 . . . . 10.0 111.552 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 45.7 t -92.13 155.73 17.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.027 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . 0.445 ' NH2' ' HB2' ' C' ' 291' ' ' HIS . 0.0 OUTLIER -127.31 109.95 12.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.027 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.47 ' HA ' HG13 ' E' ' 239' ' ' VAL . 32.1 t -101.22 113.69 38.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.892 -0.594 . . . . 10.0 110.927 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -116.93 106.39 13.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.035 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.454 ' HB ' HD13 ' D' ' 241' ' ' LEU . 10.7 mm -102.05 71.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.063 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' D' ' 242' ' ' GLY . . . -175.12 -167.97 35.06 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.642 -0.79 . . . . 10.0 112.266 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -114.4 166.91 11.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.484 -0.191 . . . . 10.0 110.484 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.71 147.26 48.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 10.0 110.697 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -137.91 105.14 5.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.029 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 168.8 173.72 36.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.832 -1.175 . . . . 10.0 113.516 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -96.53 43.84 2.04 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.777 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -91.97 -19.33 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 10.0 109.728 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.91 -45.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.097 -0.801 . . . . 10.0 111.097 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -169.25 143.17 2.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.244 -0.478 . . . . 10.0 109.762 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -54.98 -64.94 0.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.409 0.443 . . . . 10.0 111.65 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -140.64 108.7 5.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.091 0.472 . . . . 10.0 110.668 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . 0.467 ' H ' ' HB2' ' C' ' 292' ' ' HIS . 8.7 t-20 -132.43 165.4 24.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.061 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -92.2 -64.68 1.08 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.669 0.271 . . . . 10.0 111.072 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -135.94 -170.02 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.688 -0.233 . . . . 10.0 110.419 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -105.28 -158.01 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -74.23 121.36 21.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.717 0.294 . . . . 10.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -133.98 -174.73 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.997 -0.372 . . . . 10.0 109.997 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 63.2 m80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.627 -0.701 . . . . 10.0 110.463 179.744 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' D' ' 262' ' ' ASN . 23.4 m120 -113.65 134.95 54.43 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' E' ' 263' ' ' SER . 18.2 m -143.55 137.17 28.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.763 0.316 . . . . 10.0 110.512 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.9 146.11 50.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.19 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' E' ' 265' ' ' LYS . 35.6 tttm -95.71 -69.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.482 -0.326 . . . . 10.0 111.818 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -128.5 124.89 37.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.509 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.4 120.56 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.524 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -116.41 116.25 27.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.165 0.507 . . . . 10.0 111.214 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.683 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 29.2 p -112.68 111.41 22.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.146 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -122.59 138.72 54.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.97 87.2 0.12 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.467 -0.788 . . . . 10.0 112.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 48.81 44.25 21.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.002 -0.999 . . . . 10.0 112.214 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.683 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -98.69 160.39 14.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.172 -0.467 . . . . 10.0 109.921 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . 0.407 ' CG ' ' HG3' ' E' ' 274' ' ' ARG . 0.0 OUTLIER -135.29 148.23 49.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.635 -179.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' D' ' 275' ' ' VAL . 2.5 p -138.13 120.94 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.445 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -127.03 119.43 26.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.013 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.6 109.49 17.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . 0.456 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 161.13 -172.87 37.48 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.253 -0.499 . . . . 10.0 111.914 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -98.87 139.07 35.08 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.774 0.321 . . . . 10.0 110.932 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -98.64 124.59 51.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.001 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 27.7 t -125.97 118.32 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.361 . . . . 10.0 111.058 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.462 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 14.2 t -72.06 173.66 8.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.076 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.56 70.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 10.0 111.229 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -69.11 -20.49 64.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.953 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.24 -159.98 0.26 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.137 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 66.7 mt -96.9 124.16 40.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -80.11 86.86 5.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 10.0 109.679 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 108.76 -152.24 17.01 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.899 -0.881 . . . . 10.0 110.899 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.26 80.06 0.36 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.221 -0.99 . . . . 10.0 111.871 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 52.3 mt -73.3 -29.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.119 0.485 . . . . 10.0 110.157 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.1 74.42 1.09 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.137 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . 0.418 ' HB ' ' OE1' ' D' ' 259' ' ' GLN . 9.2 pt -81.21 124.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 14.7 m -142.33 -179.81 6.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.067 0.46 . . . . 10.0 111.786 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.97 130.9 34.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.768 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -130.2 -58.62 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.1 t -69.56 139.18 53.71 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.352 0.596 . . . . 10.0 111.375 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 35.8 m -113.93 110.81 20.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.719 -0.673 . . . . 10.0 109.797 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.91 120.85 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.081 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' E' ' 227' ' ' SER . 16.3 m -136.29 131.57 34.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.47 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.43 150.75 29.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.615 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 265' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' E' ' 229' ' ' LYS . 89.9 mttt -88.06 -88.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.788 0.292 . . . . 10.0 111.788 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 10.4 m -110.93 125.5 53.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.993 0.425 . . . . 10.0 111.49 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 5.8 t -116.1 108.98 26.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.888 -0.596 . . . . 10.0 109.518 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 16.6 t -108.54 122.15 62.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.407 -0.36 . . . . 10.0 110.875 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.73 108.96 0.69 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.734 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -120.18 123.61 43.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.344 -0.243 . . . . 10.0 110.344 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.25 74.62 1.28 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.129 -0.558 . . . . 10.0 112.106 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 61.4 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.759 0.79 . . . . 10.0 110.997 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 39.0 m -139.02 141.83 38.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.21 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . 0.407 ' HG3' ' CG ' ' E' ' 238' ' ' ARG . 0.0 OUTLIER -114.98 97.76 6.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 10.0 111.154 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 43.0 t -89.27 104.16 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 10.0 109.708 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.05 114.02 23.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.608 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 34.0 mm -119.41 107.29 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.925 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 162.74 -125.67 1.44 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.528 -0.844 . . . . 10.0 112.395 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -138.24 129.15 26.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.913 0.387 . . . . 10.0 110.284 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 0.2 OUTLIER -92.43 138.45 31.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.327 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -171.7 92.99 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.978 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -132.07 -87.52 0.38 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.255 -0.974 . . . . 10.0 112.829 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . 0.454 ' HA2' ' CG ' ' E' ' 290' ' ' HIS . . . 148.18 38.23 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.261 -0.495 . . . . 10.0 112.199 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -121.77 -68.87 0.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.732 -0.275 . . . . 10.0 110.744 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.56 9.9 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.175 -1.012 . . . . 10.0 113.802 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' E' ' 287' ' ' TRP . 17.6 t80 -138.27 108.68 6.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.512 0.656 . . . . 10.0 109.595 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.42 ' HB2' ' O ' ' E' ' 286' ' ' PHE . 0.7 OUTLIER 70.59 16.59 6.89 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 108.097 -1.075 . . . . 10.0 108.097 -177.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . 0.614 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.6 OUTLIER -161.14 172.81 16.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.089 -1.414 . . . . 10.0 109.357 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -172.3 158.82 4.54 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.746 -0.206 . . . . 10.0 110.539 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . 0.454 ' CG ' ' HA2' ' E' ' 283' ' ' GLY . 0.6 OUTLIER -155.51 -177.44 6.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -92.53 -70.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.363 -0.535 . . . . 10.0 112.102 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 10.9 t60 71.12 160.42 0.22 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.69 0.619 . . . . 10.0 111.364 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -96.98 119.27 35.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.409 -0.359 . . . . 10.0 110.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -105.66 154.02 21.02 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.613 -0.708 . . . . 10.0 110.847 -179.368 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' 3LS . . . . . 0.661 ' CBI' ' SAK' ' B' ' 301' ' ' 3LS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_